[{"pmid":40626748,"journal":"Anesthesiology","title":"Diabetes Mellitus in Pregnancy: Implications for Obstetric Anesthesia.","authors":"Rogers WK; Chugaieva I; Moheet A; Wernimont SA","abstract":"Diabetes in pregnancy is a common obstetric comorbidity that increases the risks of pregnancy-specific complications. The authors describe in this review how understanding ambulatory use of insulin can impact peripartum anesthesia care. Additionally, they describe the appropriate delivery, dosing, and timing of insulin during birth as relevant for anesthesiologists. They discuss the indications and limitations of technologies such as continuous glucose monitors and insulin pumps in pregnancy, and describe their relevance and appropriate management in the perioperative and peripartum period. Finally, the authors review the unique complication of euglycemic diabetic ketoacidosis and provide appropriate management strategies, as anesthesiologists may be in a position to recognize this complication that could otherwise be overlooked.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40626748\/"},{"pmid":40626746,"journal":"Anesthesiology","title":"The Story of Enhancing Recovery after Surgery.","authors":"Kehlet H","abstract":"Multimodal approach to control postoperative pathophysiology and rehabilitation. By Kehlet H. Br J Anaesth 1997; 78:606-17 Major surgery is still associated with undesirable sequelae such as pain, cardiopulmonary, infective and thromboembolic complications, cerebral dysfunction, nausea and gastrointestinal paralysis, fatigue, and prolonged convalescence. The key pathogenic factor in postoperative morbidity, excluding failures of surgical and anesthetic technique, is the surgical stress response with subsequent increased demands on organ function. These changes in organ function are thought to be mediated by trauma-induced endocrine metabolic changes and activation of several biologic cascade systems (cytokines, complement, arachidonic acid metabolites, nitric oxide, free oxygen radicals, among others). To understand postoperative morbidity, it is therefore necessary to understand the pathophysiologic role of the various components of the surgical stress response and to determine whether modification of such responses may improve surgical outcome. While no single technique or drug regimen has been shown to eliminate postoperative morbidity and mortality, multimodal interventions may lead to a major reduction in the undesirable sequelae of surgical injury with improved recovery and reduction in postoperative morbidity and overall costs.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40626746\/"},{"pmid":40626745,"journal":"Anesthesiology","title":"Three Years On: The Impact of the Dobbs Decision on Anesthesia Practice.","authors":"Gambling DR; Vogel TM; Markley JC; Traynor AJ; Cohn JH; Morgan CL","abstract":"Many individuals seeking abortion care since the Dobbs decision present at later gestations and with comorbidities. This article discusses its impact on patients and anesthesia providers and suggests opportunities to improve health outcomes.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40626745\/"},{"pmid":40615331,"journal":"British journal of anaesthesia","title":"Population-based multistate modelling of peritraumatic opioid use among trauma patients from the Norwegian Trauma Registry.","authors":"Engel S; Rosseland LA; Smits M; Skurtveit SO; Gran JM; Nordseth T; Roise O; Jacobsen HB","abstract":"BACKGROUND: Previous studies document high rates of long-term opioid use (LTU) among trauma patients, without accounting for opioid prescription doses, frequency, and medical indications. Using detailed LTU criteria, this study aimed to construct a multistate model of peritraumatic opioid use and elucidate reasons for posttraumatic LTU. METHODS: This population-based cohort study links data from the 2015-2018 cohorts in the Norwegian Trauma Registry (n=24 224) with outpatient medication prescription records from the Norwegian Prescription Database for 1 yr before and 2 yr after injury. LTU was assigned upon receiving >\/=900 morphine milligram equivalents within 90 days and another opioid prescription 91-180 days after any initial prescription; it ended after 180 days without opioid prescriptions, emigration, or death. Prescriptions to patients with LTU in the year after injury were screened for chronic pain and palliative care reimbursement codes, and for opioid maintenance treatment preparations. RESULTS: Posttraumatic opioid prescriptions primarily increased as a result of short-term opioid use (STU), peaking at 38.2% and returning to pre-injury levels (5.4%) within 6 months. Increases in LTU were smaller (4.3% to 6.7%). Among patients with LTU in the year after injury (n=1946), 47.4% exhibited LTU and 18.3% STU in the 6 months pre-injury. Moreover, 36.0% were reimbursed for chronic pain medications, 5.9% for palliative care, and 13.1% received opioid maintenance treatment. CONCLUSIONS: In our cohort, most patients with posttraumatic long-term opioid use had used opioids before injury, underscoring the need to address such use to minimise posttraumatic long-term opioid use. Few patients with long-term opioid use received palliative care or opioid maintenance treatment, indicating subacute and chronic pain as primary indications. As long-term opioid use for pain is highly controversial, findings emphasise a need for effective nonopioid alternatives.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40615331\/"},{"pmid":40571477,"journal":"British journal of anaesthesia","title":"Frailty and perioperative outcomes: SNAP-3 as a call to action.","authors":"McIsaac DI; Amado L","abstract":"Generalisable, prospectively collected data from 7800 older UK surgical patients in the 3(rd) Sprint National Anesthesia Project (SNAP-3) confirm that the presence of frailty is a key risk factor for adverse outcomes among older surgical patients. What comes next? Anaesthetists should strive to identify all patients with a Clinical Frailty Scale score >\/=4 as being at elevated risk. Researchers, in collaboration with patients, clinicians and health system leaders, should move from a scientific focus on frailty as a risk factor to developing and evaluating interventions to improve outcomes for the growing population of surgical patients with frailty.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40571477\/"},{"pmid":40562634,"journal":"British journal of anaesthesia","title":"Frailty in the perioperative setting: lessons from SNAP-3.","authors":"Howell SJ; Dhesi JK","abstract":"The third Sprint National Anaesthesia Project (SNAP-3) is the largest prospective, multicentre UK study to examine the impact of frailty, multimorbidity, and delirium on postoperative outcomes in patients aged >\/=60 yr. Conducted across 214 National Health Service (NHS) hospitals, SNAP-3 enrolled 7134 surgical patients over 5 days in March 2022. The investigators identified frailty in one-fifth of patients using multiple tools, including the Clinical Frailty Scale (CFS). Frailty was especially prevalent in emergency surgery and socioeconomically deprived populations. Multimorbidity was present in two-thirds of patients but only partially overlapped with frailty. Frailty was strongly associated with increased length of stay, delirium, complications, and mortality, with adverse outcomes escalating with higher CFS scores. In contrast, multimorbidity (without frailty) had limited association with most adverse outcomes. Directed acyclic graphs guided causal analysis, but by assuming frailty and multimorbidity were independent, the investigators might have underestimated the impact of multimorbidity. SNAP-3 highlights the need for routine perioperative frailty screening, comprehensive perioperative services, and workforce development. The data inform service planning and support prioritisation of frailty-focused care, especially in high-burden specialties and deprived areas.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40562634\/"},{"pmid":40541484,"journal":"British journal of anaesthesia","title":"Sustainability assessment of perioperative patient warming devices: a comparative life cycle assessment and costing.","authors":"Rebello TA; Spoyalo K; Chhipi-Shrestha G; Hewage K; Sadiq R; MacNeill AJ","abstract":"BACKGROUND: Perioperative patient warming is an integral component of quality surgical care, subject to highly variable clinical practices. We evaluated the environmental and economic impacts of currently available patient warming methods. METHODS: We conducted a comparative life cycle assessment (LCA) and life cycle costing (LCC) of three active warming devices (forced air warmer, resistive blanket, and circulating water garment) using a functional unit of 1 h of active patient warming. Passive warming was investigated using a singular LCA and LCC of warmed flannel blankets, with the functional unit defined as the use of one warmed flannel blanket. These results were applied to eight clinical scenarios modelling different combinations of warming devices within perioperative settings. We used multicriteria decision analysis to aggregate environmental and financial impacts into sustainability indexes. RESULTS: The resistive blanket had the lowest environmental and economic impacts. The global warming potential and cumulative energy demand of the resistive blanket were <7% and 25%, respectively, of the impacts assessed for the forced air warmer. The most sustainable patient warming pathway used the resistive blanket throughout the perioperative period. Clinical scenarios using flannel blankets before and after surgery entailed the highest environmental impacts, and the highest cost was incurred with the circulating water garment. CONCLUSIONS: The environmental and economic sustainability of perioperative patient warming can be optimised by minimising flannel blankets and disposable consumables in the perioperative period and by using the resistive blanket for active warming. This study presents a novel multicriteria sustainability index and simulates clinically relevant scenarios to inform practical, evidence-based recommendations for sustainable patient warming.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40541484\/"},{"pmid":40533323,"journal":"British journal of anaesthesia","title":"Cortical integration and control of spontaneous neuropathic pain-like behaviour in mice.","authors":"Li Z; Huang X; Ma J; Liu Q; Chen L; Liu X; Qin Q; Yang H; Han R; Li K; Hu R; Yan X; Huang Y; Huang D; Zhou H","abstract":"BACKGROUND: Spontaneous pain is commonly reported in patients with nerve injuries, posing a great challenge to physicians. However, the mechanisms underlying spontaneous pain remain largely unknown in comparison to evoked pain (e.g. allodynia and hyperalgesia). Cortical processing is vital in coding nociception, and dysfunction of anterior cingulate cortex might facilitate pain hypersensitivity. This indicates a distinct pattern of ensemble activity during spontaneous pain-like behaviour. METHODS: Combining in vivo calcium imaging and ex vivo electrophysiological recording, we explored the maladaptive changes of cortical neurones at individual and population levels induced by several models of neuropathic pain in mice. We also examined the role of the anterior cingulate cortex in the regulation of spontaneous pain-like behaviour using optogenetic methods. RESULTS: We identified a common status of cortical hyperactivity in pyramidal neurones and neural ensembles recorded in the anterior cingulate cortex. Optogenetic inhibition of the anterior cingulate cortex inhibited spontaneous pain-like behaviour, while optogenetic activation restored it. In addition, the cortical representation of spontaneous behaviour was inhibited by nerve injury, which conversely was restored with pain relief. In freely moving animals, we further demonstrated a stable mode of cortical integration in response to spontaneous grooming episodes, independent of the presence of pain, with a dynamic reconfiguration mechanism. CONCLUSIONS: Our data reveal an essential role of the anterior cingulate cortex in the processing and modulation of non-evoked reflex in distinct preclinical models of neuropathic pain in mice.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40533323\/"},{"pmid":40526440,"journal":"Anesthesiology","title":"Pediatric Regional Anesthesia: A Practical Guideline for Daily Clinical Practice.","authors":"Marhofer P; Zadrazil M; Opfermann PL","abstract":"The past two decades have seen remarkable progress in pediatric regional anesthesia. Significant efforts have been made to develop central and peripheral techniques that are both practicable and reliable, with increasing success and very low complication rates driving a growing appreciation for this subspecialty. Regional anesthesia can be used to optimize perioperative pain control, to avoid mechanical ventilation, and to take advantage of favorable immunomodulatory and gastrointestinal side effects in children. Implementing a broad spectrum of these techniques will require specialized knowledge of anatomic structures, experience to select appropriate techniques for specific surgical procedures, and considerable hand skills to execute these techniques. This review has been written to summarize state-of-the-art information about all relevant aspects of pediatric regional anesthesia and to provide a practical approach to how regional anesthesia in children can be implemented in daily clinical practice.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40526440\/"},{"pmid":40514282,"journal":"British journal of anaesthesia","title":"Non-anaemic iron deficiency in surgical patients: more than just a laboratory finding?","authors":"Munoz M; Shander A","abstract":"The prevalence of non-anaemic iron deficiency among the surgical population is high. However, evidence regarding its impact on surgical patients' outcomes is scant and conflicting. Therefore, further investigations using an appropriate definition of non-anaemic iron deficiency and measuring relevant postoperative outcomes are needed to verify previous studies to determine whether non-anaemic iron deficiency is more than just a laboratory finding.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40514282\/"},{"pmid":40500601,"journal":"British journal of anaesthesia","title":"Association between preoperative anaemia, transfusion, and outcomes in children undergoing noncardiac surgery.","authors":"McCormack G; Faraoni D; DiNardo JA; Goobie SM","abstract":"BACKGROUND: We aimed to evaluate the incidence of preoperative anaemia and transfusion over the last 11 yr and the association between anaemia, transfusion, and postoperative outcomes in children undergoing noncardiac surgery. METHODS: We identified children 1-18 yr of age who had a preoperative haematocrit recorded between 2012 and 2023 in the American College of Surgeons National Surgical Quality Improvement Program paediatric databases. Patients were included in four groups: patients without anaemia who did not receive a transfusion, patients without anaemia who did receive a transfusion, patients with anaemia who did not receive a transfusion, and patients with anaemia who did receive a transfusion. The outcomes were 30-day mortality and postoperative complications. RESULTS: The incidence of preoperative anaemia was 25.7% (n=110 341), and the overall transfusion rate was 10.4% (n=44 808). Between 2012 and 2023, the incidences of preoperative anaemia and transfusion remained stable. The incidence of 30-day mortality increased significantly between children without anaemia who did not receive a transfusion (0.08%), without anaemia who did receive a transfusion (0.30%), with anaemia who did not receive a transfusion (0.27%), or with anaemia who did receive a transfusion (1.11%). The highest incidence of complications was found in children with anaemia exposed to perioperative transfusion. CONCLUSIONS: The incidence of preoperative anaemia and transfusion in children have remained stable in the last 11 yr. Anaemia, transfusion, and the combination of both increased 30-day mortality and the incidence of postoperative complications.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40500601\/"},{"pmid":40493406,"journal":"Anesthesiology","title":"Continuing Anesthesia Services in the Face of a Prolonged Digital Health System Outage.","authors":"Cheon EC; Shaffer S; McCarthy K; Leavitt O; Mukerji S; Hardy C","abstract":"In today's digitized healthcare environment, electronic health records (EHRs) and other electronic systems are key to daily hospital operations, patient care, and compliance. The authors' institution underwent a prolonged EHR system outage that caused the Department of Pediatric Anesthesiology to rely on established downtime procedures. While the intraoperative EHR is lost, this is only one of many domains that can be affected by an outage. In fact, all aspects of care, from patient identification materials to operating room schedules to in-house communication, can be significantly affected. Anesthesia providers must be ready to revert to preestablished downtime protocols to continue safe care while also maintaining financial sustainability. The following narrative review details the department's operational responses and outlines how safe and quality health care continued to be delivered, providing recommendations for other hospitals that may face similar challenges.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40493406\/"},{"pmid":40483184,"journal":"British journal of anaesthesia","title":"Predictive role of central nervous system-driven symptoms in the development of chronic primary pain.","authors":"Trouvin AP; Bailly F","abstract":"A recent study by Kelleher and colleagues highlights a significant association between central nervous system-driven symptoms and subsequent development of chronic primary pain. Utilising data from the UK Biobank, the study suggests that symptoms such as sleep disturbances, mood disorders, and cognitive impairments precede the onset of chronic primary pain, presenting a potential window for early intervention. This research enhances our understanding of nociplastic pain mechanisms, emphasising the need for preventive strategies for individuals at risk.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40483184\/"},{"pmid":40483183,"journal":"British journal of anaesthesia","title":"Regional anaesthesia modalities for primary total hip arthroplasty: a systematic review and component network meta-analysis.","authors":"Lee KH; Wang JC; Chang CY; Teng WN; Wang HY; Lee CC; Tsai SW; Chen CF; Wu PK; Chen WM","abstract":"BACKGROUND: Regional nerve blocks potentially offer superior pain control for patients undergoing primary total hip arthroplasty. However, the optimal single-shot regional anaesthesia modality remains unclear. METHODS: PubMed, Embase, Cochrane, and Web of Science databases were searched from inception to May 5, 2024. Randomised controlled trials comparing various single-shot regional anaesthesia modalities were included. Frequentist and component network meta-analyses were performed. The primary outcomes included static and dynamic pain (visual analogue scale [VAS]) at 6 and 12 h after operation and total morphine consumption at 24 h. Additional outcomes included opioid-related adverse effects, patient satisfaction, quality of recovery, and postoperative lower limb muscle power. RESULTS: Eighty-seven randomised controlled trials were included. In static VAS, femoral nerve block ranked best (surface under the cumulative ranking curve (SUCRA)=92.8%), followed by lumbar plexus block (LPB) plus local infiltrative analgesia (LIA) (SUCRA=85.7%) at 6 h after operation. At 12 h after operation, LPB plus LIA was top ranked (SUCRA=89.2%), followed by quadratus lumborum block plus fascia iliaca compartment block (FICB) (SUCRA=84.8%). In dynamic VAS, pericapsular nerve group (PENG) block plus LIA (SUCRA=86.3%) and LPB plus LIA (SUCRA=83.4%) ranked best at 6 and 12 h after operation, respectively. In total morphine consumption at 24 h after operation, quadratus lumborum block plus FICB ranked highest (SUCRA=85.5%), followed by LPB plus LIA (SUCRA=82.2%) and PENG plus LIA (SUCRA=76.5%). LPB, FICB, and femoral nerve block were associated with increased motor blockade affecting quadriceps or adductor muscles based on qualitative analysis. CONCLUSIONS: Combined regional anaesthesia modalities, particularly PENG plus LIA, are favourable options for primary total hip arthroplasty procedures, as they result in lower pain scores, reduced opioid consumption, and motor-sparing effects in the early postoperative period. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42024544358).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40483183\/"},{"pmid":40483182,"journal":"British journal of anaesthesia","title":"Direct inhibition of cystathionine-beta-synthase by isoflurane contributes to delayed neurocognitive recovery after isoflurane general anaesthesia in mice.","authors":"Xu F; Zhang P; Liu H; Wang R; Fan Z; Gao Y; Lu Z; Cong P; Chen H; Wang J; Dong H; Xiong L; Zhao G","abstract":"BACKGROUND: Perioperative neurocognitive disorders (PND) are severe complications of surgery and other invasive procedures. However, the underlying mechanisms by which general anaesthetics contribute to PND remain largely unknown. Based on our findings of a link between hyperhomocysteinaemia and increased risk of PND, we investigated functional alterations in cystathionine-beta-synthase (CBS) and its role in memory function after general anaesthesia. METHODS: Mice were subjected to isoflurane 1.4 vol% anaesthesia for 2 h, and the levels of homocysteine, homocysteine-associated enzyme expression, and CBS activity were measured using ELISA. The time course of memory reconstruction after general anaesthesia was evaluated using the contextual fear conditioning test. WaterLOGSY was used to examine the interaction between isoflurane and CBS. A hydrogen sulfide (H(2)S) probe, AZ-NO(2), was used for H(2)S bioimaging, and RNA sequencing, sulfhydrome detection, and in vivo electrophysiological recordings were performed to explore the underlying mechanisms. RESULTS: The decline in cognitive function persisted for at least 8 h after isoflurane anaesthesia, which is attributed to the selective homocysteine accumulation in the brain via direct inhibition of CBS activity by isoflurane. Activation of CBS alleviates the reduction of H(2)S and alters the sulfhydration of synaptic-related proteins, ultimately accelerating the restoration of neuronal firing rates in the hippocampus (saline, 1.42 [0.49] vs NaHS, 2.45 [0.68] Hz). Pretreatment with S-adenosylmethionine (SAM, CBS activator) could increase the freezing time of mice after isoflurane anaesthesia (control 4.86 [3.30]% vs SAM, 9.89 [3.03]%). CONCLUSIONS: Isoflurane contributes to delayed cognitive recovery after isoflurane anaesthesia in mice by directly inhibiting CBS activity, providing novel insights into the involvement of isoflurane in PNDs and their underlying mechanisms.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40483182\/"},{"pmid":40480916,"journal":"British journal of anaesthesia","title":"Patterns of prevention effectiveness in postoperative neurocognitive disorder and delayed neurocognitive recovery research: a systematic review with meta-regression of randomised trials.","authors":"Lahiri NK; Vuckovic N; Sidhu AS; Li J; Sun Y; Naiken S; Curtis SJ; Bisch E; Bolda R; Nagra PS; Mann G; Gonzales AE; Smith L; Anderson BP; Liu Z; Adams DC; Meng L","abstract":"BACKGROUND: Postoperative neurocognitive disorder and delayed neurocognitive recovery (pNCD\/dNCR) are common yet unresolved complications after surgery. METHODS: We conducted a systematic literature search in resources of Ovid MEDLINE, EMBASE, Web of Science, and ClinicalTrials.gov and multivariable meta-regression analyses of RCTs to identify trial-level characteristics associated with prevention effectiveness in pNCD\/dNCR research. Trials investigating pNCD\/dNCR prevention in adult surgical patients were eligible. Trials performed in paediatric patients or assessing cognitive changes on the same day of surgery were excluded. Effectiveness associated with trial-level characteristics was assessed using ratio of odds ratio (OR) and 95% confidence interval (CI). RESULTS: We analysed 187 eligible trials. Trials originating from the USA\/Canada (ratio of OR, 3.04; 95% CI, 1.62-5.73; P=0.001), Europe\/Australia\/New Zealand (1.58; 1.04-2.40; P=0.033), and other regions (2.0; 1.19-3.36; P=0.009) were associated with reduced effectiveness compared with trials from China. Higher pNCD\/dNCR incidence in control groups was associated with greater effectiveness (0.98; 0.97-0.99; P<0.001). Trials involving volatile anaesthetics (2.12; 1.16-3.86; P=0.014) were associated with reduced effectiveness compared with dexmedetomidine and abdominal surgery, respectively. Registered trials exhibited enhanced effectiveness (0.69; 0.50-0.95; P=0.022), whereas those with power analyses reported reduced effectiveness (1.43; 1.06-1.94; P=0.021). Trials with a high risk of bias in the selection of the reported result were associated with reduced effectiveness (2.99; 1.04-8.59; P=0.041). Dexmedetomidine was the most studied intervention, showing potential benefits, though evidence certainty was very low. CONCLUSIONS: Trial-level characteristics were significantly associated with prevention effectiveness in pNCD\/dNCR research. Identifying and addressing the underlying causes of regional differences might enhance the quality and consistency of future trials on a global level. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42024543584).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40480916\/"},{"pmid":40480914,"journal":"British journal of anaesthesia","title":"Development of insulin and its pharmacology and perioperative use: a narrative review.","authors":"Dhatariya K; Levy NA; Stubbs D; Frank C; Tinsley SL; Knaggs RD","abstract":"Diabetes mellitus is characterised by an elevated blood glucose concentration. Over the last two decades, a plethora of new agents have emerged to help treat the condition, of which several classes of agent have been shown to reduce the risk of cardiovascular morbidity and mortality. In addition, there have been several developments in the pharmacology of insulin, improving the pharmacokinetics and pharmacodynamics of insulin analogues to better mimic physiological insulin concentrations in the liver, skeletal muscle, and other tissues. Furthermore, the technologies used to deliver insulin and measure glucose have improved; for example, in the UK, hybrid closed loop systems are now the standard of care for people with type 1 diabetes mellitus. This review focuses on insulin and insulin delivery. We consider the history of insulin development and the pharmacology of newer insulin analogues. We also describe the novel technologies available and the considerations that need to be made by anaesthetists, surgeons, and other members of the perioperative team when looking after someone with diabetes mellitus on these insulins, or using these devices, to ensure safe care and the avoidance of complications.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40480914\/"},{"pmid":40480912,"journal":"British journal of anaesthesia","title":"Chemical ablation of pericapsular nerve group with 95% ethanol for pain relief and quality of life in patients with hip osteoarthritis: a prospective, double-blinded, randomised, controlled trial.","authors":"Reysner M; Reysner T; Kowalski G; Mularski A; Daroszewski P; Wieczorowska-Tobis K","abstract":"BACKGROUND: Chronic hip pain from osteoarthritis greatly diminishes quality of life, and standard treatments often fail to provide sufficient relief. Ultrasound-guided pericapsular nerve group (PENG) neurolysis using ethanol is a minimally invasive technique that may provide extended analgesia. This study evaluated the efficacy and safety of ultrasound-guided 95% ethanol neurolysis of the PENG compared with a sham procedure in patients with chronic hip pain. METHODS: This double-blinded, single-centre, RCT included 100 patients (median age: 82 yr [IQR 74-89]; 49% male) with chronic hip pain unresponsive to conservative treatments. Participants were assigned to either ethanol neurolysis (n=50) or a sham procedure (n=50). The primary outcome was pain intensity (numeric rating scale [NRS]) assessed at 7 days, 30 days, 3 months, and 6 months. Secondary outcomes included opioid consumption (oral morphine equivalents), quality of life (EQ-5D-5L), and neurological deficits. RESULTS: Ethanol neurolysis significantly reduced NRS scores at all follow-ups (P<0.0001). The mean NRS scores decreased from baseline 6.0 (sd 0.9) to 3.1 (0.8) at 7 days, 2.9 (0.7) at 30 days, 2.8 (0.7) at 3 months, and 3.0 (0.7) at 6 months. Opioid consumption was lower in the neurolysis group at 7 days (median [IQR]: 1.5 [0.5-3.5] mg vs 11.5 [9.1-13.7] mg, P=0.002) and remained reduced through 6 months. Quality of life improved significantly (P<0.0001), and no neurological deficits were observed. CONCLUSIONS: Ultrasound-guided ethanol neurolysis of the PENG is a safe and effective intervention for chronic hip pain, providing long-term relief and reducing opioid dependency. Further multicentre trials are needed to validate long-term outcomes. CLINICAL TRIAL REGISTRATION: NCT06087588.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40480912\/"},{"pmid":40480911,"journal":"British journal of anaesthesia","title":"Characteristics and outcome of preoperative multidisciplinary team discussions for high-risk noncardiac surgical patients in the Netherlands: a multicentre prospective observational study.","authors":"Vernooij JEM; Hobrink E; Boerlage RM; van Beest P; van de Calseijde S; Holl T; Janssen LMJ; Klinkert L; Marsman M; Nouwen MJ; Wefers Bettink MA; Preckel B; Kalkman CJ; van Leeuwen B; Festen S; Koning NJ","abstract":"BACKGROUND: Guidelines recommend preoperative multidisciplinary team (MDT) discussions for high-risk noncardiac surgical patients, but there is a lack of guidance and underlying evidence. The present study aims to describe the characteristics of MDT meetings and their effect on 30-day patient outcomes. METHODS: A prospective, multicentre, observational study was conducted in nine hospitals in the Netherlands. From each hospital, 25 consecutive adult high-risk noncardiac surgical patients discussed in a preoperative MDT meeting were included. Data were collected between April 2022 and September 2023, including patient and MDT characteristics, clinical information, and patient outcomes up to 30 days after surgery. RESULTS: The present study included 225 patients, with a median age of 73 yr (interquartile range 64-79 yr). Patients were selected for an MDT discussion because of doubt regarding the harm-benefit ratio of the proposed surgery (n=168; 75%) or as part of a standardised surgical pathway (n=57; 25%). Clinical management was modified after MDT discussions for 183 (81%) patients, including 71 patients (32%) who underwent nonsurgical management after MDT discussion. Within 30 days after surgery, 75 patients (49%) experienced adverse events, compared with 16 patients (23%) after nonsurgical management. The 30-day mortality rate was 3% after surgery and 11% after nonsurgical management. CONCLUSIONS: Preoperative MDT discussions lead to management modifications for high-risk noncardiac surgical patients. Almost one-third of the discussed patients did not undergo surgery. The rate of postoperative adverse events was high in this selected population. Further research is needed to evaluate the effectiveness of MDT decisions on the quality of life and disability experienced by these patients. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov NCT05703230 (registered on Mar 22, 2022).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40480911\/"},{"pmid":40461346,"journal":"British journal of anaesthesia","title":"Efficacy and safety of adamgammadex for reversing rocuronium-induced deep neuromuscular block: a multicentre, randomised, double-blind, positive-controlled phase III trial.","authors":"Zhao Y; Ren Y; Xie W; Wang Y; Lei Y; Zhu Y; Zhang X; Wu X; Guo X; Jiang Y; Wang S; Lei Q; You J; Yu Y; Zhou Y; Zhou W; Xu G; Li C; Gu Z; Luo F; Wang H; Chen J; Wang R; Qi Y; Jie Q; Su D; Gu X; Yu W","abstract":"BACKGROUND: Adamgammadex, a newly developed modified gamma-cyclodextrin derivative, has demonstrated efficacy in reversing deep rocuronium-induced neuromuscular block in early clinical trials. METHODS: This multicentre, randomised, double-blind, positive-controlled, noninferiority phase III clinical trial aimed to investigate the efficacy and safety of adamagammadex compared with sugammadex in reversing deep rocuronium-induced neuromuscular block. In total, 321 patients were randomly assigned to either the adamgammadex 8 mg kg(-1) group or the sugammadex 4 mg kg(-1) group. The primary outcome was the success rate of antagonism, defined as recovery of the train-of-four ratio (TOFR) to 0.9 within 10 min. Standard safety data were collected throughout the trial period. RESULTS: For the primary efficacy outcome, the success rate for recovery of TOFR to 0.9 was 98.7% in the adamgammadex group and 100% in the sugammadex group, with an observed difference of -1.3% (95% confidence interval [CI] -4.6%, 1.2%). The lower limit of -4.6% was higher than the noninferiority margin of -10%. For the key secondary efficacy outcomes, the median (interquartile range) time from administration of adamgammadex or sugammadex to recovery of TOFR to 0.9 was 2.5 (2.0, 3.2) min and 2.2 (1.7, 2.7) min, respectively. The difference was 0.5 min (95% CI 0.3, 0.7), and the upper limit of 0.7 min was lower than the noninferiority margin of 5 min. We observed no inferiority in secondary efficacy outcomes. There was no significant difference in the safety profile between adamgammadex and sugammadex. CONCLUSIONS: Adamgammadex was noninferior to sugammadex in reversing deep neuromuscular block from rocuronium. CLINICAL TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR2200056471, registered February 6, 2022; https:\/\/www.chictr.org.cn\/showproj.html?proj=141077).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40461346\/"},{"pmid":40441987,"journal":"British journal of anaesthesia","title":"Association between plasma growth differentiation factor-15 and postoperative nausea and vomiting incidence and severity: a secondary analysis of a randomised trial.","authors":"Mai Y; Zhang S; Huang Q; Liang C; Shi J; Zheng J; Lv K; Liu H; Yang X; Zhao Y","abstract":"BACKGROUND: Postoperative nausea and vomiting (PONV) distresses patients and hinders recovery. Identifying biomarkers can optimise prophylactic strategies. This study investigated whether plasma growth differentiation factor-15 (GDF-15) concentrations were associated with PONV in at-risk adult patients undergoing laparoscopic gastrointestinal surgery. METHODS: Patients (n = 896) from a previous randomised controlled trial were included. Blood samples were collected before surgery in the pre-anaesthesia room and at the end of surgery. Plasma GDF-15 concentrations were measured using the Human GDF-15 ELISA Kit. The primary outcome was PONV, defined as nausea, retching, or vomiting, within 120 h after surgery. RESULTS: A total of 860 (96.0%) of patients were female. During 0-120 h after surgery, 531 (59.3%) patients experienced PONV. Unadjusted logistic models showed negative associations between preoperative and postoperative GDF-15 concentrations and PONV, but this association was not significant for postoperative concentrations after adjustment for confounders including preoperative concentrations. Compared with the first tertile of preoperative GDF-15 concentrations, the second tertile had an adjusted odds ratio (aOR) of 0.63 (95% confidence interval [CI] 0.44-0.91; P=0.013), and the third tertile had an aOR of 0.44 (95% CI 0.30-0.64; P<0.001) for PONV. Restricted cubic splines showed that PONV odds decreased rapidly until the preoperative GDF-15 concentrations were 830.36 pg ml(-1) and then plateaued (P for overall <0.001, P for non-linearity=0.002). Compared with a low-maintaining trajectory, a high-increasing trajectory had an aOR of 0.64 (95% CI 0.46-0.89; P=0.008) for PONV. CONCLUSIONS: Lower preoperative plasma GDF-15 concentrations or low-maintaining trajectory were associated with higher odds of PONV in laparoscopic gastrointestinal surgery patients.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40441987\/"},{"pmid":40410097,"journal":"British journal of anaesthesia","title":"Sex-specific genetics underlie increased chronic pain risk in women: genome-wide association studies from the UK Biobank.","authors":"Parisien M; Fillingim M; Tanguay-Sabourin C; Roy M; Vachon-Presseau E; Diatchenko L","abstract":"BACKGROUND: Chronic pain disproportionately affects women, but the reasons for this disparity are unclear. METHODS: We investigated this disparity from a genetic perspective using data from the UK Biobank, focusing on multisite chronic pain, which is highly heritable and manifests a sex bias. RESULTS: Genome-wide association studies (GWAS) revealed that women have approximately 4500 sex-specific causal loci for overlapping pains, four times more than men, accounting for their higher heritability. Heritability partitioning indicated that pain-related loci are primarily enriched in specific brain regions, but only in women. Additionally, 200 imaging-derived brain phenotypes were significantly associated with pain in women, compared with only six in men. GWAS of these brain phenotypes showed stronger genetic correlations with pain in women, particularly regarding cortical thickness and striatal volume. When disentangling pleiotropy from causation in genetically correlated pairs of brain- and pain-related traits, we found that the genetics of brain phenotypes are more often causally implicated with the presence of chronic pain in women. CONCLUSIONS: Our findings suggest that genetics play a crucial role in the increased risk of chronic pain observed in women.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40410097\/"},{"pmid":40404500,"journal":"British journal of anaesthesia","title":"Association of non-anaemic iron deficiency with postoperative outcomes after fast-track hip and knee arthroplasty: a prospective cohort study.","authors":"Jorgensen CC; Lindberg-Larsen M; Gromov K; Varnum C; Bider MJ; Overgaard S; Andersen MR; Hansen TB; Kehlet H","abstract":"BACKGROUND: Preoperative iron deficiency anaemia is a common risk factor for worse postoperative outcomes. However, the influence of preoperative iron deficiency without anaemia on postoperative outcomes after hip and knee arthroplasty is uncertain. METHODS: We used the Fast-track Center for Hip and Knee Replacement Database registry from eight Danish departments for this prospective cohort study. Anaemia and iron deficiency were defined as haemoglobin of <130 g L(-1) and transferrin saturation <20%, respectively. Patient characteristics were collected using patient-reported questionnaires and information on prescribed medication, laboratory results and follow-up using electronic healthcare records. Quantile regression was used to analyse changes in median days alive and at home at postoperative day 30 (DAH(30)) and day 90 (DAH(90)), adjusting for procedure, hospital, and comorbidity. Additional endpoints included length of hospital stay >2 days, 30-day readmission rate, and self-evaluated health (EuroQol Visual Analogue Scale [EQ-VAS]) at 90 days. RESULTS: The cohort included 964 iron deficient and 3919 iron replete participants undergoing primary unilateral hip or knee arthroplasty. Median DAH(30) was 29.0 (interquartile range 29.0-30.0) days in both groups, but differently distributed (P<0.001). Adjusted difference in median DAH was -0.00 (95% confidence interval -0.00 to -0.00; P=0.001) and -0.00 (95% confidence interval -0.00 to -0.00; P=0.006) days for DAH(30) and DAH(90), respectively. There was no association between iron deficiency and any of the other endpoints. CONCLUSIONS: The influence of iron deficiency on days alive and at home at 30 and 90 days after fast-track hip or knee arthroplasty was statistically significant, but of minimal clinical importance. Correction of preoperative iron deficiency without anaemia is unlikely to improve common postoperative outcomes in these procedures. CLINICAL TRIAL REGISTRATION: NCT05613439.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40404500\/"},{"pmid":40404497,"journal":"British journal of anaesthesia","title":"Neurone-satellite glial cell interactions in dorsal root ganglia drive peripheral sensitisation in a mouse burn pain model.","authors":"Zhang R; Zhang N; Chen D; Hu X; Zhang M; Yao M; Zhang Q; Wu S; Zhang X; He Y; Gao F; Xu B; Fang Q","abstract":"BACKGROUND: Accumulating evidence suggests that glial mechanisms are pivotal in regulating chronic pain. Our previous findings revealed that the interactions between spinal microglia and astrocytes are crucial for burn-induced pain hypersensitivity. However, the mechanisms underlying burn-induced peripheral sensitisation remain incompletely understood. METHODS: Sensory neurone-satellite glial cell (SGC) interactions within peripheral dorsal root ganglia were investigated using in vitro and in vivo experiments. Behavioural tests were conducted to evaluate the therapeutic potential of targeting peripheral sensitisation mechanisms for burn pain management. RESULTS: Burn injury upregulated calcitonin gene-related peptide (CGRP) expression in sensory neurones (1.5-fold; P=0.013) through transient receptor potential vanilloid 1 (TRPV1) channels. Pharmacological blockade of the TRPV1\/CGRP signalling pathway effectively attenuated burn-induced mechanical allodynia and thermal hyperalgesia. Additionally, neurone-derived CGRP triggered SGC activation (from 6.8% pre-injury to 41.6% at day 5 post-injury), concomitant with enhanced gap junction-mediated SGC coupling (from 16.7% pre-injury to 40.5% at day 5 post-injury). Furthermore, chemokine expression (particularly CXCL1) in SGCs was elevated after burn injury, which potentiated sensory neurone excitability and exacerbated pain hypersensitivity. Blocking SGC coupling exerted potent analgesic effects in this burn pain model. CONCLUSIONS: A novel neurone-SGC interaction mechanism drives burn-induced peripheral sensitisation, providing translational implications for burn pain therapeutics.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40404497\/"},{"pmid":40384317,"journal":"European journal of anaesthesiology","title":"Long-term and pre-operative benzodiazepine use in older adults and risk for postoperative delirium: An additional analysis of the multicentre Biomarker Development for Postoperative Cognitive Impairment in the Elderly Study.","authors":"Starks SCE; Pohrt A; Halzl-Yurek F; Heinrich M; Muller A; Spies CD; Winterer G; Zacharias N","abstract":"BACKGROUND: Postoperative delirium (POD) is a common acute neurocognitive disorder characterised by sudden changes in mental status, including altered alertness, consciousness and cognition, and usually occurs in elderly patients. There is an urgent need to identify predictors of POD to prevent its onset, as it can significantly delay recovery from surgery. Benzodiazepines are among the most frequently prescribed medications, particularly for female individuals. They have a depressant effect on the central nervous system and are used to treat sleep disorders, anxiety, muscle relaxation and epilepsy. However, benzodiazepines may increase the risk of POD. OBJECTIVE: We sought to investigate whether long-term benzodiazepine use, premedication and the interaction of benzodiazepines with sex are associated with the occurrence of POD and postoperative neurocognitive ability. DESIGN: A part analysis of the prospective multicentre BioCog cohort study. SETTING: Two-centre study conducted at Charite - Universitatsmedizin Berlin (Germany) and University Hospital Utrecht (Netherlands), both primary care hospitals, between October 2014 and September 2019. PATIENTS: Data from 928 patients from the BioCog cohort study who underwent elective surgery were analysed. Of these, 42.3% were women, 18.6% reported long-term benzodiazepine use and 12.4% received premedication with benzodiazepines. MAIN OUTCOME MEASURES: We studied the association of benzodiazepine use on cognition and the development of POD. We found that the timing of benzodiazepine use was crucial. RESULTS: Long-term benzodiazepine use was significantly associated with the risk of developing POD, independent of sex ( P  < 0.001). In contrast, premedication with benzodiazepines immediately before surgery was not associated with the risk of POD ( P  = 0.242). males and females developed POD at similar rates. Regardless of sex, long-term benzodiazepine use elevated the risk of POD, unlike premedication with benzodiazepines. CONCLUSION: Long-term use of benzodiazepines is associated with the development of POD, but short-term use as a premedicant is not. However, as this is an observational study, further research is needed to confirm these findings in a controlled setting. TRIAL REGISTRATION: The study was registered at clinicaltrials.gov (NCT02265263).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40384317\/"},{"pmid":40371564,"journal":"European journal of anaesthesiology","title":"Effects of an opioid-free care pathway vs. opioid-based standard care on postoperative pain and postoperative quality of recovery after laparoscopic bariatric surgery: A multicentre randomised controlled trial.","authors":"Olausson A; Jildenstal P; Andrell P; Angelini E; Stenberg E; Wallenius V; Ohrstrom H; Thorn SE; Wolf A","abstract":"BACKGROUND: Opioid-free anaesthesia (OFA) may enhance postoperative recovery after bariatric surgery, but its combined effect with opioid-free interventions has not been studied. OBJECTIVES: To compare postoperative pain and recovery after laparoscopic bariatric surgery with a total opioid-free care pathway and conventional opioid-based treatment. DESIGN: A multicentre nonblinded controlled trial. SETTING: Two university hospitals in Sweden. PATIENTS: Adult patients scheduled for laparoscopic bariatric surgery were enrolled between May 2019 and November 2023. Of 837 patients screened, 112 were randomised, and 110 were included in the analysis: 55 in the intervention and 55 in the control group. INTERVENTIONS: Patients were randomised to an opioid-based standard care (control group) or to an opioid-free care pathway (intervention group), including intraoperative OFA and postoperative first-line transcutaneous electrical nerve stimulation (TENS) treatment. MAIN OUTCOME MEASURES: The primary outcome was the change in patient-reported postoperative pain intensity on a numerical rating scale (NRS) from arrival in the postanaesthesia care unit (PACU) until discharge to the surgical ward. Key secondary outcomes were postoperative pain intensity, in-hospital opioid consumption, and postoperative quality of recovery scale (PQRS) scores. RESULTS: There was no difference between the groups regarding the changes in pain intensity from arrival in PACU until discharge to the ward, with mean +\/- SD changes in NRS of 3.20 +\/- 3.01 (intervention) vs. 3.15 +\/- 2.25 (control); mean difference (MD) 0.04 [(95% confidence interval (CI), -1.00 to 1.08); P  = 0.97], and pain intensity at 24 h ( P  = 0.078), 72 h ( P  = 0.060), and 3 months ( P  = 0.30) postoperatively. The intervention group had a significantly lower opioid consumption in the PACU; mean morphine equivalents 6.08 +\/- 12.31 vs. 51.1 +\/- 14.9 mg; MD -45.0 (95% CI, -50.1 to -39.8) mg; P  < 0.0001; and during the hospital stay MD -40.3 (95% CI, -54.4 to -25.9) mg; P  < 0.0001. Total PQRS scores did not differ significantly over the 3-month follow-up. CONCLUSION: The opioid-free care pathway offers patients pain relief and recovery outcomes comparable to conventional opioid-based care and reduces opioid use after laparoscopic bariatric surgery. TRIAL REGISTRATION: ClinicalTrials.gov NCT03756961.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40371564\/"},{"pmid":40355106,"journal":"Anesthesiology","title":"Pharmacokinetics and Pharmacodynamics of Remimazolam for Procedural Sedation in Children and Adolescents.","authors":"Colin PJ; Bichajian LH; Curt VR; Koomen JV; Stohr T; Struys MMRF; Mason KP","abstract":"BACKGROUND: Remimazolam is not approved for use in pediatric patients. The pharmacokinetics of remimazolam have been reported to be similar to those of adult patients after scaling for body size. This article reports on the pharmacokinetics and pharmacodynamics of pediatric patients aged 6 to 18 yr and a subsequent model-based optimization of the used dosing regimen. METHODS: Thirty-one patients were included in the trial and stratified across four treatment arms: bolus administration, infusion, bolus plus fentanyl, or infusion plus fentanyl. The University of Michigan (Ann Arbor, Michigan) Sedation Scale (UMSS) was used to assess the depth of sedation. Blood samples were drawn to measure the concentrations of remimazolam and its metabolite CNS7054. Population pharmacokinetic pharmacodynamic modeling was performed in NONMEM (GloboMax LLC, USA). RESULTS: A population pharmacokinetic model was developed for remimazolam and CNS7054. The elimination clearance of remimazolam was 0.70 l . min -1 . 70 kg -1 . A proportional odds model combined with a simplified Minto model described the observed UMSS well. The EC50 of remimazolam for a UMSS score of 3 or greater was 777 ng . ml -1 in the absence of fentanyl, and decreased to 655, 533, and 287 ng\/ml for concomitant fentanyl steady state concentrations of 1, 2, or 4 ng . ml -1 , respectively. Simulations confirmed that the studied dosing regimen resulted in 9.2 to 22.0% of patients not reaching a UMSS score of 3 or greater at the end of the induction. Model-based optimization resulted in higher per-kilogram dosages and the removal of the maximum allowable dose. Simulations indicated that the percentage of patients achieving a UMSS score of 3 or greater can be expected to be high (88 to 97%). CONCLUSIONS: This study has shown that the pharmacokinetics of remimazolam are likely different between children 6 yr or older and adults (after correcting for size). In addition, the exposure-response relationship shows that to effectively use remimazolam for procedural sedation in children 6 yr or older, the dosing regimen should be modified to allow for higher remimazolam exposures.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40355106\/"},{"pmid":40351134,"journal":"Anaesthesia","title":"Impact of tracheal extubation location after surgical procedures on peri-operative times: a prospective dual-centre observational study.","authors":"Godet T; Wajew C; Fabrizi M; Monet C; Pouzeratte Y; Lapeyre M; Adelou S; Pereira B; Garnier M; Chanques G; Jabaudon M; Futier E; Jaber S; De Jong A","abstract":"INTRODUCTION: Extubation of the trachea in the operating theatre may increase the time spent there. Conversely, tracheal extubation in the post-anaesthesia care unit may prolong the duration of anaesthesia and increase the incidence of complications. Our primary objective was to quantify the additional occupancy time associated with tracheal extubation in the operating theatre compared with the post-anaesthesia care unit. Secondary objectives were to assess the incidence of complications after tracheal extubation, including the need for ventilatory support. METHODS: This was a prospective dual-centre observational cohort study of patients whose tracheas were intubated for surgery in the operating theatre of two university hospitals. The primary endpoint was operating theatre occupancy time between the end of surgical procedure and discharge from the operating theatre. RESULTS: In total, 756 patients were included, and 494 (65.3%) tracheal extubations occurred in the operating theatre. Room occupancy time was increased by 7 min (95%CI 5-8 min, p = 0.001) when tracheal extubation was performed in the operating theatre compared with the post-anaesthesia care unit. After adjustment by matched or weighted propensity score, this time increased to 8 min (95%CI 6-10 min, p = 0.001) and 8 min (95%CI 6-9 min, p = 0.001), respectively. Desaturation after tracheal extubation (20.9% vs. 36.3%, p < 0.001) and arterial hypotension (0.6% vs. 3.1%, p = 0.019) were less frequent when tracheal extubation took place in the operating theatre. DISCUSSION: Tracheal extubation in the operating theatre is associated with an increase in theatre occupancy of < 8 min and a lower incidence of postoperative respiratory and cardiovascular complications.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40351134\/"},{"pmid":40333028,"journal":"Anesthesiology","title":"General Anesthesia-activated Neurons in the Central Amygdala Mediate Antinociception: Distinct Roles in Acute versus Chronic Phases of Nerve Injury.","authors":"Zhao J; Furutani K; McGinnis A; Mathew JP; Wang F; Ji RR","abstract":"BACKGROUND: General anesthesia, such as isoflurane, induces analgesia (loss of pain) and loss of consciousness through mechanisms that are not fully understood. A distinct population of gamma-aminobutyric acid-mediated neurons has been recently identified in the central amygdala (CeA) that can be activated by general anesthesia (CeA GA ) and exert antinociceptive functions. In this study, the authors aimed to explore the underlying cellular mechanisms of CeA GA neurons across different phases of nerve injury-induced nociceptive sensitization in mice. METHODS: This study used 107 mice, including 57 males and 50 females. The authors induced c-fos activation in the mice brains using 1.2% isoflurane and validated Fos expression via RNAscope (Advanced Cell Diagnostics, USA) in situ hybridization. Unlike previous studies using the capturing activated neuronal ensembles method, CeA GA neurons (tdTomato + ) were labeled using the Fos-Targeted Recombination in Active Populations (TRAP2) method. The authors then performed ex vivo electrophysiologic recordings to assess the properties of both Fos-positive\/CeA GA neurons and Fos-negative CeA neurons. Using chemogenetic strategy to selectively activate the CeA GA neurons, the authors investigated pain-like behaviors and associated comorbidities in mice after spared nerve injury (SNI). RESULTS: Isoflurane induced robust Fos expression in CeA gamma-aminobutyric acid-mediated neurons. Electrophysiologic recordings in brain slices revealed that compared to Fos-negative CeA neurons, CeA GA neurons had higher excitability and exhibited distinct patterns of action potentials. Chemogenetic activation of Fos-TRAPed CeA GA neurons increased nociceptive thresholds in naive mice and in mice 2 weeks after SNI, but demonstrated modest antinociception 8 weeks after SNI. Finally, Fos-negative CeA neurons, but not CeA GA neurons, exhibited increased excitability in the chronic phase of SNI, which was correlated with a downregulation of K + -Cl - cotransporter-2 (KCC2) in the CeA (sham vs . SNI 8 weeks). CONCLUSIONS: These results validate the antinociceptive power of CeA GA neurons using a different approach. Additionally, the authors highlight distinct roles of CeA GA neurons in governing physiologic pain, acute pain, and the transition to chronic pain through KCC2 dysregulation.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40333028\/"},{"pmid":40327558,"journal":"Anesthesia and analgesia","title":"A Randomized Controlled Trial of Sugammadex versus Neostigmine for Reversal of Rocuronium on Gastric Emptying in Adults Undergoing Elective Colorectal Surgery.","authors":"Togioka BM; Rakshe SK; Ye S; Tekkali P; Tsikitis VL; Fang SH; Herzig DO; Lu KC; Aziz MF","abstract":"BACKGROUND: Gastrointestinal function is mediated by the cholinergic pathway, which is impacted by neostigmine and glycopyrrolate, but not sugammadex. We hypothesized that sugammadex is associated with earlier gastric emptying in adults undergoing colorectal surgery, compared to neostigmine-glycopyrrolate. METHODS: Patients were enrolled in a pragmatic, single-center, patient and assessor-blinded, randomized, controlled trial. At skin closure, subjects were randomized to sugammadex 2 mg\/kg or neostigmine 0.07 mg\/kg and glycopyrrolate (0.2 mg per 1 mg of neostigmine). The primary end point, gastric emptying, was assessed with the paracetamol absorption test, with greater area under the curve representing faster gastric emptying. Secondary end points included time to first bowel movement, time to achieve adequate reversal (train-of-four ratio >\/=0.9), gastrointestinal complications, hospital length of stay, and postanesthesia care unit recovery time. The analysis was intention-to-treat. RESULTS: All 60 patients randomized to sugammadex received the allocated intervention. Of 60 patients randomized to neostigmine-glycopyrrolate, 56 received neostigmine-glycopyrrolate, 2 received sugammadex, and 2 received both agents. Gastric emptying did not differ significantly between sugammadex (mean [standard deviation SD] area under the curve AUC 1118 [122]) and neostigmine (AUC 1130 [117], P = .58). Sugammadex treatment was associated with shorter time to first bowel movement (44.3 hours [33.8] vs 61.0 hours [43.0]; difference = 16.7 hours, 95% confidence interval CI, [2.3-31.1], P = .02) and time to adequate reversal (5.2 minutes [6.3] vs 17.5 minutes [10.1]; difference = 12.3 minutes, 95% CI, [9.2-15.4], P < .001). Neostigmine-glycopyrrolate treatment was not associated with a significant increase in gastrointestinal complications (32% vs 17%; OR = 2.3, 95% CI, [0.9-6.2], P = .09), a longer hospital length of stay (7.8 days [19.8] vs 4.8 days [4.9]; difference = 3 days, 95% CI, [ - 2.2 to 8.3], P = .27), or a difference in postanesthesia care unit recovery time (108 minutes [56.4] vs 115 minutes [50.3]; difference= -6.9 minutes, 95% CI, [ - 26.4 to 12.6], P = .48). Adverse events were similar between groups. CONCLUSIONS: Sugammadex treatment was not associated with faster gastric emptying (primary end point). Regarding prespecified secondary end points, sugammadex treatment was associated with a 12.3-minute shorter time to adequate reversal in real-life practice conditions, but it did not benefit the proportion of subjects with a gastrointestinal complication, hospital length of stay, or postanesthesia care unit recovery time. Further studies are needed to confirm our finding that sugammadex is associated with a clinically significant 16.7-hour shorter time to first bowel movement, and to establish the role of sugammadex in colorectal surgery enhanced recovery protocols.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40327558\/"},{"pmid":40324166,"journal":"Anesthesiology","title":"Sugammadex for Reversal of Neuromuscular Blockade in Neonates and Infants Less than 2 Years Old: Results from a Phase IV Randomized Clinical Trial.","authors":"Mensah-Osman E; Mukai Y; Wang A; Matuszczak M; Saldien V; Leibensperger H; Speek M; Locco A; Wrishko R; Gee A; Herring WJ","abstract":"BACKGROUND: Sugammadex is well tolerated and effective for reversing neuromuscular blockade (NMB) in adults and children as young as 2 yr old. There is little information on its use in younger children. The aim of this study was to evaluate the efficacy and tolerability of sugammadex in children under 2 yr of age. METHODS: This was a phase IV, randomized, parallel-group, multicenter clinical trial of sugammadex in participants aged birth to less than 2 yr (NCT03909165). Part A was open label and included pharmacokinetic assessments to determine whether sugammadex dose adjustment for part B was necessary based on age. Part B was double-blind and evaluated doses of 2 and 4 mg\/kg sugammadex. Participants were randomized to (1) moderate NMB and reversal with 2 mg\/kg sugammadex; (2) moderate NMB and reversal with neostigmine + glycopyrrolate or atropine (hereafter, called neostigmine); or (3) deep NMB and reversal with 4 mg\/kg sugammadex. The primary efficacy endpoint was time to neuromuscular recovery (TTNMR). The primary efficacy hypothesis was that 2 mg\/kg sugammadex would be superior to neostigmine for the reversal of moderate NMB as measured by TTNMR in part B. RESULTS: A total of 138 participants aged 1 to 720 days were treated in parts A and B (2 mg\/kg sugammadex, n = 44; 4 mg\/kg sugammadex, n = 63; and neostigmine, n = 31). Based on pharmacokinetic assessments in part A, no dose adjustments for age were needed. In part B, TTNMR for reversal of moderate NMB was faster with 2 mg\/kg sugammadex than neostigmine (median of 1.4 min vs. 4.4 min; hazard ratio, 2.40; 95% CI, 1.37 to 4.18; P = 0.0002). A 4-mg\/kg dose of sugammadex achieved rapid TTNMR for reversal of deep NMB with a median of 1.1 min (parts A and B). The percentage of participants with one or more adverse events (parts A and B) was similar for sugammadex and neostigmine. No deaths, drug-related serious adverse events, or hypersensitivity or anaphylaxis events were reported. CONCLUSIONS: In children less than 2 yr old, 2 mg\/kg sugammadex reversed moderate NMB faster than neostigmine, and 4 mg\/kg sugammadex rapidly reversed deep NMB. Sugammadex doses of 2 and 4 mg\/kg were well tolerated.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40324166\/"},{"pmid":40321015,"journal":"Anaesthesia","title":"Impact of honey on post-tonsillectomy pain in children (BEE PAIN FREE Trial): a multicentre, double-blind, randomised controlled trial.","authors":"Sommerfield D; Sommerfield A; Evans D; Hauser N; Vijayasekaran S; Bumbak P; Herbert H; Locher C; Lim LY; Khan RN; von Ungern-Sternberg BS","abstract":"INTRODUCTION: Tonsillectomy, a common childhood surgery, is associated with difficult postoperative recovery. Previous reviews provided low-grade evidence that honey may improve recovery. The BEE PAIN FREE study investigated whether honey alongside multimodal analgesia improved the recovery trajectory in children following tonsillectomy. METHODS: A prospective randomised controlled trial was conducted across three centres in Western Australia. Children undergoing extracapsular tonsillectomy by coblation were allocated randomly to one of four postoperative treatment groups: standard treatment alone; Marri honey (from Western Australia); Manuka honey (from Western Australia); or placebo. The intervention groups took 5 ml of honey or placebo, six times a day, for at least 7 days, in addition to usual discharge analgesia (standard treatment). Data for daily pain scores, Parents' Postoperative Pain Measure scores, medications and unplanned re-presentations were collected. RESULTS: A total of 400 children were recruited; 20% were lost to follow-up or withdrew. The mean number of honey doses taken varied between 2 and 3 doses per day over 7 days. Treatment with honey at this frequency did not impact postoperative pain scores significantly, with all groups showing similar trajectories. These findings did not alter with as-treated analysis or using imputed models for missing data. Most children experienced significant pain until around postoperative day 8. Children allocated to the honey and placebo groups showed some improved oral tolerance around day 6 but had increased vomiting during earlier days. There were no clinically significant differences in medical re-presentations, simple analgesia or oxycodone usage between groups. DISCUSSION: Two to three doses daily of oral honey\/placebo in children post-extracapsular tonsillectomy for 7 days, in addition to regular paracetamol, ibuprofen and as required oxycodone did not result in a clinical improvement in pain or recovery over a 14-day follow-up period.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40321015\/"},{"pmid":40260456,"journal":"European journal of anaesthesiology","title":"Context-specific clinical applicability of the end-expiratory occlusion test to predict fluid responsiveness in mechanically ventilated patients: A systematic review and meta-analysis.","authors":"Mulder MP; Potters JW; van Loon LM; Rumindo K; Hallback M; Maksuti E; Donker DW; Diez C","abstract":"BACKGROUND: The emergence of context-specific clinical evidence from the end-expiratory occlusion test (EEOT) may change the perception of its operative performance to predict fluid responsiveness. OBJECTIVES: Assessment of predictive performance of the EEOT in the intensive care unit (ICU) and operating room. DESIGN: Systematic review of observational diagnostic test accuracy studies with meta-analysis. DATA SOURCES: MEDLINE, Embase and Scopus were used as data sources for relevant publications until February 2024. ELIGIBILITY CRITERIA: Prospective clinical studies in which the EEOT was used to predict fluid responsiveness in mechanically ventilated adults, regardless of the clinical care context. The operative performance characteristics must also have been reported. RESULTS: Twenty-four studies involving 1073 adult patients (588 receiving intensive care and 485 in the operating room) were systematically reviewed, and 22 studies comprising 1049 volume expansions were meta-analysed. The pooled sensitivity [95% confidence interval (CI)] of the EEOT was 0.87 (0.81 to 0.92), and the pooled specificity was 0.90 (0.85 to 0.94); the median [interquartile range] cardiac index ( CI ) threshold for a positive test was a 5.0 [3.3 to 5.3] increase. The clinical context, the method used for haemodynamic monitoring, the ratio of the averaging time of the monitoring method to the occlusion time, the levels of positive end-expiratory pressure and the choice of cardiac output marker were identified as significant sources of heterogeneity. However, the occlusion duration and tidal volume did not significantly affect its performance. A novel insight is that performance was notably lower in the operating room setting. The likelihood ratios were 14 (positive) and 0.12 (negative) for the ICU, both better than 3.1 and 0.21 for the operating room. The overall quality of the evidence was assessed to be very low, mainly due to high heterogeneity and risk of bias; however, no publication bias was detected. CONCLUSION: The EEOT for predicting fluid responsiveness in critical care performs acceptably well overall and is a confirmative test. In the operating room and\/or with specific technical settings, its performance and clinical utility are reduced, driving the need for more context-specific and patient-specific fluid responsiveness assessments.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40260456\/"},{"pmid":40258137,"journal":"Anesthesiology","title":"Breath Analysis of Propofol and Associated Metabolic Signatures: A Pilot Study Using Secondary Electrospray Ionization-High-resolution Mass Spectrometry.","authors":"Zeng J; Stankovic N; Singh KD; Steiner R; Frey U; Erb T; Sinues P","abstract":"BACKGROUND: Propofol is a widely used anesthetic for total IV anesthesia. Although it is generally safe, rare but serious complications can occur in vulnerable groups, such as critically ill patients and children. Clinicians often rely on surrogate measures ( e.g. , predicted effect-site concentrations or Bispectral Index), yet more direct indicators of anesthetic exposure and metabolic stress would be valuable. The authors hypothesized that pharmacometabolomics via breath analysis could yield real-time insights into propofol concentrations as well as accompanying metabolic responses to surgery. METHODS: In this pilot study, 10 pediatric patients (median age, 5.9 yr; interquartile range, 4.3 to 6.6) undergoing propofol anesthesia contributed 47 breath samples (10 preinduction, 37 postinduction) and 37 blood samples. All samples were analyzed by high-resolution mass spectrometry. Linear mixed-effects models examined associations between exhaled compounds and serum propofol concentrations while accounting for repeated measures in individual patients. Volcano plots were used to identify differential changes in metabolites after propofol induction. RESULTS: Propofol, its metabolites, and endogenous metabolites were readily detected in exhaled breath, demonstrating strong correlations with serum propofol concentrations (partial R (2) >\/= 0.65; adjusted P < 0.001). Differential analysis showed significant upregulation of endogenous fatty aldehydes (log 2 [postinduction\/preinduction] >\/= 1; adjusted P <\/= 0.05), suggestive of lipid peroxidation and oxidative stress. Exogenous compounds, including benzene and phenols, were also observed, reflecting propofol metabolism in vivo . CONCLUSIONS: This pilot study highlights a robust breath-serum relationship for propofol and reveals surgery-associated shifts in metabolic pathways, including evidence of oxidative stress. These findings underscore the feasibility of exhaled-breath pharmacometabolomics for individualized anesthetic care. Further validation in larger cohorts is warranted to confirm clinical utility and to determine whether real-time breath analysis could ultimately serve as a useful adjunct for guiding anesthetic management and monitoring perioperative metabolic responses.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40258137\/"},{"pmid":40251137,"journal":"Anesthesia and analgesia","title":"Association Between Neuromuscular Blockade and Its Reversal With Postoperative Delirium in Older Patients: A Hospital Registry Study.","authors":"Ahrens E; Wachtendorf LJ; Shay D; Tenge T; Paschold BS; Rudolph MI; Redaelli S; Kaiser L; Suleiman A; Ma H; Fassbender PJ; Schaefer MS","abstract":"BACKGROUND: Nondepolarizing neuromuscular blocking agents (ND-NMBAs) are dose-dependently associated with residual paralysis, delayed recovery, and prolonged hospitalization, factors that can predispose patients to postoperative delirium. We hypothesized that neuromuscular blockade is associated with a higher risk of delirium after surgery, and that this can be mitigated by administration of reversal agents. METHODS: In total, 53,772 adult hospitalized patients aged >\/=60 years who underwent general anesthesia for noncardiac, nonneurosurgical, nontransplant procedures between 2008 and 2024 at a tertiary health care network in Massachusetts, were included. The exposure was the intraoperative administration of ND-NMBAs. The primary outcome was 7-day delirium, identified from nursing and physician charts using a keyword-based search strategy paired with manual chart review, Confusion Assessment Method assessments, and International Classification of Diseases (9th\/10th Revision, Clinical Modification) diagnostic codes. RESULTS: In total, 43,723 (81.3%) patients received neuromuscular blockade. Approximately 2259 (4.2%) patients developed delirium, 1884 (4.3%) with, and 375 (3.7%) without ND-NMBA administration. In adjusted analyses, administration of ND-NMBAs was dose-dependently associated with a higher risk of postoperative delirium (adjusted odds ratio [OR adj ] 1.15; 95% confidence interval [CI], 1.01-1.31; P = .038 and 1.09; 95% CI, 1.06-1.12; P < .001 per each unit increase in the effective dose required to achieve a 95% twitch reduction). 38,143 (87.2%) patients who received ND-NMBAs also received a reversal agent, which was associated with a lower risk of impaired neuromuscular recovery (preextubation train-of-four ratio <95; OR adj 0.60; 95% CI, 0.49-0.74; P < .001) and delirium (OR adj 0.73; 95% CI, 0.64-0.83; P < .001), compared to no reversal. The adverse effect of ND-NMBAs on delirium risk was eliminated by reversal agent administration (OR adj 1.07; 95% CI, 0.94-1.23; P = .30 with and OR adj 1.52; 95% CI, 1.28-1.79; P < .001 without reversal agent administration). There was no association between administration of neostigmine, compared to sugammadex, with postoperative delirium (OR adj 0.91; 95% CI, 0.73-1.12; P = .36). CONCLUSIONS: Neuromuscular blockade during general anesthesia is dose-dependently associated with a higher risk of postoperative delirium. The administration of reversal agents mitigates this risk and might help reduce the occurrence of delirium after surgery.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40251137\/"},{"pmid":40237779,"journal":"Anesthesiology","title":"Obstetric Anesthesia Workforce Survey: Forty-year Update.","authors":"Bucklin BA; Hawkins JL; Asdigian NL; Kennerley V; Pattee J; Traynor AJ","abstract":"BACKGROUND: For 40 yr, Obstetric Anesthesia Workforce Surveys have been used every decade to assess trends in obstetric anesthesia practice and potential areas for improvement. Anesthesia providers from U.S. hospitals were surveyed in 2022 to 2023 to provide data for their hospitals from 2021. The primary hypothesis was that obstetric anesthesia services have changed in the last decade. METHODS: Previous workforce surveys were used to develop the 32-question survey about contemporary obstetric anesthesia practice. A hospital sample (n = 1,180) was generated based on number of births per year and U.S. census region. Using web-push survey methodology, a QR code was assigned to the \"Chief of Anesthesiology\" at each hospital. A link to an online Research Electron Data Capture survey was emailed to individuals along with reminder communications. Nonresponding hospitals received paper surveys and self-addressed stamped envelopes for survey return. The results were analyzed using R statistical package at a significance level of P < 0.05. RESULTS: There were 284 (24%) responses to the survey. Hospitals providing obstetric care have decreased 50% over four decades. Of all the respondents, 77% work in nonacademic hospitals without residency programs. Comparing academic to nonacademic hospitals, academic providers are less likely to have other clinical responsibilities: 35% versus 62%, respectively. The weighted overall rate of neuraxial labor analgesia is 84%. Elective cesarean deliveries are usually performed with spinal anesthesia (85%). Neuraxial anesthesia is used in 86% of urgent cesareans, while 14% use general anesthesia. CONCLUSIONS: Despite stable annual birth rates in the United States, the number of hospitals providing obstetric care decreased by 50% over the last 40 yr. This study describes nonacademic practice and not just academic teaching hospitals. Increased access to neuraxial labor analgesia is a dramatic step toward reducing in-hospital maternal mortality and improving healthcare disparities.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40237779\/"},{"pmid":40237771,"journal":"Anesthesiology","title":"Development and External Validation of a Novel In-hospital Mortality Model after Pediatric Congenital Heart Surgery: A Multicenter Retrospective Cohort Study.","authors":"Tong C; Li Q; Du X; Shan M; Zhang Y; Wu H; Shen Z; Xu Z; Ge X; Cai S; Fu X; Zhang K; Zhang H; Li S; Miao C; Zheng J","abstract":"BACKGROUND: The applicability of four major traditional in-hospital mortality models in the Chinese setting is unclear due to disease spectrum and population heterogeneity. This study aimed to test the performance of these models in the Chinese setting and to construct and externally validate a novel model. METHODS: A total of 21,855 consecutive pediatric patients who underwent congenital heart surgery from January 2015 to December 2021 in Shanghai Children's Medical Center were enrolled. For external validation, the study additionally pooled 5,221 consecutive pediatric patients who underwent this surgical treatment from January 2020 to December 2021 in Beijing Fuwai Hospital. The performance of the Aristotle Basis Complexity (ABC) score, Risk Adjustment for Congenital Heart Surgery (RACHS)-1 categories, Society of Thoracic Surgeons-European Association for Cardiothoracic Surgery (STAT) score, and STAT categories was tested. Independent predictors were used to develop a model. The area under the receiver operating characteristic curves (AUROCs) and Brier score were used to examine the model performance. RESULTS: The AUROCs were 0.778 for ABC score, 0.685 for RACHS-1 categories, 0.808 for STAT score, and 0.784 for STAT categories. When preoperative covariates were added to the four models, the AUROCs improved: ABC score (AUROC = 0.860), RACHS-1 categories (AUROC = 0.844), STAT score (AUROC = 0.856), and STAT categories (AUROC = 0.864). The best-performing model incorporated six variables, including age, height, oxygen support, previous cardiac operation, emergency surgery, and STAT categories. The AUROCs and Brier score were 0.864 and 0.00977 in the development cohort and 0.860 and 0.00654 in the external validation cohort. CONCLUSIONS: The four major traditional models were only moderately effective in predicting in-hospital mortality after congenital heart surgery in the Chinese setting. The novel model founded on the STAT categories in combination with preoperative covariates can serve as a useful and effective tool for predicting the risk of in-hospital mortality after congenital heart surgery in the Chinese setting.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40237771\/"},{"pmid":40235368,"journal":"Anaesthesia","title":"Pulmonary complications after intrathecal morphine administration: a systematic review and meta-analysis with meta-regression and trial sequential analysis.","authors":"El-Boghdadly K; Renard Y; Rossel JB; Moka E; Volk T; Rawal N; Jaques C; Szyszko M; Albrecht E","abstract":"INTRODUCTION: Intrathecal morphine provides effective postoperative analgesia, but there are concerns about potential pulmonary complications influencing peri-operative management. We aimed to determine whether there is an association between intrathecal morphine administration and pulmonary complications after non-obstetric surgery. We also aimed to determine whether there was a dose-dependent effect on pulmonary complications. METHODS: We searched the literature systematically for randomised controlled trials comparing intrathecal morphine vs. control in patients undergoing any type of non-obstetric surgery under general or spinal anaesthesia. Primary outcomes were rates of postoperative sedation, respiratory depression and hypoxaemia. We performed a meta-analysis and meta-regression for each of our outcomes of interest and conducted trial sequential analysis to assess whether the required information size was achieved. RESULTS: We included 127 trials (7388 patients). Rates of sedation and hypoxaemia were not increased significantly in patients receiving intrathecal morphine (odds ratio 1.00, 95%CI 0.78-1.28, p = 0.98, moderate quality evidence; and 1.22, 95%CI 0.84-1.79, p = 0.30, moderate quality evidence, respectively). There were more episodes of respiratory depression in patients receiving intrathecal morphine than control (odds ratio 1.78, 95%CI 1.19-2.67, p = 0.005, very low-quality evidence), which was no longer significant when morphine doses > 500 mug were not included (odds ratio1.49, 95%CI 0.99-2.23, p = 0.06). Meta-regression revealed associations between dose and rate of sedation, respiratory depression and hypoxaemia, but when doses of > 500 mug were not included, these associations did not persist. Trial sequential analyses suggest that further data may still be required for all outcomes, but statistical significance was reached for respiratory depression. DISCUSSION: There is moderate evidence that intrathecal morphine does not increase rates of sedation or hypoxaemia after non-obstetric surgery. There is very low-quality evidence that intrathecal morphine might increase the rate of respiratory depression.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40235368\/"},{"pmid":40230320,"journal":"Anaesthesia","title":"Outcomes in patients with chronic heart failure undergoing non-cardiac surgery: a secondary analysis of the METREPAIR international cohort study.","authors":"Kirkopoulos A; M'Pembele R; Roth S; Stroda A; Larmann J; Gillmann HJ; Kotfis K; Ganter MT; Bolliger D; Filipovic M; Guzzetti L; Mauermann E; Ionescu D; Spadaro S; Szczeklik W; De Hert S; Beck-Schimmer B; Howell SJ; Lurati Buse GA","abstract":"INTRODUCTION: Heart failure is a frequent comorbidity in patients undergoing non-cardiac surgery and an acknowledged risk factor for postoperative mortality. The associations between stable chronic heart failure and postoperative outcomes have not been explored extensively. The aim of this study was to determine associations between stable chronic heart failure and its peri-operative management and postoperative outcomes after major non-cardiac surgery. METHODS: This is a secondary analysis of MET-REPAIR, an international prospective cohort study including patients undergoing non-cardiac surgery aged >\/= 45 y with increased cardiovascular risk. Main exposures were stable chronic heart failure and availability of a pre-operative transthoracic echocardiogram. The primary endpoint was the incidence of postoperative major adverse cardiovascular events at 30 days. Secondary endpoints included 30-day mortality and severe in-hospital complications. Multivariable logistic regression models were calculated. RESULTS: Of 15,158 included patients, 3880 (25.6%) fulfilled the diagnostic criteria for stable chronic heart failure, of whom 1397 (36%) were female. Chronic heart failure was associated with increased risk of postoperative 30-day major adverse cardiovascular events (OR 2.04, 95%CI 1.59-2.60), 30-day mortality (OR 1.50, 95%CI 1.17-1.92) and in-hospital complications (OR 1.47, 95%CI 1.30-1.66). Transthoracic echocardiography was performed in 1267 (32.7%) patients with heart failure; 146 (11.5%) patients with heart failure presented with a left ventricular ejection fraction < 40%. Reduced ejection fraction was associated with major adverse cardiovascular events (OR 2.0, 95%CI 1.01-3.81). DISCUSSION: Stable chronic heart failure is independently associated with major adverse cardiovascular events, mortality and severe postoperative complications when measured 30 days after non-cardiac surgery.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40230320\/"},{"pmid":40230308,"journal":"Anaesthesia","title":"Pre-operative reference ranges for ROTEM((R)) sigma in patients undergoing cardiac surgery: a secondary analysis of two prospective trial cohorts.","authors":"van Haeren MMT; Brouwers M; Schenk J; Breel JS; Noteboom SH; Kho E; Eberl S; Veelo DP; Vlaar APJ; Muller MCA; Hermanns H","abstract":"INTRODUCTION: Rotational thromboelastometry (ROTEM((R))) is used widely in cardiac surgery. Reference ranges are derived from healthy volunteers but may not be interchangeable with those from patients undergoing cardiac surgery. Furthermore, sex and age seem to influence rotational thromboelastometry profiles. We performed a secondary analysis of two prospective observational study cohorts from a single centre in the Netherlands, which establishes pre-operative ROTEM((R)) sigma reference ranges for adult patients undergoing cardiac surgery and examines sex- and age-specific variations. METHODS: Reference ranges (2.5-97.5th percentiles) were compared with those reported by the manufacturer by calculating 95%CIs around the percentiles. Sex- and age-specific variations were evaluated similarly by creating subgroups (comparing males with females and different age groups) and calculating the 95%CIs for the ranges in each subgroup. Non-overlapping CIs indicated statistically significant different ranges. RESULTS: We included 381 patients in the analysis. Differences were found in ROTEM sigma reference ranges compared with those stated by the manufacturer: EXTEM and FIBTEM clot firmness upper limits were higher, and clotting time ranges in EXTEM and INTEM were wider. The lower limit of LI60 EXTEM was lower. When comparing males (n = 260) and females (n = 121), female patients had shorter CT EXTEM and higher A5, A10 and MCF in EXTEM and FIBTEM, but the reference ranges were not significantly different. No differences in medians or reference bounds were found across four age categories, divided by quartiles. DISCUSSION: Reference ranges for patients undergoing cardiac surgery differed from the manufacturer reference ranges. Pre-operatively, female patients exhibited a slightly more hypercoagulable ROTEM profile than males when comparing medians, though the reference ranges were similar. No differences were found across age categories. Cardiovascular-specific, but not sex- or age-specific ROTEM sigma reference ranges might be needed.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40230308\/"},{"pmid":40227959,"journal":"Anesthesiology","title":"Development of the Pediatric Scale for Quality of Recovery (PedSQoR).","authors":"Graydon C; Stricker PA; Kelleher S; Cravero J; Karim N; Muhly WT; Lee-Archer P","abstract":"BACKGROUND: Measuring the quality of a patient's recovery is vital, and reliable patient-centered outcome metrics are needed for clinical investigations and quality improvement. Currently, assessment tools to measure quality of recovery in pediatric patients are lacking. This study aimed to develop a scale to assess the quality of recovery construct in pediatric patients. METHODS: Using a mixed-methods investigative model, item generation was achieved using two complementary approaches. First, a comprehensive review of the literature identified tools and questions that assessed the endpoints relevant to recovery in children. Questions were categorized and then assessed by an expert Delphi panel who determined the most significant domains and items to be included. Concurrently, semistructured interviews were conducted with patients and their families to identify themes related to recovery that were important to patients and families. The resulting pilot questionnaire was administered to patients and their families presenting for elective surgery in the United States and Australia. RESULTS: The literature search identified 41 instruments, comprising 216 questions relevant to recovery. After the initial Delphi round, the item list was reduced to 91 questions, and then to 50 questions after the second round. The themes identified in the semistructured interviews aligned with domains considered important by a panel of experts. A 50-item questionnaire was administered to 1,162 children at multiple timepoints after surgery. Item reduction and factor analysis resulted in the 20-item Pediatric Scale for Quality of Recovery that assesses the domains relevant to physical and psychologic recovery. CONCLUSIONS: The Pediatric Scale for Quality of Recovery scale is a 20-item questionnaire designed to provide a holistic representation of a child's physical, emotional, and psychologic recovery after surgery and anesthesia. It was developed and validated with consumer involvement and a strong patient-centered focus. Once further validation has been established, it is expected to become a standardized endpoint in pediatric perioperative trials and quality improvement projects.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40227959\/"},{"pmid":40223488,"journal":"European journal of anaesthesiology","title":"Remimazolam for successful sedation in children with left-to-right shunt congenital heart disease: An up-and-down sequential allocation trial.","authors":"Jin M; Lin H; Qiu L; Xu H; Zhang H; Hou S","abstract":"BACKGROUND: The findings of this study offer insights into the utilisation of remimazolam for sedation in paediatric patients with left-to-right shunt congenital heart disease (CHD). OBJECTIVE: To study the median effective dose (ED 50 ) and 95 percentile of the effective dose (ED 95 ) of remimazolam for successful sedation in children with CHD. DESIGN: A nonrandomised, nonblinded study based on the Dixon sequential method. SETTING: Tertiary hospitals in Zhengzhou, Henan Province, study dates: 20 October 2023 to 18 May 2024. PATIENTS: A total of 78 patients, comprising 32 males and 45 females, successfully completed the study. They were selected based on the following criteria: children aged 1 to 6 years with left-to-right shunt CHD; ASA physical status II-III. The key exclusion criteria were: history of allergy to sedative drugs; administration of sedative medications other than the study drug before surgery; severe pre-operative liver or kidney dysfunction; pre-operative bradycardia; and severe pre-operative respiratory diseases. INTERVENTION: The sedation status of the patients was observed for 5 min after intravenous administration of different doses of remimazolam. MAIN OUTCOME MEASURES: The ED 50 and ED 95 of remimazolam for successful sedation in children with CHD. RESULTS: The ED 50 (95% CI) of remimazolam for successful sedation in infants, toddlers and preschool children with CHD were 0.209 (0.184 to 0.234) mg kg -1 , 0.259 (0.234 to 0.284) mg kg -1 and 0.266 (0.207 to 0.325) mg kg -1 , respectively. ED 95 (95% CI) were 0.356 (0.282 to 0.672) mg kg -1 , 0.404 (0.330 to 0.741) mg kg -1 and 0.408 (0.334 to 0.752) mg kg -1 , respectively. No serious adverse reactions were observed with intravenous remimazolam. CONCLUSION: This study explored the ED 50 and ED 95 of remimazolam for pre-operative sedation in children with left-to-right shunt CHD. It provides guidance for pre-operative sedation medication in children with left-to-right shunt CHD. TRIAL REGISTRATION: https:\/\/www.chictr.org.cn\/Identifier: ChiCTR2300076458.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40223488\/"},{"pmid":40203181,"journal":"Anesthesiology","title":"Effects of Sedative Doses of Propofol, Dexmedetomidine, and Fentanyl on Memory and Pain in Healthy Young Adults: A Randomized, Controlled, Single-blind Crossover Study Using Functional Magnetic Resonance Imaging at 7 Tesla.","authors":"Vogt KM; Simmons MA; Reddy SN; Burlew AC; Kozdron CN; Lavage DR; Wang S; Pryor KO; Shafer SL; Ibrahim T; Aizenstein HJ; Reder LM; Ibinson JW; Fiez JA","abstract":"BACKGROUND: Anesthetic agents are well known for their effects on memory and pain; however, previous studies quantifying anesthetic modulation of memory have not included experimental noxious stimulation. This study used functional magnetic resonance imaging to determine how low doses of propofol, dexmedetomidine, and fentanyl affect the brain systems for memory encoding and pain perception. METHODS: This was a single-blind, 1:1:1, randomized, placebo-controlled crossover study of 92 healthy volunteers ages 18 to 40 yr. Effect-site concentrations were targeted for propofol (1.0 mcg\/ml), dexmedetomidine (0.15 ng\/ml), or fentanyl (0.9 ng\/ml). Participants listened to a series of 80 words creating a mental picture. Thirty were accompanied by a 2-s painful shock. Blood oxygen-weighted images were obtained at 7 T using a custom head coil. The primary outcome was next-day memory performance, measured by d', a normalized measure of correct identifications versus false positives. Mixed models were fit to test outcome differences between drug groups. Only statistically significant ( P < 0.05) changes are reported, after adjustment for multiple comparisons. RESULTS: Recollection, reported as mean d' (95% CI), was 1.16 (95% CI, 0.97 to 1.34) under no drug. This was reduced under propofol (0.51; 95% CI, 0.182 to 0.842; P = 0.006) but not under dexmedetomidine (1.04; 95% CI, 0.73 to 1.35; P = 0.99) or fentanyl (0.98; 95% CI, 0.68 to 1.28; P = 0.99). Propofol decreased memory-encoding activation of the hippocampus and amygdala. Propofol reduced pain-related activation in the insula, anterior cingulate, hippocampus, and amygdala. Dexmedetomidine showed decreased memory-related activation in the hippocampus but did not change pain ratings or show activation differences in pain-processing areas. Fentanyl showed decreased memory activation in the hippocampus and amygdala. During painful stimulation, fentanyl decreased activation in the primary somatosensory cortex and insula and increased activation in the anterior cingulate, hippocampus, and amygdala. CONCLUSIONS: These findings add important details to the complex framework of how these distinct anesthetics affect different aspects of cognition through diverse neuroanatomic targets in the brain.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40203181\/"},{"pmid":40203179,"journal":"Anesthesiology","title":"Perioperative Nitric Oxide Conditioning Reduces Acute Kidney Injury in Cardiac Surgery Patients with Chronic Kidney Disease (the DEFENDER Trial): A Randomized Controlled Trial.","authors":"Kamenshchikov NO; Tyo MA; Berra L; Kravchenko IV; Kozlov BN; Gusakova AM; Podoksenov YK","abstract":"BACKGROUND: Postoperative acute kidney injury (AKI) is a significant concern for cardiac surgery patients with chronic kidney disease (CKD). Effective pharmacologic interventions to mitigate these risks are urgently needed. This study aimed to evaluate the efficacy and safety of perioperative nitric oxide (NO) administration in preventing AKI and limiting CKD progression in patients undergoing cardiac surgery. METHODS: A total of 136 patients with CKD undergoing elective cardiac surgery with cardiopulmonary bypass were randomized into two equal groups: the NO group (n = 68), receiving 80 parts per million NO during the intraoperative period and for 6 h postsurgery, and the control group (n = 68), receiving a sham treatment. The primary outcome was AKI incidence within 7 days postsurgery. RESULTS: AKI incidence was significantly lower in the NO group (16 of 68 patients, 23.5%) compared to the control group (27 of 68 patients, 39.7%) with a relative risk of 0.59 (95% CI, 0.35 to 0.99; P = 0.043). Six months postsurgery, the glomerular filtration rate was higher in the NO group (50 ml . min -1 . 1.73 m -2 [45; 54]) compared to the control group (45 ml . min -1 . 1.73 m -2 [41; 51]; P = 0.038). Postoperative pneumonia was significantly less frequent in the NO group: 10 of 68 (14.7%) versus 20 of 68 (29.4%) with a relative risk of 0.5 (95% CI, 0.25 to 0.99; P = 0.039). NO administration was safe: methemoglobin and nitrogen dioxide levels remained within acceptable ranges, oxidative-nitrosyl stress did not increase, and there were no significant differences between the groups in blood transfusion requirements, platelet counts, or postoperative blood loss volumes. CONCLUSIONS: Perioperative NO administration in CKD patients undergoing cardiac surgery with cardiopulmonary bypass is safe, reduces the incidence of AKI, and slows the progression of renal dysfunction.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40203179\/"},{"pmid":40133080,"journal":"Anaesthesia","title":"Intra-operative ventilation strategies and their impact on clinical outcomes: a systematic review and network meta-analysis of randomised trials.","authors":"Jivraj NK; Lakbar I; Sadeghirad B; Muller MM; Sohn SY; Peel JK; Jaffer A; Phoophiboon V; Trivedi V; Chaudhuri D; Lu C; Liu Y; Giammarioli B; Einav S; Burns KEA","abstract":"INTRODUCTION: Postoperative pulmonary complications are common and associated with significant morbidity and mortality; however, the optimal intra-operative ventilation strategy to prevent postoperative pulmonary complications remains unclear. The aim of this study was to evaluate the effect of intra-operative ventilation strategy, including tidal volumes, positive end-expiratory pressure (PEEP) and use of recruitment manoeuvres on the incidence of postoperative pulmonary complications in adults having non-cardiothoracic surgery. METHODS: Relevant databases were searched to identify randomised controlled trials that directly compared intra-operative ventilation strategies among surgical patients who were followed up for > 24 hours postoperatively and reported at least one outcome of interest. RESULTS: A total of 51 randomised controlled trials were included. Compared with a high tidal volume\/zero PEEP strategy, low tidal volume strategies likely reduced the risk of postoperative pulmonary complications when combined with: high PEEP (risk ratio (RR) 0.44, 95%CI 0.22-0.87); high PEEP with recruitment manoeuvres (RR 0.60, 95%CI 0.49-0.75); personalised PEEP with recruitment manoeuvres (RR 0.53, 95%CI 0.42-0.69); low PEEP (RR 0.63, 95%CI 0.50-0.78); and low PEEP with recruitment manoeuvres (RR 0.65, 95%CI 0.46-0.93) (all moderate certainty evidence). Compared with a low tidal volume\/low PEEP strategy, a low tidal volume strategy with personalised PEEP likely reduces the risk of postoperative pulmonary complications (RR 0.85, 95%CI 0.73-0.99, moderate certainty). DISCUSSION: Among patients undergoing non-cardiothoracic surgery, the use of intra-operative low tidal volume ventilation with a range of acceptable PEEP levels likely reduced the risk of postoperative pulmonary complications compared with high tidal volumes and zero PEEP. This study highlights the need for implementation research at both the provider and system levels to improve intra-operative adherence to lung protective ventilation strategies.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40133080\/"},{"pmid":40127959,"journal":"Anaesthesia","title":"The use of iron after surgery: a systematic review and meta-analysis.","authors":"Lim J; Joo J; MacLean B; Richards T","abstract":"INTRODUCTION: Anaemia in patients having surgery is associated with worse postoperative outcomes. Management with intravenous iron is an attractive therapeutic option, however, pre-operative intravenous iron administration is challenging. Evidence from interventional trials suggests that the greatest benefit is after hospital discharge. As anaemia is common after surgery, this meta-analysis aimed to evaluate the efficacy of postoperative iron therapy to increase haemoglobin levels. METHODS: Relevant databases were searched from inception to 6 April 2023. Randomised controlled trials in adults undergoing elective surgery with postoperative anaemia, comparing intravenous or oral iron with control groups were included. The primary outcome was haemoglobin level at the end of study. Secondary outcomes included quality of life; blood transfusion requirements; incidence of adverse events; requirement for readmission; and mortality. RESULTS: Fifteen randomised controlled trials including 1865 patients were identified. Seven studies investigated intravenous iron, six investigated oral iron and two compared intravenous with oral iron. Intravenous iron increased postoperative haemoglobin levels compared with placebo or no intervention (mean difference 4.51 g.l(-1), 95%CI 2.63-6.38, I(2) = 0%, p < 0.01), while oral iron was ineffective (mean difference 0.61 g.l(-1), 95%CI -2.79-4.01, I(2) = 23%, p = 0.66). The subgroup analysis identified patients after orthopaedic surgery as the group with the greatest benefit (mean difference 3.63 g.l(-1), 95%CI 0.78-6.47, I(2) = 20%, p = 0.02). There were no significant differences in the secondary outcomes. DISCUSSION: Our meta-analysis of iron therapy for treating anaemia after major surgery found that intravenous iron administered within 30 days of surgery increased haemoglobin levels effectively, whereas oral iron showed no benefit.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40127959\/"},{"pmid":40070308,"journal":"European journal of anaesthesiology","title":"A dynamic elastance-based protocol to guide intra-operative fluid management in major abdominal surgery: A randomised clinical trial.","authors":"Russo A; Aceto P; Cascarano L; Menga LS; Romano B; Carelli S; Console E; Pugliese F; Cambise C; Fiorillo C; Alfieri S; Antonelli M; Sollazzi L; Dell'Anna AM","abstract":"BACKGROUND: Arterial hypotension during major surgery is related to postoperative complications and mortality. Both fluids and vasopressors increase blood pressure (BP) by inducing different physiological response. We devised a protocol which relies on dynamic arterial elastance (Ea dyn ) to guide BP optimisation during major abdominal surgery, and tested its effectiveness on tissue perfusion. OBJECTIVE: To explore if an Ea dyn -based optimisation protocol could affect lactate levels, fluid administration, and postoperative clinical complications. DESIGN: Randomised open-label clinical trial. SETTING: High-volume tertiary care centre for pancreatic surgery. PATIENTS: From 58 patients scheduled for cephalic duodenopancreatectomy 46 were eligible for the study. MAIN OUTCOMES AND MEASURES: The primary endpoint was the lactate value one hour after extubation. Secondary endpoints were fluid balance, intra-operative hypotension and postoperative complications. In the control group, hypotension (mean arterial pressure < 65 mmHg) was treated based on stroke volume variation (SVV) while in the experimental group the treatment was based on assessment of dynamic arterial elastance (Ea dyn group). Patient demographic and pre-operative laboratory data were recorded. All haemodynamic data, including oxygen delivery and consumption, were recorded at four time points: after intubation (T0), after fascia opening (T1), after fascia closing (T2) and one hour after extubation (T3). RESULTS: The patients were 70 [63 to 76] years and 15 (33%) were ASA 3. Lactate levels at T3 were similar between the control and Ea dyn groups. Oxygen consumption was higher in the Ea dyn group at T3, and lactate had a significant percentage decrease from T2 to T3: median [IQR], -24.5 [-30 to -14] vs. 0 [-24 to 7.6]%, P  = 0.004). Those in Ea dyn group received more vasopressors and had a lower fluid balance at T3: 2700 [2100 to 3800] vs. 2200 [1060 to 3000] ml, P  = 0.020). There were no significant differences either in postoperative complications or hospital stay. CONCLUSIONS: A protocol including Ea dyn to treat hypotension did not reduce lactate after major abdominal surgery, but it was associated with a significant reduction in fluid balance and increase in oxygen consumption. TRIAL REGISTRATION: ClinicalTrials.gov NCT05187273.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40070308\/"},{"pmid":40070011,"journal":"Anaesthesia","title":"Outcomes for patients with alcohol-related liver disease admitted to Scottish intensive care units 2010-2018.","authors":"Shariff A; Rhode S; Forbes SJ; Lone N; Docherty A","abstract":"INTRODUCTION: Alcohol-related liver disease is recognised as a major cause of liver-related morbidity and mortality. Our aim was to report the prevalence of, and outcomes from, alcohol-related liver disease after admission to ICUs in Scotland. METHODS: We performed a secondary data analysis using linked Scottish national databases of all adult general ICUs in Scotland. We compared emergency non-surgical patients admitted to ICU with and without alcohol-related liver disease. The primary outcome was ICU mortality, and secondary outcomes were ICU admission rate ratio; 60-day mortality; 2-year mortality; duration of ICU and hospital stay; and need for hospital readmission. RESULTS: Of the 49,420\/103,103 (47.9%) patients admitted to ICU with emergency non-surgical diagnoses between 2010 and 2018, we identified 2629\/49,420 (5.3%) patients with alcohol-related liver disease. Patients with alcohol-related liver disease were more likely to receive three-organ support (14.0% vs. 10.0%, p < 0.001). Mortality in the ICU was higher in patients with alcohol-related liver disease (964\/2629 (36.7%) vs. 10,517\/46,791 (22.5%), respectively; aOR 2.03 (95%CI 1.85-2.24)). Patients with alcohol-related liver disease who specifically presented to ICU with a gastrointestinal bleed had a lower ICU mortality (95\/487 (19.5%)). Sixty-day mortality of patients with alcohol-related liver disease increased with higher levels of organ support (186\/516 (36.0%) mortality with zero organs supported vs. 162\/196 (82.7%) mortality with three organs supported). DISCUSSION: Early mortality was high in patients with alcohol-related liver disease who were admitted to ICU, especially if multi-organ support was required. However, nearly one-fifth of patients on multi-organ support survived to hospital discharge. Early mortality for patients with alcohol-related liver disease admitted with a gastrointestinal bleed was considerably lower and should be taken into consideration when considering management in ICU. In discussion with the patient and hepatologists, a trial of organ support with continuous re-evaluation may be appropriate.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40070011\/"},{"pmid":40052487,"journal":"European journal of anaesthesiology","title":"Peri-operative dexmedetomidine and emergence agitation in adults undergoing nasal surgery: A systematic review and meta-analysis.","authors":"Wegner GRM; Wegner BFM; Silva LS; Arias JA","abstract":"BACKGROUND: There is a high risk of emergence agitation associated with nasal surgery. OBJECTIVE: We aimed to assess the effect of dexmedetomidine on the incidence of emergence agitation during anaesthetic recovery in patients undergoing nasal surgeries under general anaesthesia. DESIGN: A systematic review and meta-analysis of randomised controlled trials. DATA SOURCES: A systematic search was conducted in Embase, Web of Science (all databases), Cochrane Library and PubMed up to 20 June 2024, following the recommendations of the Cochrane Handbook and the PRISMA statement. ELIGIBILITY CRITERIA: Adult patients undergoing nasal surgeries under general anaesthesia (P), peri-operative dexmedetomidine use (I), placebo (C) and emergence agitation assessment (O). RESULTS: Nine randomised controlled trials with a total of 620 patients were included in the analysis. The incidence of emergence agitation with the use of dexmedetomidine was significantly lower than with placebo (relative risk (RR) = 0.31, 95% CI 0.19 to 0.49, P  < 0.0001, I2  = 63%, GRADE: moderate). No significant difference was found in the incidence of severe emergence agitation (RR = 0.5, 95% CI 0.24 to 1.02, P  = 0.0552, I2  = 0%, GRADE: Very low). A trial sequential analysis (TSA) was conducted to assess the reliability of the findings, with parameters set at a type 1 error (alpha) of 5% and a power (1-beta) of 80%. TSA confirmed the result for emergence agitation, but did not reach required information size for severe emergence agitation. Both assessment results were consistent and not dependent on any single study, as shown by the leave-one-out sensitivity analysis. CONCLUSIONS: The use of dexmedetomidine significantly reduces the incidence of emergence agitation in patients undergoing nasal surgeries under general anaesthesia. REGISTRATION PROSPERO ID: CRD42024561188.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40052487\/"},{"pmid":39957489,"journal":"European journal of anaesthesiology","title":"The immunomodulatory effect of sugammadex in vitro and after total hip arthroplasty : A randomised controlled pilot and retrospective cohort study.","authors":"Bijkerk V; Jacobs LMC; Visser J; van Helden EV; Keijzer C; Helder LS; Albers KI; Warle MC","abstract":"BACKGROUND: Postoperative immunosuppression is a well known phenomenon associated with infectious complications. Peri-operative immune dysregulation is likely induced by surgical damage and anaesthetics, but remains far from comprehensively characterised. To address this, the effects of individual drugs on immune function must be explored. Sugammadex, a cyclodextrin that encapsulates rocuronium, also binds other drugs and structures and may influence the inflammatory response. OBJECTIVE: Investigate the potential immunomodulatory effect of sugammadex. DESIGN: An in-vitro experiment, randomised controlled pilot study and retrospective cohort study. SETTING: Tertiary teaching hospital. PATIENTS: Twelve healthy donors, 20 adults undergoing total hip arthroplasty and 1000 major abdominal surgery patients. INTERVENTION: In vitro: isolated peripheral blood mononuclear cells were exposed to sugammadex and rocuronium before stimulation with Escherichia coli lipopolysaccharides (LPS).Pilot study: patients undergoing total hip arthroplasty under single shot spinal anaesthesia randomised to sugammadex (8 mg kg -1 ) or placebo at the end of surgery. MAIN OUTCOME MEASURE: In vitro: TNF, IL-1beta and IL-6 production capacity.Pilot study: Ex-vivo cytokine production capacity after whole blood stimulation with LPS.Retrospective cohort: sugammadex as a predictor of postoperative infectious complications. RESULTS: In vitro : rocuronium suppressed TNF and IL-1beta production capacity. Higher doses of sugammadex (100 and 1000 mug ml -1 ; 100 mug ml -1 corresponds to plasma concentration reached upon 8 mg kg -1 sugammadex) restored suppression of TNF and IL-1beta.Pilot study: no differences in ex-vivo cytokine production capacity between the sugammadex and placebo group at the end of surgery or on postoperative day 1.Retrospective cohort study : no association between sugammadex and postoperative infectious complications (OR = 1.000, 95% CI 0.998 to 1.002). CONCLUSION: Sugammadex preserved cytokine production capacity of TNF and IL-1beta in vitro . The clinical pilot study and retrospective cohort study revealed no early postoperative immunomodulatory effects for sugammadex in the clinically used dosing range. TRIAL REGISTRATION: clinicaltrials.gov identifier: NCT05723406 and NCT05244655.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39957489\/"},{"pmid":39899452,"journal":"Anesthesia and analgesia","title":"Gut Microbiota Influences Developmental Anesthetic Neurotoxicity in Neonatal Rats.","authors":"Chaki T; Horiguchi Y; Tachibana S; Sato S; Hirahata T; Nishihara N; Kii N; Yoshikawa Y; Hayamizu K; Yamakage M","abstract":"BACKGROUND: Anesthetic exposure during childhood is significantly associated with impairment of neurodevelopmental outcomes; however, the causal relationship and detailed mechanism of developmental anesthetic neurotoxicity remain unclear. Gut microbiota produces various metabolites and influences the brain function and development of the host. This relationship is referred to as the gut-brain axis. Gut microbiota may influence developmental anesthetic neurotoxicity caused by sevoflurane exposure. This study investigated the effect of changes in the composition of gut microbiota after fecal microbiota transplantation on spatial learning disability caused by developmental anesthetic neurotoxicity in neonatal rats. METHODS: Neonatal rats were allocated into the Control (n = 10) and Sevo (n = 10) groups in Experiment 1 and the Sevo (n = 20) and Sevo+FMT (n = 20) groups in Experiment 2, according to the randomly allocated mothers' group. The rats in Sevo and Sevo+FMT groups were exposed to 2.1% sevoflurane for 2 hours on postnatal days 7 to 13. Neonatal rats in the Sevo+FMT group received fecal microbiota transplantation immediately after sevoflurane exposure on postnatal days 7 to 13. The samples for fecal microbiota transplantation were obtained from nonanesthetized healthy adult rats. Behavioral tests, including Open field, Y-maze, Morris water maze, and reversal Morris water maze tests, were performed to evaluate spatial learning ability on postnatal days 26 to 39. RESULTS: Experiment 1 revealed that sevoflurane exposure significantly altered the gut microbiota composition. The relative abundance of Roseburia (effect value: 1.01) and Bacteroides genus (effect value: 1.03) increased significantly after sevoflurane exposure, whereas that of Lactobacillus (effect value: -1.20) decreased significantly. Experiment 2 revealed that fecal microbiota transplantation improved latency to target (mean +\/- SEM; Sevo group: 9.7 +\/- 8.2 seconds vs, Sevo+FMT group: 2.7 +\/- 2.4 seconds, d =1.16, 95% confidence interval: -12.7 to -1.3 seconds, P = .019) and target zone crossing times (Sevo group: 2.4 +\/- 1.6 vs, Sevo+FMT group: 5.4 +\/- 1.4, d =1.99, 95% confidence interval: 2.0-5.0, P < .001) in the reversal Morris water maze test. Microbiota analysis revealed that the alpha-diversity of gut microbiota increased after fecal microbiota transplantation. Similarly, the relative abundance of the Firmicutes phylum (effect value: 1.44), Ruminococcus genus (effect value: 1.69), and butyrate-producing bacteria increased after fecal microbiota transplantation. Furthermore, fecal microbiota transplantation increased the fecal concentration of butyrate and induced histone acetylation and the mRNA expression of brain-derived neurotrophic factor in the hippocampus, thereby suppressing neuroinflammation and neuronal apoptosis. CONCLUSIONS: The alternation of gut microbiota after fecal microbiota transplantation influenced spatial learning ability in neonatal rats with developmental anesthetic neurotoxicity. Modulation of the gut microbiota may be an effective prophylaxis for developmental anesthetic neurotoxicity in children.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39899452\/"},{"pmid":39773745,"journal":"Anesthesia and analgesia","title":"Pharmacokinetics of Methadone in Adult Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass.","authors":"Salas WE; Cortinez LI; Lopez RA; Rolle A; Elgueta F; Godoy CO; Giordano A; Contreras V; Anderson BJ","abstract":"BACKGROUND: Cardiopulmonary bypass (CPB) induces profound physiological changes that may alter the pharmacokinetics of methadone. We aimed to describe the pharmacokinetics of an intravenous bolus of methadone racemate in adult patients undergoing heart surgery with CPB. METHODS: We prospectively studied 29 patients aged 45 to 75 years scheduled for cardiac surgery with CPB who received methadone 0.2 mg\/kg after anesthesia induction. Arterial blood samples (n = 10) were taken, before, during, and after CPB. Pharmacokinetic analysis was undertaken using nonlinear mixed effects models. RESULTS: All patients completed the study. The median [interquartile range] methadone concentrations decreased from 34.8 [23.9-48.2] ng\/mL (10 minutes before CPB) to 18.2 [9.9-26] ng\/mL after 60 minutes of CPB ( P < .001). A 3-compartment model adequately described the observed changes in methadone concentrations. The influence of CPB on methadone pharmacokinetics was best described by hemodilution in a fixed volume of 1.5 L (CPB circuit volume) and by sequestration from the CPB components (CL SEQ = 93.4 L\/h, 95%CI 59-124, P < .01). The observed effect of CPB in methadone pharmacokinetics can be compensated by giving a supplementary bolus dose of 0.05 mg\/kg at the end of CPB. CONCLUSIONS: Our results confirmed a decay in methadone concentrations during CPB, which, in our modeling analysis, was attributed to hemodilution and sequestration within the CPB components.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39773745\/"},{"pmid":39504272,"journal":"Anesthesia and analgesia","title":"Development and Validation of a Predictive Model for Maternal Cardiovascular Morbidity Events in Patients With Hypertensive Disorders of Pregnancy.","authors":"Meng ML; Li Y; Fuller M; Lanners Q; Habib AS; Federspiel JJ; Quist-Nelson J; Shah SH; Pencina M; Boggess K; Krishnamoorthy V; Engelhard M","abstract":"BACKGROUND: Hypertensive disorders of pregnancy (HDP) are a major contributor to maternal morbidity, mortality, and accelerated cardiovascular (CV) disease. Comorbid conditions are likely important predictors of CV risk in pregnant people. Currently, there is no way to predict which people with HDP are at risk of acute CV complications. We developed and validated a predictive model for all CV events and for heart failure, renal failure, and cerebrovascular events specifically after HDP. METHODS: Models were created using the Premier Healthcare Database. The inclusion criteria for the model dataset were delivery with an HDP with discharge from October 1, 2015 to December 31, 2020. Machine learning methods were used to derive predictive models of CV events occurring during delivery hospitalization (Index Model) or during readmission (Readmission Model) using a training set (60%) to estimate model parameters, a validation set (20%) to tune model hyperparameters and select a final model, and a test set (20%) to evaluate final model performance. RESULTS: The total model cohort consisted of 553,658 deliveries with an HDP. A CV event occurred in 6501 (1.2%) of the delivery hospitalizations. Multilabel neural networks were selected for the Index Model and Readmission Model due to favorable performance compared to alternatives. This approach is designed for prediction of multiple events that share risk factors and may cooccur. The Index Model predicted all CV events with area under the receiver operating curve (AUROC) 0.878 and average precision (AP) 0.239 (cerebrovascular events: AUROC 0.941, heart failure: AUROC 0.898, and renal failure: AUROC 0.885). With a positivity threshold set to achieve >\/=90% sensitivity, model specificity was 65.0%, 83.5%, 68.6%, and 65.6% for predicting all CV events, cerebrovascular events, heart failure, and renal failure, respectively. CV events within 1 year of delivery occurred in 3018 (0.6%) individuals. The Readmission Model predicted all CV events with AUROC 0.717 and AP 0.022 (renal failure: AUROC 0.748, heart failure: AUROC 0.734, and cerebrovascular events AUROC 0.698). Feature importance analysis indicated that the presence of chronic renal disease, cardiac disease, pulmonary hypertension, and preeclampsia with severe features had the greatest effect on the prediction of CV events. CONCLUSIONS: Among individuals with HDP, our multilabel neural network model predicted CV events at delivery admission with good classification and events within 1 year of delivery with fair classification.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39504272\/"},{"pmid":39504268,"journal":"Anesthesia and analgesia","title":"Association Between Two Muscle-Related Parameters and Postoperative Complications in Patients Undergoing Colorectal Tumor Resection Surgery.","authors":"Gao D; Miao H; Sheng W; Liu L; Wang R; Shi H; Li T","abstract":"BACKGROUND: This study aimed to investigate the associations of 2 preoperative muscle-related parameters, the third lumbar vertebra skeletal muscle index (L3 SMI) for muscle mass and the Hounsfield unit average calculation (HUAC) for muscle density, with the occurrence of postoperative complications among patients undergoing colorectal tumor resection surgery under general anesthesia. We hypothesized that muscle-related parameters are associated with the occurrence of postoperative complications. METHODS: This was a single-center, retrospective observational study. Adult patients who underwent colorectal tumor resection surgery under general anesthesia between 2018.09.01 and 2021.09.01 were enrolled. The last abdominal computed tomography (CT) scan images obtained within 3 months before surgery were used to calculate the L3 SMI and HUAC. The primary outcome was defined as the occurrence of any postoperative complications corresponding to Clavien-Dindo classification before discharge. The secondary outcome was defined as the occurrence of any severe postoperative complications (Clavien-Dindo grade >\/=3) before discharge. Multivariable logistic regression analyses were used to estimate the association between muscle-related parameters and incidence of postoperative complications. Patients' baseline demographics, past medical history and intraoperative parameters were adjusted in the multivariable logistic regression analysis. RESULTS: A total of 317 patients with a median age of 66 (58-72) years were included. Sarcopenia (muscle mass reduction) patients in our cohort and myosteatosis (muscle density decline) were present in 254 (80.1 %) and 79 (24.9%) patients, respectively. A total of 135 patients (42.6 %) developed postoperative complications. According to the multivariable logistic regression, myosteatosis (odds ratio [OR], 1.8, 95% confidence interval [CI], 1.0-3.3, P = .039) was significantly associated with postoperative complications. CONCLUSIONS: A significant association was observed between myosteatosis and postoperative complications (corresponding to Clavien-Dindo classification before discharge), especially severe postoperative complications (Clavien-Dindo grade >\/=3) in patients undergoing colorectal tumor resection. Screening for myosteatosis with HUAC using the CT before surgery may help clinicians identify high-risk perioperative patients early.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39504268\/"},{"pmid":39466672,"journal":"Anesthesia and analgesia","title":"Comparative Electroencephalographic Profile of a New Anesthetic and Anticonvulsant That Is Selective for the GABA A R Slow Receptor Subtype.","authors":"Maciver MB; McCarren HS; Eagleman SL; Davies FM; Jahangir A; Pal D; Mashour GA; Bertaccini EJ","abstract":"BACKGROUND: Anesthetics like propofol increase electroencephalography (EEG) power in delta frequencies (0.1-4 Hz), with a decrease of power in bandwidths >30 Hz. Propofol is nonselective for gamma amino butyric acid type A receptor subtypes (GABA A R) as it enhances all 3 GABA A R subtypes (slow, fast, and tonic). Our newly developed anesthetic class selectively targets GABA A R-slow synapses to depress brain responsiveness. We hypothesized that a selective GABA A R-slow agonist, KSEB 01-S2, would produce a different EEG signature compared to the broad-spectrum GABA A R agonist (propofol), and tested this using rat EEG recordings. METHODS: Male rats were studied after Institutional Animal Care and Use Committees (IACUC) approval from the US Army Medical Research Institute of Chemical Defense and the University of Michigan. Rats were anesthetized using isoflurane (3%-5% induction, 1%-3% maintenance) with oxygen at 0.5 to 1.0 L\/min. Stainless steel screws were placed in the skull and used to record subcranial cortical EEG signals. After recovery, either propofol or KSEB 01-S2 was administered and effects on EEG signals were analyzed. RESULTS: As previously reported, propofol produced increased power in delta frequencies (0.1-4 Hz) compared to predrug recordings and produced a decrease in EEG power >30 Hz but no significant changes were seen within +\/-20 seconds of losing the righting reflex. By contrast, KSEB 01-S2 produced a significant increase in theta frequency percent power (median 14.7%, 16.2\/13.8, 75\/25 confidence interval; to 34.7%, 35\/31.8; P < .015) and a significant decrease in low gamma frequency percent power (16.9%, 18.6\/15.8; to 5.45%, 5.5\/5.39; P < .015) for all rats at +\/- 20 seconds of loss of consciousness (LOC). Both anesthetics produced a flattening of chaotic attractor plots from nonlinear dynamic analyses, like that produced by volatile and dissociative anesthetics at LOC. CONCLUSIONS: KSEB 01-S2 produced a markedly different EEG pattern, with a selective increase observed in the theta frequency range. KSEB 01-S2 also differs markedly in its activity at the GABA A R-slow receptor subtype, suggesting a possible mechanistic link between receptor subtype specificity and EEG frequency band signatures. Increased theta together with depressed gamma frequencies is interesting because GABA A R slow synapses have previously been suggested to underlie theta frequency oscillations, while fast synapses control gamma activity. These reciprocal effects support a previous model for theta and nested gamma oscillations based on inhibitory connections between GABA A R fast and slow interneurons. Although each anesthetic produced a unique EEG response, propofol and KSEB 01-S2 both increased slow wave activity and flattened chaotic attractor plots at the point of LOC.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39466672\/"},{"pmid":39453983,"journal":"Anesthesia and analgesia","title":"Xenon and Argon as Neuroprotective Treatments for Perinatal Hypoxic-Ischemic Brain Injury: A Preclinical Systematic Review and Meta-Analysis.","authors":"Barros M; Liang M; Iannucci N; Dickinson R","abstract":"Xenon and argon are currently being evaluated as potential neuroprotective treatments for acquired brain injuries. Xenon has been evaluated clinically as a treatment for brain ischemia with equivocal results in small trials, but argon has not yet undergone clinical evaluation. Several preclinical studies have investigated xenon or argon as treatments in animal models of perinatal hypoxic-ischemic encephalopathy (HIE). A systematic review of MEDLINE and Embase databases was performed. After screening of titles, abstracts, and full text, data were extracted from included studies. A pairwise meta-analysis of neuroprotective efficacy was performed using a random effects model. Heterogeneity was investigated using subgroup analysis, funnel plot asymmetry, and Egger's regression. The protocol was prospectively registered on PROSPERO (CRD42022301986). A total of 21 studies met the inclusion criteria. The data extracted included measurements from 1591 animals, involving models of HIE in mice, rats, and pigs. The meta-analysis found that both xenon and argon had significant ( P < .0001) neuroprotective efficacies. The summary estimate for xenon was 39.7% (95% confidence interval [CI], 28.3%-51.1%) and for argon it was 70.3% (95% CI, 59.0%-81.7%). The summary effect for argon was significantly ( P < .001) greater than that of xenon. Our results provide evidence supporting further investigation of xenon and argon as neuroprotective treatments for HIE.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39453983\/"},{"pmid":39413034,"journal":"Anesthesia and analgesia","title":"Developing a Wearable Sensor-Based Digital Biomarker of Opioid Dependence.","authors":"Carreiro S; Ramanand P; Akram W; Stapp J; Chapman B; Smelson D; Indic P","abstract":"BACKGROUND: Repeated opioid exposure leads to a variety of physiologic adaptations that develop at different rates and may foreshadow risk of opioid-use disorder (OUD), including dependence and withdrawal. Digital pharmacovigilance strategies that use noninvasive sensors to identify physiologic adaptations to opioid use represent a novel strategy to facilitate safer opioid prescribing. This study aims to identify wearable sensor-derived features associated with opioid dependence by comparing opioid-naive individuals to chronic opioid users with acute pain and developing a machine-learning model to distinguish between the 2 groups. METHODS: Using a longitudinal observational study design, continuous physiologic data were collected on participants with acute pain receiving opioid analgesia. Monitoring continued throughout hospitalization and for up to 7 days posthospital discharge. Opioid administration data were obtained from electronic health record (EHR) and participant self-report. Participants were classified as belonging to 1 of 3 categories based on opioid use history: naive, occasional, or chronic use. Thirty features were derived from sensor data, and an additional 9 features were derived from participant demographic and treatment characteristics. Physiologic feature behavior immediately postopioid use was compared among naive and chronic participants, and subsequently features were used to generate machine learning models which were validated using cross-validation and holdout data. RESULTS: Forty-one participants with a combined total of 169 opioid administrations were ultimately included in the final analysis. Four interpretable decision tree-based machine learning models with 14 sensor-based and 5 clinical features were developed to predict class membership on the level of a given observation (dose) and on the participant level. Ranges for model metrics on the participant level were as follows: accuracy 70% to 90%, sensitivity 67% to 100%, and specificity 67% to 100%. CONCLUSIONS: Wearable sensor-derived digital biomarkers can be used to predict opioid use status (naive versus chronic) and the differentiating features may be detecting opioid dependence. Future work should be aimed at further delineating the phenomenon identified in these models (including opioid dependence and\/or withdrawal) and at identifying transition states where an individual changes from 1 profile to another with repetitive opioid exposure.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39413034\/"},{"pmid":39259695,"journal":"Anesthesia and analgesia","title":"Intrathecal Drug Delivery System in Prepontine Cistern for Patients with Intractable Craniofacial Cancer Pain: A Multicenter Retrospective Study.","authors":"Long D; Li X; Zhang Y; Luo J; Liu B; Hong B; Yang F; Zou C; Ge F; Zhang A; Zhou H; Xiao Y; Wang Y","abstract":"BACKGROUND: Patients with craniofacial cancer frequently suffer from severe pain. The traditional intrathecal, oral, or intravenous analgesics could only provide insufficient pain relief with many side effects. Thus, a more effective analgesia approach is required. This study aimed to investigate the safety and efficacy of placing the catheter of an intrathecal morphine pump in the prepontine cistern for the treatment of craniofacial cancer pain. METHODS: We performed a retrospective study of patients with primary or metastatic craniofacial cancer pain who received the catheter placement of an intrathecal morphine pump into the prepontine cistern in eleven medical centers from September 2019 to December 2023. Friedman test and pairwise signed-rank test were used to evaluate the difference in numeric rating scale (NRS) scores, the number of breakthrough pain episodes, dose of intrathecal morphine, and dose of systemic morphine equivalents (oral, patch, intravenous) from preoperative period to postoperative days 1, 7, and 30. P values were corrected for multiple comparisons using Bonferroni test. RESULTS: The study included 33 patients. The median (interquartile range [IQR]) of NRS scores at days 1, 7, and 30 postimplant were 2.0 (1.0-3.5), 2.0 (1.0-2.0), and 1.0 (1.0-2.0), respectively, which was significantly lower than that before surgery (median, 8.0; IQR, 7.0-10.0; all P < .001). Compared to baseline number\/d of breakthrough pain episodes (median, 6.0; IQR, 4.5-10.0), there was a progressive decrease in the number\/d of breakthrough pain episodes at day 1, day 7, and day 30 postimplant, and the median (IQR) were 1.0 (0.0-3.0), 2.0 (0.0-3.0), and 0.0 (0.0-1.2), respectively (all P < .001). Approximately 78.8% and 96.7% of patients reported pain relief >50% at days 1 and 30 postimplant, respectively. Compared with that at day 1 postimplant, the proportion of patients with a pain relief rate >75% at day 30 postimplant also increased with continued intrathecal treatment. Compared to the dose of baseline systemic morphine equivalents (median, 228 mg.d -1 ; IQR, 120-408 mg.d -1 ), the dose of systemic morphine equivalents reduced significantly from 0(0-120) mg.d -1 at day 1 postimplant ( P = .001), to 0 (0-0) mg.d -1 at days 7 and 30 postimplant (both P < .001). Few patients reported perioperative adverse events, including nausea, constipation, hypotension, urinary retention, dry mouth, headache, and sedation. No severe adverse events occurred. CONCLUSIONS: Placing the catheter tip of an intrathecal morphine pump into the prepontine cistern could effectively relieve refractory craniofacial cancer pain with an extremely low total morphine dose requirement and few adverse events. This procedure could be considered in patients with severe refractory craniofacial cancer pain.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39259695\/"},{"pmid":39207913,"journal":"Anesthesia and analgesia","title":"Ketamine Analgo-sedation for Mechanically Ventilated Critically Ill Adults: A Rapid Practice Guideline from the Saudi Critical Care Society and the Scandinavian Society of Anesthesiology and Intensive Care Medicine.","authors":"Amer M; Hylander Moller M; Alshahrani M; Shehabi Y; Arabi YM; Alshamsi F; Ingi Sigurethsson M; Rehn M; Chew MS; Kalliomaki ML; Lewis K; Al-Suwaidan FA; Al-Dorzi HM; Al-Fares A; Alsadoon N; Bell CM; Groth CM; Parke R; Mehta S; Wischmeyer PE; Al-Omari A; Olkkola KT; Alhazzani W","abstract":"BACKGROUND: This Rapid Practice Guideline (RPG) aimed to provide evidencebased recommendations for ketamine analgo-sedation (monotherapy and adjunct) versus non-ketamine sedatives or usual care in adult intensive care unit (ICU) patients on invasive mechanical ventilation (iMV) and to identify knowledge gaps for future research. METHODS: The RPG panel comprised 23 multinational multidisciplinary panelists, including a patient representative. An up-to-date systematic review and meta-analysis constituted the evidence base. The Grading Recommendations, Assessment, Development, and Evaluation approach, and the evidence-to-decision framework were used to assess the certainty of evidence and to move from evidence to decision\/recommendation. The panel provided input on the balance of the desirable and undesirable effects, certainty of evidence, patients' values and preferences, costs, resources, equity, feasibility, acceptability, and research priorities. RESULTS: Data from 17 randomized clinical trials (n=898) and 9 observational studies (n=1934) were included. There was considerable uncertainty about the desirable and undesirable effects of ketamine monotherapy for analgo-sedation. The evidence was very low certainty and downgraded for risk of bias, indirectness, and inconsistency. Uncertainty or variability in values and preferences were identified. Costs, resources, equity, and acceptability were considered varied. Adjunctive ketamine therapy had no effect on mortality (within 28 days) (relative risk [RR] 0.99; 95% confidence interval [CI] 0.76 to 1.27; low certainty), and may slightly reduce iMV duration (days) (mean difference [MD] -0.05 days; 95% CI -0.07 to -0.03; low certainty), and uncertain effect on the cumulative dose of opioids (mcg\/kg\/h morphine equivalent) (MD -11.6; 95% CI -20.4 to -2.7; very low certainty). Uncertain desirable effects (cumulative dose of sedatives and vasopressors) and undesirable effects (adverse event rate, delirium, arrhythmia, hepatotoxicity, hypersalivation, use of physical restraints) were also identified. A possibility of important uncertainty or variability in patient-important outcomes led to a balanced effect that favored neither the intervention nor the comparison. Cost, resources, and equity were considered varied. CONCLUSION: The RPG panel provided two conditional recommendations and suggested (1) against using ketamine as monotherapy analgo-sedation in critically ill adults on iMV when other analgo-sedatives are available; and (2) using ketamine as an adjunct to non-ketamine usual care sedatives (e.g., opioids, propofol, dexmedetomidine) or continuing with non-ketamine usual care sedatives alone. Large-scale trials should provide additional evidence.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39207913\/"},{"pmid":39178159,"journal":"Anesthesia and analgesia","title":"Racial and Ethnic Differences in Postoperative Nausea and Vomiting Care.","authors":"Owusu-Agyemang P; Idowu O; Muthukumar A; Guerra-Londono JJ; Idowu T; Diaz NN; Feng L; Miller M; Gundre S; Wright C; Cata JP","abstract":"BACKGROUND: Racial and ethnic differences in health care may result in significant morbidity. The objective of this study was to determine whether there was an association between a patient's race or ethnicity and the receipt of an antiemetic agent preoperatively, during surgery, and in the recovery room. METHODS: A single-institution retrospective study of adult patients (>18 years) who had undergone cancer-related operating room procedures under anesthesia between March 2016 and August 2021 was conducted. A multivariable logistic regression model was fitted to estimate the effects of covariates on antiemetic administration. RESULTS: Of the 60,595 patients included in the study, 3053 (5.0%) self-identified as Asian, 5376 (8.9%) as Black, 8431 (13.9%) as Hispanic or Latino, 42,533 (70.2%) as White, and 1202 (2.0%) as belonging to another racial or ethnic group. Multivariable analyses showed significant associations between a patient's race or ethnicity and the receipt of antiemetics in the preoperative holding area, operating room, and recovery room (all P < .001). In the preoperative holding area, White patients (8962 of 42,533 [21.1%]; odds ratio [OR], 1.188; 95% confidence interval [CI], 1.100-1.283; P < .001) had higher odds of receiving an antiemetic than Black patients (1006 of 5376 [18.7%]). Intraoperatively, the odds were significantly greater for Hispanic or Latino (7323 of 8431 [86.9%]; OR, 1.175; 95% CI, 1.065-1.297; P = .001) and patients who identified as belonging to another race (1078 of 1202 [89.7%]; OR, 1.582; 95% CI, 1.290-1.941; P < .001) than for Black patients (4468 of 5376 [83.1%]). In the recovery room, Asian (499 of 3053 [16.3%]; OR, 1.328; 95% CI: 1.127-1.561; P < .001), Hispanic or Latino (1335 of 8431 [15.8%]; OR, 1.208; 95% CI, 1.060-1.377; P < .005), and White patients (6533 of 42,533 [15.4%]; OR, 1.276; 95% CI, 1.140-1.427; P < .001) had significantly higher odds of receiving antiemetics than Black patients (646 of 5376 [12%]). CONCLUSIONS: This retrospective study suggests significant differences between the administrations of antiemetics to patients of different races or ethnicities, with Black patients often being less likely to receive an antiemetic than patients belonging to all other races or ethnicities.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39178159\/"},{"pmid":39137053,"journal":"Anesthesia and analgesia","title":"The Glass Ceiling in Global Health: Perspectives of Female and Male Anesthesiologists.","authors":"Matejic B; Nelson BD; Collins L; Milenovic MS","abstract":"BACKGROUND: Gender equity is essential for improving health outcomes globally. Despite comprising 75% of the global health workforce and dominating academic global health programs, women remain underrepresented in leadership positions in global health organizations. Our study aimed to identify potential gender differences in the beliefs and attitudes regarding barriers that women anesthesiologists encounter in pursuing careers and leadership roles in global health and to identify recommendations for improving gender equity in global health. METHODS: We conducted a cross-sectional online survey focusing on career leadership opportunities and challenges uniquely faced by women clinicians in global health. We obtained permission from the World Federation of Societies of Anaesthesiologists to distribute our questionnaire to their leadership committee members during 2 months (May-July 2022). RESULTS: The questionnaire was distributed to 164 study participants with 67 individuals (44.8% female) based in 38 different countries completing the survey (response rate 40.9%). Overall, 47.8% of the participants aspired to a leadership position in global health and 58.2% agreed women face unique barriers to global health leadership (70.0% of women compared to 48.6% of men; P = .081). Female gender (odds ratio [OR], 19.22, P = .004) and divorced marital status (OR, 746.26, P = .004) were positively associated and African ethnicity (OR, 0.002, P = .017) was negatively associated with the perception of gender bias in their career growth. The main challenges included balancing work and family responsibilities, lack of female mentors or role models, gender-based discrimination, and limited opportunities for career advancement. Men acknowledged these challenges but reported personally experiencing them to a lesser extent, particularly concerning lack of opportunities ( P = .005), inadequate pay ( P = .000), and lack of training ( P = .000). CONCLUSIONS: Gender disparities exist in the pursuit of global health careers. This study underscored that more women than men perceive barriers in pursuing leadership roles in global health and that men generally encounter these obstacles to a lesser extent. Female representation in leadership positions could be supported through evidence-informed policies that promote work-life balance, improve mentorship, offer equal opportunities for career advancement and adequate pay, and combat gender-based discrimination.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39137053\/"},{"pmid":39116012,"journal":"Anesthesia and analgesia","title":"Effect of In Vivo Administration of Fibrinogen Concentrate Versus Cryoprecipitate on Ex Vivo Clot Degradation in Neonates Undergoing Cardiac Surgery.","authors":"Downey LA; Moiseiwitsch N; Nellenbach K; Xiang Y; Brown AC; Guzzetta NA","abstract":"BACKGROUND: Neonates undergoing cardiac surgery require fibrinogen replacement to restore hemostasis after cardiopulmonary bypass (CPB). Cryoprecipitate is often the first-line treatment, but recent studies demonstrate that fibrinogen concentrate (RiaSTAP; CSL Behring) may be acceptable in this population. This investigator-initiated, randomized trial compares cryoprecipitate to fibrinogen concentrate in neonates undergoing cardiac surgery ( ClinicalTrials.gov NCT03932240). The primary end point was the percent change in ex vivo clot degradation from baseline at 24 hours after surgery between groups. Secondary outcomes included intraoperative blood transfusions, coagulation factor levels, and adverse events. METHODS: Neonates were randomized to receive cryoprecipitate (control group) or fibrinogen concentrate (study group) as part of a post-CPB transfusion algorithm. Blood samples were drawn at 4 time points: presurgery (T1), after treatment (T2), arrival to the intensive care unit (ICU) (T3), and 24 hours postsurgery (T4). Using the mixed-effect models, we analyzed the percent change in ex vivo clot degradation from a patient's presurgery baseline at each time point. Intraoperative blood product transfusions, coagulation factor levels, perioperative laboratory values, and adverse events were collected. RESULTS: Thirty-six neonates were enrolled (intent to treat [ITT]). Thirteen patients in the control group and seventeen patients in the study group completed the study per protocol (PP). After normalizing to the patient's own baseline (T1), no significant differences were observed in clot degradation at T2 or T3. At T4, patients in the study group had greater degradation when compared to those in the control group (826.5%, 95% confidence interval [CI], 291.1-1361.9 vs -545.9%, 95% CI, -1081.3 to -10.4; P < .001). Study group patients received significantly less median post-CPB transfusions than control group patients (ITT, 27.2 mL\/kg [19.0-36.9] vs 41.6 [29.2-52.4]; P = .043; PP 26.7 mL\/kg [18.8-32.2] vs 41.2 mL\/kg [29.0-51.4]; P < .001). No differences were observed in bleeding or thrombotic events. CONCLUSIONS: Neonates who received fibrinogen concentrate, as compared to cryoprecipitate, have similar perioperative ex vivo clot degradation with faster degradation at 24 hours postsurgery, less post-CPB blood transfusions, and no increased bleeding or thrombotic complications. Our findings suggest that fibrinogen concentrate adequately restores hemostasis and reduces transfusions in neonates after CPB without increased bleeding or thrombosis risk.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39116012\/"},{"pmid":38861464,"journal":"Anesthesia and analgesia","title":"In Vitro Investigation of Insulin Dynamics During 4 Hours of Simulated Cardiopulmonary Bypass.","authors":"Schweizer T; Nossen CM; Galova B; Schild C; Huber M; Bally L; Vogt A; Siepe M; Nagler M; Fischer K; Guensch DP","abstract":"BACKGROUND: Hyperglycemia is common in patients undergoing cardiovascular surgery with cardiopulmonary bypass. We hypothesize that intraoperative hyperglycemia may be, at least partially, attributable to insulin loss due to adhesion on artificial surfaces and\/or degradation by hemolysis. Thus, our primary aim was to investigate the loss of insulin in 2 different isolated extracorporeal circulation circuits (ECCs), that is, a conventional ECC (cECC) with a roller pump, and a mini-ECC (MiECC) system with a centrifugal pump. The secondary aim was to assess and compare the relationship between changes in insulin concentration and the degree of hemolysis in our 2 ECC models. METHODS: Six cECC and 6 MiECC systems were primed with red packed blood cells and thawed fresh-frozen plasma (1:1). Four additional experiments were performed in cECC using only thawed fresh-frozen plasma. Human insulin (Actrapid) was added, targeting a plasma insulin concentration of 400 mU\/L. Insulin concentration and hemolysis index were measured at baseline and hourly thereafter. The end points were the change in insulin level after 4 hours compared to baseline and hemolysis index after 4 hours. The insulin concentration and hemolysis index were analyzed by means of a saturated linear mixed-effect regression model with a random offset for each experiment to account for the repeated measure design of the study, resulting in mean estimates and 95% confidence intervals (CIs) of the primary end points as well as of pairwise contrasts with respect to ECC type. RESULTS: Insulin concentration decreased by 63% (95% CI, 48%-77%) in the MiECC and 92% (95% CI, 77%-106%) in the cECC system that contained red blood cells. Insulin loss was significantly higher in the cECC system compared to the MiECC ( P = .022). In the cECC with only plasma, insulin did not significantly decrease (-4%; 95% CI, -21% to 14%). Hemolysis index in MiECC increased from 68 (95% CI, 46-91) to 76 (95% CI, 54-98) after 4 hours, in cECC from 81 (95% CI, 59-103) to 121 (95% CI, 99-143). Hemolysis index and percent change of insulin showed an excellent relationship (r = -0.99, P < .01). CONCLUSIONS: Our data showed that insulin levels substantially decreased during 4 hours of simulated cardiopulmonary bypass only in the ECC that contained hemoglobin. The decrease was more pronounced in the cECC, which also exhibited a greater degree of hemolysis. Our results suggest that insulin degradation by hemolysis products may be a stronger contributor to insulin loss than adhesion of insulin molecules to circuit surfaces.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38861464\/"},{"pmid":40713194,"journal":"British journal of anaesthesia","title":"Perioperative cardiac arrest requiring admission to intensive care units in Japan: epidemiological differences between emergency and elective surgery.","authors":"Anezaki H; Aoki Y; Kato H; Nakajima M; Kaszynski RH; Suzuki K; Yamaguchi T; Naruse S; Kimura T; Mimuro S; Nakajima Y","abstract":"BACKGROUND: Perioperative cardiac arrest is more prevalent in emergency surgery and carries substantial mortality risks; however, large-scale studies examining its incidence, aetiology, and outcomes remain scarce. This study investigated the epidemiology of perioperative cardiac arrest in emergency and elective surgeries in Japan. METHODS: We conducted a multicentre retrospective cohort study using the Japanese Intensive care PAtient Database (JIPAD), a nationwide ICU registry. Patients coming from the operating theatre who experienced cardiac arrest before ICU admission between April 2015 and March 2023 were included. Patients were categorised as undergoing emergency or elective surgery, and group comparisons were performed for the incidence, surgical procedures, aetiologies, and clinical outcomes. RESULTS: Perioperative cardiac arrest occurred in 874\/214 303 (0.41%) surgical ICU admissions, including 563\/32 408 (1.74%) of emergency surgeries and 311\/181 895 (0.17%) of elective surgeries. In emergency surgeries, the most frequent surgical procedure was acute aortic dissection repair (n=90, 16.0%), whereas the most common procedure in elective surgeries was gastrointestinal neoplasm resection (n=39, 12.5%). Acute aortic syndrome was the leading aetiology in emergency surgery (n=176, 31.3%), whereas valvular heart disease (n=48, 15.4%) and acute coronary syndrome (n=42, 13.5%) were the leading aetiologies in elective surgery. Both in-hospital mortality (46.2% vs 15.8%) and transfers to other healthcare facilities (28.8% vs 14.8%) were significantly higher in emergency surgeries. CONCLUSIONS: This nationwide study reveals significant differences in the incidence, surgical procedures, aetiologies, and clinical outcomes of perioperative cardiac arrest between emergency and elective surgery.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40713194\/"},{"pmid":40707353,"journal":"Regional anesthesia and pain medicine","title":"Pulsed radiofrequency of lumbar dorsal root ganglion versus epidural neuroplasty for lumbar radicular pain: a systematic review and network meta-analysis.","authors":"Park JH; Jang JN; Park S; Choi YS; Ryu DK; Miah R; Park S","abstract":"BACKGROUND: Lumbar radicular pain (LRP) and\/or lower back pain is a challenging condition, particularly in cases refractory to conservative treatments like epidural steroid injections (ESI). Pulsed radiofrequency (PRF) to the dorsal root ganglion and epidural neuroplasty techniques are emerging as alternative interventional treatments. However, there are no direct comparison studies between PRF and epidural neuroplasty, leading to uncertainty in optimal treatment selection. OBJECTIVE: This network meta-analysis (NMA) aims to indirectly compare the efficacy of PRF and epidural neuroplasty techniques in managing LRP. EVIDENCE REVIEW: We conducted a systematic review and NMA of randomized controlled trials (RCTs) comparing PRF, epidural neuroplasty, and conservative treatments, including ESI and sham procedures. Data sources included PubMed, Cochrane Central, Embase, and Web of Science up to December 31, 2024. Inclusion criteria comprised RCTs evaluating adult patients with lumbar radicular pain from disc herniation, spinal stenosis, or failed back surgery syndrome. Two reviewers independently extracted data on study design, interventions, outcomes, and risk of bias. The primary outcome was pain reduction at 1, 3, 6, and 12 months post-treatment. The secondary outcome was disability reduction, measured by the Oswestry Disability Index (ODI). A frequentist random-effects model was used for data synthesis, and the certainty of evidence was assessed using the Grading of Recommendation, Assessment, Development and Evaluation approach. Prediction intervals were not calculated due to data limitations, which is acknowledged as a limitation. FINDINGS: 14 RCTs comprising 1229 patients were included. At 1 month, there was no significant difference between PRF and epidural neuroplasty. At 3 months, epidural neuroplasty showed significant advantages over PRF (mean difference: -1.47, 95% CI -2.73 to -0.46); however, the certainty of evidence for this comparison was rated low. Similar trends were observed at 6 and 12 months, but the confidence in these estimates remained low to very low. For ODI, no significant differences were found at time points, and the certainty of evidence was moderate to very low across comparisons. CONCLUSION: PRF and epidural neuroplasty may offer comparable long-term pain and disability outcomes for patients with lumbar radicular pain, but the overall certainty of evidence was low to very low, limiting confident clinical recommendations. These findings highlight the need for high-quality, head-to-head trials to better inform interventional treatment strategies for LRP.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40707353\/"},{"pmid":40707283,"journal":"British journal of anaesthesia","title":"Accuracy of continuous glucose monitoring during noncardiac surgery: a prospective, blinded observational multicentre cohort study.","authors":"Janssen H; Dias P; Ahuja S; Alharbi S; Hiller L; Khan K; Iyer K; Sundar A; Abousharkh I; Thomas C; Jhanji S; Oliver NS; Ackland GL","abstract":"BACKGROUND: Hyperglycaemia after noncardiac surgery is rarely detected outside of the critical care environment, yet occurs commonly and is associated with excess complications including infections and myocardial injury. Systematic, prospectively collected data regarding the accuracy of continuous glucose monitoring commenced immediately before surgery and throughout the early perioperative period are lacking. METHODS: We prospectively enrolled patients aged >50 yr undergoing noncardiac surgery who required at least 24 h of hospital stay. We used real-time continuous glucose monitoring (Dexcom G7 sensor, placed in the upper outer arm) (Dexcom, San Diego, CA, USA) with reference values from arterial blood glucose measurements by amperometry. The primary outcome was the overall mean difference (bias) before surgery, at end of surgery, and 24 h after surgery (Bland-Altman analysis). Secondary outcomes included the mean absolute relative difference and surveillance error grid analyses. RESULTS: We compared paired blood (73% arterial) and continuous glucose monitoring glucose values at each prespecified timepoint in 118 participants (64\/118 [54%] female; mean age: 66 [range: 51-89] yr; 25% with diabetes mellitus). The overall bias between continuous glucose monitoring and blood glucose from measurements at each of the three timepoints in the first 24 h after induction of anaesthesia was 0.38 mM (95% confidence interval [95% CI]: 0.23-0.53; n=340 paired readings). Bias decreased from before the start of surgery (1.08 mM [95% CI: 0.87-1.29]; n=116) to 0.15 mM at the end of surgery (95% CI: -0.15 to 0.46; n=113). Mean absolute relative difference ranged from 12.0% to 18.3%. Error grid analyses found that >98% continuous glucose monitoring values were within acceptable risk ranges. CONCLUSIONS: The accuracy of state-of-the-art continuous glucose monitoring is sufficient for perioperative use and could enhance perioperative surveillance of dysglycaemia. CLINICAL TRIAL REGISTRATION: ISRCTN46862025.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40707283\/"},{"pmid":40705855,"journal":"Pain","title":"Borders that hurt: the link between anti-immigration attitudes in Europe and the epidemic of chronic pain in immigrant adolescents.","authors":"Roman-Juan J; Hood AM; Marbil MG; Birnie KA; Noel M","abstract":"Global immigration is increasing and is expected to continue rising because of the growing frequency of environmental disasters and sociopolitical conflicts. Emerging research shows that adolescents who immigrated to Europe are disproportionately affected by chronic pain compared to their nonimmigrant peers. Anti-immigration attitudes, which are also rising in Europe, may contribute to this disparity by fostering social exclusion and discrimination, which can heighten psychological distress and contribute to chronic pain. Using an intersectional approach, this study examined (1) the association between country-level anti-immigration attitudes and chronic pain in immigrant adolescents and (2) whether this association differed by sex and socioeconomic status. Cross-sectional data were drawn from 5621 immigrant adolescents across 20 European countries using the Health Behaviour in School-aged Children 2018 survey. Country-level anti-immigration attitudes were obtained from the European Social Survey 2018. Weighted mixed-effects logistic regression models assessed the association between anti-immigration attitudes and chronic pain and tested for interaction effects with sex and socioeconomic status. Results showed that stronger country-level anti-immigration attitudes were significantly associated with a higher prevalence of chronic pain among immigrant adolescents (OR = 1.17; 95% CI = 1.11-1.38) and that this association was stronger in immigrants with low socioeconomic status (OR = 1.39; 95% CI = 1.08-1.77). Sociopolitical exclusion of immigrants may contribute to higher chronic pain rates in immigrant adolescents, especially those with lower socioeconomic status. Country-specific responses must acknowledge the public health burden of anti-immigration rhetoric. Findings underscore the need for structural interventions to reduce anti-immigration sentiments at societal and political levels.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705855\/"},{"pmid":40705710,"journal":"Pain","title":"Chronic pain is associated with sleep apnea severity but attenuated by intermittent hypoxemia in people using opioids.","authors":"Orr JE; Bosompra NO; Norby B; Velazquez J; Khalaf A; DeYoung P; Schmickl CN; Sands SA; Jain S; He F; Goodin B; Wallace M; Owens RL; Malhotra A","abstract":"Patients using long-term opioids for pain often have uncontrolled symptoms which might drive ongoing opioid use and contribute to the opioid public health crisis. Opioids also cause sleep disordered breathing (SDB), which might impact pain via arousals and hypoxemia, with potential for a vicious cycle. Adults with noncancer pain using opioids daily for >3 months were recruited. Subjects underwent pain and sleep questionnaires, pain tolerance via 10 degrees C cold pressor testing, and polysomnography. Hypoxic burden was determined from polysomnographic signal analysis. Participants (n = 143) had a median (interquartile range) age of 60 (51, 67) years, body mass index 29 (25, 35) kg\/m2. 80 (56%) subjects were female. The median daily morphine equivalent dose was 20 (10, 45). 78% had an apnea-hypopnea index (AHI) >5\/hour and 41% with AHI >15\/hour. PROMIS pain interference scores differed across SDB severity, with increased symptoms in mild and moderate but not severe SDB. With increasing AHI, there was worsened pain (beta = 2.2 [95% confidence interval [CI]: 0.08, 4.4]; betastd = 1.3; P = 0.043), but this relationship was attenuated at higher levels of hypoxic burden (per interaction; beta = -0.42 [95% CI: -0.78, -0.06]; betastd = -0.85; P = 0.023). During cold pressor testing, there was a reduced time to hand withdrawal with increasing AHI (hazard ratio [HR] 2.60 [95% CI: 1.48, 4.57]; P = 0.001), but this was also attenuated at higher hypoxic burden (HR: 0.86 [95% CI: 0.78, 0.94]; P = 0.002). Overall, SDB is linked with worsened pain in those using opioids for chronic pain, but hypoxemia attenuates the effect. Individuals with the same AHI may have different symptoms depending on hypoxic burden. Interventional studies will help elucidate mechanisms and the role for SDB treatment in pain management.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705710\/"},{"pmid":40705707,"journal":"Pain","title":"Enhancing clinical translation of analgesics for neuropathic pain: a systematic review and meta-analysis on the role of non-evoked pain assessment in preclinical trials.","authors":"Huerta MA; Roza P; Cisneros E; Alique M; Roza C","abstract":"Current therapies for neuropathic pain are often inadequate and several promising preclinical drugs have failed in clinical trials. This may stem from an overreliance on reflex-based outcomes, which do not accurately reflect the spontaneous or non-evoked pain (NEP) characteristic of neuropathic pain. To bridge this gap, we evaluated the preclinical efficacy of standard analgesics in relieving NEP associated with neuropathic pain, thereby providing valuable insights that could optimize preclinical testing. A comprehensive search was performed in PubMed, Scopus, and Web of Science (July 2023). A random-effects model evaluated the effect of the intervention, with subgroup analyses exploring variability sources. Of the 91 included studies, 65 were eligible for meta-analysis, yielding 196 drug evaluations. Most evaluations involved traumatic nerve injury (91%) in male animals, although fewer were nontraumatic neuropathies (6%) or spinal cord injuries (4%). Standard pharmacotherapy for neuropathic pain relieved NEP with efficacy patterns closely matching clinical results. Tricyclic antidepressants and selective serotonin reuptake inhibitors showed the highest efficacy, followed by gabapentinoids and strong opioids, whereas nonsteroidal anti-inflammatory drugs and mild opioids had no significant effect. Next, we confirmed that all the NEP-related behaviors were significantly alleviated by standard analgesics, validating that they are indeed pain associated. Moreover, drug efficacy was greater in traumatic nerve injury models compared with nontraumatic neuropathy models. In conclusion, standard analgesics demonstrated robust preclinical efficacy in alleviating NEP, mirroring their clinical performance. These findings underscore the importance of incorporating assessments of spontaneous pain into classical tests in preclinical studies to enhance the clinical translation of investigational analgesics.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705707\/"},{"pmid":40705706,"journal":"Pain","title":"Familial risk of carpal tunnel syndrome among first-degree relatives and interaction with obesity and hyperglycemia-a population-based study in Korea.","authors":"Kim JE; Kim B; Kim HJ; Hwang J; Swan H; Kim YS; Cha J; Kang T; Kim KH; Kim M; Hann HJ; Kim KU; Ahn HS","abstract":"Although genetic and lifestyle factors are known to be involved in carpal tunnel syndrome development, population-level familial risk and interactions between gene and environmental factors have been scarcely studied. We investigated population-based familial risk and assessed the interactions between family history and obesity or hyperglycemia. By using the National Health Insurance database, which covers the total population in Korea, we constructed a cohort of 5,524,403 individuals with information on familial relationships and lifestyle factors from 2002 to 2019. Familial risk was calculated using hazard ratios (HRs) that compare the risk of individuals with and without affected first-degree relatives (FDRs). Interactions between familial risk and obesity\/hyperglycemia were assessed on an additive scale using the relative excess risk due to interaction (RERI). Individuals with affected FDRs showed a 1.99-fold increased risk of disease, with twin, brother, sister, paternal, and maternal risks (95% confidence interval) of 17.53 (9.43-32.58), 2.57 (2.20-3.00), 2.38 (2.04-2.77), 1.72 (1.60-1.86), and 1.95 (1.88-2.03), respectively. In the interaction analysis, the combined risk of positive family history and high body mass index or hyperglycemia exceeded the sum of their individual risks (HR 3.33 vs 2.55, 2.51 vs 2.28, respectively), showing statistically significant interactions (RERI 0.78, 0.23, respectively). Obese individuals with a family history (RERI 1.12) showed a more prominent interaction than overweight individuals (RERI 0.26), and similarly, excess risk was higher in severe hyperglycemic (RERI 0.82) compared with moderate hyperglycemic individuals (RERI 0.28), suggesting a dose-response interaction pattern. Our interaction findings indicate that individuals with a family history and obesity\/hyperglycemia should be considered a high-risk population.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705706\/"},{"pmid":40705703,"journal":"Pain","title":"Experience of endometriosis pain: a qualitative study.","authors":"de C Williams AC; Azadi A; McGrigor H","abstract":"Endometriosis is a common disorder in postpubertal women and often associated with pain in the pelvis and elsewhere. Pain and related symptoms, such as fatigue, adversely affect quality of life. Surgical and hormonal treatments have limited efficacy and can cause additional problems. There are surprisingly few studies of psychologically based interventions aimed at pain management and a better quality of life, although women with endometriosis are included within mixed chronic pain populations. As studies of pain management applied to endometriosis start to emerge, it is important to ascertain whether the assumptions of the dominant psychological model of pain, fear, and avoidance (developed mainly in musculoskeletal pain) are appropriate for the population and the problems associated with pain. We conducted a qualitative study of 16 women with endometriosis, using a very open interview technique (Grid Elaboration Method) and thematic analysis of women's accounts. We elicited 6 interrelated themes: 1 on the nature of pain; 3 on impact on everyday life, social life, and relationships, and emotions; 1 on healthcare experiences; and 1 on the burden of being female. Even when describing concerns about what was causing pain, women expressed few fears about physical integrity, nor did they avoid activities with the intention of protecting themselves from damage or increased pain. This leads us to question the applicability of the fear and avoidance model, and we encourage further exploration of the psychology of endometriosis-related pain to better design effective pain management interventions.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705703\/"},{"pmid":40704593,"journal":"Anesthesiology","title":"The role of supramammillary nucleus glutamatergic neurons in modulating consciousness transitions during propofol anesthesia in mice.","authors":"Li JY; Wu YH; Wang YH; Long S; Hu R; Huang WQ; Wang ZX","abstract":"BACKGROUND: Glutamatergic neurons in the supramammillary nucleus (SuM) have previously been shown to be pivotal parts of the wakefulness\/sleep regulation system. However, whether they play a role in propofol-mediated modulation of consciousness remains unclear. This study hypothesized that glutamatergic neurons in the SuM contribute to the regulation of altered states of consciousness under propofol anesthesia in mice. METHODS: The effects of propofol anesthesia on neuronal activity were measured by calcium fiber photometry recording. Lesions and chemogenetic activation were used to investigate the role of glutamatergic neurons in the SuM in anesthesia induction, emergence, and sensitivity to propofol. Optogenetic methods were used to further explore the effects of SuM glutamatergic neurons or the projections from the SuM to the medial septum (MS) on cortical activity and behavioral changes during the maintenance of propofol anesthesia. RESULTS: Activities of glutamatergic neurons in the SuM decreased before propofol-induced loss of consciousness and rapidly increased at the onset of consciousness recovery. Chemogenetic ablation of glutamatergic neurons in the SuM reduced the induction time (mCherry vs. caspase-3, mean +\/- SD, 150.1 +\/- 25.3 s vs. 97.3 +\/- 22.2 s, P < 0.001, n = 12) and prolonged the recovery time (1536.0 +\/- 422.8 s vs. 2672.0 +\/- 1048.0 s, P < 0.001, n = 12) under propofol anesthesia. Chemogenetic activation of glutamatergic neurons in the SuM had opposite effects. Optogenetic stimulation of glutamatergic neurons in the SuM or the neuronal projections from the SuM to the MS induced behavioral arousal and cortical activation during the maintenance of propofol anesthesia. CONCLUSIONS: Glutamatergic neurons in the SuM and their projections to the MS contribute to the regulation of altered states of consciousness under propofol anesthesia in mice.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40704593\/"},{"pmid":40704591,"journal":"Anesthesiology","title":"Sensory-selective peripheral and neuraxial nerve blockade with 2',6'-pipecolylxylidine.","authors":"Ostertag-Hill CA; Chen S; Xue T; Shao R; Torre M; Bin F; Vahedi Z; Chen L; Staffa SJ; Zheng Y; Kohane DS","abstract":"BACKGROUND: Safe sensory-selective local anesthetics would be a major advance in the management of acute and chronic pain. Here we describe the sensory-selective local anesthetic properties and the toxicity profile of a known metabolite of amino-amide local anesthetics, 2',6'-pipecolylxylidine (PPX). METHODS: PPX was synthesized and made into its hydrochloride salt. PPX or ropivacaine (ROP) were injected at the sciatic nerve or intrathecally in rats, who then underwent modified hotplate (sensory) testing and weight-bearing (motor) testing. Rats injected with PPX or ROP were assessed for clinical toxicity endpoints. Conduction blockade was studied with single-unit recordings in mice. Biocompatibility was assessed histologically. RESULTS: In male rats, sciatic sensory and motor block from 15 mM ROP lasted ~150 min; sensory nerve block from 30 mM PPX lasted 67.4 +\/- 17.4 min without motor block. Addition of chemical permeation enhancers to 30 mM PPX abolished sensory selectivity. Intrathecal 15 mM ROP produced sensory and motor block lasting ~15 min; sensory block from 30 mM PPX lasted 24.8 +\/- 8.7 min without motor block; repeated injection caused continuous sensory-selective block. In female rats, sciatic nerve blocks with ROP were similar to blocks in males, while blocks with PPX were sensory-selective but higher PPX concentrations were required. Ex vivo, 1.5 mM ROP caused reversible block of Adelta and C-fibers; 15 mM PPX blocked Adelta- but not C-fibers. Systemic 39.0 +\/- 1.8 mg\/kg ROP caused severe clinical toxicity; 75.3 +\/- 3.2 mg\/kg PPX caused none. Tissue reaction to PPX was benign, comparable to that of ROP. CONCLUSIONS: PPX provides sensory-selective local and neuraxial anesthesia with a good safety profile. The sensory selectivity may be attributable to the particular hydrophilic-hydrophobic balance of PPX.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40704591\/"},{"pmid":40702899,"journal":"European journal of anaesthesiology","title":"Incidence of transient sinus pause in cardiac rhythm increases with the use of hyperangulated videolaryngoscope blade compared to standard angle blade during tracheal intubation: A prospective randomised controlled trial.","authors":"Lee YJ; Lee S; Kim JW; Oh CS; Kim TY","abstract":"BACKGROUND: The hyperanglulated videolaryngoscope blade may exert different forces on the larynx compared to the standard angle blade, potentially leading to haemodynamic changes, particularly in cardiac rhythm. OBJECTIVE: This study aimed to investigate the impact of the hyperangulated blade on haemodynamic changes during tracheal intubation. DESIGN: A prospective randomised controlled trial. SETTING: Tertiary, university hospital, single centre. PATIENTS: A total of 134 patients scheduled for general anaesthesia were included in the final analysis. INTERVENTION: Tracheal intubation using either a standard angle videolaryngoscope blade (Standard group) or a hyperangulated blade (Hyperangulated group). MAIN OUTCOME MEASURES: The occurrence of a transient decrease in heart rate or a transient sinus pause during tracheal intubation was recorded. RESULTS: The incidence of transient sinus pause was significantly higher in the Hyperangulated group compared to the Standard group (19% vs. 4%, respectively, P = 0.009). The percentage of the glottic opening score was significantly higher, and the incidence of backward, upward, and rightward pressure was significantly lower in the Hyperangulated group. The incidences of direct epiglottis lifting was significantly higher in the Hyperangulated group, and the total length of time of the blade in the mouth was significantly longer in the Hyperangulated group. Multivariate logistic analysis identified the use of a hyperangulated blade as an independent predictor of transient sinus pause during tracheal intubation (odds ratio = 5.73, 95% confidence interval = 1.53 to 21.53; P = 0.010). CONCLUSION: The hyperangulated videolaryngoscope blade is associated with a higher incidence of transient sinus pause than the standard angle blade during tracheal intubation. TRIAL REGISTRATION: Clinical Research Information Service. Korea Centers for Disease Control and Prevention, Ministry of Health and Welfare (Republic of Korea). (Identifier: KCT0006534). Online address: http:\/\/cris.nih.go.kr.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40702899\/"},{"pmid":40707290,"journal":"British journal of anaesthesia","title":"Microglia-neuronal communication mediated by P2X4R-BDNF-TrkB promotes synaptic plasticity and anterior cingulate cortex hyperactivity in muscle pain chronicity.","authors":"Liang Y; Luo M; Xu Q; Zhang S; Niu S; Li X; Sun W; Song M; Wang L; Xing X; Wang J; Feng M; Zhao L; Chen H; Sheng R; Wang Y","abstract":"BACKGROUND: Microglia-neuronal communication is crucial for the development and maintenance of pain. However, the exact mechanisms underlying this interaction and its role in anterior cingulate cortex (ACC) circuitry in pain regulation are under exploration. METHODS: We explored the role of P2X4R-brain-derived neurotrophic factor (BDNF)-TrkB signalling of ACC in regulating muscle pain (MP). Mechanical and thermal pain thresholds along with open field tests were used to assess pain and anxiety-like behaviours. Golgi staining, transmission electron microscopy, and patch-clamp recordings were performed to evaluate synaptic plasticity changes. Meanwhile, cFos staining and calcium imaging substantiate the neuronal excitability. In addition, we used chemogenetic and optogenetic approaches to manipulate ACC neuronal activity. RESULTS: The ACC exhibited increased excitability, together with enhanced synaptic plasticity in rats with chronic MP. Microglial inhibition alleviated pain and anxiety-like behaviours. Furthermore, microglial P2X4R promoted BDNF expression, which acted on TrkB to regulate neuronal excitability and synaptic plasticity in ACC; these effects were reversed by P2X4R knockdown and TrkB inhibition in MP. Chemogenetic and optogenetic suppression of ACC hyperactivity relieved chronic MP and anxiety-like behaviours. CONCLUSIONS: Our findings highlight a critical microglia-neuronal communication via the P2X4R-BDNF-TrkB signalling, which enhances synaptic plasticity and cortical excitability in the anterior cingulate cortex, thereby participating in the regulation of muscle pain. Understanding how to assess and modulate microglia-neuronal communication and abnormal cortical activity will be key to developing novel therapies for MP disorders.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40707290\/"},{"pmid":40707288,"journal":"British journal of anaesthesia","title":"DAGs for dummies: how to extract causation from correlation.","authors":"Gaskell A; Sleigh J","abstract":"Directed acyclic graphs (DAGs) offer a clear, structured approach to depicting causal relationships in observational research, helping to distinguish likely causation from mere association. By explicitly mapping assumptions about confounders, mediators, and colliders, DAGs guide appropriate variable selection for adjustment and help avoid common sources of bias and confounding. This transparent framework supports more rigorous causal inference and serves as a compelling complement or alternative to large randomised controlled trials. Here we introduce some foundational principles of DAGs in support of recent DAG-guided work published around the SNAP-3 project.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40707288\/"},{"pmid":40707287,"journal":"British journal of anaesthesia","title":"Technology, evidence, and continuing clinical education: a role for self-directed learning?","authors":"Webster CS; Weller JM","abstract":"Clinical technology in anaesthesia is rapidly advancing, challenging clinicians to find the time for the vital task of keeping up-to-date with new equipment. Self-directed learning using video has been shown to be an effective and flexible method to meet this training challenge, but this mode of learning seems unlikely to entirely replace instructor-led learning.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40707287\/"},{"pmid":40707285,"journal":"British journal of anaesthesia","title":"Erector spinae plane block versus paravertebral block for major oncological breast surgery: a multicentre randomised controlled trial.","authors":"Raft J; Dureau S; Fuzier R; Auge M; Lamotte AS; Lemoine A; Albi-Feldzer A","abstract":"BACKGROUND: Breast cancer is the most common cancer in women, and oncological breast surgery often results in significant postoperative pain. Regional analgesia techniques such as thoracic paravertebral block (PVB) are effective but carry risks, whereas the erector spinae plane block (ESPB) is a newer, potentially safer alternative. We compared the efficacy of ESPB and PVB for managing acute pain after major breast cancer surgery. METHODS: This prospective, multicentre, randomised, double-blind trial involved 292 women who underwent major breast surgery. Patients were randomised to receive either ESPB or PVB. The primary outcome was the percentage of participants requiring morphine within the first 2 h after surgery, and the secondary outcomes included pain scores, morphine consumption, complications, and participants satisfaction. RESULTS: A total of 75.2% and 50.3% of the participants in the ESPB and PVB groups, respectively, required morphine, and the noninferiority criterion for ESPB was not met. However, morphine consumption was similar between the groups. Pain scores were greater in the ESPB group, especially during mobilisation, and ESPB provided less reliable dermatomal coverage than PVB, with the required area was not covered in 55.9% of participants in the ESPB group compared with 20.4% of participants in the PVB group. Satisfaction was similar between groups, with participants in both groups reporting high satisfaction. No major complications were observed. CONCLUSIONS: Compared with thoracic paravertebral block, erector spinae plane block did not meet the noninferiority criteria and was less effective for complete analgesia. Thoracic paravertebral block remains the preferred technique for major breast surgery. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (NCT04827030).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40707285\/"},{"pmid":40706477,"journal":"Journal of clinical anesthesia","title":"Impact of early high flow nasal oxygen on diaphragmatic function and pulmonary complications after thoracic surgery: A randomized clinical trial.","authors":"Fogagnolo A; Grasso S; Dres M; Azzolina D; Dalla Corte F; Dolci G; Tamburini N; De Paoli G; Murgolo F; Pedarzani E; Andalo A; Volta CA; Savino S","abstract":"BACKGROUND: Postoperative pulmonary complications (PPCs) are common after thoracic surgery, particularly in patients that develop postoperative diaphragmatic dysfunction. High-flow nasal cannula (HFNC) oxygen therapy decreases postoperative work of breathing and provides a positive end-expiratory pressure (PEEP) effect. As a result, it may decrease the occurrence of diaphragmatic dysfunction and PPCs after thoracic surgery. METHODS: Single-centre, open-label, randomized controlled trial. Patients undergoing video-assisted thoracoscopic lobectomy were randomized to receive conventional oxygen therapy (COT) or high flow nasal cannula oxygen therapy. In both groups, inspiratory oxygen fraction was titrated to reach a peripheral oxygen saturation of >94 %. Diaphragmatic displacement (DD) and diaphragmatic thickening fraction (TF%) were measured 2 and 24 h after surgery. Diaphragmatic dysfunction was identified by DD <10 mm. PPCs occurring within 7 days after study enrollment were recorded. RESULTS: We analyzed 116 patients in the study. Postoperative diaphragmatic dysfunction occurred in 17\/58 patients (29 %) in the HFNC group compared to 21\/58 (36 %) in the COT group (p = 0.55). The rate of PPCs was similar between the two groups: 32\/58 (55 %) in the HFNC group and 37\/58 (64 %) in the COT group (p = 0.449). Patients who developed postoperative diaphragmatic dysfunction experienced fewer PPCs when treated with HFNC (20\/37; 54 %) compared to COT (17\/21; 81 %) (p = 0.037). A post hoc mixed-model analysis confirmed that HFNC reduced the risk of PPCs in patients with diaphragmatic dysfunction (OR 0.16, 95 % CI 0.02-0.83). CONCLUSIONS: Early HFNC support does not decrease the rate of postoperative diaphragmatic dysfunction rate or respiratory complications. In patients who develop postoperative diaphragmatic dysfunction, HFNC may play a role in mitigating the risk of PPCs. CLINICAL TRIAL REGISTRATION: NCT05532033.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40706477\/"},{"pmid":40705704,"journal":"Pain","title":"A combined activity of peripheral nociceptive and nonnociceptive neurons is necessary to trigger spinal microglial reactivity and sustained pain.","authors":"Isler M; Chu Sin Chung P; Deftu AF; Kirschmann G; Decosterd I; Suter MR","abstract":"Abnormal activity in injured nerve fibers triggers spinal microglial reactivity, a critical step in the development of chronic postoperative pain. It remains unclear whether spinal microglia respond to inputs from nociceptive fibers alone or require combined activity from nociceptors and nonnociceptors. Using electrical and optogenetic approaches, we selectively activated different fiber subtypes without causing neuronal injury. Our findings demonstrate that only simultaneous activation of both nociceptive and nonnociceptive fibers induces sustained hypersensitivity and a spinal microglia response. This response is characterized by increased cell proliferation, altered electrophysiological profile with hyperpolarized membrane potential, increased potassium currents, and a less ramified morphology. In contrast, activation of nociceptive or nonnociceptive fibers alone does not induce these changes. In addition, inhibiting spinal microglia with minocycline prevents those changes. Overall, our study suggests that both types of peripheral sensory input are necessary to elicit microglial reactivity in the spinal cord and the subsequent development of sustained pain-related behavior.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705704\/"},{"pmid":40705692,"journal":"Pain","title":"Understanding the untreated course of adults with chronic pain seeking psychological intervention: a systematic review and meta-analysis.","authors":"Morgan Z; Scott A; Bisby MA; Chandra S; Hathway T; Correa AB; Dear BF","abstract":"The untreated course of chronic pain is not well understood, despite the importance of this information for treatment planning and benchmarking. This study examined symptom change over time and potential moderators in control groups of people seeking psychological pain management for chronic pain. After preregistration, we conducted a systematic literature search for RCTs of psychologically based treatment for chronic pain, which included a control condition whereby participants do not receive treatment (ie, waitlist control or no-treatment control). Meta-analyses were performed to determine that magnitude of symptom change across the control period for pain intensity, disability\/interference, depression, and anxiety. Several potential moderators were also analysed. Data were extracted from 52 eligible studies (n = 2190), and the average control period was 13.5 weeks (range: 3-34). Overall, untreated participants demonstrated very small but statistically significant improvements in pain intensity (g = -0.07; CI: -0.13, -0.01) and disability\/interference (g = -0.07; CI: -0.12, -0.01) over the control period. No significant change in depression (g = -0.06; CI: -0.11, 0.00) and anxiety (g = -0.05; CI: -0.11, 0.01) symptoms were observed. Some moderators were found. The findings suggest that people with chronic pain do not deteriorate or improve while waiting short periods of time for psychologically based pain management programs, contrary to some previous reports. Instead, the findings suggest that symptoms are relatively stable. These findings may be helpful for treatment and service planning as well as benchmarking activities concerning psychologically based pain management.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705692\/"},{"pmid":40705690,"journal":"Pain","title":"Silent information regulator sirtuin 1-mediated neuronal excitation-inhibition imbalance in the central amygdala is involved in peripheral nerve injury-induced depression-related behavior in mice.","authors":"Lin JT; Ding XB; Dong W; Wu WF; Lin YW; Zhou CR; Zhang CD; Chen C; Sun YM; Liu Q; Liu YP; Zhou CH; Wu YQ","abstract":"Chronic pain often coexists with depression. We have found that histone deacetylase Silent information regulator sirtuin 1 (SIRT1) is involved in peripheral nerve injury-induced depression-related behavior in mice. However, the underlying mechanism is still unclear. In this study, using a mouse spared nerve injury (SNI) model, we found that SIRT1 was downregulated in both glutamatergic and GABAergic neurons in the central amygdala (CeA) of mice with peripheral nerve injury-induced depression-related behavior. SIRT1 overexpression in CeA glutamatergic or GABAergic neurons effectively alleviated peripheral nerve injury-induced depression-related behavior in mice. Moreover, peripheral nerve injury induced significant neuronal excitation-inhibition (E-I) imbalance in CeA, manifested by the increased glutamatergic neuronal excitability and decreased GABAergic neuronal excitability in SNI mice. SIRT1 overexpression in CeA glutamatergic neurons decreased glutamatergic neuronal activity without influence on GABAergic neuronal activity, while SIRT1 overexpression in CeA GABAergic neurons increased GABAergic neuronal activity and reduced glutamatergic neuronal activity in SNI mice. Moreover, optogenetic induction of neuronal E-I imbalance in CeA by activating glutamatergic neurons or inhibiting GABAergic neurons reversed the improvement of peripheral nerve injury-induced depression-related behavior by SIRT1 overexpression. These findings suggest that the dysfunction of SIRT1 is related to the development of peripheral nerve injury-induced depression-related behavior by decreasing GABAergic neuronal excitability and enhancing glutamatergic neuronal excitability, leading to the neuronal E-I imbalance in CeA. These results demonstrate that SIRT1 is a key regulator in peripheral nerve injury-induced depression-related behavior.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705690\/"},{"pmid":40701802,"journal":"Regional anesthesia and pain medicine","title":"Addition of liposomal bupivacaine in brachial plexus blocks: a systematic review and meta-analysis of randomized controlled trials.","authors":"Shing CH; Wang F; Lam PM; Tsui OWK; Chan TCW; Wong SSC","abstract":"BACKGROUND: Adding liposomal bupivacaine to brachial plexus block may improve postoperative analgesia after upper limb surgery. OBJECTIVE: This study aimed to assess the postoperative analgesic efficacy of adding liposomal bupivacaine to brachial plexus block compared with non-liposomal local anesthetic. EVIDENCE REVIEW: A systematic literature search was conducted in PubMed, Web of Science, EMBASE, ClinicalTrials.gov, and the Cochrane Library up to June 30, 2024. Randomized controlled trials (RCTs) that evaluated the postoperative pain scores in patients who received liposomal bupivacaine via brachial plexus block were identified. The primary outcome was resting pain scores (Numerical Rating Scale, 0-10) at 24 hours after nerve block injection derived from the random effects model. A mean difference (MD) of 1\/10 was considered to represent a minimal clinically important difference in pain scores. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework was applied to examine the level of evidence. FINDINGS: 21 RCTs (1478 participants) were included. Liposomal bupivacaine was associated with statistically significant reduction in resting pain scores at 24 hours after nerve block injection compared with non-liposomal local anesthetic (MD=-1.04, 95% CI=-1.54 to -0.53, p<0.001, 95% prediction interval=-3.05 to 0.98). This was associated with significant heterogeneity (Q=107, p<0.001, I(2)=81%, tau(2)=1.0, 95% CI=0.42 to 2.07) and a low-GRADE rating. Liposomal bupivacaine was also associated with a statistically significant reduction in resting pain scores at 48 hours and 72 hours. Opioid consumption at 0-24 hours, 25-48 hours and 49-72 hours was lower in the liposomal bupivacaine group with statistical significance (p values <0.05). Liposomal bupivacaine was associated with a lower incidence of nausea. CONCLUSIONS: There is low-level evidence that liposomal bupivacaine in brachial plexus block may reduce pain intensity after upper limb surgery, but the clinical significance may be limited.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40701802\/"},{"pmid":40700091,"journal":"Anesthesia and analgesia","title":"Trends in Comorbidities and Complications Among Octogenarians and Nonagenarians Undergoing Primary Total Joint Arthroplasty in the United States.","authors":"Reisinger L; Cozowicz C; Zhong H; Illescas A; Giannakis P; Memtsoudis SG; Poeran J; Liu J","abstract":"BACKGROUND: With an aging population and gaining popularity of total knee and hip arthroplasty (TKA, THA), patients aged 80+ are likely to increase. These patients present unique challenges regarding perioperative risks. Large population data characterizing this group is lacking. The aim of this study was to offer an overview of trends in practices and outcomes among octogenarians and nonagenarians. METHODS: We utilized the Premier Healthcare database to identify patients undergoing TKA and THA from 2006 to 2022. Patients 80 to 88 years and 89+ years old were compared to those aged 65 to 70, the typical age group for TKA\/THA recipients. We evaluated trends of practice pattern, patient demographics, and comorbidity burden. Multivariable models were applied to compare major complications. RESULTS: Neuraxial anesthesia was used more frequently among older patients undergoing TKA. Mean length of stay for both TKA and THA continuously decreased over time. Interestingly, octogenarian and nonagenarian TKA recipients had fewer comorbidities than 65- to 70-year-olds, while the reverse was observed among THA recipients. Multivariable analysis showed that among patients with similar comorbidity burden, octogenarian and nonagenarian patients had higher odds [95% CI] of major complications (TKA: OR 2.2 [2.0-2.4] and 2.7 [2.0-3.7] in 2006, OR 1.8 [1.6-2.1] and 2.0 [1.5-2.8] in 2022, respectively; for THA: OR 2.5 [2.1-3.0] and 3.7 [2.7-5.1] in 2006, OR 2.1 [1.8-2.4] and 2.7 [2.1-2.4] in 2022, respectively). CONCLUSIONS: Although THA\/TKA patients appear to be in good health relative to 65- to 70-year-olds, age remains a significant risk factor for increased morbidity.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40700091\/"},{"pmid":40701886,"journal":"British journal of anaesthesia","title":"Factors associated with a reduction in the preventive effect of intravenous dexamethasone on rebound pain after axillary brachial plexus block.","authors":"Touil N; Pavlopoulou A; Barbier O; Libouton X; Gruson D; Gala JL; Lavand'homme P","abstract":"BACKGROUND: Rebound pain after regional anaesthesia remains a significant clinical problem. Intravenous dexamethasone is commonly used as an adjuvant to prevent rebound pain although its effectiveness varies among patients. We aimed to identify phenotypic and biological factors influencing glucocorticoid sensitivity contributing to dexamethasone resistance in the prevention of rebound pain. METHODS: Patients undergoing ambulatory upper limb surgery with an axillary brachial plexus block were enrolled prospectively to receive dexamethasone (0.1 mg kg(-1) i.v.) before surgery. Preoperative factors analysed encompassed clinical aspects (central sensitivity, anxiety, and pain scores) and biological parameters (salivary cortisol, annexin-A1, and blood inflammatory markers). Postoperative outcomes comprised rebound pain incidence (numerical rating scale >7 within the first 24 h) and persistent pain at 3 months. RESULTS: Of the 104 patients included, 36 (34.6%) developed rebound pain. Preoperative nocturnal awakening pain (odds ratio [OR]=3.09, P=0.03), severe anxiety (OR=3.54, P=0.01), high catastrophising score (OR=4.14, P=0.01), and low salivary cortisol levels (<1147 pg ml(-1)) (OR=3.33, P=0.02) were associated with an increased risk of rebound pain. Persistent pain at 3 months (27%) was associated with the presence of postoperative rebound pain (P=0.04). CONCLUSIONS: Preoperative nocturnal pain, severe anxiety, high catastrophising, and low salivary cortisol levels are factors that might reduce the efficacy of dexamethasone in preventing rebound pain. These findings support the development of personalised preventive strategies. CLINICAL TRIAL REGISTRATION: NCT05763433.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40701886\/"},{"pmid":40705694,"journal":"Pain","title":"Upregulated natriuretic peptide B expression as a hallmark of chronic itch.","authors":"Tseng PY; Liew HL; Ringkamp M; Nagao K; Hoon MA","abstract":"Chronic itch can arise from a variety of etiologies, ranging from dermatological conditions like eczema and psoriasis to systemic diseases such as liver disease and kidney failure. However, it remains unclear whether there are common molecular features associated with chronic itch, and whether these features are selective for chronic itch compared to chronic pain. To identify potential genes or molecular characteristics that are specifically associated with chronic itch, we examined transcriptomic data from sensory neurons collected from 3 mouse models of chronic itch and a monkey model of contact dermatitis. We compared these data to transcriptomic data from 3 mouse models of pain and clinical data from patients with neuropathic pain. Our analyses revealed that the upregulation of Nppb expression in sensory neurons is consistently associated with models of itch, but not with models of pain. Further, our cellular characterization showed that the increased expression of Nppb arises from increased cell-autonomous expression rather than the recruitment of Nppb expression in other classes of sensory neurons. Given that Nppb is a well-established itch neurotransmitter, our findings suggest that the increased expression of Nppb in sensory neurons may contribute to chronic itch. In addition, based on our results, we propose that Nppb could serve as a conserved biomarker for chronic itch.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705694\/"},{"pmid":40705693,"journal":"Pain","title":"Analgesic benefits of pharmacological and nonpharmacological sleep interventions for adults with fibromyalgia: a systematic review and meta-analyses.","authors":"Abolhosseini S; Malatesta A; Asmundson AJN; Gilron I; Salomons TV","abstract":"Fibromyalgia is a chronic musculoskeletal pain condition affecting 2% to 8% of the population. Most people with fibromyalgia experience poor sleep, and sleep problems consistently predict pain severity. Given the bidirectional relationship between sleep and pain, improving sleep may reduce fibromyalgia pain. This review identified trials of sleep-focused pharmacological and nonpharmacological interventions to evaluate whether they improved pain outcomes for adults with fibromyalgia. A systematic search of 7 electronic databases, 2 trial registries, and the reference lists of related studies retrieved 5728 records. Three independent reviewers completed study screening, data extraction, and risk of bias assessments. Nineteen studies met the inclusion criteria. Sleep interventions were evaluated against inactive and active control groups in a total of 10 trials with self-reported pain outcomes. Sodium oxybate significantly improved pain compared with placebo (4.5 g: MD = -9.55, 95% CI [-11.97, -7.12]; 6.0 g: SMD = -3.41, 95% CI [-6.49, -0.32]) at postintervention. Cognitive behavioural therapy (CBT) for insomnia also significantly improved pain compared with usual care (MD = -5.47, 95% CI [-9.64, -1.30]) at postintervention. Comparisons of CBT for insomnia with sleep hygiene training, and combined CBT for insomnia and pain with CBT for pain showed no significant postintervention differences. Other interventions (eg, melatonin and zopiclone) were identified but had insufficient data to allow meta-analysis. This review provided preliminary support for the analgesic benefits of some sleep interventions for adults with fibromyalgia. Long-term effects of sleep interventions on pain should be investigated to further inform treatment planning efforts.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705693\/"},{"pmid":40694882,"journal":"Journal of clinical anesthesia","title":"The utility of the Ascertain Dementia Eight-item Questionnaire (AD8) and Mini-Cog in detecting cognitive impairment in older surgical patients - The Detect CI study.","authors":"Yan E; Alhamdah Y; Campbell S; He D; Lovblom LE; Tang-Wai DF; Saripella A; Wong J; Chung F","abstract":"BACKGROUND: Brain health is often overlooked before surgery, missing an opportunity to identify at-risk patients. This study aimed to (1) examine the diagnostic performance of two ultra-rapid cognitive screening tools, the Ascertain Dementia Eight-item Questionnaire (AD8) and Mini-Cog, against a tool validated in surgical populations, the Montreal Cognitive Assessment (MoCA); and (2) compare preoperative patient-centered assessments and postoperative outcomes between those with and without cognitive impairment (CI). METHODS: CI was classified by scoring >\/=2 on the AD8, <\/=2 on the Mini-Cog, and\/or <\/=25 on the MoCA in non-cardiac patients >\/=65 years old. RESULTS: Of 394 participants, 35 % had preoperative CI on the MoCA, 15 % on the AD8, and 12 % on the Mini-Cog. Both the AD8 and Mini-Cog demonstrated moderate area under the curve, with superior specificity over sensitivity. In contrast to the Mini-Cog, participants with CI on the MoCA and AD8 reported poorer preoperative patient-centered assessments than those without. Specifically, the AD8 was associated with poorer functional disability, frailty, anxiety and\/or depression, pain level, sleep quality, and quality of life. Contrary to the MoCA and Mini-Cog, CI on the AD8 was associated with higher all-cause complications (15.1 % vs. 3.7 %, P = 0.003), emergency department visits (11.3 % vs. 2.5 %, P = 0.007), and composite adverse outcomes (15.1 % vs. 4.6 %, P = 0.008) at 90 days. CONCLUSIONS: Although the AD8 and Mini-Cog demonstrated comparable diagnostic accuracy for CI, the AD8 provided additional insights into preoperative patient-centered assessments and 90-day adverse outcomes. Our study emphasizes the importance of preoperative screening for CI, highlighting the AD8 as a valuable tool.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40694882\/"},{"pmid":40691088,"journal":"Regional anesthesia and pain medicine","title":"The impact of local anesthetic systemic toxicity advisories on reporting to the National Poison Data System (NPDS).","authors":"Fettiplace M; Weinberg G; Nixon H; Barabanova A; Chiang C; Gitman M","abstract":"INTRODUCTION: In 2010, multiple anesthesia societies introduced recommendations for treating local anesthetic systemic toxicity, but the impact of those recommendations is uncertain. OBJECTIVE: To test the hypothesis that reports of local anesthetic-related poisoning and mortality have declined since the publication of advisories in 2010. METHODS: We analyzed reports of local anesthetic poisoning and mortality from the American Poison Centers National Poison Data System (NPDS) spanning 1983-2022. We conducted a case-non-case disproportionality analysis using the reporting odds ratio (ROR) to evaluate the effect of the 2010 recommendations on reports of poisoning and death to the NPDS by comparing reports of poisoning and death from 2011 to 2022 relative to 2001-2010. Multiple linear regression and Poisson regression were used for confirmation, together with exploratory analyses of individual cases of mortality. RESULTS: In the decade following the introduction of recommendations (2011-2022), reports of local anesthetic poisoning decreased relative the prior decade (2001-2010, ROR=0.77, 95% CI 0.76 to 0.78, p<0.0001), driven by a decrease in non-lidocaine-related reports. Conversely, reports of lidocaine poisoning and reports of lidocaine mortality increased after 2010 (ROR=2.7 95% CI 1.3 to 5.6, p=0.0094). Case analysis revealed a decrease in reports of death in the operating room from 47% before 2010 to 15% after 2010, but an increase in reports of death from intravenous lidocaine delivery (3% to 27%, respectively). DISCUSSION: The decrease in poisoning reports aligns with the implementation of professional recommendations and advancements, such as ultrasound-guided nerve blocks and lipid emulsion therapy. However, the rise in reports of lidocaine-related deaths-primarily in emergency settings-underscores significant risks. These findings emphasize the need for improved guidance on lidocaine use and dosing strategies to prevent lidocaine-related mortality.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40691088\/"},{"pmid":40690383,"journal":"Anesthesia and analgesia","title":"Prevalence of Point-of-Care Ultrasound Abnormalities and Raised Serum NT-proBNP in Early-Onset Preeclampsia.","authors":"Fantin RL; Uys F; Schuetz T; Flint M; Lombard CJ; Matjila MJ; Osman A; Swanevelder JL; Dyer RA; Ortner CM","abstract":"BACKGROUND: Preeclampsia is a multisystem disorder associated with adverse maternal and fetal outcomes. A previous study in patients with late-onset preeclampsia (LOPE), showed an association between pulmonary interstitial syndrome (PIS), detected by lung ultrasound, and elevated left ventricular end-diastolic pressure (LVEDP), measured by transthoracic echocardiography (TTE). In early onset preeclampsia (EOPE); however, the cardiopulmonary status remains poorly characterized. METHODS: This prospective observational cohort study enrolled women with EOPE with severe features. Point of care ultrasound (POCUS) assessments included lung ultrasound, TTE, and sonographic assessment of the optic nerve sheath diameter (ONSD). PIS was defined as the presence of bilateral B-lines on lung ultrasound. An ONSD >5.8 mm was considered compatible with raised intracranial pressure. Serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) and albumin levels were measured. The primary aim was to assess the association between PIS and elevated LVEDP in EOPE. Secondary aims included assessing the prevalence of POCUS abnormalities in EOPE and their association with serum NT-proBNP and albumin levels, and comparing the results with historical data from patients with LOPE. RESULTS: Sixty-4 patients completed the study. There was no association between PIS and elevated LVEDP (P = .53). PIS, diastolic dysfunction, systolic dysfunction, and elevated LVEDP were observed in 23% (95% CI, 14.4-35.4%), 52% (95% CI, 39.3-63.8%), 30% (95% CI, 19.9-42.5%), and 35% (95% CI, 24.2-47.6%) of women, respectively. Increased ONSD was noted in 2 women (3%). Median (IQR) NT-proBNP levels were significantly elevated (278 [119-678] ng\/L) and associated with PIS (P = .015) and elevated LVEDP (P = .003). Using a threshold for NT-proBNP of 125 ng\/L, the sensitivity and specificity for predicting PIS were 93.3% and 34%, and for increased LVEDP, 90.5% and 40%, respectively. Receiver operating characteristic analysis showed limited diagnostic value of NT-proBNP for PIS (AUC = 0.78) and for elevated LVEDP (AUC = 0.68). No association was found between serum albumin and PIS, systolic dysfunction, or elevated LVEDP. The prevalence of systolic dysfunction was significantly higher (P < .01) and raised ONSD lower (P < .01) than in historical controls with LOPE. CONCLUSIONS: Lung ultrasound and TTE showed a high prevalence of PIS, systolic dysfunction, and raised LVEDP in women diagnosed with EOPE. PIS was not associated with elevated LVEDP. NT-proBNP level was significantly associated with PIS and elevated LVEDP, however clinical predictive value was limited. Women with EOPE had a higher prevalence of systolic dysfunction than those with LOPE.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40690383\/"},{"pmid":40690380,"journal":"Anesthesia and analgesia","title":"High-Flow Nasal Oxygen versus Mechanical Ventilation Through a Laryngeal Mask During General Anesthesia Without Muscle Paralysis: A Randomized Clinical Trial.","authors":"Frassanito L; Grieco DL; Vassalli F; Piersanti A; Scorzoni M; Ciano F; Zanfini BA; Catarci S; Catena U; Scambia G; Antonelli M; Draisci G","abstract":"BACKGROUND: Apneic oxygenation with high-flow nasal oxygen is a novel intraoperative respiratory support strategy for patients undergoing general anesthesia, but data about its clinical effects are scarce. We conducted a randomized trial to assess whether high-flow nasal oxygen is noninferior to mechanical ventilation through a laryngeal mask in terms of success rate of intraoperative respiratory support among patients undergoing a 30-minute general anesthesia session. METHODS: Single-center, randomized, noninferiority trial conducted in Italy between May 2022 and June 2023 and involving American Society of Anesthesiologists class I and II patients undergoing general anesthesia for operative hysteroscopy. Participants were randomized to receive laryngeal mask ventilation (volume-controlled ventilation to obtain end-tidal carbon dioxide between 35 and 45 mm Hg, inhaled oxygen fraction to achieve peripheral oxygen saturation greater than 95%) or high-flow nasal oxygen (70 L per minute, inhaled oxygen fraction of 100%) for intraoperative respiratory support. Patients received general anesthesia with propofol target-controlled infusion without neuromuscular blockade. Primary outcome was intraoperative respiratory support success rate, which was defined as peripheral oxygen saturation greater than 94% and transcutaneous carbon dioxide lower than 65 mm Hg with no need for rescue airway interventions for the entire procedure. Secondary outcomes included the rate of airway-related complications (including need for bag-mask or laryngeal mask ventilation, or tracheal intubation), postoperative respiratory symptoms, and postoperative dyspnea. RESULTS: All 180 patients who were randomized completed the trial (90 patients in each group). Median [interquartile range] anesthesia duration was 25 [20-36] minutes in high-flow group and 32 minutes [27-44] in the laryngeal mask group. Intraoperative respiratory support was successful in 89 patients (99%) in both groups (absolute difference 0, unilateral 95% confidence interval, 3%, noninferiority P < .001). Incidence of postoperative respiratory symptoms was significantly lower in high-flow versus laryngeal mask group (2% vs 19%, P < .001), while airway-related complications and postoperative dyspnea were not different. Intraoperative transcutaneous carbon dioxide was significantly higher in high-flow group, with 43% of patients showing values greater than 55 mm Hg. CONCLUSIONS: High-flow nasal oxygen is noninferior to laryngeal mask ventilation for intraoperative respiratory support during 30-minute general anesthesia without muscle paralysis. The risk of hypercarbia warrants careful patient selection and monitoring.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40690380\/"},{"pmid":40690301,"journal":"Anesthesiology","title":"Evaluation of the potential for lung recruitment with the Recruitment-to-Inflation ratio during general anesthesia.","authors":"Rosa T; Menga LS; Mastropietro C; Settanni D; Russo A; Frassanito L; Cascarano L; Catarci S; Delle Cese L; Zanfini BA; Scaramuzzo G; Dell'Anna AM; Spadaro S; Antonelli M; Grieco DL","abstract":"BACKGROUND: During general anesthesia, the effect of positive end-expiratory pressure (PEEP) on lung injury depends on the potential for lung recruitment, which is variable among patients. The recruitment-to-inflation ratio (R\/I) is measured from ventilator data during a single-breath PEEP-release maneuver, and has been proposed to assess recruitability without the need for additional equipment during acute respiratory distress syndrome. This study hypothesized that R\/I reliably estimates the individual potential for lung recruitment during general anesthesia. METHODS: Twenty patients undergoing open abdominal surgery received mechanical ventilation with PEEP=12 cmH 2 O for thirty minutes, which was then abruptly reduced to 2 cmH 2 O. Finally, a decremental PEEP trial was performed to measure collapse and overdistension at each level. Gas exchange, end-tidal CO 2 , respiratory mechanics by ventilator waveform analysis, regional overdistension and collapse by electrical impedance tomography, end-expiratory lung volume and functional residual capacity by nitrogen dilution were measured. R\/I was calculated during the single-breath derecruitment maneuver from ventilator data. RESULTS: R\/I (median=0.41, range=0-0.86) was linearly correlated with recruited volume normalized to functional residual capacity measured by gas dilution (r=0.48, slope=0.27 [0.03, 0.52]), and recruited volume scaled to PEEP-induced inflation volume measured by tomography (r=0.82, slope=1.2 [0.77, 1.64]). Compared to patients with R\/I<\/=0.40 (n=10), those with R\/I>0.40 (n=10) required higher PEEP to optimize regional mechanics and balance collapse and overdistension (median [Q1, Q3]: 10 [8, 11] cmH 2 O vs. 8 [7, 9], p=0.03), showed decreases in dead space (-2 [-5, 1] % vs. 3 [0, 5] %, p=0.013) and greater reductions in collapse (-44 [-31, -47] % vs. -30 [-20, -38] % , p=0.016) and dynamic lung strain (-0.06 [-0.09, -0.05] vs. -0.04 [-0.05, -0.02], p=0.04) with higher PEEP. CONCLUSIONS: During general anesthesia, R\/I reflects potential for lung recruitment. R\/I may help identify patients in whom higher PEEP improves physiology and may favor less injurious ventilation.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40690301\/"},{"pmid":40689673,"journal":"Anaesthesia","title":"Comparison of two peripheral regional analgesic techniques for primary elective total hip arthroplasty: a randomised clinical trial.","authors":"Buffoli F; Bonetti C; Pugno C; Minini A; Bettinelli S; Mancini A; Colombi A; Benigni A; Mariano ER; Lorini LF; Bugada D","abstract":"INTRODUCTION: Several regional anaesthesia techniques have been used in the peri-operative pain management of patients who undergo primary elective total hip arthroplasty. The erector spinae plane, pericapsular nerve group and lateral femoral cutaneous nerve blocks offer motor-sparing analgesia of the hip region but target different areas. We designed this study to compare the pericapsular nerve group block combined with lateral femoral cutaneous nerve block with the erector spinae plane block in terms of postoperative analgesia and motor impairment. METHODS: Our study involved patients undergoing primary elective unilateral total hip arthroplasty. All patients received spinal anaesthesia and standardised peri-operative multimodal analgesia. Patients were assigned at random to either pericapsular nerve group and lateral femoral cutaneous nerve blocks ('anterior' block group) or erector spinae plane block ('posterior' block group). The primary outcome was intravenous morphine consumption within the first 24 h postoperatively. Secondary outcomes included: pain scores; assessment of sensory and motor block; incidence of complications; and incidence of chronic postsurgical pain. RESULTS: Sixty-two patients completed the study. The study groups were comparable in baseline characteristics. There was no difference in morphine consumption at 24 h between patients allocated to the anterior and posterior block groups (median (IQR [range]) 5 (1-10 [0-22]) mg vs. 5 (2-8.5 [0-20]) mg, respectively; p > 0.99). Incidence of motor block was 1\/31 for patients allocated to the anterior block group compared with 5\/31 for those allocated to the posterior block group (p = 0.09). There were no differences in any of the secondary outcome measures between groups. DISCUSSION: We found no statistically or clinically relevant difference between two motor-sparing peripheral regional analgesic techniques among patients undergoing primary elective total hip arthroplasty with multimodal analgesia. Appropriate choice of block may be situation-dependent, and physicians should consider patient and system factors when selecting a technique.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40689673\/"},{"pmid":40489632,"journal":"Anesthesiology","title":"Clinical and Genetic Factors Associated with Intraoperative Minimum Alveolar Concentration Ratio: A Single-center Retrospective Cohort and Genome-wide Association Study.","authors":"Douville NJ; Jewell ES; Zhao X; Colquhoun DA; Bertucci-Richter E; Zollner S; Davis RP; Kumar SS; Mashour GA","abstract":"BACKGROUND: Minimum alveolar concentration (MAC) is a standard dosing metric for general anesthesia. Although influences of MAC have been identified in controlled studies, the determinants of clinical delivery of MAC ratio are largely unknown. To address this knowledge gap, the authors performed this single-center retrospective study. The primary objective was to understand factors associated with MAC ratio, as indexed by the end-tidal volatile anesthetic concentration, for a given case. It was hypothesized that mean arterial pressure (MAP) was strongly associated with anesthetic delivery; a secondary objective was to perform a genome-wide association study to identify genetic variants associated with MAC ratio in clinical practice. METHODS: The primary outcome was mean age-adjusted MAC ratio during the maintenance phase of anesthesia. The primary exposure variable was mean MAP during the same time window. The correlation between the outcome, exposure, and a variety of demographic, laboratory, procedural, and anesthetic covariates was assessed in adjusted multivariable linear regressions. Next, the authors performed two genome-wide association studies of clinically delivered MAC ratio. RESULTS: Of the 30,125 cases included in the final dataset, mean +\/- SD age-adjusted MAC ratio was 1.066 +\/- 0.173, and mean MAP was 82 +\/- 10 mmHg. MAP was associated with MAC ratio in the overall model (beta = 0.0028; 95% CI, 0.0024 to 0.0032; P < 0.0001). A variety of demographic ( e.g. , female sex: beta = -0.0182; 95% CI, -0.0219 to -0.0144; P < 0.0001), laboratory, surgical, and anesthetic factors were also associated with anesthetic agent concentration. Eight variants located near six genes ( DPH6 , CPM , EEFSEC , SGSM1 , CDH9 , and DISC1 ) reached the lower suggestive threshold ( P < 1 x 10 -6 ) in one but not both models; none exceed the threshold for genome-wide significance ( P < 5 x 10 -8 ). CONCLUSIONS: The hypothesis was verified that MAP was associated with clinical delivery of MAC ratio. The authors also characterized practice patterns of inhalational anesthetic management and identified numerous covariates that need to be accounted for when modeling anesthetic requirements. Female patients received lower doses of anesthetic, despite evidence that they have a higher requirement. While genome-wide association studies failed to identify novel variants at the level of genome-wide significance ( P < 5 x 10 -8 ), multiple mechanistically plausible genes were suggested. Notably, the DISC1 gene has been shown to impact resting-state brain activations under general anesthesia with isoflurane and has been linked to abnormal sleep\/wake patterns.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40489632\/"},{"pmid":40685291,"journal":"British journal of anaesthesia","title":"Predicting arterial pressure without prejudice: towards effective hypotension prediction models.","authors":"Vistisen ST; Elbers P","abstract":"Selection bias has been identified in hypotension prediction models, but its impact on an algorithm's ability to learn relevant information from the arterial waveform remains unclear. The recent study by Yang and colleagues sheds considerable light on this by training and evaluating a deep learning prediction model with biased and unbiased data selections. Unbiased training data allowed an algorithm to learn modestly more than just current blood pressure and the bias significantly distorted and inflated the positive predictive value. We discuss these findings and offer suggestions for further developing effective hypotension prediction algorithms.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40685291\/"},{"pmid":40683805,"journal":"British journal of anaesthesia","title":"Response of the Conox quantitative electroencephalographic monitor to neuromuscular block in awake volunteers.","authors":"Schuller PJ; Pretorius JPG; Newbery KB","abstract":"BACKGROUND: The Conox monitor analyses the frontal EEG to generate two indices of anaesthetic effects: qCON, intended to indicate the level of consciousness, and qNOX, designed to reflect responsiveness to noxious stimuli. Two similar quantitative EEG devices, BIS and Entropy, have been shown to require muscle activity (EMG) to generate accurate index values in awake individuals. Without EMG, these devices produce misleadingly low values and incorrectly suggest sedation or anaesthesia despite the cortical EEG showing the subjects are awake. As EMG affects frequency bands used by Conox, it too could be incorporating muscle activity to generate high values in awake individuals. METHODS: We replayed EEGs recorded during awake paralysis to the Conox monitor via an electronic playback system to test whether it requires EMG to generate accurate values in awake subjects. RESULTS: Both qCON and qNOX decreased after neuromuscular block to values consistent with sedation or anaesthesia, despite subjects being fully awake. qCON decreased below 60 in 15 of 19 trials, and qNOX decreased below 60 in 11 of 19 trials. Overall, 42% of qCON values during paralysis were <60, the level supposedly indicating anaesthesia. CONCLUSIONS: Conox requires muscle activity to generate accurate values in awake individuals. Consequently, it might be an unreliable indicator of awareness in patients who have received neuromuscular blocking drugs. Studies conducted without neuromuscular block can provide misleading guidance when applied to Conox use in paralysed patients. Clinicians should approach manufacturer guidelines with caution and not rely solely on index values to guide dosing of anaesthetic drugs.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40683805\/"},{"pmid":40682867,"journal":"Journal of clinical anesthesia","title":"Electroencephalographic changes related to cortico-subcortical decoupling during propofol-induced loss of consciousness: A secondary analysis of a prospective observational study.","authors":"Fernandez-Candil JL; Nuttall R; Gallart L; Schneider G; Blanco-Hinojo L; Martinez-Vilavella G; Pujol J; Adalid I; Berger S; Bujosa D; Deus J; Gambus PL; Jaramillo S; Molto L; Ortega JF; Pacreu S; Perez-Sola V; Vila E","abstract":"BACKGROUND: Cortico-subcortical decoupling has been observed in functional magnetic resonance imaging (fMRI) during slow propofol-induced loss of consciousness (LOC). However, corresponding electroencephalography (EEG) free of the cardioballistic and fMRI artifacts is essential for translating decoupling observations to clinical monitoring. OBJECTIVE: To describe artifact-corrected EEG changes corresponding to cortico-subcortical decoupling at LOC. DESIGN: Secondary analysis of a prospective observational study. SETTING: Tertiary-care hospital, data collection from June 2017 to January 2019. PARTICIPANTS: Nineteen healthy volunteers receiving a targeted propofol infusion. INTERVENTIONS: Frontal EEG was recorded synchronously with clinical signs and fMRI. Gradient artifact correction was based on iterative peak detection. Cardioballistic artifact correction was accomplished with a recently described algorithmic method based on peak detection combined with temporal constraints. MAIN OUTCOME MEASURES: The qCON index and frontal EEG before and after decoupling at LOC. RESULTS: Algorithm-filtered EEG tracings were suitable for analysis in 16 subjects. Propofol-induced LOC was achieved at a median (IQR) target plasma concentration of 4.5 (3.91 to 4.61) mug\/mL and an effect-site concentration of 4.0 (2.94 to 4.31) mug\/mL. The qCON index remained over 80 before decoupling and gradually decreased to values below 60 afterwards. Frontal alpha band power increased significantly from a median of 0.07 (0.03 to 0.15) 30 s before decoupling to 0.48 (0.08 to 0.58) 30 s after decoupling (p < 0.001). CONCLUSIONS: Cortico-subcortical decoupling related to propofol-induced LOC coincides with a gradual decrease in the qCON index and an increase in frontal alpha power. These results help translate fMRI findings to bedside settings. Registered at EudraCT (reference 2016-004833-25). Principal Investigator: Juan L. Fernandez-Candil. Date of registration: January 4, 2017. Start Date: June 13, 2017.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40682867\/"},{"pmid":40681389,"journal":"British journal of anaesthesia","title":"Development and validation of a predictive model for transfusion in major abdominal surgery: a multicentre retrospective study.","authors":"Sim JH; Oh AR; Kim S; Park YS; Ha S; Kim JU","abstract":"BACKGROUND: Blood products are limited resources and preoperative transfusion often relies on protocols or clinical experience rather than objective risk assessment. Thus a systematic and accurate prediction strategy is needed for efficient blood utilisation and timely administration. We developed and validated a nomogram to predict intraoperative red blood cell (RBC) transfusion. METHODS: We developed a nomogram that integrates preoperative variables to predict intraoperative RBC transfusion in patients undergoing major abdominal surgery at a tertiary care hospital (2012-21). The model was externally validated with datasets from other tertiary hospitals and an open dataset. Variables were selected using least absolute shrinkage or selection operator logistic regression. Discriminative ability was assessed with C-statistic, and calibration plots were used to evaluate the agreement between predicted and observed outcomes. RESULTS: This retrospective study included 128 749 patients for model development and 71 590 and 3701 patients in two external validation sets, respectively. Intraoperative RBC transfusion occurred in 6.0% of patients in the development set, and in 4.5% and 7.3% of patients in the two validation sets, respectively. The nomogram incorporated seven preoperative variables including age, American Society of Anesthesiologists physical status, European Society of Cardiology surgical risk, haemoglobin, concentration, platelet number, international normalised ratio, and albumin concentration. The nomogram showed good predictive ability with C-statistics of 0.857 (95% confidence interval [CI]: 0.852-0.861), 0.847 (95% CI: 0.840-0.854), and 0.848 (95% CI: 0.822-0.873) in the development and external validation sets, respectively, demonstrating good calibration across the predicted probability range. CONCLUSIONS: This nomogram, integrating seven preoperative variables, can effectively predict intraoperative transfusion in major abdominal surgery. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (NCT06847490).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40681389\/"},{"pmid":40674546,"journal":"Anesthesiology","title":"\"The pain and suffering are just too great for me to manage\": A qualitative study of emotional distress among anesthesiologists after challenging clinical events.","authors":"Burns CJ; Marzoughi M; Sinko L; Saddawi-Konefka D; Stratton K; Sigakis M; Wixson M; Simmons S; Ramirez M; Kheterpal S; Was A","abstract":"BACKGROUND: Anesthesiologists manage acute clinical events that can cause emotional distress. These experiences can lead to mental health challenges and affect clinicians' ability to provide care. However, the literature regarding specific factors of clinical events that cause emotional distress is limited, and their impact remains understudied. The objectives were to explore elements within anesthesiologists' practice environment contributing to distress associated with clinical events and elicit emotions and symptoms regarding clinical events that are distressing long-term. METHODS: Anesthesiology faculty members at an academic institution were invited to engage in 30-minute individual qualitative interviews. They were prompted to reflect on a clinical event that caused them lasting emotional distress. Questions were based on risk factors for post-traumatic stress disorder, focusing on two time periods: during the event and after it. To maintain study rigor, a trustworthiness framework was used that emphasized four components: transferability, dependability, credibility, and confirmability. A thematic analysis approach with two coders followed, with an audit trail maintained throughout. RESULTS: Twenty anesthesiology faculty members representing nine anesthesiology subspecialties were interviewed. Risk factors leading to emotional distress represented three areas: the clinical event, context, and patient. Clinical-related risk factors included clinical errors, a physician's first time encountering a clinical scenario, lack of adequate clinical support, and unexpected outcomes. Contextual risk factors involved legal and professional repercussions, mistreatment by non-anesthesiology colleagues, personal stress, and unsupportive leadership. Patient-related risk factors included having developed a close relationship with the patient, a patient's similarity to the clinician or their loved ones, and young patient age. Participants described emotions such as sadness, guilt, shame, helplessness, and self-doubt, and physical symptoms of emotional stress, flashbacks, and intrusive thoughts. CONCLUSIONS: Anesthesiologists experience profound and lasting emotional impacts from challenging clinical events. Future research should evaluate interventions to mitigate these impacts on anesthesiologists' mental health and career longevity.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40674546\/"},{"pmid":40674264,"journal":"Anesthesia and analgesia","title":"Remote Continuous Vital Sign Monitoring of Scoliosis Surgery Patients on General Wards: A Cost-Effectiveness Analysis.","authors":"Trentino KM; Hoque ME; Lloyd A; Trentino L; Ienco R; Murray K; Bowles T; Wulff S; Burcham J; Thompson A; Waterer G","abstract":"BACKGROUND: Scoliosis surgery patients often require continuous postoperative monitoring in intensive care (ICU) or high-dependency units (HDU). We implemented a 24-hour remote continuous monitoring service for high-risk inpatients (HIVE) to allow monitoring in general wards. This study aimed to evaluate the cost-effectiveness of the HIVE service. METHODS: We compared scoliosis surgery patients admitted pre- and postimplementation of the HIVE service and applied multivariable regression to adjust for differences in baseline characteristics. The primary outcome was incremental cost per ICU hour avoided. RESULTS: We compared 155 patients admitted postimplementation to 133 admitted preimplementation. In the adjusted analysis, the post-HIVE implementation period avoided 27.1 hours in ICU and reduced overall health care costs by AU$2682 (US$2164) per patient, compared with preimplementation. There were no statistically significant differences in hospital length of stay (rate ratio [RR], 1.01; 95% confidence interval [CI], 0.93-1.11; P = .785), emergency readmissions (odds ratio [OR], 0.93; 95% CI, 0.44-1.99; P = .854), or hospital-acquired complications (OR, 0.68; 95% CI, 0.27-1.66; P = .393). CONCLUSIONS: In scoliosis surgery, the implementation of a remote continuous inpatient monitoring service reduced inpatient costs and hours in ICU. In this group of patients, the HIVE service provides economic evidence of the cost-effectiveness of remote monitoring.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40674264\/"},{"pmid":40674253,"journal":"Anesthesia and analgesia","title":"Deep versus Moderate Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recovery and Immune Function: A Randomized Controlled Trial.","authors":"Bijkerk V; Jacobs LMC; Rijnen WHC; Keijzer C; Warle MC; Visser J","abstract":"BACKGROUND: Deep neuromuscular blockade (NMB) enhances surgical working conditions in laparoscopic surgery. Whether this accounts for nonlaparoscopic surgery is not known. Additionally, the effect on clinical and patient-reported outcomes remains debated. In this study, the effect of deep NMB compared to moderate NMB during total hip arthroplasty (THA) on quality of recovery and postoperative inflammation is investigated. METHODS: This single-center randomized controlled blinded trial comprised 100 patients undergoing THA treated with deep NMB (posttetanic count 1-2) or moderate NMB (train-of-four 1-2). Continuous or bolus administration of rocuronium was used. The primary end point was quality of recovery on postoperative day 1 (POD1), measured by the Quality of Recovery-40 (QoR-40) questionnaire. The secondary end points were innate immune function and pain scores on POD1, measured by ex vivo production capacity of tumor necrosis factor (TNF) and interleukin (IL)-1beta on whole blood stimulation with lipopolysaccharide and postoperative pain as rated by the numeric rating scale. RESULTS: There was no difference in QoR-40 score on POD1 (mean difference -4.1, 95% confidence interval -10.9 to 2.8, P = .241). On POD 1, there was no difference in ex vivo production capacity of TNF (moderate NMB median [quartiles] 890 [532-1605] pg\/mL, deep NMB 1113 [651-1716] pg\/mL, P = .34, Mann-Whitney U test, median difference -125, 95% confidence interval [CI], -440 to 155) and IL-1beta (moderate NMB 1148 [545-1970] pg\/mL, deep NMB median 1386 [826-1940] pg\/mL, P = .36, median difference [MD] -135, 95% CI, -470 to 191) on lipopolysaccharide stimulation. On POD1, there was no statistically significant difference in pain scores at rest (MD 1.10, 99.6% CI, -0.53 to 2.74, P = .049) and on movement (MD 0.94, 99.6% CI, -0.63 to 2.50, P = .080). CONCLUSIONS: No evidence was found for a beneficial effect of deep NMB compared to moderate NMB in THA regarding quality of recovery or postoperative inflammation.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40674253\/"},{"pmid":40673736,"journal":"European journal of anaesthesiology","title":"The effect of methylprednisolone on the reversal time of rocuronium by sugammadex in the paediatric patient group: A randomised controlled trial.","authors":"Buyukcavlak M; Tire Y; Mermer A; Yuce MS; Yildirim SN; Kozanhan B","abstract":"BACKGROUND: Sugammadex is an effective agent for reversing aminosteroid neuromuscular blocking agents, but its effectiveness can be influenced by interactions with steroid-based drugs. Previous studies suggest corticosteroids may affect sugammadex effectiveness, but data on methylprednisolone in paediatric patients is limited. OBJECTIVE: This study aimed to determine whether methylprednisolone administration at induction affects the reversal time of rocuronium by sugammadex. DESIGN: Single centre, double blinded, randomised controlled trial. SETTINGS: Turkish tertiary care centre from September 2024 to January 2025. STUDY POPULATION: Paediatric patients undergoing elective adenoidectomy and\/or tonsillectomy. INTERVENTIONS: Patients were randomly assigned to receive either methylprednisolone 1 mg kg-1 (group M) or a placebo (group C) with anaesthesia induction. Neuromuscular block was induced with rocuronium, monitored using acceleromyography and reversed with sugammadex 2 mg kg-1 at the end of surgery. MAIN OUTCOME MEAURES: The primary outcome was the reversal time of rocuronium by sugammadex: time from sugammadex administration at train of four (TOF) count = 2 to a TOF ratio of >\/=0.9 of baseline. Secondary outcomes included extubation time (time from sugammadex administration at TOF count = 2 to extubation), postoperative pain, nausea and vomiting scores, and incidence of adverse events (stridor, hoarseness, severe cough and desaturation). RESULTS: At 89 +\/- 20.3 s, the reversal time of rocuronium by sugammadex was statistically significantly longer in group M compared with the 54.6 +\/- 9.3 s of group C (P < 0.001). The mean with 95% confidence interval (CI) of the difference was 34.5 (27.3 to 41.6) s. The extubation time was also significantly prolonged in group M compared with group C: 426.8 +\/- 134.4 vs. 331.3 +\/- 129.0 s (P = 0.002) with a difference of 95.5 (95% CI, 36.8 to 154.2) s. No significant differences were observed in postoperative pain, nausea and vomiting scores, or frequency of adverse events. CONCLUSION: Although methylprednisolone administration resulted in a significantly prolonged reversal of rocuronium-induced neuromuscular block by sugammadex and subsequent delayed extubation, the clinical importance of this interaction is minor. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06623370.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40673736\/"},{"pmid":40673713,"journal":"European journal of anaesthesiology","title":"Multimodal prehabilitation as a strategy to reduce postoperative complications in cardiac surgery: A randomised controlled trial.","authors":"Lopez-Hernandez A; Gimeno-Santos E; Navarro-Ripoll R; Arguis MJ; Lopez-Baamonde M; Sanz-de la Garza M; Sandoval E; Castella M; Martinez-Palli G","abstract":"BACKGROUND: Prehabilitation has shown efficacy in improving postoperative outcomes in abdominal surgery. Data on cardiac surgery are controversial. OBJECTIVE: To determine if a multimodal prehabilitation programme reduces the rate of postoperative complications after elective cardiac surgery. DESIGN: Randomised controlled trial. SETTING: Single-centre study in a tertiary hospital with inclusion period spanned from March 2018 to June 2021. PATIENTS: One hundred and fifty-one patients, with an expected waiting time before surgery of 6 weeks or more, completed the study. Excluded were those with functional, anatomical or cognitive impairment; cardiac instability; dynamic left ventricle outflow tract obstruction or proven exercise-induced arrhythmias. INTERVENTION: Four to six weeks of a multimodal prehabilitation programme, including exercise training, psychological and nutritional support. MAIN OUTCOME: Incidence of postoperative complications. RESULTS: No differences were found in the rate of postoperative complications (80% in both groups, P = 0.968), most of which were mild, with a Comprehensive Complication Index of 21 and more than 70% with Clavien-Dindo grade I or II. Prehabilitated patients showed a significant improvement in endurance time assessed by a constant-work rate cycling exercise test: preintervention vs. postintervention (301 +\/- 109 vs. 578 +\/- 257 s, P = 0.001), and in 6-min walk test (6MWT) (487 +\/- 77 vs. 504 +\/- 74 min, P = 0.001). No patients experienced adverse events attributable to the intervention. A sub-analysis restricted to prehabilitated patients who showed a meaningful response to exercise assessed by the 6MWT (increase >\/= 30 m) showed a reduction in the number and severity of postoperative complications, compared to nonresponders (1.1 +\/- 0.9 vs. 2 +\/- 2 complications per patient, P = 0.038); and the Comprehensive Complication Index (16 +\/- 15 vs. 25 +\/- 19, P = 0.044). CONCLUSION: A multimodal prehabilitation programme before elective cardiac surgery did not reduce the incidence of postoperative complications. Nevertheless, when analysis was restricted to meaningful responders to intervention, a significant reduction in postoperative complications and their severity was observed. TRIAL REGISTRATION: ClinicalTrials.gov (NCT03466606).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40673713\/"},{"pmid":40659442,"journal":"Regional anesthesia and pain medicine","title":"Optimal multimodal analgesia combinations to reduce pain and opioid use following non-cardiac surgery: an instrumental variable analysis.","authors":"Graham LA; Illarmo S; Wren SM; Mudumbai SC; Odden MC","abstract":"BACKGROUND: Multimodal analgesia (MMA) is a perioperative pain management strategy that targets various pain pathways, resulting in reduced postoperative pain and opioid use. Unfortunately, the optimal combinations of pain medications to use with perioperative MMA remain uncertain. Our goal was to estimate the treatment effect of MMA on postoperative pain and opioid use and identify optimal non-opioid medication combinations to enhance MMA benefits. METHODS: The study population includes all patients undergoing elective non-cardiac surgery with general anesthesia between 1 January 2017 and 31 December 2022 at six geographically similar Veterans Health Administration hospitals. An instrumental variable (IV) analysis was conducted using the anesthesiologist as the instrument to emulate randomization to receiving specific pain medication combinations. Outcomes were self-reported pain and opioid use after surgery. RESULTS: Of the 23 238 procedures included in the study, 46.1% received MMA. MMA was more common in younger patients, females and those with a lower probability of mortality. With IV analysis, inpatients with MMA required 6.8 fewer oral morphine equivalents (OMEs, 95% CI -10.2, to -3.4) in the postoperative period, and outpatients with MMA reported postoperative pain scores that were, on average, 1.0 unit lower than patients who did not receive MMA (95% CI -1.6 to -0.4). Combinations of non-steroidal anti-inflammatory drugs (NSAIDs) plus dexamethasone or regional anesthesia resulted in the greatest reductions in postoperative opioid use (mean reduction -29.5 OMEs, 95% CI -36.9 to -19.5 and mean reduction -28.4 OMEs, 95% CI -40.1 to -16.8, respectively). CONCLUSION: Our findings further support existing evidence on the effectiveness of MMA in reducing postoperative pain and opioid use following non-cardiac surgery. Importantly, our study highlights that dexamethasone and NSAIDs, not acetaminophen, which is almost universally used in MMA regimens, resulted in the greatest reduction of postoperative pain and postoperative opioid use. This has significant implications for the continued use of NSAIDs and dexamethasone in MMA protocols and underscores the need for future studies exploring the independent effect of intravenous acetaminophen on postoperative pain.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40659442\/"},{"pmid":39837579,"journal":"Regional anesthesia and pain medicine","title":"ASRA Pain Medicine consensus practice infection control guidelines for regional anesthesia and pain medicine.","authors":"Provenzano DA; Hanes M; Hunt C; Benzon HT; Grider JS; Cawcutt K; Doshi TL; Hayek S; Hoelzer B; Johnson RL; Kalagara H; Kopp S; Loftus RW; Macfarlane AJR; Nagpal AS; Neuman SA; Pawa A; Pearson ACS; Pilitsis J; Sivanesan E; Sondekoppam RV; Van Zundert J; Narouze S","abstract":"BACKGROUND: To provide recommendations on risk mitigation, diagnosis and treatment of infectious complications associated with the practice of regional anesthesia, acute and chronic pain management. METHODS: Following board approval, in 2020 the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) commissioned evidence-based guidelines for best practices for infection control. More than 80 research questions were developed and literature searches undertaken by assigned working groups comprising four to five members. Modified US Preventive Services Task Force criteria were used to determine levels of evidence and certainty. Using a modified Delphi method, >50% agreement was needed to accept a recommendation for author review, and >75% agreement for a recommendation to be accepted. The ASRA Pain Medicine Board of Directors reviewed and approved the final guidelines. RESULTS: After documenting the incidence and infectious complications associated with regional anesthesia and interventional pain procedures including implanted devices, we made recommendations regarding the role of the anesthesiologist and pain physician in infection control, preoperative patient risk factors and management, sterile technique, equipment use and maintenance, healthcare setting (office, hospital, operating room), surgical technique, postoperative risk reduction, and infection symptoms, diagnosis, and treatment. Consensus recommendations were based on risks associated with different settings and procedures, and keeping in mind each patient's unique characteristics. CONCLUSIONS: The recommendations are intended to be multidisciplinary guidelines for clinical care and clinical decision-making in the regional anesthesia and chronic interventional pain practice. The issues addressed are constantly evolving, therefore, consistent updating will be required.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39837579\/"},{"pmid":40675839,"journal":"British journal of anaesthesia","title":"Impact of desflurane removal from the operating room on carbon dioxide emissions at a tertiary academic medical centre: a retrospective analysis.","authors":"Seibold EL; Wachtendorf LJ; Needham MJ; Munoz-Acuna R; Redaelli S; Suleiman A; von Wedel D; Ratajczak N; Remotti EJ; Paschold BS; Chen G; Palardy A; Pierce T; Kienbaum P; Ramachandran SK; Schaefer MS","abstract":"BACKGROUND: Inhalational anaesthesia agents contribute to healthcare-related greenhouse gas emissions. We evaluated the carbon footprint of inhalation anaesthesia at a US academic medical centre over time and determined the relative importance of institutional measures (removal of desflurane and limiting fresh gas flow [FGF] and nitrous oxide [N(2)O] use) to reduce carbon dioxide equivalent emissions (CO(2)e-emissions). METHODS: From 124 428 patients undergoing inhalational anaesthesia between 2014 and 2022, CO(2)e-emissions per patient were calculated from minute-by-minute recordings of inspiratory concentrations of sevoflurane, isoflurane, desflurane, and N(2)O, as well as FGF data. Data were combined with the global warming potential for each gas. Interrupted time series analysis, adjusted for patient and procedural factors, was applied to assess the impact of gradual removal of desflurane from operating rooms in June 2018 and its complete elimination in January 2020. RESULTS: From June 2014 to June 2022, mean CO(2)e-emissions per patient decreased by 82.8% from an average of 83.1 (median, 23.6 [interquartile range, 10.1-107.8]) kg to 14.3 (median 8.5 [4.2-15.9]) kg. In adjusted analyses, restrictive use of desflurane (-1.53 kg per patient, 95% confidence interval, -1.88 to -1.18; P<0.001) and its subsequent elimination (additional -0.50 kg per patient, -0.80 to -0.19; P=0.002) reduced CO(2)e-emissions. Before the elimination, desflurane was the main contributor to CO(2)e-emissions (74% relative contribution). After the elimination, use of N(2)O (73%) and high FGF (>3.42 L min(-1), 4%) emerged as dominant predictors of CO(2)e-emissions. CONCLUSIONS: Eliminating desflurane led to a substantial reduction in anaesthesia-related CO(2)e-emissions of  approximately 900 metric tonnes annually. This study highlights the importance of volatile anaesthetic choice and factors including N(2)O use and fresh gas flow to minimise the carbon footprint of anaesthesia.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40675839\/"},{"pmid":40675836,"journal":"British journal of anaesthesia","title":"Development and internal validation of the patient satisfaction questionnaire: Perception of Quality in Anaesthesia (PQA)-10.","authors":"Kesting M; Sharma N; Debelak R; Braun J; Spahn DR; Tscholl DW; Fredrich H; Gasciauskaite G; Lunkiewicz J","abstract":"BACKGROUND: Patient satisfaction is a key indicator of anaesthesia quality. Existing questionnaires often lack patient input on item generation, are too lengthy, or were developed in culturally distinct regions. This study aimed to determine patient-perceived high-quality anaesthesia care and develop a short, validated questionnaire to assess patient satisfaction with peri-anaesthesia care in Switzerland. METHODS: The Swiss Perception of Quality in Anaesthesia questionnaire was developed and validated in two university hospitals in German-speaking Switzerland. A total of 245 patients identified and ranked 42 attributes of high-quality anaesthesia care, leading to the development of key themes using a six-stage thematic analysis. The final questionnaire was tested for reliability and validity with an additional 350 patients. RESULTS: Three themes were identified: communication during the pre-anaesthetic consultation, side-effects and adverse events, and the interpersonal and professional skills of the anaesthesia team. Test-retest reliability confirmed response consistency. Dimensionality analysis showed strong correlations between overall satisfaction and other item scores (0.68 and 0.74). A three-dimensional model demonstrated a very good fit: Tucker-Lewis Index of 0.977, comparative fit index of 0.985 (both range from 0 to 1; values closer to 1 indicate better fit), root mean squared error of approximation of 0.039 (values below 0.06 suggest good fit), and standardised root mean square residual of 0.04 (values below 0.08 suggest good fit). Average completion time was 146 s (sd 8 s). CONCLUSIONS: This study validated the Perception of Quality in Anaesthesia as a tool for assessing patient satisfaction in individuals receiving anaesthesia care in Switzerland.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40675836\/"},{"pmid":40668026,"journal":"Pain","title":"STIM1 functionally couples to transient receptor potential ankyrin 1 contributing to nociception.","authors":"Mei Y; Birla H; Lee BH; Li Z; Rai V; Zhang I; Huo X; Yi A; Zhang Q; Li D; Zhong Y; Wang F; Yasin B; Apai C; Rohacs T; Tao YX; Bekker A; Hu H","abstract":"STIM1 is a calcium sensor that can sense calcium level changes in the endoplasmic reticulum (ER) and respond to extracellular stimuli. We have reported that STIM1 is expressed in nociceptors. However, its functional significance remains unclear. Here, we show that STIM1 plays an important role in sensing cold, chemical, and noxious mechanical stimuli in both male and female mice. We found that activation of transient receptor potential ankyrin 1 (TRPA1) triggers ER Ca2+ release, STIM1 translocation, and store-operated Ca2+ entry (SOCE). Immunostaining and western blot results reveal that TRPA1 is expressed in the ER. In addition, STIM1 deficiency in the primary sensory neurons reduces cold-, allyl isothiocyanate (TRPA1 agonist)-, and bradykinin-induced Ca2+ entry and nociception. Moreover, intraplantar injection of thapsigargin, an ER Ca2+-ATPase inhibitor, evokes nociception and increases pain hypersensitivity, which is significantly attenuated in STIM1 conditional knockout or L3\/L4 dorsal root ganglia STIM1 knockdown mice. Mechanistic studies demonstrate that STIM1-mediated SOCE increases neuronal excitability and decreases potassium channel Kv4-mediated outward currents in small to medium-sized dorsal root ganglion neurons, which is abolished by inhibiting the mitogen-activated protein kinase\/extracellular receptor kinase pathway. Our findings demonstrate that STIM1 acts as a transducer of nociception and uncover a novel link between STIM1 and TRPA1ER. Our study also provides new insights into TRPA1-mediated nociception.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40668026\/"},{"pmid":40668025,"journal":"Pain","title":"Androgen receptors expressed in the primary sensory neurons regulate mechanical pain sensitivity.","authors":"Saika F; Uta D; Fukazawa Y; Hino Y; Hatano Y; Kishioka S; Nawa H; Hino S; Suzuki K; Kiguchi N","abstract":"The expression of hormonal receptors in pain-processing regions complicates understanding the hormonal effects on pain mechanisms. This study investigates androgen receptor (AR) involvement in pain sensitivity and sex differences in pain perception. Mechanical pain thresholds were higher in normal male mice compared to gonadectomized (GDX) male and normal female mice, correlating with serum testosterone levels. In the dorsal root ganglia (DRG), AR was expressed in normal males but undetectable in GDX males and normal females. Androgen receptor overlapped with NeuN, a neuronal nuclei marker, indicating androgen signaling activation in sensory neurons. In male sensory neuron-selective AR conditional knockout (AR-cKO) mice, mechanical pain thresholds were significantly lower than in wild-type males, with the greatest AR depletion in calcitonin gene-related peptide (CGRP)+ neurons. Electrophysiological analyses revealed increased excitability of spinal dorsal horn neurons in both GDX males and AR-cKO males. In female mice, administration of testosterone propionate or dihydrotestosterone significantly raised mechanical pain thresholds, accompanied by increased AR expression in the DRG. This effect was abolished in AR-cKO females, where AR depletion was most prominent in CGRP+ neurons, consistent with male findings. These results indicate that primary sensory neurons, particularly CGRP+ neurons, are critical targets of androgen in regulating mechanical pain sensitivity. Therefore, manipulating androgen signaling in sensory neurons may offer a promising approach to managing mechanical pain.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40668025\/"},{"pmid":40668023,"journal":"Pain","title":"Neurophysiological encoding of aversive prediction errors.","authors":"Gopalakrishnan R; Sonneborn C; Baillet S; Machado AG; Wager TD; Roy M","abstract":"Aversive prediction error (PE) brain signals generated by unexpected pain or pain absence are crucial for learning to avoid future pain. Yet, the detailed neurophysiological origins of PE signaling remain unclear. In this study, we combined an instrumental pain avoidance task with computational modeling and magnetoencephalography to detect time-resolved activations underlying pain expectations and aversive PE signals in the human brain. The task entailed learning probabilistically changing cue-pain associations to avoid receiving a pain stimulus. We used an axiomatic approach to identify general aversive PE signals that encode the degree to which the outcome deviated from expectations. Our findings indicate that aversive PE signals are generated in the alpha band (8-12 Hz) by the midbrain\/diencephalon, lateral orbitofrontal cortex, and ventrolateral prefrontal cortex approximately 150 milliseconds after outcome delivery. Moreover, alpha oscillations in these regions also encoded pain expectations before the outcome. We speculate that this may facilitate the rapid generation of PEs by allowing outcome-related nociceptive activity to be integrated with ongoing predictive signals. Finally, decisions to avoid pain recruited alpha oscillations in the anterior cingulate and dorsomedial prefrontal cortices, suggesting their active engagement in comparing predicted action values. Overall, our data reveal the rapid neurophysiological mechanisms underlying the generation of aversive PEs and subsequent decision-making.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40668023\/"},{"pmid":40705695,"journal":"Pain","title":"Evaluating the efficacy of neurokinin-1 (substance P) receptor antagonist CP-99994 on facial grimacing and allodynia in mice postsurgery: a comparative study with known analgesics.","authors":"McCoy ES; Ryan DF; Park SK; Zylka MJ","abstract":"Neurokinin-1 (substance P) receptor (NK1R) antagonists failed to effectively treat pain in humans despite having antinociceptive properties in animals. Here, we sought to evaluate the efficacy of NK1R antagonist CP-99994 at reducing facial grimacing in white-coated CD-1 mice after laparotomy surgery when compared to the analgesics carprofen and buprenorphine. To enable this investigation, we developed a machine learning algorithm to automatically score facial grimacing in white-coated mice using the PainFace software platform. This algorithm detects 5 facial action units of the mouse grimace scale (MGS; orbitals, nose, ears, whiskers, cheeks) and assigns a facial grimace score (0-10) for each video frame analyzed. Carprofen and buprenorphine significantly reduced mean MGS scores and percentage of high grimace (MGS scores >\/=5) frames for up to 4 hours postsurgery across multiple doses. In contrast, CP-99994 showed limited efficacy, with only the highest 30 mg\/kg dose reducing grimacing at 2 hours. Likewise, principal component analysis of grimace data over time indicated that carprofen and buprenorphine were effective at reducing facial grimacing, whereas CP-99994 was not. However, both buprenorphine and CP-99994 reduced mechanical allodynia at the incision site. These findings reveal a dissociation between the effects of CP-99994 on a spontaneous pain measure (grimacing) and an evoked nociceptive response, whereas a known analgesic reduced both measures. Our study suggests that using facial grimacing to assess spontaneous pain alongside traditional nociceptive assays may better predict analgesic potential and possibly reduce risk of translational failures when selecting drug candidates for clinical advancement.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40705695\/"},{"pmid":40664401,"journal":"Regional anesthesia and pain medicine","title":"Navigating current controversies in radiofrequency ablation of the genicular nerves for chronic knee pain in osteoarthritis: a daring discourse.","authors":"Ferreira-Silva N; Ferreira-Dos-Santos G; Cunat T; Ribeiro-da-Silva T; Peng P","abstract":"Chronic knee joint pain affects millions worldwide, with radiofrequency ablation (RFA) of genicular nerves emerging as a potential treatment in the last 15 years. Despite its growing popularity, with studies demonstrating its efficacy in pain reduction for up to 12 months, recent randomized controlled trials have questioned the efficacy of RFA. Discrepancies in study results may partially be explained by the heterogeneity of patient selection and technical protocols.This daring discourse aims to explore and critically analyze the ongoing debates surrounding RFA of the genicular nerves, addressing key controversies, namely: (1) Is there a role for performing prognostic blocks prior to RFA?; (2) What are the optimal target sites for final cannulae placement for the classical targets?; (3) Which and how many nerves should be targeted in RFA procedures?; (4) What are the comparative benefits of using ultrasound versus fluoroscopy guidance, and whether a combined technique may be advantageous?; (5) Is there a potential role for pulsed radiofrequency of the genicular nerves?; (6) Should genicular nerve RFA be performed after total knee arthroplasty?Through this in-depth discussion, we aim to guide pain medicine clinicians in informed decision-making and encourage further research in this field.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40664401\/"},{"pmid":40663783,"journal":"Anesthesiology","title":"Gabapentin for pain management following major surgery: a placebo controlled, double blind, randomized clinical trial (The GAP Study).","authors":"Baos S; Lui M; Walker-Smith T; Pufulete M; Messenger D; Abbadi R; Batchelor T; Casali G; Edwards M; Goddard N; Abu Hilal M; Alzetani A; Vaida M; Martinovsky P; Saravanan P; Cook T; Malhotra R; Simpson A; Little R; Wordsworth S; Stokes E; Eu-Hem JJ; Reeves B; Culliford L; Collett L; Maishman R; Chauhan N; McCullagh L; McKeon H; Abbs S; Lamb J; Gilbert A; Hughes C; Wynick D; Angelini G; Grocott M; Gibbison B; Rogers CA","abstract":"BACKGROUND: Gabapentin is an anticonvulsant medication with approval for use in neuropathic pain and epileptic disorders. It is frequently added to multimodal analgesic regimens during and after surgery to reduce opioid use while controlling pain effectively. There is little evidence to show its effectiveness in major surgery. METHODS: In this multicenter, double blinded, randomized controlled trial, adults undergoing major cardiac, thoracic or abdominal surgery were randomized to receive either gabapentin (600mg before surgery, 300mg twice daily for 2 days after surgery) or placebo. The primary outcome was length of hospital stay. Secondary outcomes included acute and chronic pain, total opioid use, adverse health events and health related quality of life. Patients were followed up daily in-hospital until discharge and then at 4-weeks and 4 months after surgery. RESULTS: 1196 participants were randomized (500 underwent cardiac, 346 thoracic and 350 abdominal surgery); 596 were allocated to placebo and 600 were allocated to gabapentin. Median length of hospital stay was similar in the two groups (gabapentin 5.94 (IQR 4.08-8.04) days, placebo 6.15 (IQR 4.22 - 8.97) days; hazard ratio 1.07, 95%CI 0.95-1.20, p=0.26). Overall, 384 participants experienced one or more serious adverse events (gabapentin 189\/596, 31.7%; placebo 195\/599, 32.6%), with some variation across surgical specialties. CONCLUSIONS: Among patients undergoing major cardiac, thoracic and abdominal surgery, adding gabapentin to multimodal analgesic regimes did not alter the length of hospital stay, or the number of serious adverse events.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40663783\/"},{"pmid":40663557,"journal":"Anesthesiology","title":"Head Strikes Among Perioperative Personnel in the United States: A Mixed Methods Study.","authors":"Piersa AP; Chan KM; Doney A; Copenhaver MS; Gartland RM; Levine WC; Collier LG; Pian-Smith MCM; Tron LE","abstract":"BACKGROUND: Healthcare workers face major occupational hazards. While various workplace safety risks for anesthesiologists have been documented, head injuries remain an underrecognized hazard. This study aimed to determine the frequency and characteristics of head strikes among anesthesiologists and perioperative nurses, examine reporting practices, and identify potential preventive strategies. METHODS: In this mixed-methods, cross-sectional national study, a 22-question survey was distributed to U.S.-based anesthesiologists and perioperative nurses in February and March of 2024. The survey, developed by a multidisciplinary team, included multiple-choice and free-response questions. The primary outcome measure was whether the individual had experienced a head strike in an operating or procedural room in the prior 12 months. Secondary outcome measures included the number of head strikes; source, timing, and head location of the strike; the amount of time taken off from work; whether a safety report was filed; and free-text responses for contributing factors, suggested changes to reduce risk, and challenges in reporting injuries. Qualitative responses were coded by investigator pairs using two collectively developed codebooks with themes and subthemes emerging inductively. RESULTS: Of the 1,549 anesthesiologists (6.6% response rate) and 287 nurses (2.7% response rate), 1,441 (78.5%) reported at least one head strike in the preceding year. Common sources included monitors (73.4% of respondents), light heads (37.4%), and boom-mounted equipment (33.4%). Most (948, 65.8%) incidents occurred intraoperatively. Causes of head strikes were multifactorial, frequently a combination of equipment placement, clinician movement, and tasks occurring under time pressure. Only 69 (4.8%) filed a safety report following a head strike. Barriers to reporting included time constraints, perception of strikes as minor incidents, and fear of negative consequences. CONCLUSIONS: Head strikes are a common but underreported occupational hazard in perioperative and periprocedural settings. Multi-faceted interventions addressing equipment design, workspace organization, and reporting culture are needed to reduce such risks.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40663557\/"},{"pmid":40663518,"journal":"Anesthesiology","title":"A Randomized Controlled Trial of Intraoperative Ketamine for Acute Postsurgical Pain after Breast Cancer Surgery: The Moderating Effect of Baseline Temporal Summation of Pain.","authors":"Wilson JM; Gokul S; Franqueiro AR; Rosado E; Yong RJ; Edwards RR; Schreiber KL","abstract":"BACKGROUND: Activation of nociceptive pathways by surgical trauma can induce central sensitization, which is associated with greater pain severity and persistence. The NMDA-receptor antagonist ketamine blocks central sensitization, but has a variable track-record for preventing postsurgical pain. Patient-level factors contribute to variability in pain and may serve as markers of differential efficacy of preventive effect. METHODS: This prospective, longitudinal randomized controlled trial investigated the effectiveness of intraoperatively administered ketamine to decrease postoperative pain after breast surgery. Before surgery, patients reported demographic and medical information and completed validated pain and psychosocial questionnaires. A subset of patients also underwent quantitative sensory testing to assess baseline temporal summation of pain (central sensitization tendency). Analyses of Covariance, controlling for relevant pre- and peri-operative factors, examined treatment group (ketamine vs. saline) differences in 2-week postoperative pain outcomes. Exploratory moderation analysis explored whether the efficacy of ketamine differed based on patients' baseline temporal summation of pain. RESULTS: Of the sample of 225 patients, 113 received ketamine and 112 received placebo. The majority of patients underwent lumpectomy (53%), with 16% undergoing mastectomy and 30% mastectomy with reconstruction. There were no significant treatment group differences in pain severity or impact reported two weeks after surgery. However, moderation analysis revealed that among patients with higher baseline temporal summation of pain, ketamine was associated with lower pain severity and impact scores. CONCLUSIONS: Ketamine was not associated with an analgesic benefit over placebo in the acute postoperative period, as measured using a variety of pain assessments. However, exploratory moderation analysis suggested that patients with evidence of a greater central sensitization at baseline may derive an analgesic effect of ketamine. These findings support future collection of baseline phenotypic patient characteristics related to relevant mechanisms in trials, to identify which patients may derive a larger benefit from analgesic interventions.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40663518\/"},{"pmid":40654033,"journal":"European journal of anaesthesiology","title":"Post discharge digital health technology interventions in ambulatory surgery: A systematic review and meta-analysis.","authors":"Bentsen SB; Stjernberg M; Raeder J; Eide GE; Tvedt MN; Hegland PA","abstract":"BACKGROUND: Given the early discharge associated with ambulatory surgery, digital health interventions (DHIs) may be useful in out of hospital follow-up. However, there are no systematic reviews concerning the use of DHIs in this setting. OBJECTIVE: To identify and evaluate the effects of DHIs on, patient safety, patient experience, and efficiency in post discharge ambulatory surgery. DESIGN: Systematic review and meta-analysis. Cochrane Risk of Bias Tool and Grading of Recommendations, Assessment, Development, and Evaluation were used. DATA SOURCES: MEDLINE, EMBASE, CINAHL, Cochrane Library, and Scopus were systematically searched from inception to 9 October 2024. ELIGIBILITY CRITERIA: Randomised controlled trials (RCTs); ambulatory surgical patients >\/=18 years; post discharge digital health interventions, including but not limited to computer tablets, mobile applications, and smart phones. Control group interventions included post discharge follow-up by a general practitioner, office-based follow-up, telephone follow-up, or no intervention. RESULTS: Six RCTs, with a total of 1397 patients were included. The meta-analyses showed no significant effects of DHIs compared with control group interventions on average pain intensity during postoperative days one to three, standardised mean difference = -0.15 (95% CI, -0.66 to 0.35), P = 0.556, or on unplanned healthcare encounters up to six months postoperatively, relative risk = 0.98 (95% CI, 0.92 to 1.05), P = 0.580. A review of individual articles showed that patients in the DHI groups reported significantly less impaired sleep, mood swings, stress, dizziness, headaches, sore mouth, constipation, and wound-related problems. Additionally, costs were lower, and patients reported improved functional status and well being compared with the control group. The risk of bias varied from low to moderate and the quality of evidence was low. CONCLUSIONS: Digital health interventions may reduce some symptoms and costs following discharge from ambulatory surgery, while improving quality of life. However, uncertainty remains due to the limited number of studies, some inconsistent results, and the low certainty of evidence.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40654033\/"},{"pmid":40653956,"journal":"Anaesthesia","title":"Incidence of postoperative delirium and quality of recovery in older patients undergoing gastrectomy under general anaesthesia with remimazolam vs. propofol: a randomised non-inferiority study.","authors":"Sim JH; Kim KM; Lee U; Lee EK; Noh GJ; Choi BM","abstract":"INTRODUCTION: Due to its haemodynamic stability and rapid recovery from anaesthesia, remimazolam is an attractive hypnotic drug for general anaesthesia in older patients. However, remimazolam must show non-inferiority in terms of the incidence of delirium and quality of postoperative recovery to be used as an alternative to propofol for maintenance of general anaesthesia. METHODS: Patients aged >\/= 65 y scheduled to undergo gastrectomy were randomly allocated to maintenance of general anaesthesia with a remimazolam infusion (remimazolam group) or propofol target-controlled infusion (propofol group) in a 1:1 ratio. The primary outcome measure was the incidence of delirium within 72 h of surgery (assessed using the confusion assessment method). Secondary outcomes included the quality of recovery at 24 h postoperatively (assessed using the translated Korean version of the 15-item Quality of Recovery questionnaire) and the incidence of postoperative nausea, retching and vomiting. RESULTS: Of 461 patients randomly allocated in the study, 432 were included in the analysis (216 in each group). The incidence of delirium was 17\/216 (7.9%) in patients allocated to the remimazolam group and 17\/216 (7.9%) in those allocated to the propofol group (unadjusted odds ratio 1.00, 95%CI 0.50-2.02, p = 1.000). Quality of recovery scores were also similar between groups at 24 h postoperatively (median (IQR [range]) 109 (102-115 [54-140]) vs. 109 (104-115 [70-137]) for the remimazolam and propofol groups, respectively (p = 0.627); unadjusted odds ratio -0.03, 95%CI -0.19-0.13). DISCUSSION: Remimazolam can be used as an alternative to propofol in older patients undergoing gastrectomy from the perspective of the incidence of postoperative delirium and quality of recovery.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40653956\/"},{"pmid":40653913,"journal":"Anaesthesia","title":"Efficacy of laparoscopic-installed rectus sheath block for postoperative pain reduction in transabdominal preperitoneal inguinal hernia repair: a double-blind, randomised-controlled trial.","authors":"Altenburg M; Rath T; Tasi A; Mann O; Guraya SY; Krause T; Strate T; Herzberg J","abstract":"INTRODUCTION: Postoperative pain management plays a crucial role in early recovery after laparoscopic inguinal hernia repair, particularly as most repairs are done as day-case surgery. The aim of this study was to evaluate the anaesthetic effect of a laparoscopically-guided rectus sheath block on postoperative pain. METHODS: Within this prospective, double-blinded, randomised controlled trial, patients planned for inguinal hernia repair using the transabdominal preperitoneal patch plastic were recruited. Patients were assigned randomly to either a control group or an intervention group. Both received standardised pre-emptive anaesthesia during the surgical procedure with self-fixating mesh. In the intervention group, an intra-operatively implemented rectus sheath block was performed for postoperative pain control. The primary outcome was the postoperative pain score 3 h after surgery. RESULTS: Thirty-five patients were included in the study; 17 patients were randomised to the intervention group and 18 to the control group. Patient demographics and procedural times were similar in both groups. Postoperative median (IQR [range]) pain scores were not significantly different between the groups 3 h after surgery (intervention group 3.0 (3.0-5.0 [1.0-8.0]) vs. control group 3.5 (2.25-4.75 [1.0-8.0]); p = 0.854). The median (IQR [range]) oxycodone requirement after surgery was not different between the groups (intervention group 0 (0-3 [0-7]) mg vs. control group 0 (0-3 [0-7]) mg; p = 0.869). DISCUSSION: This study has shown that a laparoscopic rectus sheath block has no beneficial effect in postoperative pain management following laparoscopic transabdominal inguinal hernia repair.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40653913\/"},{"pmid":40659443,"journal":"Regional anesthesia and pain medicine","title":"To trial or not to trial before peripheral nerve stimulation for chronic pain: a retrospective multicenter comparative analysis of temporary-to-permanent and direct-to-permanent implantation approaches.","authors":"D'Souza RS; Yu Y; Singh V; Karri J; Javed S; Her YF; Chai N; Hoffmann C; Warner DO; Hussain N","abstract":"BACKGROUND: Peripheral nerve stimulation (PNS) is an emerging neuromodulation therapy for chronic pain, yet its use in clinical practice varies significantly. Although temporary PNS is widely incorporated, either as a screening trial or a treatment itself, the evidence supporting the use of temporary PNS prior to permanent implantation is limited. We aimed to compare pain relief, opioid consumption, and adverse events between an approach implementing temporary PNS before permanent implantation (temporary-to-permanent (TTP)) vs proceeding directly to permanent PNS implantation (direct-to-permanent (DTP)). METHODS: A multicenter retrospective study was undertaken at seven major academic institutions from January 1, 2014, to January 1, 2024. Adult patients who underwent permanent PNS implantation for the treatment of chronic pain conditions were included and were divided into TTP or DTP cohorts based on their clinical approach. The dual primary outcomes were pain relief and opioid consumption (in oral morphine equivalents) at 6 months compared with baseline before any PNS therapy. Multivariable Tobit regression analysis was performed to identify predictors of pain relief at 6 months using a stepwise approach. RESULTS: A total of 130 patients were analyzed (54 in TTP approach, 76 in DTP approach). Patient-reported percentage pain relief was 56.7%+\/-27.9% at 6 months compared with baseline (before PNS implantation) in the TTP cohort, and 45.1%+\/-33.6% in the DTP cohort. The estimated mean percentage pain relief at 6 months was similar in the TTP and DTP cohorts (between-group difference 15.24%; 95% CI -0.32 to 30.80, p=0.052), with consistent findings after sensitivity analysis with multiple imputation. Opioid consumption declined similarly in the TTP (-3.1+\/-9.9 mg) and DTP (-2.1+\/-8.1 mg) cohorts at 6 months with no statistical difference between cohorts (mean between-group difference: -1.00, 95% CI -4.57 to 2.57, p=0.580), and with consistent findings after sensitivity analysis. Device explantation rates and adverse event profiles were comparable between cohorts. CONCLUSION: Although temporary PNS is widely performed prior to permanent PNS implantation, there was no evidence that the TTP approach is associated with superior analgesic outcomes compared with the DTP approach. Further, patients in both approaches achieved clinically meaningful pain relief at 6 months compared with baseline status prior to PNS therapy.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40659443\/"},{"pmid":40668003,"journal":"Pain","title":"Androgen levels and experimental pain sensitivity in healthy young adolescent girls.","authors":"Banerjee G; Brown J; McMichael A; Ben Abdallah A; Buday S; Baranski TJ; Haroutounian S; Barch D; AuBuchon J; Nahman-Averbuch H","abstract":"Androgens, such as testosterone, have an antinociceptive effect based on animal and adult studies. However, because androgens may exert different physiological effects during puberty, it is not clear whether the antinociceptive effect would also be found in adolescents. Thus, this study examined the relationships between testosterone levels and experimental pain sensitivity in healthy young adolescent girls. In addition, the relationships between experimental pain sensitivity and other androgens, including dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulfate (DHEA-S), dihydrotestosterone, and androstenedione, were explored, and the role of puberty in moderating these relationships was tested. Forty-five healthy girls (11.91 +\/- 1.35 years) completed comprehensive psychophysical assessments of heat, cold, and pressure pain thresholds, heat and cold pain intensity ratings, temporal summation, heat- and pressure-conditioned pain modulation, offset analgesia, and cold pain tolerance. Blood samples were collected to analyze sex hormone levels. Participants also completed the Pubertal Developmental Scale. Correlations and regression models examined the associations between androgens and experimental pain sensitivity, and whether pubertal stage moderated these relationships. Overall, no significant associations were found between levels of testosterone, DHEA, DHEA-S, dihydrotestosterone, or androstenedione and experimental pain sensitivity, nor were these associations moderated by pubertal stage. Only DHEA-S levels were related to cold pain threshold and tolerance, and pubertal stage moderated the relationship between DHEA-S and cold pain tolerance, which was significant only in the late (r = 0.453, P = 0.027) but not early-mid puberty group. The results of this study suggest that androgens may have a minimal effect on experimental pain sensitivity in healthy young adolescent girls.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40668003\/"},{"pmid":40667996,"journal":"Pain","title":"Peripheral contributions to offset analgesia: effects of stimulus duration, intensity, and location.","authors":"Sun P; Wong APH; Asplund CL; Derbyshire SWG","abstract":"Offset analgesia (OA) is a substantial decrease in pain perception after a minor reduction in noxious stimulus intensity. The peripheral mechano- and heat-sensitive A-fibre nociceptors (AMH-I and AMH-II) and the C-fibre nociceptors (CMH) are hypothesised to contribute to OA. These nociceptors differ in initial response latency, peak response latency, and heat threshold, and the AMH-II fibres may be absent from the palm. Stimuli targeting those different nociceptive properties were used to decide which nociceptors critically contribute to OA. Healthy volunteers (N = 64) underwent 16 unique trials with continuous noxious heat (45-47 degrees C). These trials included 3-second (short) or 12-second (long) periods of increased noxious heat (46-48 degrees C), or an intense 0.2 seconds pulse of heat (51 degrees C). Stimuli were delivered to the dorsum (back) and palm of the hands. Notable OA effects were observed for long-duration trials on both the dorsum and palm of the hand. Offset analgesia was inconsistently present and much smaller for the short-duration trials and for the pulse trials. Pain ratings generally increased more slowly during palm stimulation compared with dorsum stimulation. The demonstration of OA on the palm suggests that AMH-II nociceptors are either not critical for OA or that the AMH-II nociceptors are present in the palm. The small OA after the intense pulse and the substantial reduction in OA during the short trials suggests that AMH-I nociceptors are not necessary for OA and that the faster response of the AMH-II or CMH nociceptors is not sufficient to generate OA.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40667996\/"},{"pmid":40667986,"journal":"Pain","title":"Decreased KCC2 expression in the human spinal dorsal horn associated with chronic pain and long-term opioid use.","authors":"Davis OC; Ferland S; Lorenzo LE; Murray-Lawson C; Shiers S; Yousuf MS; Dedek A; Tsai EC; Vines E; Horton P; Cervantes A; Khan T; Funk G; Dussor G; Godin AG; Ferrini F; De Koninck Y; Hildebrand ME; Price TJ","abstract":"Loss of GABAergic and glycinergic inhibitory efficacy in the spinal dorsal horn is associated with neuropathic pain and opioid-induced hyperalgesia in rodent models. Downregulation of the KCC2 chloride extrusion transporter is a key mechanism underlying this decreased inhibitory efficacy, but to-date there is no evidence supporting or opposing this hypothesis in humans. Here, we demonstrate that KCC2 expression is decreased in superficial dorsal horn neurons of organ donors who died with a documented history of pain, or of long-term opioid use. We show profoundly decreased KCC2 dorsal horn membrane expression in a primary cohort associated with either chronic pain or opioid use, and in a replication cohort of mixed chronic pain and opioid use history. These results show that decreased dorsal horn inhibitory efficacy likely promotes chronic pain in humans and support the development of therapeutics augmenting KCC2 function as a treatment for chronic pain and opioid use disorders.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40667986\/"},{"pmid":40651878,"journal":"British journal of anaesthesia","title":"Non-insulin diabetes medicines: a narrative review for anaesthetists and intensivists.","authors":"Tinsley S; Frank C; Stubbs D; Dhatariya K; Knaggs RD; Levy NA","abstract":"Diabetes mellitus is characterised by an increased blood glucose concentration. Over the past two decades, multiple new agents have emerged to help treat the condition, of which several classes of agent have been shown to reduce the risk of cardiovascular morbidity and mortality. In addition, there have been several developments in the pharmacology of non-insulin diabetes medicines, working on different aspects of gut and renal glucose absorption, hepatic metabolism, insulin sensitivity, and incretin hormone physiology. This narrative review focuses on these non-insulin diabetes medicines. We discuss the different classes, including insulin secretagogues, biguanides, alpha-glucosidase inhibitors, thiazolidinediones, sodium glucose co-transporter 2 (SGLT2) inhibitors, and the newer incretin-based therapies. Each section focuses on the mode of action but also considerations relevant to anaesthetists, surgeons, and other members of the perioperative team caring for people with diabetes mellitus receiving these agents to ensure safe care and avoidance of complications.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40651878\/"},{"pmid":40651058,"journal":"Journal of clinical anesthesia","title":"Effect of dexamethasone and lidocaine combination on incidence of post-operative sore throat: A meta-analysis and trial sequential analysis.","authors":"Ikram J; Ali A; Moeez A; Khan MM; Ubaidullah; Mujeeb A; Ali MA; Tanveer S; Khan MWZ; Zaman B; Syed A; Nadeem MA; Zahid A; Khudirat M; Sawaira; Minear S; Ayad S","abstract":"BACKGROUND: Postoperative sore throat (POST) is a common complication after endotracheal intubation, occurring in 30-50 % of patients. While lidocaine (local anesthetic) and dexamethasone (anti-inflammatory) are used individually to prevent POST, their combined efficacy remains unclear. This meta-analysis synthesizes evidence from randomized controlled trials to determine whether Intravenous dexamethasone-lidocaine combination is more effective than dexamethasone alone in reducing POST incidence. METHODS: A systematic search was conducted across PubMed, Embase, and Web of Science to identify studies comparing the effect of dexamethasone with and without lidocaine on the incidence of POST, cough, and hoarseness. Statistical analysis was performed on RevMan. Data were pooled using a random-effects model (Mantel-Haenszel method), with results reported as risk ratios (RR) and 95 % confidence intervals (CIs); heterogeneity was assessed using the I(2) statistic. A p-value less than 0.05 was considered statistically significant. We use Gradpro GDT and Trial sequential analysis to assess the certainty and reliability of evidence, respectively. RESULTS: Our search retrieved 116 articles, of which 31 were duplicates. At the end of the selection process based on prespecified eligibility criteria, three randomized controlled trials were included in the final meta-analysis. Dexamethasone-lidocaine significantly reduces the incidence of POST compared to dexamethasone alone, with a (RR: 0.53; 95 % CI: 0.37-0.75; P = 0.0003, I(2) = 0 %). The meta-analysis showed no statistically significant difference in postoperative cough (RR: 0.81; 95 % CI: 0.41-1.61; P = 0.55, I(2) = 24 %) and hoarseness (RR: 0.60; 95 % CI: 0.29-1.22; P = 0.16, I(2) = 24 %) between the dexamethasone-lidocaine combination and dexamethasone alone. Non-significance doesn't prove groups are comparable; wide confidence intervals suggest a potentially meaningful difference in cough incidence. GRADE assessment analysis showed high evidence for POST and cough but showed moderate evidence for hoarseness and cough. Trial sequential analysis showed insufficient evidence to conclude that Dexamethasone-lidocaine reduces the incidence of POST. CONCLUSION: The dexamethasone-lidocaine combination suggests a clinically meaningful reduction in POST compared to dexamethasone alone, with consistent effects across studies. While not impacting hoarseness and cough, these robust findings support adopting this readily available, cost-effective strategy to enhance recovery after intubation. The combination's benefit on the most common postoperative complications justifies its inclusion in airway management protocols. Further trials are needed to support and enhance the reliability of this current evidence.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40651058\/"},{"pmid":40644393,"journal":"Anesthesiology","title":"Recovery of the acute hypoxic ventilatory response after reversal of a minimal neuromuscular block. A randomized, controlled trial in healthy, non-obese volunteers.","authors":"Snoek MAJ; van Lemmen MA; van der Schrier R; van Velzen M; Dahan A; Boon M","abstract":"BACKGROUND: Neuromuscular blocking agents inhibit the peripheral chemoreflex. We examined the effect of sugammadex 2 mg\/kg and 4 mg\/kg compared to spontaneous recovery of neuromuscular block (NMB) on the recovery of the acute hypoxic ventilatory response (AHVR). METHODS: This was a 2-experiment, randomized, controlled trial in healthy volunteers. Participants received a continuous infusion of rocuronium, to achieve stable symptoms of neuromuscular block in the head and neck region (symptomatic NMB). Thereafter, NMB was allowed to recover spontaneously in the first experiment, while in experiment 2, volunteers were randomized to receive sugammadex 2 mg\/kg or 4 mg\/kg for reversal. The depth of neuromuscular block was assessed with electromyography at the adductor pollicis muscle. AHVR was measured at baseline; during stable NMB; and at 0-, 20-, and 40-minutes post-recovery. RESULTS: Thirty-seven volunteers were enrolled; data from 27 volunteers were eligible for analysis. AHVR was reduced by 32% (mean difference versus baseline (MD) -0.22 L.%-1.min-1, 95% CI -0.32 to -0.12) during symptomatic NMB (mean train of four ratio 0.42 +\/- 0.22;). At the disappearance of all symptoms, AHVR remained on average depressed by 23% (MD -0.16 L.%-1.min-1, 95% CI -0.28 to -0.04). In 57% of volunteers following spontaneous recovery versus 28% following sugammadex reversal, AHVR did not return to baseline values during the measurement period. In addition, the magnitude of residual AHVR depression was greater following spontaneous recovery compared to reversal with sugammadex. However, on average AHVR was not significantly different from baseline at 20 and 40 minutes post-recovery in any group. CONCLUSIONS: The AHVR after reversal of a minimal NMB with sugammadex did not significantly differ with spontaneous recovery of NMB. However, fewer patients had residual depression of AHVR when sugammadex was used. In all groups, a considerable proportion of patients had residual depression of the AHVR 40 minutes after recovery.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40644393\/"},{"pmid":40644378,"journal":"Anesthesiology","title":"Cerebral Blood Flow Under Pressure: Investigating Cerebrovascular Compliance with Phase Contrast Magnetic Resonance Imaging During Induced Hypertension.","authors":"Osterlind J; Birnefeld J; Eklund A; Hultin M; Wahlin A; Holmlund P; Zarrinkoob L","abstract":"BACKGROUND: Induced hypertension is used clinically to increase cerebral blood flow (CBF) in conditions such as vasospasm after subarachnoid hemorrhage. However, increased blood pressure also raises pulsatile force. Cerebrovascular compliance plays a key role in buffering flow dynamics and protecting the microcirculation, but whether it adapts to elevated pressure remains unclear. This study assessed the response of compliant cerebral arteries to induced hypertension in healthy adults using phase-contrast magnetic resonance imaging (PCMRI) and two compliance models: a two-element Windkessel (CWK) and a simplified model (CVP), representing the extremes of pulsatility transmission at the capillary level. METHODS: Eighteen healthy adults (median age: 34 years; 9 females) underwent PCMRI at baseline and after increasing mean arterial pressure by 20% using norepinephrine (NE) infusion. PCMRI quantified CBF and cardiac output, while cerebrovascular resistance and systemic vascular resistance were derived. Flow waveforms were combined with blood pressure to assess CWK and CVP in CBF, ascending\/descending aorta, and external carotid arteries, while corresponding regions of interest were used to calculate cross-sectional flow areas. Data are reported as median (interquartile range). RESULTS: NE increased cerebrovascular compliance significantly; CWK by 110% (56% to 163%; P=0.001) and CVP by 11% (-2% to 26%; P=0.018). CWK increased in the external carotid artery by 12% (1% to 32%; P=0.037) but did not change in the ascending or descending aorta. CVP decreased in the descending aorta by 5% (-11% to 2%; P=0.028), with no changes in the ascending aorta or external carotid artery. Cross-sectional area of cerebral arteries contributing to CBF decreased by 5% (-17% to -3%; P=0.033), while the ascending and descending aorta areas increased by 7% (4% to 11%; P=0.012) and 8% (6% to 11%; P<0.001), respectively. CONCLUSION: Cerebral arteries enhanced their compliance during NE-induced hypertension, unlike systemic arteries, regardless of the assumed degree of pulsatility transmission.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40644378\/"},{"pmid":40667997,"journal":"Pain","title":"12\/15-lipoxygenases mediate toll-like receptor 4-dependent nociplastic pain hypersensitivity in female mice.","authors":"Miliano C; Chen I; Brown B; Murdaugh LB; Dong Y; Eddinger KA; Geng S; Li L; Yaksh TL; Burton MD; Buczynski MW; Gregus AM","abstract":"Chronic nociplastic pain syndromes are characterized by sensitization of peripheral and central nervous systems and exhibit increased incidence in women. However, nonsteroidal anti-inflammatory drugs are ineffective in mitigating nociplastic pain, and current prescription treatments, such as opioids, anticonvulsants, and antidepressants, provide limited therapeutic benefit for these indications. In the current work, we extended previous studies in rats of central Toll-like receptor 4-dependent pain hypersensitivity to male and female C57BL\/6N mice, uncovering an unexpected hyperalgesic phenotype in female mice following intrathecal (IT) lipopolysaccharide (LPS). In contrast to previous reports in female C57BL\/6J mice, female C57BL\/6N mice displayed tactile and cold allodynia, grip force deficits, and a modest increase in locomotor activity in response to IT LPS. Congruent with our previous observations in male rats, LPS released spinal 12\/15-lipoxygenase (12\/15-LOX) metabolites (12\/15-LMs) in female C57BL\/6N mice. Likewise, 12\/15-LOX enzymes are basally expressed in multiple tissues and cell types relevant to nociceptive transmission. Systemic inhibition of 12\/15-LOX in female C57BL\/6N mice with selective inhibitors ML355 (targeting 12-LOX-p) or ML351 (targeting 15-LOX-1) completely reversed allodynia and grip force deficits. 12\/15-LMs also produce tactile allodynia when administered spinally (IT) or peripherally (paw intraplantar) at a subthreshold dose in a hyperalgesic priming model, similar to others' observations with a subthreshold dose of the cyclooxygenase metabolite prostaglandin E2. Collectively, these data suggest that 12\/15-LOX enzymes contribute to peripheral and central pain hypersensitivity in rodents, with potential translatability as druggable targets across sexes and species using multiple reflexive and functional outcome measures.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40667997\/"},{"pmid":40645808,"journal":"British journal of anaesthesia","title":"Coding of post-surgical pain in ICD-11: between conceptual richness and practical constraints.","authors":"Martinez V; Spagna A; Attal N","abstract":"The 11th revision of the International Classification of Diseases (ICD-11) marks a decisive step forward in recognising chronic postsurgical pain as a distinct clinical entity. Yet, significant gaps remain between its conceptual framework, coding tools, and real-world clinical practice. Here we highlight these inconsistencies and call for stronger integration of the diagnostic criteria, along with improved visibility of neuropathic pain mechanisms as well as the psychosocial dimensions of pain.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40645808\/"},{"pmid":40640043,"journal":"British journal of anaesthesia","title":"Perioperative Quality Initiative consensus statement on goal-directed haemodynamic therapy.","authors":"Edwards MR; Kunst G; Forni LG; Chappell D; Miller TE","abstract":"Perioperative goal-directed haemodynamic therapy (GDHT) includes a variety of protocolised approaches to the assessment and management of the circulatory system and blood flow for patients undergoing surgery. Here we present updated consensus statements on perioperative GDHT developed during the 11th Perioperative Quality Initiative (POQI) consensus conference meeting held in London, UK in June, 2023. Statements relating to the definitions, components, and underlying physiology surrounding GDHT are proposed. We recommend considering use of GDHT in specific settings including during cardiopulmonary bypass (CPB), after cardiac surgery, and during hip fracture surgery. However, the level of evidence is weak in these settings. Clinicians can consider use of GDHT protocols on an individual patient basis for moderate- to high-risk patients undergoing major noncardiac surgery; however, we recommend against use of fixed low-dose inotrope infusions as part of GDHT protocols. We do not recommend routine use of GDHT protocols for patients undergoing major elective abdominal surgery. There is currently insufficient evidence to recommend routine use of GDHT during emergency abdominal surgery. Future research should focus on individualisation of GDHT to individual patients' haemodynamic requirements, newer paradigms such as technology-assisted delivery of GDHT protocols, and the role of predictive models using artificial intelligence.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40640043\/"},{"pmid":40639955,"journal":"Regional anesthesia and pain medicine","title":"Risk of dementia following gabapentin prescription in chronic low back pain patients.","authors":"Eghrari NB; Yazji IH; Yavari B; Van Acker GM; Kim CH","abstract":"INTRODUCTION: Gabapentin is widely used to treat chronic pain, but its association with cognitive decline and dementia remains unclear. This study examined whether gabapentin prescription is associated with dementia in adults with chronic low back pain. METHODS: We conducted a retrospective cohort study using the TriNetX national database of de-identified patient records from 2004 to 2024. Adults diagnosed with chronic low back pain were included; those with prior gabapentin use, dementia, epilepsy, stroke, or cancer were excluded. Propensity score matching controlled for demographics, comorbidities, and pain medications. Patients were stratified by age and gabapentin prescription frequency. Primary outcomes were dementia and mild cognitive impairment. RESULTS: 26,416 adults we analyzed following propensity-score matching. Patients with six or more gabapentin prescriptions had an increased incidence of dementia (RR: 1.29; 95% CI: 1.18-1.40) and mild cognitive impairment (RR: 1.85; 95% CI: 1.63-2.10). When stratified by age, non-elderly adults (18-64) prescribed gabapentin had over twice the risk of dementia (RR: 2.10; 95% CI: 1.75-2.51) and mild cognitive impairment (RR: 2.50; 95% CI: 2.04-3.05) compared to those not prescribed gabapentin. Risk increased further with prescription frequency: patients with 12 or more prescriptions had a higher incidence of dementia (RR: 1.40; 95% CI: 1.25-1.57) and mild cognitive impairment (RR: 1.65; 95% CI: 1.42-1.91) than those prescribed gabapentin 3-11 times. CONCLUSIONS: Gabapentin prescription in adults with chronic low back pain is associated with increased risk of dementia and cognitive impairment, particularly in non-elderly adults. Physicians should monitor cognitive outcomes in patients prescribed gabapentin.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40639955\/"},{"pmid":40639954,"journal":"Regional anesthesia and pain medicine","title":"Objective, long-term mobility data in patients with chronic pain after lumbar spine surgery treated with spinal cord stimulation-a prospective, multicenter trial.","authors":"Hallen T; Meier K; Kallewaard JW; Billet B; Elzinga L; Schapendonk J; Van den Bosch E; Zuidema X; Eygloardottir KL; Gulisano H; Gatzinsky K","abstract":"OBJECTIVE: Spinal cord stimulation (SCS) is a treatment option for chronic neuropathic pain conditions when conventional therapies have failed. However, objective and measurable long-term data on the effects of SCS are lacking. This study evaluates changes in objectively recorded mobility and the correlation with patient-reported outcomes in SCS-treated patients with intractable back and\/or leg pain following lumbar spine surgery. METHODS: Fifty patients were enrolled. Baseline mobility was recorded over 4 weeks using an external neurostimulator with a built-in accelerometer. Patients achieving >\/=50% pain relief during a subsequent SCS test trial received a permanently implanted stimulator at the same site. Mobility data were extracted at 3, 6, and 12 months and compared with baseline alongside work status, medication usage, and patient-reported outcome measures. RESULTS: Thirty-seven patients received a permanent stimulator, and 32 completed the 12 month follow-up of activity data. Time spent in mobility episodes lasting at least 30 s was 34+\/-27 min\/24 hours for SCS-patients at baseline compared with 92+\/-51 min for healthy controls (p=0.009). Mobility increased gradually after SCS, reaching statistical significance at 12 months (p=0.045). The increase was significant in patients with predominant leg pain (35+\/-27 to 54+\/-32 min, p=0.011) but not in those with predominant back pain. Significant improvements were observed in working ability, medication reduction, and self-reported outcomes. Increased mobility correlated significantly with reduction in self-reported disability (p=0.044) and leg pain (p=0.046). CONCLUSION: The new objective data indicate that SCS has beneficial, long-term effects on mobility in patients with intractable leg pain after spine surgery. TRIAL REGISTRATION NUMBER: NCT04710355.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40639954\/"},{"pmid":40639953,"journal":"Regional anesthesia and pain medicine","title":"Unilateral subcostal anterior quadratus lumborum block versus intrathecal morphine for postoperative pain in laparoscopic nephrectomy: a randomized controlled trial.","authors":"Kaya C; Dost B; Turunc E; Ustun YB; Kibar AN; Cebeci H; De Cassai A; Elsharkawy H","abstract":"BACKGROUND: Intrathecal morphine (ITM) offers effective analgesia after laparoscopic nephrectomy but may cause side effects. The anterior subcostal quadratus lumborum (QL) block has been proposed as a safer alternative. This study evaluated whether anterior subcostal QL block is non-inferior to ITM in reducing postoperative opioid use. METHODS: This single-center, randomized, observer-blinded, non-inferiority trial allocated 80 adult patients undergoing elective laparoscopic nephrectomy to receive single-injection unilateral anterior subcostal QL block (0.25% bupivacaine (0.4 mL\/kg) containing epinephrine 1:400,000) or spinal anesthesia with 5 mcg\/kg ITM (maximum 200 mcg) plus 7.5 mg isobaric bupivacaine. The primary outcome was the 24-hour cumulative intravenous morphine milligram equivalent (MME). Pain scores were recorded at rest and during activity at 0, 3, 6, 12, and 24 hours postoperatively. Patient satisfaction, recovery quality, and adverse effects were also evaluated. RESULTS: The median difference in 24 hours intravenous MME consumption between anterior subcostal QL block and ITM was 9.5 mg (95% CI 7 to 12; p<0.001), exceeding the non-inferiority margin. Patients with ITM reported lower pain scores and greater satisfaction at 24 hours (median (Q1-Q3), ITM 108 (102.25-113.5) vs anterior subcostal QL block 75.5 (58-100)) and discharge (ITM 117 (115-123.75) vs anterior subcostal QL block 94 (77-110); p<0.001). However, no between-group differences were observed in 30-day complication rates, including the Clavien-Dindo and Comprehensive Complication Index scores. Adverse effects, such as nausea, pruritus, and respiratory events, were comparable. CONCLUSIONS: Although designed as a non-inferiority trial, anterior subcostal QL block did not meet the threshold. While ITM resulted in lower opioid use, the study was not powered to establish superiority. Anterior subcostal QL block may be considered for patients at risk of ITM-related respiratory depression; however, its inconsistent cranial spread and limited visceral analgesia may explain its lower efficacy. Caution is also required in anticoagulated patients because of the deep anatomical location of the block. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT06630858.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40639953\/"},{"pmid":40638528,"journal":"Anesthesia and analgesia","title":"How Well Do Accreditation Council for Graduate Medical Education Milestones Track Readiness for Anesthesiology Certifying Examinations in a National Resident Cohort?","authors":"Sun H; Mitchell JD; Deiner SG; Andreae MH; Banerjee A; Ye T; Edgar L; Levine AI; Harman AE; Weinger MB","abstract":"BACKGROUND: Milestones evaluation is mandated by the Accreditation Council for Graduate Medical Education (ACGME) to help training programs measure residents' progress toward competency and identify specific areas for trainee improvement. Data from training programs raised concerns that Milestones ratings may reflect the year of training more than resident progress toward competency. We examined the relationship between residents' Milestones ratings toward the end of residency training and their performance on the American Board of Anesthesiology (ABA) examinations, widely considered as the gold standard of competency. METHODS: We compared Milestones 2.0 ratings and board scores of all anesthesiologists who completed an ACGME-accredited residency program between July 2021 and June 2022 (AY22) and had their first-time ABA ADVANCED Examination (written), Standardized Oral Examination (SOE) and Objective Structured Clinical Examination (OSCE) performance available by 2023. We first assessed the correlation between the average rating achieved across all 23 Milestones during the last 6 months of residency training and the Z-scores of these three examinations among first-time takers. Then, we evaluated the correlations between 9 specific Milestones and their conceptually related domains tested by the ADVANCED, the SOE, and the OSCE; we calculated Pearson and polychoric correlation coefficients for continuous and ordinal data, respectively. RESULTS: All 23 Milestones 2.0 AY22 ratings were available for 1849 Post Graduate Year (PGY)-4, Clinical Anesthesia Year 3 (CA-3) residents. These were matched to 1799 first-time ADVANCED and 1383 first-time SOE and OSCE takers. The average ACGME Milestones ratings across all competencies were significantly correlated with examination Z-scores (all P < .001)-the ADVANCED (r = 0.135 [95% confidence interval CI, 0.089-0.180], the SOE (r = 0.117 [0.065-0.169]), and the OSCE (r = 0.112 [0.060-0.164]). For the domain-specific comparisons, scores on the ADVANCED Examination correlated modestly with the Medical Knowledge Milestone domain (r = 0.289, P < .001), but there were no statistically significant associations between SOE task ratings and their related Milestones domains (rho = 0.027 to 0.091, P = .31 to 0.81). In comparisons of similar domains evaluated by OSCE stations and the Milestones, 2 were statistically significantly correlated with a weak magnitude (Interpretation of Monitors and Echocardiograms [rho = 0.093, P = .031] and Ethical Issues [rho = 0.049, P = .003]) while 2 others were not statistically significant (Application of Ultrasonography [rho = 0.052, P = .775] and Communication with other Professionals [rho = 0.052, P = .086]). CONCLUSIONS: There was a modest correlation between the last Medical Knowledge Milestone achieved and the ADVANCED Examination. However, the weak correlations between residency Milestones and the SOE or OSCE performance suggest that the Milestones system, as currently implemented by anesthesiology training programs, does not predict certifying examination performance.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40638528\/"},{"pmid":40638527,"journal":"Anesthesia and analgesia","title":"Age-Dependent Entropic Features During Propofol Anesthesia in Developing Brain.","authors":"Zhang Y; Liang ZH; Wang X; Zhang N; Zhu HT; Wang DX; Guo XY; Li XL; Song LL","abstract":"BACKGROUND: Precise monitoring of anesthetic depth in children receiving propofol anesthesia is crucial. Commercial depth of anesthesia monitoring devices do not account for age-related changes in brain states and provide misleading information regarding the actual depth in young children. Entropy analysis, a typical complexity methodology, has been demonstrated to be a simple and robust tool for monitoring consciousness levels during anesthesia in adults. The validity of entropic measures for depth of anesthesia monitoring in children receiving general anesthesia remains largely unexplored. The age-related entropic feature dynamics during propofol anesthesia are still not clear. METHODS: We prospectively studied frontal electroencephalogram (EEG) recordings from subjects aged 1 to 18 years receiving propofol anesthesia. We calculated spectral power, permutation entropy (PeEn), sample entropy (SampEn), beta ratio, and bispectral index (BIS) from EEG segments obtained during wakefulness, maintenance, and recovery. PeEn quantifies the randomness of a time series and SampEn quantifies its unpredictability. Both measures convey complexity information on local connectivity within neural circuits for an EEG signal. The accuracy of these EEG measures to distinguish between propofol-induced unresponsiveness and clinical recovery was assessed. The changes in entropic feature dynamics with age during propofol anesthesia were investigated. RESULTS: Seventy-seven subjects were included for analysis. Propofol induced a significant decrease in frontal PeEn (from a median [interquartile range] of 0.75 [0.71-0.78] during wakefulness to 0.61 [0.57-0.63] during maintenance, P < .001), which returned to wakefulness levels during recovery (0.75 [0.71-0.79]), contrasting with BIS, which remained lower. A significant increase in SampEn was noted from wakefulness to maintenance (0.04 [0.04-0.06] vs 0.25 [0.20-0.28], P < .001). PeEn provided excellent performance for distinguishing between unresponsiveness and clinical recovery at an optimal classification threshold of 0.67 with the accuracy of 96.6%. The distinguishing capability of PeEn appeared superior in toddlers compared to BIS (accuracy: 94.7% vs 88.9%). SampEn also exhibited good distinguishing accuracy of 81.1% at an optimal threshold of 0.18. Frontal PeEn and SampEn, indicating information amount of intracortical neural circuits connectivity, decreased with age during propofol maintenance (P = .017 and .026, respectively). The adolescents exhibited significantly lower frontal power, PeEn, and SampEn values during propofol administration. CONCLUSIONS: The frontal PeEn served as an excellent indicator for distinguishing propofol-induced unresponsiveness from recovery in children. Frontal complexity, represented by PeEn and SampEn, decreased with age during propofol maintenance, which was hypothesized to reflect sequential neurophysiological development in frontal cortex, particularly its maturation during adolescence.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40638527\/"},{"pmid":40637299,"journal":"Anesthesiology","title":"Potential Benefits of Medical Nutrition Therapy for Timely Ventilator Weaning in the Critically Ill.","authors":"De Rosa S; Rauseo M; Umbrello M; Lassola S; Battaglini D","abstract":"Nutritional support and metabolic assessment are crucial in weaning from invasive mechanical ventilation. This review explores strategies for metabolic assessment and tailored nutritional interventions and their impact on weaning outcomes, highlighting individualized nutritional interventions. While indirect calorimetry provides direct metabolic data, diaphragm ultrasound can complement metabolic monitoring by assessing respiratory muscle function and detecting early signs of muscle wasting. Protein intake in critically ill patients remains controversial, as early high protein administration (greater than 1.2 g\/kg each day) has not demonstrated clear benefits and may even be detrimental to successful ventilator weaning, supporting the adoption of a moderate, individualized nutritional strategy. Vitamin D deficiency is common in critically ill patients, and targeted supplementation may reduce mechanical ventilation duration. High-fat and ketogenic diets have shown limited benefit and are not currently recommended. Some nutritional supplements (e.g., creatine, branched-chain amino acids, beta-hydroxy-beta-methylbutyrate) are under investigation, but current evidence does not support their routine use. A personalized approach integrating metabolic assessment, tailored protein intake, and vitamin D optimization may improve weaning success, functional recovery, and post-intensive care unit outcomes. Further research is needed to refine evidence-based guidelines.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40637299\/"},{"pmid":40315373,"journal":"Anesthesiology","title":"Effects of the Quinone Analog Ubiquinone-5 on Murine Mitochondria and Hypnosis.","authors":"Somnay YR; Wang A; Lim H; Griffiths KK; Zandkarimi F; Chen K; Yang G; Wasilczuk AZ; Kelz MB; Larr D; Yang M; Gil-Iturbe E; Moon A; Quick M; Levy RJ","abstract":"BACKGROUND: A functional anesthetic target has long been suspected to reside within mitochondria, and disruption of bioenergetic capacity is believed to play a role in the anesthetic response. Unfortunately, the exact mechanism by which changes in mitochondrial target activity result in clinically relevant anesthetic endpoints remains unknown. Here, the authors leveraged knowledge of propofol toxicity to guide drug discovery and uncover a previously unknown pharmacologic target within mitochondria. They hypothesized that, like propofol, quinone analogs would interfere with electron transfer, cause excessive proton leak within mitochondria, and induce hypnosis. The authors tested their hypothesis using the short-chain coenzyme Q analog ubiquinone-5 (Ub5) and aimed to characterize its anesthetic phenotype in the mouse and elucidate the source of Ub5-induced mitochondrial leak. METHODS: Anesthetic phenotype was assessed in vivo in the mouse using behavioral and neurophysiological approaches. The authors measured biologic activity in isolated mitochondria using polarography and spectrophotometry and identified source of proton leak using pharmacologic inhibitors, mutant mouse strains, and transport activity assays in proteoliposomes. Finally, they assessed cardiotoxic effects in the isolated-perfused mouse heart ex vivo . RESULTS: Coenzyme Q analogs caused uncompensated proton leak in developing cardiomyocyte mitochondria and reversible cardiotoxicity in a manner reminiscent of propofol. Tail vein injection of Ub5 induced short-lived loss of righting, electroencephalogram changes consistent with a deep state of anesthesia, and reversible decreases in neuronal calcium transients and mitochondrial membrane potential in vivo . Precipitous decline in mitochondrial membrane potential played a role in Ub5-induced unconsciousness, and the authors identified the aspartate-glutamate carrier Aralar as a functional target and source of Ub5-mediated proton leak. CONCLUSIONS: The data indicate that uncompensated mitochondrial proton leak is an important mechanistic contributor to the anesthetic response in addition to electron transport inhibition. These findings advance the authors' understanding of how anesthetics induce hypnosis and lay the foundation for next-generation drug discovery.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40315373\/"},{"pmid":40640047,"journal":"British journal of anaesthesia","title":"Impact of superficial and deep parasternal blocks on recovery after cardiac surgery with sternotomy: a randomised controlled trial.","authors":"Demarquette A; Jeanneteau A; Blanchard-Daguet A; Fouquet O; Parot-Schinkel E; Lasocki S; Rineau E; Leger M","abstract":"BACKGROUND: Pain is common after cardiac surgery and can impair recovery. Regional anaesthesia has been proposed to limit pain, but its impact on recovery is unknown. This study compared the impact of superficial or deep parasternal intercostal plane blocks (SPIP or DPIP) in addition to standard care vs standard care alone on postoperative quality of recovery (QoR) after cardiac surgery with sternotomy. METHODS: In this single-centre, randomised, single-blind, controlled trial, adult patients undergoing cardiac surgery with sternotomy were randomly assigned to one of three groups (with a 1:1:1 allocation ratio): control group (standard care without regional anaesthesia), SPIP group, or DPIP group. The primary endpoint was QoR assessed using a French validated version of the Quality of Recovery-15 questionnaire at 24 h after surgery. Secondary outcomes included postoperative pain scores, analgesic consumption, ICU and hospital length of stay, and adverse events. RESULTS: Between July 1, 2022, and August 30, 2023, we randomised 254 patients (81.1% men, 65.5 [27-85] yr). The French validated version of the Quality of Recovery-15 scores did not significantly differ between any parasternal block group (SPIP or DPIP) and the standard care group (P=0.248). Postoperative pain and analgesic consumption were similar across groups, with low pain scores (median [interquartile range] 24-h numerical rating scale: 2.0 [3.0-0.0]). There were more pneumothoraces in the DPIP group (P=0.032). No significant differences were observed for other complications. CONCLUSIONS: Regional anaesthesia by parasternal intercostal plane blocks after sternotomy did not improve QoR at 24 h compared with standard care. CLINICAL TRIAL REGISTRATION: NCT05345639.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40640047\/"},{"pmid":40640046,"journal":"British journal of anaesthesia","title":"Pharmacokinetic modelling and simulation for prolonged infusion of levobupivacaine with or without epinephrine in transversus abdominis plane and erector spinae plane blocks: a randomised controlled trial and analysis of pooled data.","authors":"Araneda A; De la Cuadra JC; Corvetto M; Balde D; Fuente R; Ibacache M; Contreras V; Solari S; Cortinez I","abstract":"BACKGROUND: Interfacial blocks often require large volumes of local anaesthetic, raising concerns about systemic absorption and potential toxicity. This study examined the pharmacokinetics of levobupivacaine with and without epinephrine during thoracic erector spinae plane (ESP) or transversus abdominis plane (TAP) blocks, simulating reported 48-h dosing regimens to evaluate safety. METHODS: Data from three studies were analysed. Study 1 included 38 patients receiving an ESP block before video-assisted thoracoscopy, whereas Study 2 analysed published data on TAP blocks. Both studies used 20 ml of levobupivacaine 0.25% with or without epinephrine (5 mug ml(-1)), measuring arterial concentrations over 90 min. Study 3 involved intravenous bupivacaine administration in 10 healthy volunteers. Pharmacokinetic analysis used NONMEM software, with significance set at P<0.05. RESULTS: We analysed 258 ESP samples, 150 TAP samples, and 190 bupivacaine i.v. SAMPLES: A one-compartment model described the data, with a mean distribution volume of 41.9 L (coefficient of variation, 47%) and clearance rate of 0.288 L min(-1) (coefficient of variation, 38%). Epinephrine reduced bioavailability (54.3% vs 32.8%) and prolonged absorption half-life (0.84 min vs 1.55 min; P<0.05). Simulated doses of 50 mg plus 300 mg per 24 h over 48 h remained below toxic thresholds. CONCLUSIONS: Similar dosing regimens for ESP and TAP blocks are supported by this pharmacokinetic analysis, with epinephrine effectively reducing systemic drug concentrations by prolonging absorption half-life and lowering bioavailability. The findings suggest that extended 300 mg per 24 h dosing for 48 h is likely to be safe. Further studies in broader patient populations are warranted to evaluate safety. CLINICAL TRIAL REGISTRATION: NCT04799184.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40640046\/"},{"pmid":40640044,"journal":"British journal of anaesthesia","title":"Are adults with chronic pain more likely to develop hypertension than adults without chronic pain? A systematic review and meta-analysis.","authors":"Taylor HE; Salf JC; Roper-Marchand CR; Senaratne DNS; Smith BH; Colvin LA; George J","abstract":"BACKGROUND: An association between persistent pain and blood pressure is increasingly recognised but is not fully understood. In this systematic review, we aimed to establish whether chronic pain (CP) is associated with a diagnosis of hypertension (HTN). METHODS: After prospective registration (PROSPERO ID: CRD42025629486), we searched six databases from inception until January 8, 2025, for studies investigating the association between CP and HTN. Title and abstract screening, full-text review, data extraction, and risk of bias assessment were performed by two independent reviewers. Study quality assessment used the Risk of Bias In Non-randomised Studies of Exposures (ROBINS-E) tool. Meta-analysis was conducted using a random effects model. RESULTS: From 7973 records, we identified 23 eligible studies for inclusion, of which 20 provided suitable data for meta-analysis (total participants n=1 594 264). The pooled odds ratio for HTN in people with CP compared with controls was 1.66 (95% confidence interval [CI] 1.28-2.15) with high inter-study heterogeneity (I(2)=99.8%, Cochran Q=10 132, p<0.001). For specific pain conditions, the pooled odds ratio for HTN was 1.38 (95% CI 1.20-1.58, n = 374 234, heterogeneity: I(2)=65.1%, Cochran Q=14.34, p=0.014) in people with chronic, widespread pain, and 1.56 (95% CI 1.37-1.79, n=477 681, heterogeneity: I(2)=0%, Cochran Q=0.17, p=0.92) in people with chronic headache. There was no association between HTN and musculoskeletal pain, lower back pain, or gender. CONCLUSIONS: In line with a growing body of evidence in this field, this systematic review and meta-analysis confirms an association between chest pain and hypertension. Further research is warranted to understand this association and elucidate any mediating factors. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42025629486).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40640044\/"},{"pmid":40634187,"journal":"British journal of anaesthesia","title":"Videolaryngoscopy versus direct laryngoscopy for teaching direct laryngoscopy skills: a systematic review and meta-analysis.","authors":"Gunning SGS; Urwin D; Cook TM; Hansel J","abstract":"BACKGROUND: It is established that videolaryngoscopy improves intubation success rates and views compared with direct laryngoscopy. However, concerns regarding default adoption of videolaryngoscopy include a negative impact on skill acquisition for direct laryngoscopy. This study aimed to assess the utility of Macintosh videolaryngoscopy for teaching direct laryngoscopy. METHODS: We systematically searched MEDLINE and Embase databases for relevant randomised controlled trials, crossover, and observational studies. Two authors screened abstracts and full-text manuscripts for inclusion before extracting and cross-checking data. Critical outcomes included first-attempt success, overall success, and time to intubation, with trainee confidence and ease of guidance assessed as secondary outcomes. Meta-analysis was performed using random-effects models. Risk of bias was assessed using the Cochrane RoB-2 tool. RESULTS: We identified 21 relevant studies, 10 of which assessed Macintosh videolaryngoscopy for teaching direct laryngoscopy. For first-attempt success, videolaryngoscopy outperformed direct laryngoscopy with a risk ratio (RR) of 1.16 ([95% confidence interval 1.07-1.25]; five studies; I(2)= 17%). Overall intubation success did not differ significantly between videolaryngoscopy and direct laryngoscopy training (RR 1.05 [0.99-1.12]; seven studies; I(2)=27%) and neither did time to successful intubation (mean difference -7.4 s [-15.8 s to 0.9 s]; seven studies; I(2)=73%). All but two studies raised concern for risk of bias in at least one domain. Limitations included small sample sizes and heterogeneous data presentation. Sensitivity analyses favoured videolaryngoscopy. CONCLUSIONS: Videolaryngoscopy appears to be an effective tool for teaching direct laryngoscopy. Its role as a preferred teaching tool should be considered. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42023493366).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634187\/"},{"pmid":40634186,"journal":"British journal of anaesthesia","title":"Bone cement implantation syndrome: a scoping review.","authors":"Brokke KE; Graman M; Servaas S; Sierevelt IN; Steegers MAH; Nolte PA","abstract":"BACKGROUND: Bone cement implantation syndrome comprises the occurrence of hypoxaemia, hypotension, unexpected loss of consciousness, or cardiac arrest occurring around the time of cementation, prosthesis insertion, or reduction of the joint in arthroplasty. As the yearly number of arthroplasties will increase, the number of complications including bone cement implantation syndrome is also expected to increase. Therefore, a good understanding of this syndrome is important. This scoping review aims to provide a comprehensive overview of the current knowledge of bone cement implantation syndrome. METHODS: This scoping review was conducted based on the PRISMA-ScR Checklist. A literature search was done in PubMed, Cochrane, and Embase. A total of 85 studies were included in the study. RESULTS: The incidence of bone cement implantation syndrome during cemented hip or knee arthroplasty varied from 15.4% to 46.7% and 27.5% to 70.7%, respectively. The incidence in shoulder arthroplasty was 16.2%. In uncemented hip arthroplasty, the incidence ranged from 0.0% to 21.8%. Risk factors identified for bone cement implantation syndrome included advanced age, ASA physical status 3 or 4, and primary lung cancer or lung metastasis. CONCLUSIONS: Bone cement implantation syndrome is a potentially severe complication that can occur during both cemented and uncemented arthroplasty. Moreover, the occurrence of bone cement implantation syndrome is not dependent on the use of cement. However, the severity does seem to have an association with the fixation method.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634186\/"},{"pmid":40634185,"journal":"British journal of anaesthesia","title":"Hydroxocobalamin for vasoplegia in cardiac surgery: a retrospective cohort analysis.","authors":"Zakaria L; Shah K; Yang D; Kelava M; Elgharably H; Khanna AK; Ahuja S; Hohlfelder B; Alfirevic A; Duncan AE; Skubas NJ; Sessler DI","abstract":"BACKGROUND: Vasoplegia during cardiac surgery is common and associated with perioperative mortality. Hydroxocobalamin is a catecholamine-sparing approach for treating vasoplegia. However, there is currently limited evidence to inform its use. METHODS: We conducted a single-centre retrospective propensity-matched cohort study of patients who developed vasoplegia after cardiopulmonary bypass. Our primary outcome was vasopressor requirement, expressed as norepinephrine equivalents (NEE), at 1, 4, 24, and 48 h after treatment. Our secondary outcome was a collapsed composite of in-hospital complications comprising stroke, sternal wound infection, mesenteric ischaemia, renal failure, and death. RESULTS: We identified 2727 (11%) patients with vasoplegia from 2018 to 2024. The final analysis cohort included 229 matched pairs. Hydroxocobalamin administration was associated with a significant reduction in median NEE infusion rates of -0.04 (95% confidence interval [CI]: -0.07 to -0.02; P=0.008) mug kg(-1) min(-1) at 1 h, -0.05 (95% CI: -0.07 to -0.02; P<0.001) mug kg(-1) min(-1) at 4 h, and -0.04 (95% CI: -0.06 to -0.02; P=0.004) mug kg(-1) min(-1) at 24 h, but not at 48 h, -0.02 (95% CI: -0.05 to 0.0; P=0.220) mug kg(-1) min(-1). Over the initial 24 h, hydroxocobalamin reduced NEE by 14% compared with the reference group. The risk of in-hospital complications was similar in each group (odds ratio: 1.06; 95% CI: 0.74-1.54; P=0.745). CONCLUSIONS: Hydroxocobalamin administration was associated with reduced vasopressor requirement over 24 h, but not thereafter. Robust trials are needed to determine whether this relationship is causal, and whether a reduction in vasopressor use improves substantive clinical outcomes.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634185\/"},{"pmid":40634184,"journal":"British journal of anaesthesia","title":"Orexinergic projections to substantia innominata mediate arousal and analgesia.","authors":"Xiang X; Wang F; Chen C; Guan Z; Zhou W","abstract":"BACKGROUND: Understanding neural circuits involved in anaesthesia is crucial for improving its safety and efficacy. Lateral hypothalamic area orexinergic neurones (LHA(OX)), projecting broadly, are essential in regulating arousal and pain. However, the precise targets remain unclear. Here we investigated the orexin projections to the substantia innominata (SI). METHODS: Combining optogenetics, fibre photometry, electroencephalography, and electromyography allowed us to manipulate orexin activities while simultaneously recording local ligand release and global cortical activities during isoflurane anaesthesia. Brain slice electrophysiology revealed the synaptic connections in SI, while RNAscope was used to examine the distribution of orexin receptors and downstream neuronal types. RESULTS: Presynaptic vesicles were identified in the orexin-releasing axon terminals in SI, where 49.2% of cells expressed orexin receptor-2 (OX2R) and 6.8% expressed orexin receptor-1 (OX1R). Orexin release in SI was reversibly suppressed by isoflurane. Optogenetic activation of the LHA(OX)-->SI circuit increased orexin release and promoted arousal from various anaesthesia stages, including during isoflurane 0.75 vol% (P<0.0001), prolongation of isoflurane 3 vol% induction (P=0.0033), and acceleration of emergence from isoflurane 2 vol% (P<0.0001). Furthermore, activating this circuit induced analgesia to both thermal (P<0.0001) and inflammatory (P<0.0001) pain. Patch-clamp recordings revealed that optogenetic activation of orexin terminals in SI elicited excitatory postsynaptic currents, which were blocked by an OX2R antagonist. The SI contains more GABAergic (28.2%) and glutamatergic (12.0%) neurones than cholinergic neurones (4.1%), all of which expressed OX2R. CONCLUSIONS: Hypothalamic area orexinergic neurones innervate substantia innominata neurones to regulate both arousal and pain predominantly through orexin receptor-2.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40634184\/"},{"pmid":40626589,"journal":"Anesthesiology","title":"Leveraging Large Language Models to Enhance Emotional Intelligence Training in Anesthesiology.","authors":"Nanda M; Gabriel RA; Sakai T","abstract":"Emotional intelligence is essential for high-stakes interactions in the perioperative setting. Whether addressing patient concerns, resolving conflicts, or triaging cases, anesthesiologists rely on emotional intelligence for effective communication. However, stressors such as fatigue and heavy workloads can deplete the ability to sustain emotional intelligence during critical moments. Emotional intelligence can be strengthened with structured training. Large language models (LLMs), with their ability to generate empathetic responses, offer an innovative approach to enhancing emotional intelligence training in anesthesiology. LLMs can generate a variety of on-demand scenarios that can be fine-tuned, validated, and implemented by experts. They can be used to create tailored simulation scenarios for a variety of pedagogical methods to help clinicians prepare for emotionally charged conversations and enhance their communication skills. While not a replacement for human training, LLMs can serve as easily accessible supplemental tools to bolster clinicians' emotional intelligence skills when integrated with proper oversight.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40626589\/"},{"pmid":40626585,"journal":"Anesthesiology","title":"Anesthetic Amnesia: The Forgotten Importance of Forgetting?","authors":"Pryor KO; Jiang Y; Sleigh JW","abstract":"There is increasing evidence that the impairment of consciousness by anesthetic drugs does not always lead to its complete absence and that the loss of subjective experience with anesthesia may at times be an illusion created by amnesia. However, the study of how anesthetic drugs cause amnesia, and importantly how they fail, has received less attention than the other cardinal properties of anesthesia. There is no reliable biomarker to determine the adequacy of pharmacologic amnesia in real time. Anesthetic drugs can influence all stages of memory formation and recall, and their amnestic effects are dissociable from their hypnotic effects; for example, propofol has potent specific amnestic potential, whereas dexmedetomidine is a pure hypnotic. Post-traumatic stress disorder cluster symptoms, which constitute a disorder of amygdala-centered memory systems, are commonly related to surgical memories under both general anesthesia and procedural sedation and need to be better understood and managed.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40626585\/"},{"pmid":40625141,"journal":"European journal of anaesthesiology","title":"Ultrasonographic assessment of sugammadex-enhanced early recovery of diaphragmatic function in children: A randomised double-blind controlled trial.","authors":"Park JB; Kim TW; Ji SH; Jang YE; Kim EH; Kim JT; Kim HS; Lee JH","abstract":"BACKGROUND: In adults, sugammadex promotes faster neuromuscular recovery compared with neostigmine; however, its impact on diaphragmatic recovery and atelectasis in children remains unelucidated. OBJECTIVES: We compared the effects of sugammadex and neostigmine on restoration of diaphragmatic function and postoperative atelectasis in paediatric patients. DESIGN: A prospective randomised controlled study. SETTING: Seoul National University Children's Hospital, Seoul, Republic of Korea. PATIENTS: A total of 73 children aged 2 to 7 years were randomised to receive either sugammadex (2 mg kg-1, n = 36) or neostigmine (0.02 mg kg-1, n = 37) for neuromuscular blockade reversal when the train-of-four count reached 4 (train-of-four ratio < 0.9). MAIN OUTCOME MEASURES: The diaphragmatic excursion (DE) and thickening fraction (TF) were measured by ultrasound at three timepoints: baseline (T0), before postanaesthesia care unit (PACU) admission (T1) and 30 min after PACU admission (T2). Atelectasis was assessed via lung ultrasonography at T1 and T2. The primary outcome was the diaphragmatic excursion ratio at T1 (DET1\/DET0), and secondary outcomes included the DET2\/DET0, TFT1\/TFT0, TFT2\/TFT0 atelectasis score and incidence of significant atelectasis. RESULTS: At T1, the DET1\/DET0 was significantly higher in the sugammadex group (neostigmine vs. sugammadex group, 0.91 +\/- 0.19 vs. 1.02 +\/- 0.24; P = 0.034) as was the TFT1\/TFT0 (0.93 +\/- 0.39 vs. 1.15 +\/- 0.49; P = 0.041). No significant intergroup differences were found in the DET2\/DET0 and TFT2\/TFT0. The atelectasis score and incidence of significant atelectasis were comparable between the groups. CONCLUSIONS: Compared to neostigmine, sugammadex accelerates diaphragmatic recovery immediately after extubation; however, this early recovery does not significantly reduce the incidence of postoperative atelectasis. TRIAL REGISTRATION NUMBER: NCT05724550.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40625141\/"},{"pmid":40408187,"journal":"Anesthesiology","title":"Intergenerational Postoperative Neurocognitive Disorder in a Rat Model: Initiating Mechanisms and Pharmacological Prevention.","authors":"Ju LS; Khan ZA; Gravenstein N; Seubert CN; Setlow B; Martynyuk AE","abstract":"BACKGROUND: Vulnerability to perioperative neurocognitive disorder (PND) and the mechanisms initiating PND, which may serve as targets for prevention, are incompletely understood. This study hypothesized that sevoflurane can induce persistent upregulation of the hypothalamic-pituitary-adrenal axis, inflammation, and behavioral deficits in young adult male rats by stimulating hypothalamic arginine vasopressin (AVP) production via Na + -K + -Cl - (NKCC1) Cl - importer\/gamma-aminobutyric acid type A receptor signaling. These changes may also result in neurocognitive deficits in the offspring of exposed rats ( i.e. , intergenerational PND). METHODS: Sprague Dawley male rats (generation F0) were exposed to 2.1% sevoflurane for 3 h on postnatal days 56, 58, and 60. Before each sevoflurane exposure. they received vehicle (F0M_S group), the NKCC1 inhibitor bumetanide (F0M_BS group), or the glucocorticoid receptor inhibitor RU486 (F0M_RS group). They were mated on postnatal day 90 with treatment-naive females to generate offspring (generation F1). RESULTS: Consistent with our hypothesis, short-term and sustained changes in F0M_S rats, but not F0M_BS and F0M_RS rats, included increased hypothalamic c-FOS and AVP (but not oxytocin) expression, increased hypothalamic-pituitary-adrenal axis activity, increased levels of systemic and central inflammatory markers, and increased Nkcc1 \/ K + -2Cl - ( Kcc2 ) Cl - exporter mRNA ratios in the brain. F0M_S males, but not F0M_BS and F0M_RS males, exhibited anxiety-like behavior and deficits in sensorimotor gating and spatial memory. Male offspring of F0M_S sires, but not F0M_BS or F0M_RS sires, exhibited behavioral abnormalities similar to those in F0M_S, as well as alterations in social behavior. The only deficit in F1 females was impaired spatial memory in the offspring of F0M_S. CONCLUSIONS: These findings suggest a role for hypothalamic NKCC1\/gamma-aminobutyric acid type A receptor\/AVP signaling in sevoflurane-triggered PND in adult male rats, which also affects their future sevoflurane-unexposed offspring. NKCC1 and glucocorticoid receptors could serve as therapeutic targets for prevention of sevoflurane-induced PND in exposed rats and in their future offspring.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40408187\/"},{"pmid":40628584,"journal":"British journal of anaesthesia","title":"Training and assessment of skills in neuraxial space access: a scoping review of educational approaches to lumbar puncture, epidural anaesthesia, and spinal anaesthesia.","authors":"Nielsen MS; Ilkjaer FV; Grejs AM; Nielsen AB; Konge L; Brochner AC","abstract":"BACKGROUND: Neuraxial space access, including lumbar puncture, spinal anaesthesia, and epidural anaesthesia, is important in clinical practise for diagnostics and anaesthesia. Despite frequent use, standardised educational recommendations for training and assessing proficiency in these procedures are not well-integrated. The following research question was formulated: what is known from published literature to guide future educational recommendations for training and skills assessment of neuraxial space access with and without the use of ultrasound? METHODS: On May 7, 2024, searches were performed in the Cochrane Library, MEDLINE (Ovid), Scopus, PubMed, CINAHL (EBSCO), and EMBASE (Ovid). Studies were eligible if they involved physicians, medical students, or nurses and focused on training or assessment of neuraxial space access skills. No comparator was required, and all study designs were included if outcomes could be assessed using Kirkpatrick framework. There were no restrictions on language or publication date. Methodological quality was assessed using the Medical Education Research Study Quality Instrument (MERSQI). RESULTS: The review included 99 studies, and overall, 28 (28%) of the included studies were of low quality with a MERSQI score <9, whereas 22 (22%) were of high quality with a MERSQI score of >\/=14. The designs were primarily cohort studies (68%) and RCTs (24%). Specialities represented were mainly anaesthesia (22%) and paediatrics (17%), but many were not reported (30%). Training modalities varied, predominantly using low-fidelity manikins (55%). Simulation-based methods enhanced procedural confidence and technical skills. CONCLUSIONS: Studies on education in neuraxial space access show substantial variation in educational approaches and assessment. Consistent findings indicate that simulation-based training enhances outcomes across multiple Kirkpatrick levels, although the studies generally have low methodological quality. Further high-quality research is needed, especially linking training and assessment to patient outcomes.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40628584\/"},{"pmid":40628582,"journal":"British journal of anaesthesia","title":"Effects of ketamine on postoperative cognition: a scoping review.","authors":"Brenna CTA; He XW; Liu D; Kaustov L; Choi S; Orser BA","abstract":"Postoperative delirium and other forms of perioperative neurocognitive deficits occur commonly in older adult patients. Ketamine, administered either before or during general anaesthesia, may have cognitive-sparing properties owing to its ability to reduce neuroinflammation, increase neurotrophin levels, or allow reductions in the doses of other general anaesthetic drugs. However, the efficacy of ketamine in preventing perioperative neurocognitive disorders remains highly controversial. This scoping review summarises clinical studies that examined the cognitive-sparing properties of ketamine in adult surgical patients. Clinical trials and retrospective cohort analyses that assessed cognition in adult patients after treatment with racemic (R,S) ketamine, esketamine, or arketamine were identified through a systematic search of the Embase and Embase Classic databases (from 1947 to 2025). Overall, we identified 58 studies involving 6830 patients. Most studies (n=31) evaluated postoperative delirium and, of these, most used a derivative of the Confusion Assessment Method as the primary measurement tool (81%). Thirty-nine studies evaluated other types of perioperative neurocognitive disorders; of these, 24 (62%) used the Mini Mental State Examination and six (15%) used the Montreal Cognitive Assessment. Ketamine produced no cognitive benefits in 35 of the 58 studies (60%), whereas 23 studies (40%) reported a reduced incidence or duration of perioperative neurocognitive disorders, or both. There were no clear trends in terms of the doses, enantiomeric formulations, or timing of ketamine administration associated with favourable cognitive outcomes. However, ketamine studies that evaluated cognition at only early postoperative timepoints were more likely to report no cognitive benefit. Most trials were underpowered to detect changes in cognitive endpoints, and study populations and methods were too heterogeneous to support meaningful meta-analyses. Although the current results summarised in this extensive review are inconsistent, the data nevertheless support the need for larger, well-designed trials to determine whether subgroups of patients that undergo specific types of surgeries might benefit from ketamine. Recommendations regarding the direction of future research are proposed.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40628582\/"},{"pmid":40627996,"journal":"Journal of clinical anesthesia","title":"Association between race, ethnicity, and surgical case cancellations: A retrospective study in a cohort of patients undergoing oncological surgeries.","authors":"Cata JP; Owusu-Agyemang P; Adesoye T; Feng L","abstract":"BACKGROUND: Surgical delays and cancellations have been shown to occur more frequently in racial and ethnic minority patients. We hypothesized that race and ethnicity are independent risk factors for surgical cancellations in patients with cancer. METHODS: This retrospective study reviewed surgical procedures in a large tertiary cancer center. The primary outcome was surgical cancellation before or on the intended surgery date. The primary exposure variable was a patient's self-reported race and ethnicity. A multivariable logistic regression model was fitted to estimate the effects of covariates on the status of case cancellation. A p-value <0.05 was considered statistically significant. RESULTS: Of 109,400 surgical cases, the overall rate of cancellation was 4.45 %. The highest rate was among patients in the head and neck service (15.04 %). Overall, changes in treatment were a frequent cause of cancellations (54.9 %). Black patients had the highest rate of cancellations among all ethnicities (5.4 %), with the breast surgical oncology service having the highest rate of cancellations among Black patients (16.6 %). After only including unique first clinical encounters of each patient (N = 78,227) and with adjustment of gender, age-adjusted CCI and primary surgery type in a mixed effects model which treated surgery date as a cluster variable, patients identified as NH-Asian (OR, 99.8 % CI: 0.56, 0.40-0.79), and NH-White (OR, 99.8 % CI: 0.64, 0.53-0.78) had statistically significant lower odds of surgical cancellation compared to NH-Black patients. Those identified as NHPIA (OR, 99.8 % CI: 0.57, 0.22-1.51), Hispanic or Latino (OR, 99.8 %: 0.82, 0.65-1.03), and Other (OR, 95 % CI: 0.76, 0.46-1.26) did not have significant lower odds of surgical cancellation compared to NH-Black patients. CONCLUSIONS: Our work suggests that in the context of cancer care, Black or African-American patients have an increased risk of surgical cancellations.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40627996\/"},{"pmid":40623285,"journal":"Pain","title":"The impact of chronic pain on brain gene expression.","authors":"Collier L; Seah C; Hicks EM; Holtzheimer PE; Krystal JH; Girgenti MJ; Huckins LM; Johnston KJA","abstract":"Chronic pain affects one-fifth of American adults, contributing significant public health burden. Chronic pain can be further understood through investigating brain gene expression, potentially informing on brain regions, cell types, and gene pathways. We tested for differentially expressed genes (DEGs) in chronic pain, migraine, lifetime fentanyl and oxymorphone use, and with chronic pain genetic risk in 4 brain regions (dorsal anterior cingulate cortex [dACC], dorsolateral prefrontal cortex [DLPFC], medial amygdala [MeA], and basolateral amygdala [BLA]) and imputed cell type expression data from 304 deeply phenotyped postmortem donors, potentially highlighting variation relevant to factors such as predisposition to chronic pain development, mechanisms of chronic pain development and persistence, and indirect effects of chronic pain and associated treatment or medication, and substance use. We also investigated sex differences in chronic pain differential gene expression. At the brain region level, we identified 2 chronic pain DEGs: B4GALT2 and VEGFB in dACC. At the cell level, we found more than 2000 chronic pain cell-type DEGs, significantly enriched in microglia of the basolateral amygdala. The findings were enriched for mouse microglia pain genes, and for hypoxia and immune response pathways. Small amounts of cross-trait DEG overlap in migraine and chronic pain highlighted medial amygdala cells, and in chronic pain and oxymorphone use suggested the amygdala as a key region. Chronic pain differential gene expression was not significantly different between men and women. Overall, chronic pain-associated gene expression is heterogeneous across region and cell type, is largely distinct from that in pain-related factors and migraine, and our results highlight BLA microglia as a key brain cell type in chronic pain.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623285\/"},{"pmid":40623269,"journal":"Pain","title":"Diminished transient receptor vanilloid 1 on skin nerve fibers in painful bortezomib-induced peripheral neuropathy.","authors":"Jin Y; Aravamudhan A; Cebulla N; Schirmer D; Runau E; Flamm L; Terhorst C; Jahnel L; Guse J; Giordani N; Wieser A; Sodmann A; Blum R; Kittel RJ; Sommer C","abstract":"Bortezomib-induced peripheral neuropathy (BIPN) is frequently accompanied by reduced thermal sensation and neuropathic pain. We explored the relation between transient receptor vanilloid 1 (TRPV1) receptors on skin nerves and BIPN pain. We combined PGP9.5 and TRPV1 immunofluorescence labelling on skin biopsy sections from 67 individuals, 27 patients with BIPN without pain, 18 patients with BIPN with pain, and 22 healthy volunteers. A total of 332 bioimages were collected and quantified using objective image analysis. qPCR was used to measure TRPV1 mRNA in the skin. Quantitative sensory testing and pain questionnaires were used to gather clinical data. Transient receptor vanilloid 1 immunoreactivity appeared as distinct puncta along the nerve fibers. Its normalized mean fluorescence intensity (TRPV1\/PGP9.5 MFI) (P < 0.05) and TRPV1 puncta area (P < 0.001) were decreased in small nerve fibers of patients with BIPN, concomitantly with reduced thermal sensitivity. Further stratification based on pain symptoms demonstrated a greater reduction in TRPV1\/PGP9.5 MFI and severe impairment in thermal difference detection ability (TSL) and heat pain thresholds (HPT) in painful BIPN. Pain levels were negatively correlated with TRPV1\/PGP9.5 MFI in the epidermis and subepidermis (P < 0.001 r = -0.44; P < 0.001, r = -0.42), and with z-scores of TSL and HPT (P < 0.05; P < 0.05). Transient receptor vanilloid 1 mRNA levels in skin were not different between groups, indicating that cellular synthesis of TRPV1 was not altered. Diminished TRPV1 immunoreactivity on nerves of patients with BIPN with pain aligns with their insensitivity to thermal stimuli which may help to better understand the pathophysiology of pain in patients with BIPN.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623269\/"},{"pmid":40623266,"journal":"Pain","title":"Spinal disk injury induces germinal center formation, pronociceptive antibody production, and chronic nociceptive sensitization in a male mouse back pain model.","authors":"Wei T; Guo TZ; Shi X; Li WW; Clark JD; Kingery WS","abstract":"Accumulating evidence suggests that spinal intervertebral disk damage is associated with activation of the adaptive immune system. Key unknown features of this response are the mechanism and time course for the generation of pronociceptive antibodies and the antibody classes involved. This study used the lumbar spinal disk puncture (DP) model in male wildtype (WT) and muMT mice (lacking mature B cells) to evaluate pronociceptive immune responses. Sera collected up to 33 weeks after DP were purified for immunoglobulin (Ig)M and IgG intrathecal injections and antigen binding experiments. Spinal cords and disks were collected for quantitative polymerase chain reaction, western, and immunohistochemical analyses. Disk puncture injury in muMT mice had minimal effect, but in WT mice, it induced hindpaw allodynia, hyperalgesia, and grip weakness that gradually resolved after 6 months. Spinal cord expression of inflammatory cytokines and complement components was chronically upregulated after DP, peaking at 1 to 3 weeks. Increased IgM and IgG autoantigen binding and deposition in the spinal cord peaked at 10 to 20 weeks after DP injury. Lumbar lymph node immunostaining demonstrated B-cell germinal center formation beginning at 3 weeks and peaking at 10 to 20 weeks after DP injury. Intrathecal injection of IgM and IgG collected between 3 and 20 weeks after DP in WT mice was pronociceptive in muMT DP mice. Preemptive pharmacologic intervention targeting B cells had no effect on early nociceptive sensitization but reduced sensitization when administered at 10 weeks after DP injury in WT mice. Collectively, these data support the pronociceptive autoimmunity hypothesis for the transition from tissue injury to chronic musculoskeletal pain state.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623266\/"},{"pmid":40623248,"journal":"Pain","title":"Identifying risk and protective factors in the transmission of chronic pain from mothers to children: a longitudinal cohort study.","authors":"Beveridge JK; Noel M; McArthur BA; Madigan S; Orr SL; McDonald S; Tough S; Birnie KA","abstract":"Chronic pain is common and can significantly affect the individual and their family. Indeed, children have an increased risk of developing chronic pain when one or both of their parents have it. However, many children of parents with chronic pain do not report pain problems. The aim of this longitudinal study was to identify psychosocial factors throughout childhood that either increased or decreased the odds for chronic pain among children of mothers with and without chronic pain. Participants were 1128 mother-child dyads from a community-based cohort. Mothers self-reported on their chronic pain when children were 5 and 8 years and on potential risk and protective factors (anxiety and depressive symptoms, parenting practices, social support, coping, and optimism) at various time points between child ages 8 and 11 years. Children self-reported on their chronic pain at 13 years and on potential protective factors (optimism, connections with adults and peers, and community engagement) at 12 years. Logistic regression and moderation analyses demonstrated that children had increased odds for chronic pain at 13 years when their mothers reported both chronic pain and greater anxiety symptoms or ineffective parenting practices earlier in childhood. No protective factors moderated the association between mother-child chronic pain; however, greater child optimism and connections with adults at 12 years lowered the odds of chronic pain for all children, regardless of maternal chronic pain. These findings highlight factors that can be targeted in prevention efforts to mitigate the risk of chronic pain, but future research is needed to explore additional protective factors.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623248\/"},{"pmid":40623245,"journal":"Pain","title":"Subjective salience ratings are a reliable proxy for physiological measures of arousal.","authors":"Hadjis GE; Atlas LY; Mouseli P; Sexton CA; McAndrews MP; Moayedi M","abstract":"Pain is an inherently salient multidimensional experience that signals potential bodily threats and promotes nocifensive behaviours. Any stimulus can be salient depending on its features and context. This poses a challenge in delineating pain-specific processes in the brain, rather than salience-driven activity. It is thus essential to salience match control (innocuous) stimuli and noxious stimuli, to remove salience effects, when aiming to delineate pain-specific mechanisms. Previous studies have salience-matched either through subjective salience ratings or the skin conductance response (SCR). The construct of salience is not intuitive, and thus, matching through self-report poses challenges. SCR is used as a proxy measure that captures physiological arousal, which overcomes the nebulous construct of salience. However, SCR cannot be used to salience match in real time (ie, during an experiment) and assumes an association between salience and physiological arousal elicited by painful and non-painful stimuli, but this has not been explicitly tested. To determine whether salience and physiological arousal are associated, 41 healthy adults experienced 30 heat pain and 30 non-painful electric stimuli of varying intensities. Stimuli were subjectively matched for salience, and SCR was measured to each presentation. A linear mixed model found no differences in SCR between salience-matched heat and electric stimuli. A mediation analysis showed that salience fully mediated the relationship between stimulus intensity and SCR. In conclusion, salience and physiological arousal are associated, and subjective salience ratings are suitable for salience matching pain with non-painful stimuli. Future work can thus use subjective salience ratings to delineate pain-specific processes.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623245\/"},{"pmid":40622860,"journal":"Anesthesiology","title":"Adverse events associated with airway management in pediatric anesthesia: A prospective, multicenter, observational Japan Pediatric Difficult Airway in Anesthesia (J-PEDIA) study.","authors":"Kojima T; Yamauchi Y; Watanabe F; Ichiyanagi S; Kobayashi Y; Kaiho Y; Toyama H; Kasuya S; Kuratani N; Suzuki Y","abstract":"BACKGROUND: The incidence of adverse events and desaturation during airway-securing procedures (a sequence from preoxygenation to completion of tracheal intubation or supraglottic airway placement) under general anesthesia in children remains underexplored. Thus, we investigated the incidence of adverse and desaturation events and associated risk factors. METHODS: This was a prospective, multicenter, observational study conducted between June 2022 and January 2024 in 10 tertiary care (six pediatric and four university [mixed adult-pediatric]) hospitals in Japan. A standardized data collection system was applied through the recruited institutions to collect >\/=95% of cases. The primary and secondary outcomes were adverse events and a >\/=10% drop in oxygen saturation (desaturation) associated with airway-securing procedures. RESULTS: There were 17007 airway management procedures in 16695 children (mean age 6.3 years, standard deviation 4.8). Any adverse events occurred in 346\/17007 (2.0%; 95% CI, 1.8-2.3) children, including 189\/17007 (1.1%; 0.96-1.3) respiratory adverse events. Desaturation occurred during 395\/17007 (2.3%; 2.1-2.6) procedures, with 66\/308 (21.4%; 17.0-26.4) in neonates and 210\/2298 (9.1%; 8.0-10.4) in infants. Multilevel regression analysis showed younger age (adjusted odds ratio 0.92, 95% CI, 0.90-0.95; p<0.001), airway management in radiation diagnostic\/therapy rooms (5.7, 1.64-19.9; p=0.006), airway sensitivity (1.46, 1.09-1.94; P=0.010), craniocervical surgery (1.41, 1.09-1.83; p=0.009), and presence of 1 or >\/=2 anatomical difficult airway features (1.74, 1.02-2.95; p=0.042 and 2.82, 1.21-6.6; p=0.017, respectively) as risk factors of any adverse events. Supraglottic airway device usage at the first attempt and muscle relaxant administration (0.42, 0.288-0.62; p<0.001 and 0.62, 0.43-0.89; p=0.009, respectively) showed a beneficial effect. CONCLUSIONS: The J-PEDIA study demonstrated adverse event and desaturation incidences and the impact of clinically relevant risk factors during airway-securing procedures in Asian children. This study can help anesthesiologists to identify high-risk children and create a safe airway-securing strategy.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40622860\/"},{"pmid":40622858,"journal":"Anesthesiology","title":"Effects of increased cardiopulmonary bypass pump flow on renal filtration, perfusion, oxygenation and tubular injury in cardiac surgical patients - a randomized controlled trial.","authors":"Wijk J; Cordefeldt-Keiller A; Bragadottir G; Redfors B; Ricksten SE; Lannemyr L","abstract":"BACKGROUND: Cardiac surgery with cardiopulmonary bypass (CPB) is associated with impaired renal oxygenation and acute kidney injury. We investigated whether a higher than our standard blood flow during CPB could improve renal blood flow, oxygen demand\/supply relationship, function and attenuate tubular injury. METHODS: After ethical approval and informed consent, 36 adult patients undergoing cardiac surgery received either high-flow (2.9 L\/min\/m2, n=19) or standard-flow (2.4 L\/min\/m2, n=17) during CPB in this randomized, non-blinded, parallell-arm study. Systemic hemodynamics and renal variables were measured before and during CPB. Glomerular filtration rate was measured by infusion clearance of iohexol and renal blood flow by infusion clearance of para-aminohippuric acid, corrected for renal extraction of para-aminohippuric acid, using a renal vein catheter. Renal oxygen demand\/supply relationship was estimated from renal oxygen extraction and tubular injury assessed by urinary N-acetyl-beta-D-glucosaminidase. RESULTS: During CPB, high-flow lead to a larger increase in systemic oxygen delivery (100 ml\/min\/m2, 95% CI [60;141], vs 31[1.9;65], between group p<0.001, effect size Cohen s dz 0.59) and target mean arterial pressure was maintained at a lower norepinephrine dose (0.03 microg\/kg\/min [-0.01;0.06] vs 0.10 [0.02;0.19], p=0.048, Cohen s dz=0.62) compared with standard-flow. There were no differences in renal blood flow or oxygen extraction between groups. Glomerular filtration rate increased during high-flow CPB (6.4 ml\/min\/1.73m2 [1.9;10.9]), but not in the standard-flow group (-2.3 [-10.9;6.2], between group p=0.044, Cohen s dz 0.66). The peak urinary excretion of N-acetyl-beta-D-glucosaminidase was 1.42 units\/micromol creatinine [0.87,3.6] vs 3.74 [1.5,7.7] in the high-flow and standard-flow groups, respectively (p=0.049). No perfusion-related adverse events were seen in either group. CONCLUSIONS: A 20% higher than standard CPB flow during cardiac surgery improved renal function while no change in renal blood flow or oxygen demand\/supply relationship could be detected. Higher CPB flow was associated with a less pronounced tubular injury marker release compared with standard flow.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40622858\/"},{"pmid":40620035,"journal":"European journal of anaesthesiology","title":"'The trachea heals but the hypoxia does not' an emergency front-of-neck access in a 4-year-old with foreign body airway obstruction.","authors":"Asgeirsdottir S; Karlsson EK; Sigurdsson T","abstract":"'Can't Intubate Can't Oxygenate' (CICO) situation is a life-threatening emergency, and an uncommon event in the healthy paediatric population. In children without anatomical airway anomalies, this scenario is most often due to laryngospasm or airway obstruction and can in most cases, be reversed with appropriate medical treatment or removal of the foreign body. This case report describes an emergency front-of-neck surgical airway (eFONA) with a scalpel-bougie-tube method, during cardiopulmonary resuscitation in a 4-year-old child due to foreign body airway obstruction.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40620035\/"},{"pmid":40623762,"journal":"Regional anesthesia and pain medicine","title":"Guidelines on neurostimulation for chronic pain: a compliance appraisal of reporting standards.","authors":"D'Souza RS; Ege E; McMullin P; Hussain N","abstract":"INTRODUCTION: The field of neuromodulation has experienced substantial growth, accompanied by an increase in clinical practice guidelines aimed at supporting evidence-based practice. However, adherence to reporting standards remains critical in the development of a comprehensive and transparent clinical practice guideline. This study evaluated the reporting quality of guidelines on neurostimulation for chronic pain by assessing compliance with the Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist and the Appraisal of Guidelines for Research and Evaluation (AGREE) checklist and explored predictors of reporting quality. METHODS: A search strategy was conducted from database inception to April 17, 2024 to identify guideline articles on neurostimulation treatment (spinal cord stimulation, dorsal root ganglion stimulation, peripheral nerve stimulation) for chronic pain. Primary outcomes included the percentage of completed RIGHT and AGREE checklist items. Secondary outcomes included the identification of under-reported checklist items, predictors of reporting quality, and agreement between the two checklists. RESULTS: A total of 24 guideline articles were included, with a mean percentage of completed items being 55.12%+\/-12.68% for the RIGHT checklist and 52.16%+\/-10.51% for the AGREE checklist. Items that were most frequently under-reported (<25% completion) included themes of population-specific considerations, cost\/resource implications, guideline limitations, recommendation development process, magnitude of benefit versus magnitude of harm, and statement of competing interests and how they were managed. Secondary analysis revealed no significant associations between RIGHT\/AGREE reporting quality and journal impact factor, year of publication, number of authors, or guideline themes. There was good inter-checklist agreement between the RIGHT and AGREE checklists (intraclass correlation coefficient 0.76, 95% CI 0.44 to 0.90), suggesting overlapping but distinct evaluation criteria. CONCLUSIONS: Current guidelines of neurostimulation for chronic pain exhibit significant variability in reporting items, with notable deficiencies in the description of key methodological areas. While adherence to established checklists such as RIGHT and AGREE remains poor and inconsistent, these tools provide a critical framework for enhancing comprehensiveness, transparency, and methodological rigor in future guideline development.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623762\/"},{"pmid":40619168,"journal":"Anaesthesia","title":"Dose-dependent relationship between intra-operative ketamine administration and postoperative delirium: a retrospective cohort study.","authors":"Kaiser L; Paschold BS; Wachtendorf LJ; Ahrens E; Tenge T; Redaelli S; Hentges M; Sahli SD; Chen G; Novack V; Eikermann M; Ma H; Schaefer MS","abstract":"INTRODUCTION: Ketamine is used frequently as an adjunct for general anaesthesia, exerting analgesic and opioid-sparing properties at lower doses and psychotomimetic effects at higher doses. All dose ranges may have effects on the incidence of postoperative delirium, but clinical trials have been equivocal. We hypothesised that intra-operative low-dose ketamine is associated with a lower risk of postoperative delirium. METHODS: A total of 106,982 adult patients undergoing general anaesthesia for non-cardiac, non-neurosurgical and non-transplant procedures between 2008 and 2024 were included. Primary exposure was the intra-operative cumulative ketamine dose (mg.kg(-1) body weight) dichotomised into high vs. low-dose, based on the median of the cohort. Primary outcome was postoperative delirium within 7 days, based on keyword-based search strategy, manual chart review, Confusion Assessment Method recordings and International Classification of Diseases diagnostic codes. Multivariable logistic regression and fractional polynomial regression analyses to assess a potential nonlinear dose-response relationship were performed. RESULTS: Postoperative delirium occurred in 2837 (2.7%) patients. In total, 12,199 (11.4%) patients received ketamine, with a median (IQR [range]) intra-operative dose of 0.35 (0.25-0.52 [0.01-3.86]) mg.kg(-1). Compared with patients not receiving ketamine, a low dose (<\/= 0.35 mg.kg(-1), 6109 patients) was associated with lower risks of postoperative delirium (adjusted odds ratio 0.74 (95%CI 0.59-0.89), adjusted risk difference -0.7% (95%CI -1.0 to -0.3%); p = 0.003). Higher doses of ketamine (> 0.35 mg.kg(-1), 6090 patients) did not affect the risk of postoperative delirium (adjusted odds ratio 1.00 (95%CI 0.85-1.18); p = 0.96). Fractional polynomial regression analyses indicated a U-shaped dose-response relationship, with a minimum postoperative delirium risk at a cumulative ketamine dose of 0.25-0.34 mg.kg(-1). DISCUSSION: Intra-operative low-dose ketamine was associated with a lower risk of postoperative delirium, while high doses did not influence the risk.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40619168\/"},{"pmid":40619312,"journal":"British journal of anaesthesia","title":"Quality of patient-centred recovery trajectories after different types of surgery: a prospective cohort study.","authors":"Myles PS; Phillips B; Robertshaw S; Haughney H; Houle TT; Rowland R; Johnson D; Wallace S","abstract":"BACKGROUND: We sought to measure patient recovery trajectory up to 90 days after surgery using both the 15-item quality of recovery score (QoR-15) (range 0-150) and the number of days alive and at home up to 30 days after surgery (DAH(30)). METHODS: This prospective cohort study included adult patients undergoing either elective intermediate (mostly arthroplasty) or cardiac surgery, or day case gastroscopy (control group). We asked eligible patients to record their QoR-15 scores before their procedure and then daily via smartphone text messaging for 2 weeks, then weekly for 2 weeks, and then monthly up to 90 days after their procedure to track recovery trajectory. We also recorded their DAH(30). The co-primary endpoints were differences in the nadir and slope of the trajectory of recovery as measured by the QoR-15 scale. Differences between groups were compared using time series analysis. RESULTS: Of 199 eligible and consenting patients who underwent surgery, 188 (94%) had complete follow-up. Median (interquartile range) nadir QoR-15 scores were 128 (93-145), 87 (70-102), and 70 (60-81) for the gastroscopy, intermediate, and cardiac surgery groups, respectively (P<0.001). Compared with the gastroscopy group (29.9 [29.9-29.9]), the median (IQR) DAH(30) was lower in both the intermediate (28.8 [26.1-29.1]) and cardiac (22.9 [18.9-24.1]) surgery groups (each P<0.001). There was an association between the QoR-15 nadir and DAH(30) (rho=0.52, P<0.001). Most patients were very satisfied or satisfied with the frequent text messaging. CONCLUSIONS: Recovery after surgery varies according to the extent of surgery and the presence of postoperative complications. Follow-up and measurement of recovery was highly valued by patients. REGISTRATION: Open Science Framework (https:\/\/doi.org\/10.17605\/OSF.IO\/ANBJ5).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40619312\/"},{"pmid":40617055,"journal":"Journal of clinical anesthesia","title":"The usefulness of the modified steep ramp test as a practical exercise test for preoperative risk assessment in patients scheduled for pancreatic surgery.","authors":"Driessens H; Hoeijmakers LSM; Zwerver ODJ; Wijma AG; Hildebrand ND; Queisen RRYC; Kuikhoven M; den Dulk M; Olde Damink SWM; Klaase JM; Bongers BC","abstract":"BACKGROUND: The widespread implementation of a preoperative assessment of aerobic capacity requires a practical field test. This study investigated the validity of the modified steep ramp test (SRT) for evaluating preoperative aerobic capacity and to evaluate its usefulness for preoperative risk assessment in patients planned for pancreatic surgery. METHODS: Patients scheduled for pancreatic surgery who preoperatively performed cardiopulmonary exercise testing (CPET) and the modified SRT within 14 days were included. To assess its criterion validity, the correlation between the achieved work rate at peak exercise (WR(peak)) at the modified SRT and oxygen uptake (VO(2)) at peak exercise (VO(2peak)) during CPET was determined. To evaluate the ability of the modified SRT to correctly classify patients as fit or unfit, receiver operating characteristic (ROC) analyses were performed based on the CPET VO(2peak) cutoff 18.0 ml.kg(-1).min(-1) and VO(2) at the ventilatory anaerobic threshold (VAT) cutoff 11.0 ml.kg(-1).min(-1). RESULTS: Forty-eight patients (21 females) aged 68.7 +\/- 7.6 years were included. Modified SRT WR(peak) (W\/kg) demonstrated a very strong correlation with CPET VO(2peak) (rho = 0.865, r = 0.926). The modified SRT WR(peak) cutoff to most accurately classify patients as fit or unfit was 2.095 W\/kg for the CPET VO(2peak) cutoff (area under the curve (AUC) of 0.948) and the CPET VO(2) at the VAT cutoff (AUC of 0.814). CONCLUSIONS: The modified SRT is a valid short-term practical exercise test to preoperatively assess aerobic capacity in patients undergoing pancreatic surgery. A modified SRT performance below 2.1 W\/kg seems clinically most suitable to select candidates for further preoperative CPET evaluation and\/or prehabilitation, given its positive and negative predictive value.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40617055\/"},{"pmid":39084703,"journal":"Regional anesthesia and pain medicine","title":"One-year opioid consumption trajectories among individuals receiving multidisciplinary postsurgical care: a single-center observational study from the Toronto General Hospital Transitional Pain Service.","authors":"Page MG; Katz J; Darville R; Gabriel G; Ladha KS; Huang A; Ganty P; Katznelson R; Tamir D; Fiorellino J; Kahn M; Tao L; Slepian M; Wieskopf J; Clarke H","abstract":"INTRODUCTION: The Transitional Pain Service (TPS) is an innovative, personalized approach to postsurgical opioid consumption and pain management. The objectives of this study were to identify trajectories of opioid consumption and pain intensity within 12 months after initiating treatment through the TPS, identify biopsychosocial factors associated with trajectory membership, and examine the relationship between trajectory membership and other outcomes of interest over the same 12-month period. METHODS: Consecutive patients referred to the TPS were included in the present study (n=466). After providing informed consent, they completed self-report questionnaires at the initial visit at the TPS (either pre surgery or post surgery) and at every TPS visit until 12 months. Growth mixture modeling was used to derive trajectories and identify associated factors. RESULTS: Results showed three distinct opioid consumption trajectories for both presurgical opioid consumers and opioid-naive patients. These trajectories all decreased over time and among those who were consuming opioids before surgery that returned to presurgical levels. Being man, having a substance use disorder, or reporting higher levels of pain interference were associated with higher daily opioid consumption for presurgical opioid consumers. For presurgical opioid-naive individuals, higher opioid consumption trajectories were associated with higher levels of psychological distress. Five pain intensity trajectories were identified, and there were no significant association between opioid consumption and pain intensity trajectories. CONCLUSIONS: Results suggest that opioid consumption and pain intensity trajectories mostly decrease after surgery in a high-risk population enrolled in a TPS. Results also show heterogeneity in postsurgical recovery and highlight the importance of using personalized interventions to optimize individual trajectories.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39084703\/"},{"pmid":38925712,"journal":"Regional anesthesia and pain medicine","title":"Pericapsular nerve group block: a 3D CT scan imaging study to determine the spread of injectate.","authors":"Balocco AL; Gautier N; Van Boxstael S; Lopez AM; Carella M; Corten K; Sala-Blanch X; Hadzic A; Gautier PE","abstract":"BACKGROUND: Current understanding of the mechanism of action of the pericapsular nerve group (PENG) block is primarily based on cadaver studies. We performed an imaging study in patients undergoing hip surgery to enhance the understanding of the analgesic mechanisms following a PENG block. MATERIALS AND METHODS: 10 patients scheduled for hip surgery received an ultrasound-guided PENG block with 18 mL of 0.5% ropivacaine mixed with 2 mL of a contrast agent. After completion of the block, a high-resolution CT scan was performed to obtain a three-dimensional reconstruction of the injectate's dispersion. RESULTS: The CT imaging revealed that injectate was mainly confined to the epimysium of the iliacus and the psoas muscle, with a minor spread to the hip capsule. Contrast dye was detected within the iliacus and\/or the psoas muscle in all patients. No observed spread to either the subpectineal plane or the obturator foramen was detected. CONCLUSION: Our study suggests that the analgesic effect of the PENG block may be related to the block of the branches of the femoral nerve traveling within the iliopsoas muscle without a spread pattern commensurate with the block of the obturator nerve. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Registry (NCT06062134).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38925712\/"},{"pmid":38876802,"journal":"Regional anesthesia and pain medicine","title":"Artificial intelligence and regional anesthesiology education curriculum development: navigating the digital noise.","authors":"Schroeder KM; Elkassabany N","abstract":"Artificial intelligence (AI) has demonstrated a disruptive ability to enhance and transform clinical medicine. While the dexterous nature of anesthesiology work offers some protections from AI clinical assimilation, this technology will ultimately impact the practice and augment the ability to provide an enhanced level of safe and data-driven care. Whether predicting difficulties with airway management, providing perioperative or critical care risk assessments, clinical-decision enhancement, or image interpretation, the indications for AI technologies will continue to grow and are limited only by our collective imagination on how best to deploy this technology.An essential mission of academia is education, and challenges are frequently encountered when working to develop and implement comprehensive and effectively targeted curriculum appropriate for the diverse set of learners assigned to teaching faculty. Curriculum development in this context frequently requires substantial efforts to identify baseline knowledge, learning needs, content requirement, and education strategies. Large language models offer the promise of targeted and nimble curriculum and content development that can be individualized to a variety of learners at various stages of training. This technology has not yet been widely evaluated in the context of education deployment, but it is imperative that consideration be given to the role of AI in curriculum development and how best to deploy and monitor this technology to ensure optimal implementation.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38876802\/"},{"pmid":38821535,"journal":"Regional anesthesia and pain medicine","title":"Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain: 3-month and 6-month results from the COMFORT-randomised controlled trial.","authors":"Hatheway J; Hersel A; Song J; Engle M; Gutierrez G; Khemlani V; Kapural L; Moore G; Ajakwe R; Trainor D; Hah J; Staats PS; Lynch P; Makous J; Heit G; Kottalgi S; Desai MJ","abstract":"BACKGROUND: We report the results from the first large, postmarket, multicentre, randomised controlled trial (RCT) evaluating peripheral nerve stimulation (PNS) for the treatment of chronic peripheral pain with a micro-implantable pulse generator (micro-IPG). METHODS: Subjects meeting eligibility were randomised (2:1) to either the active arm receiving PNS and conventional medical management (CMM) or the control arm receiving CMM alone. Treatments were limited to the following areas: lower back, shoulder, knee and foot\/ankle. RESULTS: At 6 months, the active arm achieved an 88% responder rate with a 70% average reduction in pain. At the 3-month primary endpoint, the active arm achieved an 84% responder rate with an average pain reduction of 67% compared with the control arm, which achieved a 3% responder rate with an average pain reduction of 6%. Both responder rate and pain reduction in the active arm were significantly better than in the control arm (p<0.001). A majority of patient-reported outcomes also reached statistical significance. There have been no reports of pocket pain and no serious adverse device effects. 81% of subjects found the external wearable component of the PNS system to be comfortable. CONCLUSIONS: This study successfully reached its primary endpoint-the active arm achieved a statistically significant superior responder rate as compared with the control arm at 3 months. These RCT results demonstrated that PNS, with this micro-IPG, is efficacious and safe. This ongoing study will follow subjects for 3 years, the results of which will be reported as they become available.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38821535\/"},{"pmid":38754991,"journal":"Regional anesthesia and pain medicine","title":"No quadriceps muscle weakness following anterior quadratus lumborum block compared with placebo: a randomized, non-inferiority, blinded, volunteer trial.","authors":"Tanggaard K; Nielsen MV; Holm UHU; Hoffmann BM; Bernhoff C; Andersen CH; Thomassen SS; Hansen C; Dam M; Poulsen TD; Holm PM; Borglum J","abstract":"BACKGROUND AND AIMS: Anterior quadratus lumborum block is a truncal block, applied in close proximity to the lumbar plexus, potentially causing lower limb weakness. This trial aimed to evaluate whether a unilateral anterior quadratus lumborum block caused quadriceps muscle weakness compared with placebo. METHODS: In this randomized, non-inferiority, triple-blind trial, 20 healthy volunteers received an active unilateral anterior quadratus lumborum block with 30 mL ropivacaine 0.75% and a placebo block on the contralateral side. Primary outcome was change in maximal quadriceps muscle strength from baseline to 60 min postblock compared with placebo. Secondary outcomes were change in single-leg 6 m timed hop test, change in Timed-Up and Go test, change in mean arterial pressure from baseline to 30 min postblock and dermatomal affection. RESULTS: There was no statistically significant difference in changes in maximal quadriceps muscle strength between active and placebo block; 15.88 N (95% CI -12.19 to +43.94), p(non-inf)=0.003, indicating non-inferiority. Timed-Up and Go test was performed significantly faster 60 min postblock; -0.23 s (95% CI -0.38 to -0.08, p=0.005). Mean change in mean arterial pressure from baseline to 30 min postblock was 4.25 mm Hg (95% CI 0.24 to 8.26, p=0.04). Dermatome testing revealed an affection primarily of the lower abdomen (Th10-L1) with the active block. CONCLUSION: In this randomized controlled trial including healthy volunteers a unilateral anterior quadratus lumborum block does not cause statistical or clinical significant motor block of the quadriceps muscle compared with placebo. When administered correctly, the block can be used for procedures where early postoperative mobilization is essential. TRIAL REGISTRATION NUMBER: NCT05023343.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38754991\/"},{"pmid":38754990,"journal":"Regional anesthesia and pain medicine","title":"Extended reality navigation for pain procedures: a narrative review.","authors":"Cho JS; Jotwani R; Chan S; Thaker DM; On JD; Yong RJ; Hao D","abstract":"BACKGROUND: Extended reality (XR) technology, encompassing virtual reality, augmented reality, and mixed reality, has been widely studied for procedural navigation in surgical specialties. Similar to how ultrasound transformed regional anesthesia, XR has the potential to reshape how anesthesiologists and pain physicians perform procedures to relieve pain. OBJECTIVE: This narrative review examines the clinical benefits of XR for navigation in various pain procedures. It defines key terms and concepts related to XR technology and explores characteristics of procedures that are most amenable to XR-based navigation. Finally, it suggests best practices for developing XR navigation systems and discusses the role of emerging technology in the future of XR in regional anesthesia and pain medicine. EVIDENCE REVIEW: A search was performed across PubMed, Embase, and Cochrane Central Register of Controlled Trials for primary literature investigating the clinical benefits of XR navigation for pain procedures. FINDINGS: Thirteen studies using XR for procedural navigation are included. The evidence includes randomized controlled trials, retrospective studies, and case series. CONCLUSIONS: Early randomized controlled trials show potential for XR to improve procedural efficiency, but more comprehensive research is needed to determine if there are significant clinical benefits. Case reports demonstrate XR's utility in generating patient-specific navigation plans when difficult anatomy is encountered. Procedures that facilitate the generation and registration of XR images are most conducive to XR navigation, whereas those that rely on frequent re-imaging will continue to depend on traditional modes of navigation.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38754990\/"},{"pmid":38697776,"journal":"Regional anesthesia and pain medicine","title":"Bilateral ultrasound-guided maxillary and mandibular combined nerves block reduces morphine consumption after double-jaw orthognathic surgery: a randomized controlled trial.","authors":"Esquerre T; Mure M; Minville V; Prevost A; Lauwers F; Ferre F","abstract":"BACKGROUND: Double-jaw surgeries are known to be painful and to require opioids. Maxillary (V2) and mandibular (V3) nerves block could provide adequate pain management with minimal opioid-related side effects. Our main objective was to evaluate the analgesic effect of bilateral ultrasound-guided V2 and V3 combined nerves block in patients undergoing double-jaw orthognathic surgery. METHODS: In this single-blind, randomized control study, 50 patients were prospectively allocated to either bilateral ultrasound-guided V2 and V3 combined nerves block or intraoral infiltration of local anesthetic. Primary outcome was the cumulative oral morphine equivalent (OME) consumption assessed at postoperative day 1. Secondary outcomes were cumulative OME consumption and pain scores in recovery room and at postoperative day 2, intraoperative anesthetic consumption, and opioid-related side effects. Preoperative anxiety was investigated by the Amsterdam Preoperative Anxiety and Information Scale (APAIS). RESULTS: Compared with infiltration, ultrasound-guided regional anesthesia reduced cumulative OME consumption on day 1 (45.7+\/-37.6 mg vs 25.5+\/-19.8 mg, respectively, mean difference of -20.1 (95% CI -37.4 to -2.9) mg, p=0.023) and day 2 (64.5+\/-60 mg vs 35.8+\/-30.2 mg, respectively, mean difference of -28.7 (95% CI -55.9 to -1.43) mg, p=0.040). Interestingly, worst pain score and cumulative OME consumptions on day 2 were positively correlated with the APAIS (Pearson's correlation coefficient of 0.42 (p=0.003) and 0.39 (p=0.006), respectively). CONCLUSION: Bilateral ultrasound-guided V2 and V3 combined nerves block reduces postoperative opioid consumption by about 50% in patients undergoing double-jaw surgery. TRIAL REGISTRATION NUMBER: NCT05351151.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38697776\/"},{"pmid":38688686,"journal":"Regional anesthesia and pain medicine","title":"Regional versus general anesthesia for total hip and knee arthroplasty: a nationwide retrospective cohort study.","authors":"Oh TK; Song IA","abstract":"INTRODUCTION: We aimed to determine whether regional anesthesia (RA) has any advantages over general anesthesia (GA) in total joint arthroplasty (TJA) in terms of mortality and postoperative complications. METHODS: This population-based retrospective cohort study included data of adults who underwent total knee or hip arthroplasty under RA or GA between 2016 and 2021 from the National Health Insurance Service of South Korea. RA included spinal or epidural anesthesia or a combination of both. Endpoints were 30-day mortality, 90-day mortality, and postoperative complications. Propensity score (PS) matching was used for statistical analysis. RESULTS: We included 517 960 patients (RA, n=380 698; GA, n=137 262) who underwent TJA. After PS matching, 186 590 patients (93 295 in each group) were included in the final analysis. In the logistic regression analyses using the PS-matched cohort, the RA group compared with the GA group showed 31% (OR: 0.69; 95% CI, 0.60 to 0.80; p<0.001) and 22% (OR: 0.78; 95% CI, 0.72 to 0.85; p<0.001) lower 30-day and 90-day mortality rates, respectively. However, the total postoperative complication rate did not differ significantly between the two groups (p=0.105). CONCLUSION: RA compared with GA was associated with improved 30-day and 90-day survival outcomes in patients who underwent TJA. However, the postoperative complication rate did not differ significantly. Therefore, our results should be interpreted with caution, and more well-designed future studies are needed to clarify the most appropriate type of anesthesia for TJA.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38688686\/"},{"pmid":38677883,"journal":"Regional anesthesia and pain medicine","title":"Postsurgical opioid prescribing among veterans using community care for orthopedic surgery at non-VA hospitals compared to a VA hospital with a transitional pain service: a retrospective cohort study.","authors":"Buys MJ; Anderson Z; Bayless K; Zhang C; Presson AP; Hales J; Brooke BS","abstract":"BACKGROUND: The USA provides medical services to its military veterans through Veterans Health Administration (VHA) medical centers. Passage of recent legislation has increased the number of veterans having VHA-paid orthopedic surgery at non-VHA facilities. METHODS: We conducted a retrospective cohort study among veterans who underwent orthopedic joint surgery paid for by the VHA either at the Salt Lake City VHA Medical Center (VAMC) or at non-VHA hospitals between January 2018 and December 2021. 562 patients were included in the study, of which 323 used a non-VHA hospital and 239 patients the VAMC. The number of opioid tablets prescribed at discharge, the total number prescribed by postdischarge day 90, and the number of patients still filling opioid prescriptions between 90 and 120 days after surgery were compared between groups. RESULTS: Veterans who underwent orthopedic surgery at a non-VHA hospital were prescribed more opioid tablets at discharge (median (IQR)); (40 (30-60) non-VHA vs 30 (20-47.5) VAMC, p<0.001) and in the first 90 days after surgery than patients who had surgery at the Salt Lake City VAMC (60 (40-120) vs 35 (20-60), p<0.001). Patients who had surgery at Salt Lake City VAMC were also significantly less likely to fill opioid prescriptions past 90 days after hospital discharge (OR (95% CI) 0.06 (0.01 to 0.48), p=0.007). CONCLUSION: These results suggest that veterans who have surgery at a veterans affairs hospital with a transitional pain service are at lower risk for larger opioid prescriptions both at discharge and within 90 days after surgery as well as persistent opioid use beyond 90 days after discharge than if they have surgery at a community hospital.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38677883\/"},{"pmid":40641389,"journal":"European journal of anaesthesiology","title":"New-onset postoperative hypotension in patients recovering from noncardiac surgery: A prospective observational study.","authors":"Hoppe P; Chang Y; Schwarz T; Bergholz A; Thomsen KK; Kroker A; Flick M; Krause L; Sessler DI; Saugel B","abstract":"BACKGROUND: It remains unknown whether postoperative mean arterial pressures less than 65 mmHg constitute clinically important hypotension for individual patients, or might be within their normal pressure range. OBJECTIVE: We aimed to evaluate postoperative arterial pressure in patients recovering from noncardiac surgery and determine the proportion of patients in whom a mean arterial pressure less than 65 mmHg constitutes new-onset postoperative hypotension. DESIGN: A prospective observational study. SETTING: German university medical centre between October 2020 and September 2021. PATIENTS: Patients with elevated cardiovascular risk recovering on general wards from noncardiac surgery under general anaesthesia. MAIN OUTCOME MEASURES: Before and after surgery, we automatically measured arterial pressure at 30-min intervals for about 24 h. We considered patients to have new-onset postoperative hypotension when they had a postoperative mean arterial pressure less than 65 mmHg, and their lowest postoperative mean arterial pressure was at least 5 mmHg below their lowest pre-operative mean arterial pressure. RESULTS: We enrolled 307 patients and included 248 in the final analysis. The median [IQR] duration of surgery was 62 [40 to 90] min. Postoperative mean arterial pressure was less than 65 mmHg at least once in 101 patients (41%). In 44 of these 101 patients (44%; 18% of all 248 patients), postoperative mean arterial pressures less than 65 mmHg constituted new-onset postoperative hypotension. In 57 of these 101 patients (56%; 23% of all 248 patients), postoperative mean arterial pressures less than 65 mmHg did not constitute new-onset postoperative hypotension. CONCLUSION: About 40% of our patients recovering from noncardiac surgery on general wards had at least one postoperative mean arterial pressure less than 65 mmHg, and about half of these patients had new-onset postoperative hypotension.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40641389\/"},{"pmid":40615330,"journal":"British journal of anaesthesia","title":"Effect of perioperative autonomic nervous system imbalance on surgical outcomes: a systematic literature review.","authors":"Pan WT; Ji MH; Ma D; Yang JJ","abstract":"The autonomic nervous system (ANS) is essential for maintaining physiological homeostasis. Autonomic nervous system imbalance, characterised by sympathetic hyperactivation and low parasympathetic tone, can occur during the perioperative period. These changes drive systemic stress responses, cardiovascular instability, impaired tissue repair, and immunosuppression, which in turn increase infection risk, neurocognitive decline, and multiorgan dysfunction. Surgical trauma, anaesthesia, pain, hypothermia, and psychological stressors all contribute to this dysregulation, and consequently low parasympathetic tone results in the cholinergic anti-inflammatory pathway being less effective. High sympathetic nervous system activity promotes catecholamine surges and pro-inflammatory cytokine release. Pharmacological interventions, including dexmedetomidine and beta-blockers, together with nonpharmacological strategies, such as electroacupuncture and temperature management, are measures that have potential to restore ANS balance. This systematic review covers ANS-mediated organ regulation, pathophysiological consequences of perioperative dysautonomia, and evidence-based therapeutic strategies. By integrating findings from multiple basic and clinical studies, the pivotal roles of ANS modulation in mitigating postoperative complications, including neurocognitive disorders, immunosuppression, and cancer recurrence, are discussed. Maintaining balance of the sympathetic and parasympathetic nervous systems is an important prospect in perioperative medicine that could benefit surgical patients' short- or long-term recovery.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40615330\/"},{"pmid":40615329,"journal":"British journal of anaesthesia","title":"Artificial intelligence for electrocardiographic diagnosis of perioperative myocardial ischaemia: a scoping review.","authors":"Kim A; Chatterjee M; Iansavitchene A; Komeili M; Chan ADC; Yang H; Chui J","abstract":"BACKGROUND: Perioperative electrocardiographic monitoring can offer immediate detection of myocardial ischaemia, yet its application in perioperative and remote monitoring settings is hampered by frequent false alarms and signal contamination. We performed a scoping review for the current state of artificial intelligence (AI) in perioperative ECG interpretation. METHODS: A literature search in Ovid MEDLINE, EMBASE, Compendex, and CINAHL databases was performed from inception to May 10, 2023. All original research of ECG monitoring for myocardial ischaemia, myocardial infarction, or both was included. RESULTS: A total of 182 original research articles published between 1991 and 2023 were included. Most studies (n=132) used a pre-existing ECG database to develop AI algorithms retrospectively, and the rest did not specify their sources. Processing filters were used in 58% of the studies to remove ECG noises\/artifacts before AI algorithm development. Amongst the AI technologies used, ResNet demonstrated the highest median sensitivity, precision, and specificity at 98.4%, 99.8%, and 99.1%, respectively. There are only five studies with intermittent prospective ECG collection on ST-segment elevation myocardial infarction. No studies prospectively collected continuous ECG perioperatively, with frequent false alarms and signal contamination. CONCLUSIONS: AI technology can achieve high diagnostic accuracy for myocardial ischaemia detection in clean intermittent electrocardiograms. However, almost all these algorithms were developed from a few open-source clean ECG databases without testing on 'noisy data', which limited their clinical applicability in the perioperative setting where signal contamination is frequent. AI algorithms on perioperative electrocardiography, tested in a noisy perioperative and remote monitoring environment, including wearable devices, are needed.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40615329\/"},{"pmid":40615328,"journal":"British journal of anaesthesia","title":"Adherence to prehabilitation in adult surgical patients: a systematic review, meta-analysis, meta-regression, and qualitative synthesis.","authors":"Berrio-Valencia MI; Al-Bayati M; Baxi A; Branje K; Chitiva-Martinez I; Hladkowicz E; Kidd G; Hutton B; Wolfe DM; Lalu M; Boet S; Gillis C; McIsaac DI","abstract":"BACKGROUND: Prehabilitation is hypothesised to play an important role in optimising postoperative outcomes. However, achieving high adherence can be challenging. Our objectives were to synthesise current approaches to adherence measurement and reporting, estimate prehabilitation adherence across trials, identify procedural-, programme-, or patient-level factors associated with adherence, and report barriers and facilitators to adherence. METHODS: Ovid MEDLINE, Embase, the CINAHL, PsycINFO, Web of Science, and the Cochrane CENTRAL Register of Controlled Trials were searched from inception until April 10, 2024. We included randomised trials of adults undergoing major elective surgery allocated to a prehabilitation programme, with at least one binary or continuous measure of adherence to prehabilitation, to an individual component, or both. Random-effects meta-analysis pooled overall adherence rates; meta-regression evaluated predictors of adherence. Qualitative synthesis of reported barriers and facilitators was informed by the Theoretical Domains Framework. RESULTS: We screened 11 652 titles and abstracts, followed by 1232 full texts, and included 105 trials (n=4941). Pooled adherence was 79% (95% confidence interval [CI] 70-88; I(2)=95.4%). Substantial qualitative and statistical heterogeneity existed in defining prehabilitation adherence. Only patient age was significantly associated with adherence (per year older: odds ratio 0.95 [95% CI 0.91-0.99]). Based on qualitative synthesis, common barriers were logistical issues and health conditions; facilitators included supervision by specialists and personalisation. CONCLUSIONS: Prehabilitation adherence metrics are variable across trials and standardisation is required to improve reporting and interpretation of prehabilitation evidence. Little credible evidence identifies factors associated with adherence; however, qualitative barriers and facilitators could inform programme design and implementation. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42024518851).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40615328\/"},{"pmid":40610221,"journal":"Regional anesthesia and pain medicine","title":"Using AI chatbots as clinical decision support for regional anesthesia: is the new era of \"e-Consults\" ready for primetime?","authors":"Corpman D; Auyong DB; Walters D; Gray A","abstract":"BACKGROUND AND OBJECTIVE: There is growing interest to further incorporate artificial intelligence into clinical practice. Perioperative decision-making for patients considered for regional anesthesia is complex, and the use of artificial intelligence as a clinical decision support tool in this context is underinvestigated. We aim to evaluate large language models (LLMs) when prompted with clinical scenarios and management questions in the subspecialty of regional anesthesiology. METHODS: A pilot study was conducted with four popular LLM-based chatbots. They were prompted with the same basic and complex clinical scenarios and common management questions followed by a qualitative review specific to regional anesthesiology. RESULTS: All four platforms demonstrated weaknesses in clinical judgment, thoroughness, and rationale in decision-making that were more pronounced for the complex scenario. There is evidence of confabulations in the responses. CONCLUSIONS: LLM-based chatbots applied to the subspecialty of regional anesthesiology are not ready to truly assist in basic or complex clinical scenarios.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610221\/"},{"pmid":40610220,"journal":"Regional anesthesia and pain medicine","title":"Lost in conversion: navigating the challenges of converting intrathecal opioids to oral equivalents-a case report and literature review.","authors":"Banik RK; Ko JS; Jiminez F; Horn DB; Sivanesan E; Park M; Cohen SP","abstract":"BACKGROUND: Chronic intrathecal opioid use via intrathecal drug delivery system (IDDS), while effective in some patients, can lead to serious complications and side effects. Complications related to IDDS include mechanical\/device malfunction, intrathecal catheter problems, infections, and provider errors. These issues often require urgent surgical intervention, IDDS removal, and abrupt discontinuation of the analgesic infusion. In these scenarios, the safe and effective transition to alternative opioid delivery routes such as intravenous or oral administration is critical. However, an accurate calculation of equianalgesic doses to ensure adequate pain control while minimizing the risk of withdrawal is not well documented. CASE REPORT: A patient in their 60s with a complex medical history, including chronic low back pain managed with IDDS for 30 years, presented with severe pain unresponsive to dose adjustments. Imaging revealed a catheter-related granuloma at thoracic 8 level, leading to intrathecal therapy discontinuation. A rapid weaning protocol reduced the intrathecal morphine dose by 10% daily, transitioning to systemic opioids based on pain severity and short-acting opioid needs. The final intrathecal-to-oral morphine conversion ratio by the time the pump was empty on day 10 was approximately 1:10. CONCLUSION: Current guidelines for intrathecal-to-systemic opioid conversion vary widely, with outdated literature suggesting a 1:300 ratio, whereas real-world cases report ratios between 1:2.5 and 1:70. Given this variability, a conservative, patient-specific approach is essential. Clinicians should consider pharmacokinetics, tolerance, and comorbidities, starting with lower conversion ratios and titrating carefully.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610220\/"},{"pmid":40608563,"journal":"Anesthesia and analgesia","title":"Enhancing Anesthetic Preoptimization: Promising Opportunities for Innovation in Economically Diverse Regions.","authors":"Bernstein WK; Pearl RG; Huang J; Mayrsohn BG; Mery MW; Banoub M; Pease S; Ayad S; Saffary R; Olszewski RF Jr; Aronson S; Vetter TR","abstract":"The escalating costs of perioperative care are unsustainable, necessitating the identification of high-impact investment opportunities to enhance both quality and cost-effectiveness of perioperative processes. In both rural and urban areas with less access to health care resources, a sustainable health care system must focus on delivering value-based care and prioritizing population health, promoting efficiency, preventing complications, and optimizing outcomes. Given the shortage of primary care physicians, and the lessons learned from the COVID-19 pandemic, which emphasized the importance of a systems-based approach, as well as the evolving roles in the perioperative surgical home and ERAS pathways, anesthesiologists are in a prime position to contribute to these essential value-based objectives. They can achieve this by playing a more active role in the preoperative evaluation and optimization of patients.This paper presents a comprehensive review of pertinent perioperative medical conditions (obstructive sleep apnea, hypertension, anemia, food insecurity and nutrition, diabetes, cognitive and brain health) that can be optimized before surgery. It highlights the latest research and innovations in preoperative management that can significantly alter intraoperative anesthetic management of these conditions leading to reduced morbidity and mortality among surgical patients. Furthermore, this paper highlights existing gaps in preoperative management, particularly in the optimization of comorbid medical conditions.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40608563\/"},{"pmid":40623293,"journal":"Pain","title":"Reliability and validity of the Pediatric PainSCAN: a screening tool for pediatric neuropathic pain and complex regional pain syndrome.","authors":"Mesaroli G; Davis AM; Perruccio AV; Davidge KM; Campbell F; Sun N; Walker SM; Hess CW; Simons LE; Logan D; Stinson JN","abstract":"The Pediatric PainSCAN is the first screening tool for neuropathic pain (NP) and complex regional pain syndrome (CRPS) designed for pediatrics. Prior research developed the tool and established content validity. The tool has 3 parts, part A is a preface (pain location, severity, duration), part B discriminates NP or CRPS from other pain conditions, and part C discriminates CRPS from NP. This study aimed to evaluate the tool's reliability and validity. A multicentre cross-sectional survey was administered to participants with NP, CRPS, and other pain conditions in pediatric chronic pain clinics. Test-retest reliability was evaluated by readministering the tool after 7 days. Criterion validity (sensitivity [SE] and specificity [SP]) was evaluated by comparing participant scores to a clinician diagnosis. Convergent validity was evaluated by comparing participant scores on the tool to existing NP screening tools. Participants (N = 221; 56 with NP, 57 with CRPS, 108 with other pain) were aged 9 to 18 years and 81% female. Test-retest reliability (intraclass correlation coefficients part B = 0.76 and part C = 0.82) was sufficient (>0.70). Criterion validity (part B: SE 76%, SP 63%; part C: SE 83%, SP 77%) was sufficient (>70%) except for SP of part B. Convergent validity was sufficient (correlation coefficients aligned with hypotheses: painDETECT [0.73], self-report Leeds Assessment of Neuropathic Symptoms and Signs [0.73], and Patient-Reported Outcome Measurement Information System Neuropathic Pain Quality [0.59]). The Pediatric PainSCAN demonstrated sufficient reliability and validity to screen for NP and CRPS in pediatric chronic pain clinics. Future research is needed to evaluate the tool in other settings and determine the utility of implementing the tool in clinical practice.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623293\/"},{"pmid":40623243,"journal":"Pain","title":"Convergent validity of a person-dependent definition of a low back pain flare.","authors":"Suri P; Korpak AM; Timmons AK; Tanus AD; Brubeck HF; Costa N; Staab CA; Hodges PW; Daniels CJ; Heagerty PJ; Jensen MP","abstract":"Exacerbations of existing low back pain (LBP) or new LBP episodes are colloquially referred to as \"flares.\" Although the experience of flares is common to many people with LBP, few validated measures enable people to self-report if they are experiencing a flare. This study examined the convergent validity of a person-dependent definition of flares (\"a worsening of your low back pain that lasts from hours to weeks\") as compared with (1) LBP intensity, (2) LBP-related pain interference, and (3) analgesic use, in a large, prospective research study of Veterans with LBP. Veterans seeking care for LBP (n = 465) were followed prospectively for up to 1 year. Participants completed up to 36 scheduled surveys and additional patient-initiated surveys (triggered by the onset of new flares) over follow-up. Each survey inquired about current flare status, pain intensity measured on a 0 to 10 numeric rating scale (NRS), LBP-related pain interference, and analgesic use. Linear mixed-effects models estimated the association between current flare status and pain intensity, with and without adjustment for potential confounding factors; secondary analyses examined associations with pain interference and analgesic use. In longitudinal analyses of 11,817 surveys, flare status was significantly associated with a 2.8-NRS point greater pain intensity (P < 0.0001), with and without adjustment for other factors. Statistically significant associations were found between flare status and LBP-related pain interference and analgesic use. New flare periods were associated with impacts on coping, functional limitations, and mood\/emotions. These findings support the convergent validity of a person-dependent flare definition.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40623243\/"},{"pmid":40610285,"journal":"British journal of anaesthesia","title":"Association of peripheral nerve blocks with increased postoperative pain and opioid use in orthopaedic surgery: a single-centre retrospective cohort study.","authors":"Chung AR; Mather RV; Gutierrez R; Liu R; Leung CFA; Zhang M; Santa Cruz Mercado LA; Houle TT; Bittner EA; Purdon PL","abstract":"BACKGROUND: Peripheral nerve blocks have become popular in orthopaedic surgeries to improve acute postoperative pain. However, studies are mixed on their effectiveness in decreasing postoperative opioid consumption. A more comprehensive analysis is necessary to understand if peripheral nerve blocks reduce postoperative opioid exposure and risk for opioid dependence. METHODS: This retrospective cohort study evaluated electronic health record data for adults undergoing orthopaedic surgery with general anaesthesia from 2016 to 2020 at the Massachusetts General Hospital. Linear models were fitted on propensity-weighted data to characterise the association between single injection peripheral nerve blocks and clinical outcomes. Our primary outcomes were maximum pain score and cumulative opioid dose, quantified in morphine milligram equivalents, administered in the PACU. Post-discharge outcomes associated with pain and opioid consumption were also evaluated. RESULTS: Among 22 956 patients, peripheral nerve block administration was associated with lower maximum pain scores and lower probability of opioid administration in the PACU. However, it was associated with higher maximum pain scores and a 22.7% increase in opioid consumption during the hospital stay. Peripheral nerve blocks were associated with an increase in opioid prescriptions at 30 days after discharge, but no increase at 90 or 180 days, and with decreased chronic pain diagnoses 1 yr after operation. CONCLUSIONS: Although single injection peripheral nerve blocks were effective in reducing immediate postoperative pain and opioid consumption, they were associated with greater opioid consumption that could increase the risk for opioid dependence. Standardised protocols to mitigate the risk for rebound pain could help minimise postoperative opioid exposure.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40610285\/"},{"pmid":40609218,"journal":"Journal of clinical anesthesia","title":"Pericapsular nerve group (PENG) block compared to intrathecal morphine for analgesic efficacy in total hip arthroplasty: A placebo-controlled randomized double-blind non-inferiority trial.","authors":"Oremus K; Trkulja V; Gasparini G; Sostaric S; Cicak N; Haspl M; Mihaljevic S","abstract":"BACKGROUND: We hypothesized that pericapsular nerve group (PENG) block was non-inferior to intrathecal (IT) morphine regarding analgesia after total hip arthroplasty (THA) with no untoward effects on the motor function. METHODS: In a double-blind placebo-controlled non-inferiority trial, patients undergoing unilateral THA under spinal anesthesia were randomized to receive a PENG block (20 mL 0.5 % levobupivacaine +2 mg dexamethasone) or IT morphine (100 mug). They received multimodal oral postoperative analgesia with rescue intravenous morphine for breakthrough pain, and were repeatedly evaluated for pain over the first 48 postoperative hours using a 0-10 numerical rating scale (NRS), and for the straight leg raise test at 4, 6 and 12 h. Co-primary outcomes were (i) maximum pain at rest and (ii) at active hip flexion - estimated for the overall period based on three consecutive scores - and (iii) milligram morphine equivalents (MME) delivered over 48 h. Non-inferiority margins for the PENG block - IT morphine differences were 0.75 NRS points for the pain scores, and 10 for the cumulative MME (corresponds to one 4 mg intravenous morphine rescue dose). RESULTS: All randomized patients (N = 60, 1:1 ratio) completed all trial procedures. PENG block - IT morphine differences in the maximum pain at rest (difference = 0.182, 95 %CI -0.218 to 0.582) and at hip flexion (difference = -0.270, 95 %CI -0.990 to 0.453) were well below 0.75 NRS points, and the difference in MME (difference = -2.1, 95 %CI -6.5 to 1.9) was well below 10 MME. Age-adjusted straight leg raise test failure rates were similar in the two groups (11.7 % vs. 12.8 %, difference = -1.1, 95 %CI -9.7 to 7.5). CONCLUSION: Compared to IT morphine, PENG block provides non-inferior analgesia after THA under spinal anesthesia without additional compromise of the motor function. TRIAL REGISTRATION NUMBER: NCT05308420.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40609218\/"},{"pmid":40609217,"journal":"Journal of clinical anesthesia","title":"Reliability and utility of anesthesiology entrustable professional activities assessed with a mobile web application.","authors":"Tanaka P; Park YS; Chen J; Macario A","abstract":"BACKGROUND: A prior study developed and validated 14 Entrustable Professional Activities (EPA) for anesthesia residents for anesthesiology residency programs to use as the basis for workplace assessment. OBJECTIVE: The goals of this study were to: 1) measure the reliability of seven of those 14 EPAs using entrustment data collected via a mobile web application (Web App) and 2) examine implementation and utility of the EPA Web App. METHODS: Web App design prioritized a simple and efficient user interface, and incorporated revisions based on feedback. Assessments were completed during the 2020-2021 academic year. Generalizability theory was used to examine the distribution of EPA global scores. Qualitative interview data of Web App usage by participants focused on domains of the Consolidated Framework for Implementation Research. RESULTS: The Web App was used in a total of 1116 observations in 31 residents. Two EPAs were effective in discriminating differences in resident performance, whereas two were not. With 24 observations, one of the EPAs had a G coefficient of 0.68 and phi coefficient of 0.66 approaching a level suitable for formative feedback, whereas the other EPAs did not reach the 0.7 threshold (for moderate reliability in formative assessment, not summative use) even with 24 observations. Several constructs were elicited from the interview data in the domains of intervention characteristics, individual characteristics, outer setting, and inner setting. CONCLUSION: The utility of the Web App for EPA assessment was deemed positive for formative, low-stakes assessment. EPAs may not all necessarily be able to discriminate differences in resident performance. However, even a single EPA assessment may still be useful as one component of competency-based medical education via programmatic assessment.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40609217\/"},{"pmid":40602807,"journal":"Regional anesthesia and pain medicine","title":"Practice advisory for intravenous management of headache disorders in hospitalized patients: a review of the evidence and consensus recommendations.","authors":"Hoydonckx Y; Feoktistov A; Amoozegar F; Anderson CC; Barad M; Burke E; Chitsantikul P; Doshi TL; Englesakis M; Goel A; Gupta H; Kissoon N; Kirschner A; Kohan L; Lauritsen CG; Miller F; Monsour D; Nader A; Ogunlaja O; Schuster N; Schwenk ES; Silberstein SD; Souza D; Yuan H; Narouze S","abstract":"INTRODUCTION: Patients hospitalized for headache treatment pose unique challenges to the healthcare system. Currently, there is a lack of evidence-based guidance on management. This practice advisory aims to fill this critical gap by systematically reviewing the existing literature and providing comprehensive, evidence-based recommendations for managing headache patients during hospitalization. METHODS: In February 2023, the American Society of Regional Anesthesia and Pain Medicine approved this practice advisory proposal. The steering committee selected committee members based on clinical and research expertise in the field of headache medicine. Nine questions were formulated by the committee, and each question was assigned to a group composed of 3-4 members. A systematic literature search for each question was performed in Medline, Embase, Cochrane Database of Systematic Reviews and Web of Science on June 21, 2023. The results from each search were imported into separate Covidence projects for screening, data extraction, and risk of bias assessment. Additionally, relevant systematic reviews (SR) were screened. Each group submitted a structured narrative review along with statements and recommendations based on the US Preventive Services Task Force (USPSTF) format for grading of evidence. While the USPSTF framework was used, including the language in the recommendations, the formal USPSTF methodology, including the SR with meta-analysis and summary tables with forest plots, was not followed because of low overall evidence quality. The interim draft was shared electronically with each collaborator, who was requested to vote anonymously using two rounds of the modified Delphi approach. A consensus recommendation required >75% agreement. RESULTS: The panel generated 12 statements and 17 recommendations, along with their strength and certainty of evidence. Following two rounds of Delphi voting, a high consensus was achieved for all statements and recommendations. Most statements received a low-to-moderate level of certainty, and all but one recommendation received grade B or C, which was consistent with the lack of randomized controlled trials supporting most of the drugs in this document. CONCLUSIONS: This evidence-based practice advisory provides a foundational step toward standardizing inpatient headache care and highlights existing gaps in the literature that should be addressed through rigorous prospective randomized studies.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40602807\/"},{"pmid":40602806,"journal":"Regional anesthesia and pain medicine","title":"Postsurgical Medication Awareness, Recovery, and Tracking using a Phone-Based App (SMART-APP): a randomized clinical trial.","authors":"Rolfzen ML; Shah K; Sanchez Rodriguez E; Hoffman JT; Clauw D; Mascha E; Graff V; Bartels K","abstract":"BACKGROUND: Excess postoperative opioid use is harmful. We tested the hypothesis that a patient-facing educational smartphone app would permit surgical patients to effectively manage their pain while using fewer opioids after discharge. METHODS: A two-hospital, single-health system trial randomly exposed adult surgical inpatients to a consumer electronic health app (\"educational app\") that provided pain education or to a data collection only app (\"control app\"). During the second half of the trial, a clinician-facing electronic decision-support tool was activated. Linear regression models with log-transformed outcomes estimated the effect of the educational app on the primary outcome of cumulative self-reported opioid use within 4 weeks after discharge (in morphine milligram equivalents (MME)) and the secondary outcome of opioids prescribed at discharge. RESULTS: We enrolled 711 patients from May 2, 2022, to December 10, 2023. The modified intention-to-treat analysis cohort included 606 patients, with 303 randomized to the educational app and 303 to the control app. Median (first quartile, third quartile) discharge opioids prescribed to both groups were 75 (60, 150) MME. Median (Q1, Q3) self-reported cumulative opioid use in the 4 weeks after discharge was 22 (0, 98) MME with the educational app and 15 (0, 82) MME with the control app (ratio of geometric means: 1.21; 95% CI 0.87 to 1.69; p=0.264). The use of the clinician-facing electronic decision-support tool also did not modify opioid consumption. CONCLUSIONS: Neither a patient-facing educational app nor a clinician-facing decision support tool reduced self-reported opioid consumption among surgical patients with low post-discharge opioid requirements. TRIAL REGISTRATION NUMBER: NCT05221866.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40602806\/"},{"pmid":40601488,"journal":"Anesthesia and analgesia","title":"Continuous and Noninvasive Total Blood Hemoglobin Measurement Using Near-Infrared Reflectance Spectrometry.","authors":"van Wonderen SF; Aguirre A; Benni P; van den Dool REC; Macias Pingarron JP; Solares GJ; Hatib F; Veelo DP; Vlaar APJ; Jian Z","abstract":"BACKGROUND: Continuous measurement of total hemoglobin (tHb) can be of great clinical value during surgery, visualizing tHb trends and guiding blood transfusion practices. Devices such as those pulse oximetry-based have been available and studied over the past decade with varying results on their accuracy. We recently developed a first-of-its-kind near-infrared reflectance spectroscopy (NIRS) based algorithm to measure tHb continuously and noninvasively. This study was conducted to evaluate the performance of the NIRS based tHb algorithm using a cerebral oximetry sensor. METHODS: We performed a post hoc retrospective analysis of data collected during cardiac surgery from 3 clinical sites. Both NIRS data and blood gas tHb data were collected. Then the NIRS data was postprocessed through the NIRS based tHb algorithm to generate continuous measurement of tHb. Comparison between the 2 tHb measurements was assessed using the Bland-Altman analysis, mean absolute error (MAE), root mean square error (RMSE), 4-quadrant concordance, and error-grid analysis. RESULTS: One hundred and eighty-nine (189) patients were included in the analysis. The bias (or mean difference) and precision (or 1 standard deviation of the difference) (95% confidence interval) are 0.08 (0.02-0.19) g\/dL and 1.01 (0.93-1.09) g\/dL, respectively. The limits of agreement were -1.90 and 2.06 g\/dL. The MAE is 0.79 (0.69-0.91) g\/dL, the RMSE is 1.12 (0.94-1.30 g\/dL), and the concordance is 86.1 (79.8-92.1) %. The error-grid analysis demonstrated that the majority (84%) of the measurements are in the green zone and 0% in the red zone. CONCLUSIONS: The exploratory study shows that the NIRS based tHb provided an accurate measurement of tHb in cardiac surgery patients. Further research may be needed to evaluate its accuracy and implementation in other clinical settings.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40601488\/"},{"pmid":40601485,"journal":"Anesthesia and analgesia","title":"Erector Spinae Plane Block in Multimodal Analgesia After Lumbar Spinal Fusion Surgery: A Blinded Randomized Placebo-Controlled Trial.","authors":"van de Wijgert IH; Fenten MGE; Rood A; van Boekel RLM; van Hooff ML; Vissers KCP","abstract":"BACKGROUND: Postoperative pain after lumbar spine surgery is often severe, necessitating multimodal analgesic regimens that include opioids. Locoregional anesthesia, such as the Erector Spinae Plane Block (ESPB), may be effective in reducing postoperative pain and opioid use. This study evaluated the effect of bilateral ESPB on early postoperative pain and opioid use after lumbar spinal fusion surgery. METHODS: A single-center, randomized, blinded, placebo-controlled trial included 76 patients undergoing elective lumbar spinal fusion. Participants received either bilateral ESPB with ropivacaine or placebo (normal saline) after surgery. The primary outcome was pain intensity 1-hour postanesthesia, measured using the Numeric Rating Scale (NRS). Secondary outcomes included opioid consumption in the first 12 hours, time to first opioid use, quality of recovery, and pain intensity and opioid use at 30 days. Statistical significance was set at P < .05. RESULTS: The mean NRS 1-hour postanesthesia did not differ significantly between the ropivacaine and placebo group (3.8 +\/- 3 vs 4. 2 +\/- 2.6, P = .56). The median 12-hour opioid consumption was 11.3mg [2.5-21.5] vs 12.5 mg [5.1-22.4], median time to first opioid use 64 [22-171.5] vs 41 [21.3-89.5] minutes, and mean quality of recovery on day 1: 90. 7 +\/- 36 vs 102. 8 +\/- 20.5 and day 3: 108. 3 +\/- 21.2 vs 112. 5 +\/- 22.7, for the ropivacaine and placebo group, respectively. At 30 days, the mean NRS was 3. 4 +\/- 2.4 vs 3. 6 +\/- 2.5. Opioid use at 30 days occurred in 12 patients (16.2%) of the ropivacaine and in 15 (20.3%) of the placebo group. CONCLUSIONS: Bilateral ESPB with ropivacaine did not reduce early postoperative pain or opioid use in patients undergoing lumbar spinal fusion. Its overall benefits in a multimodal analgesic regimen appear limited and application of bilateral ESPB in all patients undergoing lumbar spine surgery is not recommended.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40601485\/"},{"pmid":40590455,"journal":"Anesthesiology","title":"The History of Ultrasound-guided Regional Anesthesia.","authors":"Marhofer P; Kapral S","abstract":"Ultrasound-guided Supraclavicular Approach for Regional Anesthesia of the Brachial Plexus. By Kapral S, Krafft P, Eibenberger K, Fitzgerald R, Gosch M, and Weinstabl C. Anesth Analg 1994; 78:507-13. As science keeps evolving, there is a time for revolutionary change. The Classic Paper here revisited, published in Anesthesia & Analgesia in 1994, was the first report to describe an ultrasound-guided technique for regional anesthesia. Its publication met with a response of skepticism, given the inherent claim that here was a novel approach capable of supporting, or indeed replacing, other techniques that had been used for well more than a century. This article recounts both the early history of ultrasound guidance and how this Classic Paper started a paradigm shift in regional anesthesia. Today, ultrasound-guided techniques are being used around the world as the result of 3 decades of devoted research and education. Numerous collaborations have been part of this journey, and the authors look back on years replete with personal memories and some of the more relevant moments.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40590455\/"},{"pmid":40537200,"journal":"British journal of anaesthesia","title":"Maternal fever, epidural analgesia, and genetics: implications for the neonate.","authors":"Kearns RJ; Nelson SM; Lucas DN","abstract":"Epidural-related maternal fever affects 15-25% of labouring women, but its mechanisms remain uncertain. In a prospective observational study, the EPIFEVER-2 investigators found no firm link between interleukin-1Ra concentrations and epidural-related maternal fever, suggesting other aetiological factors. Clinically, the main challenge lies in distinguishing epidural-related maternal fever from infectious fever to avoid unnecessary antibiotic use and neonatal interventions. Despite the increased risk of fever in women receiving epidural analgesia, there is no strong evidence of harm to the newborn, and women should be supported in making informed decisions about pain relief without undue concern over potential neonatal complications.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40537200\/"},{"pmid":40537199,"journal":"British journal of anaesthesia","title":"Emergence from general anaesthesia: stochastic or deterministic?","authors":"Lee U","abstract":"Is emergence from general anaesthesia fundamentally stochastic or deterministic? A recent study using genetically identical mice found significant intra-individual and inter-individual variability in emergence times. This variability was better explained by a stochastic neural dynamics model than by traditional deterministic pharmacokinetic-pharmacodynamic models. These findings offer a new perspective on the intrinsic nature of anaesthetic emergence as a stochastic process; however, they also raise important questions about how we define and measure emergence. In particular, since the commonly used righting reflex, a basic motor response, might not adequately reflect recovery of cognitive abilities, and higher-level cognitive functions might follow more predictable, deterministic emergence trajectories, we suggest that future research examine emergence across multiple levels of brain function and adopt more comprehensive, cognition-sensitive markers.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40537199\/"},{"pmid":40537198,"journal":"British journal of anaesthesia","title":"Aspiring to mastery clinical skills learning in regional anaesthesia.","authors":"Marshall S; Eppich W","abstract":"The process of novices becoming proficient and independent in performing complex technical skills has been investigated in depth. It is clear that a mastery learning approach, with a planned programme to achieve a high level of performance, leads to superior learning and clinical outcomes. Here, we explain the process and theoretical underpinnings of mastery learning, and how emerging technologies might influence skill acquisition in the future.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40537198\/"},{"pmid":40537197,"journal":"British journal of anaesthesia","title":"Generative AI models: the next anaesthetic agent?","authors":"Julius A; Bowness JS","abstract":"A study by MacKay and colleagues addresses a pressing need in cardiac anaesthesia by demonstrating an innovative method to extract structured data from free-text intraoperative transoesophageal echocardiography reports. Narrative descriptions of echocardiographic findings are often unstructured, making manual extraction labour-intensive and susceptible to error. By deploying an ensemble of large language models in a consensus-based framework, the authors show that key echocardiographic parameters can be extracted with a high degree of accuracy and manageable error rates. This work presents a technical solution to a specific data-handling challenge and points towards broader applications of artificial intelligence (AI) in streamlining perioperative care.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40537197\/"},{"pmid":40532359,"journal":"Journal of clinical anesthesia","title":"A prospective, observational study of non-invasive venous waveform analysis (NIVA) for the detection of acute low volume blood loss in humans.","authors":"Alvis BD; Wervey D; Pein R; Wise E; Sobey J; Mede A; Vaughn L; Case M; Breed M; Priyanka J; Leisy P; Brophy C; Hocking K","abstract":"BACKGROUND: Accurate non-invasive monitoring for the diagnosis of hemorrhage is an unmet need in acute care settings. Non-Invasive Venous waveform Analysis (NIVA) has demonstrated significant sensitivity in detecting acute hemorrhage with 8-10 % blood volume loss. To determine whether NIVA can accurately and non-invasively detect lower volumes of blood loss, we performed a prospective observational study using a digital blood volume monitor at an American Red Cross (ARC) donation center to assess NIVA's performance at lower blood volume loss. METHODS: Venous waveforms were successfully captured in 33 ARC-approved patients. Waveforms were recorded for the duration of whole blood donation and then transformed from the time domain to the frequency domain. The ratiometric power contribution of the cardiac frequencies was used to calculate a representative volume status value, the IntraVAscular Number (IVAN). RESULTS: A significant decrease in the IVAN output was observed after just 200 mL (3-4 % blood volume) of whole blood donation (p < 0.05). The ROC curve demonstrated an Area Under the Curve (AUC) of 0.65 for the ability of delta IVAN to detect 200 mL of blood loss. The Receiver Operating Characteristic (ROC) curve demonstrated an AUC of 0.91 for the ability of delta IVAN to detect 500 mL of blood loss. CONCLUSION: There remains a large unmet need for accurate and timely detection of acute hemorrhage. This study supports the potential application of NIVA in the detection of acute low-volume human blood loss. NIVA is a novel technology that uses previously undetectable low-amplitude venous signals of the cardiac pulse, which may prove useful for more accurate and early detection of acute hemorrhage.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40532359\/"},{"pmid":40532358,"journal":"Journal of clinical anesthesia","title":"Opioid-free anaesthesia protocol based on thoracic paravertebral block enhances postoperative recovery after breast cancer surgery: A two-center, prospective, randomized, controlled trial.","authors":"Tong P; Guo Y; Wang Y; Feng Y; Song X; Luo G; Qin W; Lu X; Zheng L; Wang H; Lu Y; Lai R","abstract":"STUDY OBJECTIVE: To evaluate whether the implementation of an opioid-free anaesthesia (OFA) protocol based on thoracic paravertebral block (TPVB) could improve early postoperative recovery quality in patients undergoing breast cancer surgery. We hypothesized that opioid-free anaesthesia with TPVB would improve the 15-item quality of recovery (QoR-15) at 24 h relative to conventional anaesthesia protocol. DESIGN: A prospective, randomized and controlled trial. SETTING: Sun Yat-Sen University Cancer Center and Gansu Provincial Cancer Hospital. PATIENTS: Based on a minimal clinically important difference (MCID) of 6.0 and an assumed standard deviation (SD) of 16 for postoperative QoR-15 score, a total of 252 patients undergoing breast cancer surgery were enrolled. INTERVENTIONS: Patients were allocated to either opioid-based anaesthesia (OA) group or OFA group. MEASUREMENTS: The primary outcome was QoR-15 score at 24 h postoperatively. Secondary outcomes included QoR-15 score at 48 h, numerical rating scale (NRS) pain scores at rest and during activity at PACU, 6, 12, 24, and 48 h postoperatively, postoperative analgesic rescue, the occurrence of adverse effects such as nausea and vomiting, the time to first urination and the length of hospital stay. MAIN RESULTS: At 24 h postoperatively, means and standard errors (SE) of QoR-15 score were 139.12 (0.72) in the OFA group significantly higher than those in the OA group 132.48 (0.84) [difference of 6.6, 95 % Confidence Interval (CI), 4.87-8.40, P < 0.001]. The QoR-15 score of OFA [145.31 (0.67)] at 48 h is also higher than that of OA [142.18 (0.88)]. The resting NRS score at 6 h and the active NRS score within 12 h after surgery in the OFA group were significantly lower than those in the OA group (P < 0.001). Fewer patients suffered from postoperative nausea and retching in the OFA group (P < 0.05). There were no statistical differences in the time to first urination and length of stay between OFA and OA groups (P > 0.05). CONCLUSION: OFA based on TPVB improved the postoperative quality of recovery in patients undergoing breast cancer surgery. TRIAL REGISTRATION: http:\/\/www.chictr.org.cn, Identifier: ChiCTR2300072501, principal investigator: Renchun Lai, date of registration: 2023-06-15. CLINICAL TRIAL REGISTRATION: ChiCTR2300072501.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40532358\/"},{"pmid":40517567,"journal":"Journal of clinical anesthesia","title":"Optimizing pediatric premedication for general anesthesia: A comprehensive Bayesian network meta-analysis.","authors":"Wegner GRM; Wegner BFM; Cumming HS; de Oliveira HG; Campos LR; da Silva LHD; Ferreira CHO; Miranda AM; Donato AB; do Nascimento TS","abstract":"STUDY OBJECTIVE: To identify the most effective premedication strategies for improving mask acceptance, parental separation acceptance, and intravenous cannulation acceptance in pediatric patients undergoing general anesthesia. DESIGN: A systematic review and Bayesian network meta-analysis of randomized controlled trials. SETTING: Elective pediatric surgeries under general anesthesia. PATIENTS: Children aged 1-12 years, classified as American Society of Anesthesiologists (ASA) I-III, who received premedication with midazolam, dexmedetomidine, ketamine, or other relevant agents and combinations. MEASUREMENTS: Two main analyses were conducted using a Bayesian framework to generate comparative efficacy rankings. A primary analysis considered every unique combination of drug, dose, route, and timing as a distinct intervention. A secondary analysis grouped interventions solely by the pharmacological agent(s) used, regardless of dose, route, or timing. This dual approach allowed specific comparisons of route and dose while also providing a broader assessment of each drug or combination. Outcomes were satisfactory acceptance of mask application, parental separation, and intravenous cannulation. Meta-regression, sensitivity analyses, and assessment of risk of bias were also undertaken. MAIN RESULTS: Sixty-nine trials encompassing 5794 pediatric patients were included. In the primary analysis, only mask acceptance could be evaluated. Combinations of dexmedetomidine, midazolam, and ketamine demonstrated the highest probabilities of satisfactory mask acceptance, with intranasal administration at shorter premedication intervals (15-30 min) showing greater efficacy. Clonidine, melatonin, and diazepam were comparatively less effective. In the secondary analysis, mask acceptance, intravenous cannulation acceptance, and parental separation acceptance yielded similar findings, with pharmacological combinations based on dexmedetomidine and midazolam ranking highest, while clonidine, melatonin, and diazepam remained less effective. CONCLUSIONS: Dexmedetomidine-, midazolam-, and ketamine-based combinations offer superior preoperative cooperation in pediatric patients, as demonstrated by higher success rates of mask acceptance, intravenous cannulation acceptance, and parental separation acceptance. Routes, doses, and timing are critical factors influencing success.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40517567\/"},{"pmid":40516197,"journal":"Journal of clinical anesthesia","title":"Application of deep learning-based facial pain recognition model for postoperative pain assessment.","authors":"Zhang JT; Hu XY; Duan W; Ji MH; Yang JJ","abstract":"BACKGROUND: Postoperative pain is a common and complex issue that affects patients' recovery and the quality of healthcare. Traditional pain assessment methods-primarily based on self-reporting and clinical observation-are often inadequate, particularly for patients with communication impairments. Deep learning technology offers new opportunities for automatic pain assessment. However, progress in this area is hindered by the limited availability of high-quality clinical datasets and a paucity of studies addressing real-world model deployment. This gap between laboratory research and clinical application requires further study. METHODS: The study constructed two distinct datasets to capture both clinical and laboratory scenarios. The Clinical Pain Dataset (CPD) includes 3411 facial pain images from 503 postoperative patients, while Simulated Pain Dataset (SPD) contains 1038 images from 51 volunteers. The two datasets were combined to form the Combined Dataset (CD). A pre-trained VGG16 model was used for training and validation. The model's performance on different datasets and pain levels was evaluated using area under the receiver operating characteristic curve (AUROC) and F1 scores. RESULTS: In the CPD and CD, the model demonstrated its highest performance in identifying severe pain, achieving AUROC values of 0.898 (95 %CI,0.877-0.917) and 0.867 (95 %CI,0.844-0.889), respectively. For overall evaluation, the highest AUROC values were observed in CPD-train (0.898 [95 % CI: 0.877-0.917]) and CD-train (0.917 [95 % CI: 0.883-0.948]) for severe pain classification. Building on these results, a facial pain recognition software was developed based on the model, offering a new option for clinical pain identification. CONCLUSIONS: The findings indicate that deep learning models leveraging facial expression analysis hold significant potential to recognize varying degrees of pain in clinical settings, especially severe pain. In the future, they could help anesthesiologists monitor postoperative patients' pain levels in real-time, enhancing the quality of medical services.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40516197\/"},{"pmid":40513143,"journal":"Journal of clinical anesthesia","title":"Preoperative low-dose dexmedetomidine reduces postoperative delirium in elderly patients with hip fracture under spinal anesthesia: A randomized, double blind, controlled clinical study.","authors":"Geng P; Shang Z; Cheng F; Zhang Y; Deng X; Chen X; Zhan L; Zheng L; Liu X","abstract":"STUDY OBJECTIVE: This study aims to evaluate the effects of preoperative low-dose dexmedetomidine administration for one night on the incidence of postoperative delirium in elderly patients with hip fracture. DESIGN: This was a randomized, double blind, placebo-controlled clinical trial. SETTING: Lu'an Hospital of Anhui Medical University, Anhui, China. PATIENTS: Patients aged >\/=65 years with hip fracture (femoral neck, intertrochanteric, or subtrochanteric fracture) and scheduled for surgical repair(total hip arthroplasty, hemiarthroplasty, internal fixation with cannulated screw or intramedullary nail) under spinal anesthesia were eligible. INTERVENTION: Patients were randomized 1:1 to receive low-dose dexmedetomidine or placebo from 8:00 pm before surgery to 8:00 am the day of surgery. MEASUREMENTS: The primary outcome was the incidence of POD between postoperative days 1 and 7 or at hospital discharge. The secondary outcome measures included preoperative sleep quality, days of delirium, visual analog scale scores in quiet and active states on postoperative days 1-3, C-reactive protein level, number of analgesic pump presses, activities of daily living score at discharge and postoperative hospital stay. Perioperative adverse events were recorded. MAIN RESULTS: Of the 248 patients randomized to the placebo (n = 124) or dexmedetomidine (n = 124) group, 233 participants (117 in the placebo group and 116 in the dexmedetomidine group) were included in the modified intention-to-treat analysis. The incidence of POD was lower in the dexmedetomidine group (10.3 %) than placebo group (22.2 %, P = 0.014). Compared to the placebo group, the dexmedetomidine group had higher preoperative Leeds Sleep Evaluation Questionnaire (LSEQ) scores (P < 0.001), lower preoperative Insomnia Severity Index (ISI) scores (P < 0.001), and lower postoperative C-reactive protein (CRP) levels (P < 0.001). No differences in other secondary outcomes and perioperative adverse events were observed between the two groups. CONCLUSION: In patients aged >\/=65 years undergoing elective hip fracture surgery under spinal anesthesia, continuous overnight administration of low-dose dexmedetomidine improved sleep quality on the night before surgery and reduced the incidence of POD.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40513143\/"},{"pmid":40513142,"journal":"Journal of clinical anesthesia","title":"Reversal of rocuronium-induced neuromuscular blockade by sugammadex in patients undergoing kidney transplantation: Pharmacokinetics, efficacy, and safety analyses.","authors":"Tang Y; Feng Y; Jia B; Long W; Chen Q; Gu S; Zhao G; Xu B","abstract":"BACKGROUND: The pharmacokinetics of sugammadex were significantly different between severe renal failure patients and healthy subjects. The objective of our study is to investigate the pharmacokinetics of sugammadex in patients with end-stage renal disease undergoing kidney transplantation. METHODS: Seventeen ASA class III renal failure patients undergoing kidney transplantation and 17 ASA I-II healthy controls were included. Sugammadex 2 mg.kg(-1) was administered at reappearance of the second twitch of the train-of-four for reversal of rocuronium-induced neuromuscular blockade. Plasma concentration of sugammadex was measured at regular time points and pharmacokinetics determined using non-compartmental analysis. RESULTS: Pharmacokinetic data of sugammadex were obtained from 30 patients. The geometric mean of elimination half-life of sugammadex was 10 h in renal failure and 2 h in controls (P < 0.001). The geometric mean of plasma clearance of sugammadex was significantly different between the two groups (15.2 ml.min(-1) in renal patients vs 82.5 ml.min(-1) in controls, P<0.001). The recovery of train-of-four-ratio >\/= 0.9 was similar between the two groups. No sugammadex-related serious adverse events were considered. CONCLUSION: The significant differences in the pharmacokinetics of sugammadex between the patients undergoing kidney transplantation and healthy controls were observed. In patients with end-stage renal disease, sugammadex 2 mg.kg(-1) provided a safety profile similar to healthy controls. Sugammadex is safe and effective for patients undergoing kidney transplantation, although the clearance of sugammadex is slower in this patient population.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40513142\/"},{"pmid":40499279,"journal":"Journal of clinical anesthesia","title":"Effects of intranasal dexmedetomidine premedication on hemodynamics, oxygenation and bleeding in patients undergoing total knee arthroplasty under spinal anesthesia - a secondary analysis of a prospective, double-blinded, randomized controlled trial (TKADEX).","authors":"Tiainen SM; Koskinen A; Makela S; Laitio R; Loyttyniemi E; Makela K; Pirttikangas CO; Saari TI; Uusalo P","abstract":"BACKGROUND: Dexmedetomidine is a sedative adjunct with sympatholytic properties. Despite many beneficial effects, hemodynamic effects limit its use. METHODS: We performed a secondary analysis of the data from TKADEX study. This single-center, double-blind, two-arm study compared intranasal dexmedetomidine premedication (1 mug kg-1) with intranasal saline in 101 planned subjects undergoing total knee arthroplasty (TKA). We analyzed the perioperative hemodynamics, oxygenation, amount of intraoperative bleeding and perioperative change in hemoglobin and thrombocytes. RESULTS: Compared to baseline measurements, mean arterial pressure (MAP) decreased in the dexmedetomidine group 36.3 (1.7) mmHg (95 % CI 32.9-39.7; p < 0.001) and in the placebo group 26.5 (1.7) mmHg (95 % CI 23.2-29.7; p < 0.001), and heart rate (HR) in the dexmedetomidine group 11.6 (1.3) bpm (95 % CI 9.1-14.1; p < 0.001) and in the placebo group 9.7 (1.2) bpm (95 % CI 7.3-12.2; p < 0.001) after induction of spinal anesthesia. Patients in the dexmedetomidine group had lower intraoperative MAP (maximal difference - 8.5 (2.5) mmHg; 95 % CI -13.5 - -3.5; p < 0.001) and HR (maximal difference - 6.1 (2.2) bpm; 95 % CI -10.5 - -1.7; p = 0.007) compared to the placebo group. There was higher incidence of intraoperative hypertension in the placebo group (p = 0.03). There was no difference in oxygenation, in the incidence of intraoperative bradycardia, tachycardia or hypotension, in the amount of intraoperative bleeding or in the change in perioperative blood count between the groups. CONCLUSIONS: Intranasal dexmedetomidine appears to be hemodynamically well tolerated premedication for patients undergoing TKA under spinal anesthesia. It appears to lower the incidence of intraoperative hypertension without effects on intraoperative bleeding.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40499279\/"},{"pmid":40494113,"journal":"Journal of clinical anesthesia","title":"Hemidiaphragmatic paralysis after ultrasound-guided brachial plexus blocks for shoulder surgery: A systematic review and meta-analysis of randomized clinical trials.","authors":"Oliver-Fornies P; Aragon-Benedi C; Gomez Gomez R; Anton Rodriguez C; San-Jose-Montano B; Yamak Altinpulluk E; Fajardo Perez M","abstract":"STUDY OBJECTIVE: This review aimed to explore whether diaphragm-sparing regional techniques are more effective at preventing hemidiaphragm paralysis than conventional interscalene brachial plexus blockade (ISB) following shoulder surgery. DESIGN: Systematic review of randomized clinical trials (RCTs) including meta-analyses, meta-regression, trial sequential analyses (TSA) and GRADE methodology. SETTING: Online databases (Cochrane Library; MEDLINE; EMBASE; Scopus; Web of Science; and international trial registries) were searched for RCTs up to December 2022. PATIENTS: Adult patients undergoing shoulder surgery following ultrasound-guided brachial plexus blockade, where incidence of hemidiaphragmatic paralysis was reported. INTERVENTIONS: Diaphragm-sparing techniques following ultrasound-guided brachial plexus blockade were included: modifications of ISB (low-volume, extrafascial, and lower concentration); superior trunk block; supraclavicular brachial plexus block, infraclavicular brachial plexus block; costoclavicular brachial plexus block; and anterior and posterior approaches to the suprascapular nerve block. MEASUREMENTS: The primary endpoint was the incidence of complete hemidiaphragmatic paralysis. Secondary endpoints included postoperative analgesia and safety-related outcomes. MAIN RESULTS: Twenty-eight RCTs involving 1737 subjects were identified. Of these, 22 were eligible for meta-analysis. Six regional techniques were analysed. The low-volume technique significantly reduced the incidence of hemidiaphragmatic paralysis as compared with the conventional ISB (risk ratio 0.62; 95 % CI 0.42 to 0.91; p = 0.02; absolute risk difference - 0.30 [95 % CI -0.39 to -0.20]; I(2) = 80 %) at short-term follow-up. TSA confirmed the results of this meta-analysis but did not reach the required sample size by 19.5 %, indicating that the result was not definitive. The combined infraclavicular-suprascapular blocks, the extrafascial technique, the lower concentration technique, and the supraclavicular block reduced the incidence of hemidiaphragmatic paralysis by 97 %, 64 %, 57 % and 46 %, respectively. For the superior trunk block, TSA did not reach statistical significance. CONCLUSIONS: There is conclusive evidence that the extrafascial technique (high-level); lower concentration technique (moderate-level); and the supraclavicular blockade (low-level) are less detrimental to hemidiaphragmatic paralysis than the conventional ISB. However, the results for other comparisons were not definitive. Systematic review protocol: PROSPERO CRD42022335056.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40494113\/"},{"pmid":40493784,"journal":"Anesthesia and analgesia","title":"Pro-Con Debate: Air or Saline for Loss-of-Resistance Technique of Interlaminar Epidural Access with Fluoroscopy-Guided Pain Medicine Procedures.","authors":"Hao D; Bonner K; Burnham T; Stojanovic MP","abstract":"In this Pro-Con commentary article, the Pro side advocates that using the loss of resistance (LOR) to air technique for interlaminar epidural access is safe as the risk of pneumocephalus is exceptionally low. They note that case reports detailing complications typically utilize at least 1 mL of air, frequently exceeding this amount. Even a 1-mL dosage surpasses the requirement, particularly when fluoroscopy is applied in the context of chronic pain management. The proponents also suggest a modified technique, where a syringe containing a drop of saline or contrast acts as a visual cue, minimizing air injection into the epidural space to a negligible quantity. Moreover, they emphasize that air facilitates the identification of any fluid as an indicator of unintended intrathecal access. The Con perspective argues against the utilization of air for epidural access and advocates for the use of LOR with saline instead. This stance is supported by evidence pointing to a greater occurrence of adverse events, such as postdural puncture headache (PDPH) and pneumocephalus, associated with LOR to air compared to LOR with saline. They also argue that saline's physical properties enhance tactile feedback, potentially contributing to its increased safety. Both saline and air have been used for many years for epidural access via the interlaminar approach. Although both are generally accepted in practice, neither has been formally established as the standard of care. It would benefit the medical community to further delineate the pros and cons of each medium, enabling practitioners to make more informed decisions. This Pro-Con debate will provide 2 perspectives ( Table ) on the evidence and rationales for the use of air or saline for the LOR technique in interlaminar epidural access with fluoroscopy.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40493784\/"},{"pmid":40479950,"journal":"Journal of clinical anesthesia","title":"Understanding preoperative concerns and attitudes towards prehabilitation in older surgical populations: A survey study.","authors":"Li M; Yan E; Saripella A; Alhamdah Y; Nabipoor M; Alibhai SMH; Wong J; Chung F","abstract":"STUDY OBJECTIVES: To identify common preoperative concerns in older surgical populations and explore their attitudes towards prehabilitation, functional, and cognitive assessments. DESIGN: Multicenter cross-sectional study. SETTING: Preoperative questionnaire examining preoperative concerns and attitudes towards prehabilitation, functional, and cognitive assessments. PATIENTS: 236 non-cardiac surgical patients >\/=65 years old. MEASUREMENTS: Concerns across five domains-surgery, anesthesia, functional status, cognitive status, and financial burden-were measured on a five-point Likert scale, ranging from 'not concerned at all' to 'very concerned.' Attitudes towards prehabilitation and preoperative assessments were assessed on a five-point scale from 'strongly disagree' to 'strongly agree.' Exploratory factor analysis identified concerns, and confirmatory factor analysis validated them. Reliability was assessed with Cronbach's alpha, and model fit was evaluated using the root mean square error of approximation, comparative fit index, and related indices. RESULTS: Surgical concerns were highest (2.5 +\/- 1.2), particularly regarding postoperative pain, surgical failure, and complications. Concerns about anesthesia (2.0 +\/- 1.3) and functional status (1.9 +\/- 1.3) followed, with lower concerns about cognitive status (1.5 +\/- 1.1) and financial burden (1.4 +\/- 0.9). Attitudes towards prehabilitation were generally positive. Most participants were open to functional assessments and training programs, though only 37 % were willing to undergo memory assessment. Factor analysis revealed a five-factor structure of preoperative concerns: basic activities of daily living, instrumental activities of daily living, surgical\/anesthesia concerns, cognitive\/financial concerns, and discharge concerns. Confirmatory factor analysis supported this structure with adequate model fit. CONCLUSIONS: This study highlights common preoperative concerns among older adults, particularly regarding surgery, anesthesia, and functional status, with greater concern reported by those with functional dependence. While attitudes towards prehabilitation were generally positive, there was low willingness to undergo preoperative memory testing. Future research should refine prehabilitation programs to optimize effectiveness, accessibility, and adherence in older adults and further evaluate their impact on surgical outcomes.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40479950\/"},{"pmid":40462461,"journal":"European journal of anaesthesiology","title":"Effectiveness of peri-operative psychological interventions for the reduction of postsurgical pain intensity, depression, anxiety and pain catastrophising: A systematic review and meta-analysis.","authors":"Castano-Asins JR; Barcelo-Soler A; Royuela-Colomer E; Sanabria-Mazo JP; Garcia V; Neblett R; Bulbena A; Perez-Sola V; Montes-Perez A; Urrutia G; Feliu-Soler A; Luciano JV","abstract":"BACKGROUND: Evidence suggests that psychological interventions during the peri-operative period can help reduce the development of chronic postsurgical pain (CPSP); however, there is no evidence of their effects on other important pain-related variables. OBJECTIVES: This systematic review and meta-analysis evaluated the effectiveness of peri-operative psychological interventions for the reduction of postsurgical pain intensity, depression, anxiety, stress and pain catastrophising. STUDY DESIGN: Systematic review of randomised controlled trials (RCTs) with meta-analyses (registration number: CRD42023403384). The search for studies was carried out in Web of Science, PsychINFO, MEDLINE and CINAHL up to March 2023. ELIGIBILITY CRITERIA: RCTs comparing peri-operative psychological interventions with usual care or nonpsychological control interventions in adult patients with any type of surgery. The main outcome was pain intensity reduction after surgery. Secondary outcomes included patient-reported depression, anxiety, stress and pain catastrophising after surgery. RESULTS: Twenty-seven RCTs (psychological intervention: 1462 patients; control: 1528 patients) were included in the systematic review and 17 studies for the meta-analysis. Random-effect models were used to combine the effect sizes of the studies. Compared with usual care or control interventions, psychological interventions reduced pain intensity, d = -0.45 95% CI, (-0.77 to -0.13) and anxiety, d = -0.33 95% CI, (-0.54 to -0.11) after surgery. Moderator analyses revealed that psychological interventions delivered by a psychologist were more effective than those delivered by other professionals. CBT seemed the most beneficial for surgical patients. The findings in other moderator analyses were heterogeneous. CONCLUSIONS: Moderate-quality evidence exists that peri-operative psychological interventions can significantly reduce pain intensity and anxiety postsurgery. However, results should be interpreted with caution because of the presence of a high risk of bias in many trials.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40462461\/"},{"pmid":40460592,"journal":"Journal of clinical anesthesia","title":"Propofol versus sevoflurane anesthesia on postoperative sleep quality in older patients after major abdominal surgery: A randomized clinical trial.","authors":"Chen NP; Sun P; Li CJ; Xing XX; Li M; Sun ZJ; Li HJ; Mu DL; Wang DX","abstract":"STUDY OBJECTIVE: Sleep disturbances are common in older patients following major surgery. Both propofol and sevoflurane are frequently used anesthetics. In this study, we compared the effect of propofol- versus sevoflurane-based anesthesia on postoperative sleep quality in this patient population. DESIGN: A randomized clinical trial. SETTING: A university hospital. PATIENTS: Patients aged 65 to 90 years who were scheduled for elective major abdominal surgery. INTERVENTIONS: Enrolled patients were randomized to receive either propofol-based intravenous anesthesia or sevoflurane-based inhalational anesthesia. MEASUREMENTS: Primary endpoint was total sleep time monitored by actigraphy on the first postoperative night. Secondary endpoints included plasma orexin-A concentrations at various timepoints from baseline (before anesthesia) until the second postoperative morning. MAIN RESULTS: From May 23, 2022 to April 3, 2023, 144 patients (mean age 72.9 years; 58.3 % male) were enrolled and randomly assigned. Total sleep time on the first postoperative night was longer with propofol anesthesia (median 150 min [interquartile range 99 to 200]) than with sevoflurane anesthesia (111 min [80 to 160]; median difference 29 min [95 % CI 4 to 53]; P = 0.025). Plasma orexin-A concentration was lower in the propofol group at 1 h after anesthesia induction (median difference - 31.3 pg\/mL [95 % CI -58.1 to -2.2]; P = 0.033) and 6:00 on the first postoperative morning (median difference - 29.8 pg\/mL [95 % CI -58.3 to -2.3]; P = 0.036). CONCLUSIONS: Among older patients undergoing major abdominal surgery, propofol anesthesia, compared with sevoflurane anesthesia, was associated with a longer total sleep time on the first postoperative night. This difference may be partially attributable to lowered plasma orexin-A level. TRIAL REGISTRATION: This randomized trial was approved by Biomedical Research Ethical Committee of Peking University First Hospital (No.2022-155) on April 26, 2022. Chinese Clinical Trial Registry (No. ChiCTR2200060120) URL: https:\/\/www.chictr.org.cn\/showproj.html?proj=169584, May 19, 2022.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40460592\/"},{"pmid":40449315,"journal":"Journal of clinical anesthesia","title":"Maximum extension and regression rate of cutaneous sensory block: superficial vs. deep parasternal intercostal plane blocks in patients undergoing open cardiac surgery.","authors":"Dost B; Turunc E; Kaya C; Sahin CA; Genc C; Yucel SM; Demirag MK; Karakaya D","abstract":"BACKGROUND: Superficial and deep parasternal intercostal plane (S-PIP and D-PIP, respectively) blocks provide effective analgesia following median sternotomy; however, data regarding their sensory distribution and regression patterns are scarce. Therefore, we compared the extent of sensory blockade 30 min following the administration of the blocks and evaluated its regression over 24 h. METHODS: Patients who underwent open cardiac surgery under the S-PIP or D-PIP block were included in this single-center, prospective study. Sensory assessment using cold stimulation and dermatomal mapping was conducted 30 min, 12 h, and 24 h following the administration of the blocks. The primary outcome was the proportion of the blocked thoracic area at 30 min. Opioid consumption and pain scores at 12 and 24 h were the secondary outcomes. RESULTS: Thirty patients were included in this study (n = 15 per group). The total blocked area at 30 min in the S-PIP and D-PIP groups was similar (48.48 +\/- 9.50 % vs. 46.51 +\/- 10.01 %, p = 0.584). Both blocks provided consistent coverage of the T2-T6 nerves, with additional involvement of T1 and T7 in some patients. Significant sensory blockade persisted at 12 h and partially regressed after 24 h. No significant differences were observed between the groups in terms of postoperative opioid consumption (10 [5] mg vs. 9 [3] mg, p = 0.121) or pain scores. CONCLUSION: The S-PIP and D-PIP blocks provided comparable and extensive sensory coverage of the anterior thorax. Consistent dermatomal involvement between T2 and T6 was observed, with occasional spread to T1 and T7.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40449315\/"},{"pmid":40446423,"journal":"Journal of clinical anesthesia","title":"Oliceridine for postoperative pain and opioid-related complications: The intravenous oliceridine and opioid-related complications (VOLITION) prospective cohort study.","authors":"Sessler DI; Ayad S; Bakal O; Disher NS; Duran JA; Weingarten TN; Dahan A; Demitrack MA; Kim J; Khanna AK","abstract":"BACKGROUND: Oliceridine is a G protein-selective mu-opioid receptor agonist with reduced beta-arrestin activation that may produce fewer opioid-related adverse effects (ORAEs) than traditional opioids. The VOLITION prospective cohort study evaluated oliceridine for management of postoperative pain and evaluated ORAEs. METHODS: We enrolled 204 patients scheduled for major noncardiac surgery. Our primary aim was to quantify the proportion of patients having respiratory compromise over the initial two postoperative days. Cardiorespiratory function was continuously monitored with pulse oximetry, capnography, and plethysmography. Our composite of clinically meaningful respiratory events was defined by an end-tidal (Et) CO(2) <\/= 15 mmHg for >\/=3 min, respiratory rate <\/= 5 breaths\/min for >\/=3 min, oxygen saturation <\/= 85 % for >\/=3 min, apnea lasting >30 s, or any life-threatening respiratory events. All potential respiratory events were adjudicated by two independent expert reviewers. On an exploratory basis we evaluated the proportion of patients achieving a complete gastrointestinal response (no vomiting and no rescue antiemetic use). Central nervous system compromise was evaluated with the Richmond Agitation-Sedation Scale, the Pasero Opioid-Induced Sedation Scale, and the 3-min Diagnostic Confusion Assessment Method. RESULTS: Among 203 patients in the safety population (mean age 57 years, 52 % women; mean duration of surgery: 5 h), 197 patients had cardiorespiratory data available for analysis. The median cumulative oliceridine dose was 33 mg (range 1.5-75 mg). There were 174 adjudicated episodes of respiratory compromise in 45 patients (23 %) but no deaths or oliceridine-related serious adverse events. Naloxone opioid reversal was never required. There were 107 (53 %) patients who had a complete gastrointestinal response, and eight met screening criteria for delirium. CONCLUSION: Nearly one quarter of patients experienced a respiratory compromise with oliceridine analgesia, none of which was life-threatening. A randomized trial needs to determine whether oliceridine produces fewer overall ORAEs than conventional opioids. The study was registered at ClinicalTrials.gov (NCT04979247).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40446423\/"},{"pmid":40435923,"journal":"Journal of clinical anesthesia","title":"Chemical hip denervation using phenol via Pericapsular Nerve Group (PENG) block in palliative non-operative management for frail older hip fracture patients: A multicenter retrospective cohort study.","authors":"Kroes T; Wijnen HH; Bos K; Wasmoeth LG; van de Vossenberg G; Spaetgens B; Smits RJH; Schuijt HJ; Willems HC","abstract":"Effective analgesia is critical yet challenging in non-operative management (NOM) of hip fractures for frail older patients in the palliative setting. Chemical hip denervation with phenol via PEricapsular Nerve Group (PENG) block has been applied to improve pain management. This is the first multicenter retrospective study that evaluated pain experience, opioid consumption and mobility in this population. The study included 185 patients, aged 70 years or older, who received chemical hip denervation with phenol via PENG block in the context of NOM from January 2022 until August 2023 in six hospitals across the Netherlands. Patient data were extracted from electronic health records. Patients were aged median 87 years (p25 - p75 82-91) with multiple comorbidities, the majority suffered from cognitive impairment (74 %) and depended on daily care (88 %). Phenol was mostly used with a concentration of 6 % (70 % of patients) or 10 % (23 % of patients) and a median volume of 10 ml (p25 - p75 8-10). Post procedural pain was experienced as acceptable in the majority of patients (89 % rest-related, 65 % care-related). The secondary outcomes of pain on a numeric rating scale (NRS) and morphine milligram equivalents (MME) were low. However, mobility remained limited. Median survival was 9 days (p25 - p75 4-22). Significant differences were observed in fracture type and hospital location. No complications or adverse treatment effects were reported. Chemical hip denervation with phenol via PENG block may be a viable analgesic option in selected frail older hip fracture patients as part of person-centered, multidisciplinary palliative care. Study limitations included its retrospective design with unavailable data on quality of life. Future prospective studies should evaluate patient outcomes. Further research is necessary to define optimal techniques, phenol percentage and volumes and reduce practice variability.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40435923\/"},{"pmid":40425395,"journal":"British journal of anaesthesia","title":"Postoperative outcomes in older patients living with frailty and multimorbidity in the UK: SNAP-3, a snapshot observational study.","authors":"Swarbrick CJ; Williams K; Evans B; Blake HA; Poulton T; Nava S; Shah A; Martin P; Partridge JSL; Moppett IK","abstract":"BACKGROUND: Older surgical patients experience longer hospital stays and a higher risk of morbidity and mortality than their younger counterparts. Frailty (19.6% of cohort) and multimorbidity (63.1% of cohort) increase these risks. The 3(rd) Sprint National Anaesthesia Project (SNAP-3) describes the impact of frailty and multimorbidity on postoperative outcomes. METHODS: We conducted a prospective observational cohort study over 5 days in 2022 aiming to recruit all UK patients aged >\/=60 yr undergoing surgery (excluding minor procedures). Data included patient characteristics, clinical variables, Clinical Frailty Scale (CFS), multimorbidity (two or more comorbidities), length of stay (LOS), postoperative delirium, morbidity, and mortality. Quantile regression and mixed effects logistic regression were used to analyse relationships. RESULTS: We recruited 7129 patients from 214 hospitals. Increasing frailty was associated with longer LOS, higher odds of delirium, morbidity, and mortality >\/=1 yr, with a clear increase noted from CFS of 4 (19.0% of cohort). Amongst those without multimorbidity, individuals with CFS score of 4 had longer admissions than non-frail individuals (median LOS 0.75 days longer, 95% confidence interval [CI] 0.34-1.16), increasing to 2.69 days longer for CFS 5 (95% CI 0.76-4.62). Multimorbidity increased the odds of postoperative morbidity by 46% (adjusted odds ratio 1.46, 95% CI 1.24-1.73), but there was no evidence for multimorbidity impacting LOS, delirium, or mortality. CONCLUSIONS: SNAP-3 highlights the impact of frailty on postoperative outcomes. Multimorbidity had less impact, with an effect on postoperative morbidity the only one to have strong statistical evidence. The impact of these conditions must be discussed with older patients considering surgical intervention.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40425395\/"},{"pmid":40425394,"journal":"British journal of anaesthesia","title":"Directed acyclic graphs to minimise bias and optimise causal inference in SNAP-3: an observational cohort study of frailty, multimorbidity, and delirium in older surgical patients.","authors":"Swarbrick CJ; Blake HA; Martin P; Partridge JSL; Moppett IK","abstract":"BACKGROUND: The 3rd Sprint National Anaesthesia Project (SNAP-3) aims to describe the impact of frailty, multimorbidity, and delirium, and their management, on outcomes after surgery within the older surgical population. Causal diagrams, such as directed acyclic graphs (DAGs), are a useful tool for visually representing relationships between variables and for clarifying the causal assumptions underlying a chosen statistical model. METHODS: A description of how the SNAP-3 cohort study's DAGs were developed is provided. DAGs have been created for the exposure-outcome relationships between frailty, multimorbidity, and delirium (as an exposure) with postoperative outcomes (length of hospital stay, delirium, morbidity, mortality). DAGs were created following the approach of 'Evidence synthesis for constructing directed acyclic graphs', and revised after independent clinical expert input. RESULTS: DAGs provide visual representations of assumptions made, and provide an objective approach to appropriate statistical adjustments. Key nodes within all the DAGs included age, dementia, genetic predisposition, hearing and visual impairment, length of stay, malignancy, operative severity, polypharmacy, postoperative perioperative medicine service, preoperative clinic review, sex, social deprivation, urgency, with delirium, frailty, multimorbidity, interaction, morbidity acting as exposures, or outcomes in certain DAGs. CONCLUSIONS: DAGs provide a transparent framework for statistical decision-making in observational research. We provide an overview of DAGs using the SNAP-3 DAGs as examples to explain fundamental concepts for developing and using causal diagrams. This overview acknowledges the complexities of exploring clinical relationships and the assumptions that are necessary, providing an opportunity for critique of the relationships described and refinements for future studies.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40425394\/"},{"pmid":40424777,"journal":"Journal of clinical anesthesia","title":"Impact of daily, weekly, and seasonal surgical timing on postoperative outcomes in high-risk patients undergoing elective non-cardiac surgery: A retrospective, single-center study.","authors":"Sim JH; Park YS; Park B; Choi Y; Lim JS; Ha S; Kim JU","abstract":"BACKGROUND: Limited knowledge exists on the impact of surgical start timing on outcomes in high-risk patients. This study assessed its association with mortality, morbidity, and healthcare resource utilization in elective non-cardiac surgery. METHODS: A retrospective cohort study was conducted at a tertiary medical center, including 14,394 high-risk patients (ASA >\/= 3) undergoing elective non-cardiac surgery from 2012 to 2021. Patients were grouped by surgical start time into detailed time intervals (8:00-11:00 a.m., 11:00 a.m.-1:00 p.m., 1:00-3:00 p.m., 3:00-6:00 p.m.) and broader periods (morning vs. afternoon). Weekly (Monday-Wednesday vs. Thursday-Friday) and seasonal (spring, summer, fall, winter) variations were analyzed. Cox and logistic regression models assessed mortality, complications, and healthcare utilization. RESULTS: Afternoon surgeries were associated with higher mortality at 90 days (adjusted hazard ratio [aHR]: 1.28, 95 % confidence interval [CI]: 1.05-1.57, P = 0.016), 180 days (aHR: 1.30, 95 % CI: 1.12-1.51, P < 0.001), and 1 year (aHR: 1.26, 95 % CI: 1.13-1.40, P < 0.001), as well as overall mortality (aHR: 1.16, 95 % CI: 1.09-1.23, P < 0.001). Afternoon surgeries were also linked to higher composite complications (adjusted odds ratio [aOR]: 1.21, 95 % CI: 1.11-1.33, P < 0.001) along with higher intensive care unit admission (aOR: 1.40, 95 % CI: 1.28-1.52, P < 0.001) and red blood cell transfusion (aOR: 1.40, 95 % CI: 1.22-1.61, P < 0.001). Surgeries starting between 3:00 and 6:00 p.m. had the highest risk of 1-year mortality (aHR: 1.33, 95 % CI: 1.15-1.54, P < 0.001) and composite complications (aOR: 1.32, 95 % CI: 1.17-1.50, P < 0.001). Seasonal analysis showed higher 30-day (aHR: 1.80, 95 % CI: 1.08-2.99, P = 0.023) and 90-day mortality (aHR: 1.32, 95 % CI: 1.00-1.74, P = 0.048) in summer, and higher overall mortality (aHR: 1.10, 95 % CI: 1.01-1.19, P = 0.030) in winter. Subgroup analyses revealed variability by surgical type. CONCLUSIONS: Surgical start timing was significantly associated with postoperative outcomes in high-risk patients, underscoring the need for strategic scheduling.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40424777\/"},{"pmid":40414168,"journal":"Journal of clinical anesthesia","title":"Management of SGLT2i-associated perioperative ketoacidosis (SAPKA) \/ Euglycemic Diabetic Ketoacidosis (EDKA).","authors":"Wen LY","abstract":"This infographic reviews the risk of perioperative euglycemic diabetic ketoacidosis (EKDA) associated with sodium-glucose co-transporter 2 inhibitor (SGLT2i), which is more specifically called SGLT2i-associated perioperative ketoacidosis (SAPKA)(1). The incidence of SAPKA\/perioperative EDKA is estimated to be 0.17 % for nonemergent procedures and 1.1 % for emergent procedures(2). The goal is to guide both anesthesia and surgery teams regarding the perioperative management of SGLT2i's to mitigate the risk of SAPKA\/EDKA.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40414168\/"},{"pmid":40410101,"journal":"British journal of anaesthesia","title":"Impact of liberal preoperative clear fluid fasting regimens on the risk of pulmonary aspiration in children (EUROFAST): an international prospective cohort study.","authors":"Frykholm P; Modiri AR; Klaucane A; Beck CE; Bouvet L; Isserman RS; Oshan V; Stricker PA; Quintao VC; Frithiof R","abstract":"BACKGROUND: Preoperative fasting regimens designed to minimise the risk of pulmonary aspiration have undergone significant changes, but unequivocal evidence of the safety of reducing clear fluid fasting has been lacking. We compared the risk of pulmonary aspiration in children using three different recommendations for clear fluid fasting. METHODS: In this prospective multicentre cohort study, centres with >1000 paediatric anaesthesia cases per year were eligible. Regurgitation events, whether they were transient or led to consequences affecting postoperative care, were reported in detail. All centres also reported the number of anaesthetised children per year and which preoperative fasting regimen they used. RESULTS: The 31 participating centres contributed a total of 306 900 anaesthetic procedures. The incidence of confirmed pulmonary aspiration was 1.18:10 000 in the sip-til-send group, 0.96:10 000 in the >\/=1 h group, and 1.83:10 000 in the control group. There was no mortality as a result of aspiration. The 95% confidence intervals of the differences in confirmed pulmonary aspiration between the control group and the >\/=1 h clear fluid fasting and the sip-til-send group were -0.344 to 3.76 and -1.48 to 3.63, respectively. Both sip-til-send and >\/=1 h clear fluid fasting were statistically noninferior to >\/=2 h clear fluid fasting regarding the incidence of confirmed aspiration, transient regurgitation, and regurgitation leading to escalation of care or intensive care. CONCLUSIONS: The study provides evidence for the safety of reducing preoperative fasting time for clear fluids in children aged <16 yr from 2 h to <\/=1 h.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40410101\/"},{"pmid":40410100,"journal":"British journal of anaesthesia","title":"Frailty and intraoperative hypotension: is the risk significant and modifiable?","authors":"Schnetz M; Zakaria L; Ahuja S; Khanna AK","abstract":"Patient frailty and intraoperative hypotension are both independent predictors of poor postoperative outcomes. A recent paper by Daum and colleagues demonstrates that these factors work in concert to increase patient risk as frail patients are more likely to experience frequent hypotension during surgery. Frailty and hypotension are appealing as modifiable risk factors amendable to interventions already available in practice, including risk screening and stratification, prehabilitation, and continuous haemodynamic monitoring. Future studies are needed to define interventions that benefit patients most according to their frailty at the time of surgery.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40410100\/"},{"pmid":40393818,"journal":"British journal of anaesthesia","title":"No effect of tetracosactide for treatment of postdural puncture headaches in parturient women: a double-blind randomised controlled clinical trial.","authors":"Dziadzko M; Bouvet L; Steer N; Depaulis C; Pradat P; Joubert F; Lalande L; Chassard D; Aubrun F","abstract":"BACKGROUND: Postdural puncture headache (PDPH) is a common complication of neuraxial anaesthesia in obstetrics. Although epidural blood patch (EBP) remains the most effective treatment, less invasive alternatives are being explored. We assessed the efficacy and safety of tetracosactide, a synthetic adrenocorticotropic hormone analogue, for treating established PDPH in postpartum patients. METHODS: A randomised, double-blind, placebo-controlled trial was conducted in two tertiary care maternal hospitals. Postpartum patients with PDPH after neuraxial anaesthesia were randomised to receive either tetracosactide 1 mg i.v. or placebo. The primary outcome was the rate of EBP within the 15-day follow-up. Secondary outcomes included headache duration and intensity, activity limitation, length of hospital stay, and the number of EBPs performed per patient. Interim analysis to determine futility and trial termination was planned at 50% enrolment. RESULTS: At interim analysis with 44 patients enrolled (23 in the treatment group and 21 in the placebo group) no significant difference was found for the primary outcome: 21 (91%) patients in the treatment group and 18 (86%) patients in the placebo group received EBP (P=0.6575). Secondary outcomes were comparable between groups, except for a 1-day longer hospital stay in the treatment group (P=0.0486). The study was terminated because of futility. No side-effects of tetracosactide administration were observed. CONCLUSIONS: A single dose of tetracosactide did not demonstrate efficacy in preventing EBP needs in postpartum PDPH, and there was no effect on the intensity, duration of headaches, and physical activity limitations. Given these findings, adrenocorticotropic hormone analogues should not be considered for this indication. CLINICAL TRIAL REGISTRATION: European Union Clinical Trials Register (2015-003357-17); ClinicalTrials.gov (NCT02813655); French Agence Nationale de Securite du Medicament et des Produits de Sante (160214A-31).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40393818\/"},{"pmid":40389332,"journal":"British journal of anaesthesia","title":"A survey of perioperative medicine services with a focus on provision for older surgical patients in the UK and Republic of Ireland: SNAP-3.","authors":"Swarbrick CJ; Donnelly A; Williams K; Haren A; Evans B; Poulton T; Shah A; Partridge JSL; Moppett IK","abstract":"BACKGROUND: Perioperative medicine aims to improve care for high-risk patients, and is endorsed by national guidelines in the UK and Republic of Ireland (ROI). However, comprehensive perioperative medicine services are not yet uniformly available. This survey addressed the current state of perioperative medicine services for older surgical patients in the UK and ROI and how these services align with current national guidance. METHODS: A survey was distributed electronically to all publicly administered UK and ROI hospitals performing surgical procedures. The survey examined perioperative care against national recommendations regarding service organisation and conduct. RESULTS: Of 339 eligible hospitals, 54.9% (186\/339) responded. A hospital frailty lead was appointed in 54% (101\/186) of hospitals, and 9% (16\/186) had a designated anaesthetist for cognitive impairment. Hospital anaesthetic services outside the theatre were focused on preoperative assessment clinics (146\/172), with few reporting routine postoperative involvement (17\/166). Nurse-led preoperative assessments of frailty, cognition, and delirium risk were conducted in 49.5% (90\/182), 44.3% (78\/176), and 13.7% (24\/175) of hospitals, respectively. The Clinical Frailty Scale was used in 87.0% (147\/169) of hospitals for frailty screening. The 4 'A's Test (45.7% [85\/186]) and Abbreviated Mental Test (43.0% [80\/186]) were the preferred cognitive assessment tools. CONCLUSIONS: The survey highlights the variation in perioperative medicine services that exist for older surgical patients despite national guidelines advocating their widespread implementation. Opportunity exists to develop interspecialty perioperative services further and promote identification of frailty, cognitive impairment, and delirium, all of which negatively impact postoperative outcomes for older surgical patients.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40389332\/"},{"pmid":40379536,"journal":"British journal of anaesthesia","title":"Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement.","authors":"Oprea AD; Ostapenko LJ; Sweitzer B; Selzer A; Irizarry-Alvarado JM; Hurtado Andrade MD; Mendez CE; Kelley KD; Stewart E; Fernandez Robles CR; Chadha RM; Camilleri M; Mathur R; Umpierrez GE; Hepner DL","abstract":"The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate. While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication management and preoperative fasting protocols for these patients. This document represents a multidisciplinary consensus statement led by the Society for Perioperative Assessment and Quality Improvement (SPAQI). It provides updated recommendations based on a modified Delphi process and supported by a systematic review of the current literature. The recommendations address management of the glucagon-like peptide 1 receptor agonists perioperatively, and preoperative fasting times for both solids and liquids. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42023438624).","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40379536\/"},{"pmid":40374400,"journal":"British journal of anaesthesia","title":"Multimodal prehabilitation before lung resection surgery: a multicentre randomised controlled trial.","authors":"Brat K; Sova M; Homolka P; Plutinsky M; Genzor S; Pokorna A; Dosbaba F; Imrichova B; Chovanec Z; Mitas L; Mikulaskova M; Svoboda M; Olson L; Cundrle I","abstract":"BACKGROUND: Respiratory muscle training may improve ventilatory efficiency (V(E)\/VCO(2) slope), a strong predictor of postoperative pulmonary complications. We hypothesised that multimodal prehabilitation, incorporating high-intensity respiratory muscle training, before lung resection would reduce postoperative complications and length of hospital stay. METHODS: We conducted a prospective multicentre, randomised controlled trial (NCT04826575) to examine the effect of prehabilitation in individuals undergoing lung resection. Participants were defined as high-risk for postoperative pulmonary complications if they achieved V(E)\/VCO(2) slope >\/=33, as determined by cardiopulmonary exercise testing. Participants were then randomised to either usual care or multimodal prehabilitation, which consisted of a 14-day programme of high-intensity respiratory muscle training, smoking cessation, nutritional support, and psychological support. The primary outcome were postoperative pulmonary and cardiovascular complications (pneumonia, atelectasis, respiratory failure necessitating mechanical ventilation, adult respiratory distress syndrome, prolonged air leak). RESULTS: A total of 122 patients (46% female; age range: 64-75 yr) completed the study. Postoperative pulmonary complications occurred in 20\/58 (34%) of patients randomised to multimodal prehabilitation, compared with 35\/64 (55%) patients receiving usual care (odds ratio 2.29 [95% confidence interval 1.10-4.77]; P=0.029). Hospital length of stay was shorter after multimodal rehabilitation compared with patients randomised to receive usual care (from 9 [7-11] days to 7 [6-9] days; P=0.038). After prehabilitation, mean (sd) V(E)\/VCO(2) slope decreased from 39 (8) to 36 (9); P=0.01. Prehabilitation also improved patient-reported quality of life measures. CONCLUSIONS: In high-risk patients undergoing elective lung resection surgery, multimodal prehabilitation, including high-intensity respiratory muscle training to target V(E)\/VCO(2), reduced postoperative pulmonary complications and hospital length of stay.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40374400\/"},{"pmid":40368685,"journal":"British journal of anaesthesia","title":"Interleukin-1 receptor antagonist polymorphisms in women receiving epidural analgesia who develop maternal intrapartum fever: a prospective, multicentre Mendelian randomised study.","authors":null,"abstract":"BACKGROUND: Genetically predicted higher levels of the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL1-Ra) might reduce the risk of developing epidural-related maternal fever, a phenomenon that occurs exclusively in women having epidural analgesia in labour. We hypothesised that in women having epidural analgesia, the absence of specific alleles that lower circulating levels of IL1-Ra would be associated with the development of epidural-related maternal fever, administration of intrapartum antibiotics, or both. METHODS: We prospectively enrolled women >\/=18 yr of age receiving epidural analgesia during labour, excluding those with pre-existing fever, antibiotic therapy, or immunodeficiency. Allele scores were constructed from genotyping the C-allele frequency at variants rs6743376 and rs1542176; more copies of each allele independently raise IL-1Ra. The composite primary outcome was maternal intrapartum fever (>38 degrees C) or administration of intrapartum antibiotics after epidural placement. The exposure of interest was the IL1-Ra allele score, comparing 0 (lowest genetically predicted IL-1Ra levels) with >\/=1 allele scores. Maternal fever and antibiotic administration were compared in women with 0 or >\/=1 allele scores. RESULTS: Of 624 women genotyped, 155 (24.8%) developed maternal fever or received antibiotics. Fever or antibiotic administration occurred in 19\/74 (25.7%) labouring women with an IL-1Ra allele score of 0, compared with 136\/550 (24.7%) women with IL-1Ra allele scores >\/=1 (odds ratio 1.05, 95% confidence interval 0.60-1.83; P=0.89). CONCLUSIONS: In women who receive epidural analgesia during labour, genetically predicted (higher) interleukin-1 receptor antagonist levels do not alter the incidence of maternal intrapartum fever or use of intrapartum antibiotics. CLINICAL TRIAL REGISTRATION: ISRCTN99641204.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40368685\/"},{"pmid":40364780,"journal":"European journal of anaesthesiology","title":"Repeat-dose dexamethasone to prevent pain relapse after total knee arthroplasty in high-pain-response patients: A randomised, double-blind, placebo-controlled superiority trial.","authors":"Springborg AH; Varnum C; Nielsen NI; Rasmussen LE; Kjaersgaard-Andersen P; Pleckaitiene L; Gromov K; Troelsen A; Kehlet H; Foss NB","abstract":"BACKGROUND: Peri-operative glucocorticoids reduce pain after total knee arthroplasty, with evidence suggesting potential benefits of increased dosing in specific patient groups. However, the impact of repeat-dose glucocorticoids has not been studied in high-pain-response patients receiving pre-operative high-dose glucocorticoids. OBJECTIVE: To investigate the effect on pain of an oral dose of dexamethasone after total knee arthroplasty in selected high-pain-response patients who had received a pre-operative high dose of intravenous dexamethasone (1 mg kg -1 ). DESIGN: Randomised, double-blind, placebo-controlled superiority study. SETTING: A multicentre study conducted at two major arthroplasty centres in Denmark from November 2021 to March 2024. PATIENTS: One hundred and ten patients undergoing total knee arthroplasty who had received multimodal analgesia including pre-operative intravenous dexamethasone 1 mg kg -1 . Selection criteria included a Pain Catastrophising Scale score greater than 20 and moderate-to-severe pain (VAS >30) during walking 24 h postoperatively. INTERVENTION: Patients were randomised to either oral dexamethasone 24 mg or placebo on postoperative day 1. MAIN OUTCOME MEASURES: The primary outcome was the proportion of patients experiencing moderate-to-severe pain during walking at 48 h postoperatively. Secondary outcomes included pain scores at various time points within 1 week postoperatively, rescue analgesics, quality of sleep, length of hospital stay and morbidity with follow-up at 30 days. RESULTS: At 48 h postoperatively, 65% of patients in the dexamethasone group and 79% in the placebo group reported moderate-to-severe pain during walking: odds ratio 0.48 [95% confidence interval (CI), 0.20 to 1.16]; P  = 0.100. The mean +\/- SD Visual Analogue Scale (VAS) at 48 h during walking was 43 +\/- 21 in the dexamethasone group and 51 +\/- 22 in the placebo group ( P  = 0.051). There were no differences between the groups regarding secondary pain outcomes or the use of rescue analgesics. CONCLUSION: The administration of a high oral dose of dexamethasone following an initial pre-operative dose of 1 mg kg -1 intravenously in selected high-pain-response patients had no effect on postoperative pain following total knee arthroplasty. TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT05563155.","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40364780\/"}]